[
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
    "url_hash": "2202f25bfefb6886dcf7458428a3c263",
    "title": "Listing of Impairments - Adult Listings (Part A) | Disability | SSA",
    "text_content": "Listing of Impairments - Adult Listings (Part A) | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Listing of Impairments - Adult Listings (Part A) Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security Listing of Impairments -  Adult Listings (Part A) The following sections contain medical criteria that apply to the  evaluation of impairments in adults age 18 and over and that may apply to the  evaluation of impairments in children under age 18 if the disease processes  have a similar effect on adults and younger children. 1.00 Musculoskeletal Disorders 2.00 Special Senses and\n                                  Speech 3.00 Respiratory Disorders 4.00 Cardiovascular System 5.00 Digestive Disorders 6.00 Genitourinary Disorders 7.00 Hematological Disorders 8.00 Skin Disorders 9.00 Endocrine Disorders 10.00 Congenital Disorders that Affect Multiple Body Systems 11.00 Neurological Disorders 12.00 Mental Disorders 13.00 Cancer\n\n                                  (Malignant Neoplastic Diseases) 14.00 Immune System Disorders",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social SecurityListing of Impairments -  Adult Listings (Part A)"
      }
    ],
    "tables": [
      [
        [
          ""
        ],
        [
          "1.00Musculoskeletal Disorders",
          "2.00Special Senses and\n                                  Speech",
          "3.00Respiratory Disorders"
        ],
        [
          "4.00Cardiovascular System",
          "5.00Digestive Disorders",
          "6.00Genitourinary Disorders"
        ],
        [
          "7.00Hematological Disorders",
          "8.00Skin Disorders",
          "9.00Endocrine Disorders"
        ],
        [
          "10.00Congenital Disorders that Affect Multiple Body Systems",
          "11.00Neurological Disorders",
          "12.00Mental Disorders"
        ],
        [
          "13.00Cancer\n\n                                  (Malignant Neoplastic Diseases)",
          "14.00Immune System Disorders",
          ""
        ]
      ]
    ],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/1.00-Musculoskeletal-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/2.00-SpecialSensesandSpeech-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/5.00-Digestive-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/6.00-Genitourinary-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/7.00-HematologicalDisorders-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/8.00-Skin-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/9.00-Endocrine-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/10.00-MultipleBody-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/11.00-Neurological-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/12.00-MentalDisorders-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/14.00-Immune-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm"
    ],
    "html_file": "ssa_bluebook_data/html/2202f25bfefb6886dcf7458428a3c263.html",
    "fetched_at": 1762482605.0815651
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/index.htm",
    "url_hash": "907292134b8780149b8396d47af0f6a6",
    "title": "Medical/Professional Relations | Disability | SSA",
    "text_content": "Medical/Professional Relations | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Retirement Disability Who can get Disability What you could get from Disability Try returning to work without losing Disability What you must report while on Disability Get Disability back if your benefit ended Survivor Supplemental Security Income (SSI) Consultative Examination (CE) Guide (also known as the \"Green Book\") This Consultative Examination (CE) guide has been developed to give physicians and other health professionals basic information about the CE process. Explore the Consultative Examination (CE) Guide Disability Evaluation Under Social Security (also known as the \"Blue Book\") Disability Evaluation Under Social Security has been specially prepared to provide physicians and other health professionals with an understanding of the disability programs administered by the Social Security Administration. Explore Disability Evaluation Under Social Security Professional/Medical Relations Officers Professional Relations Officers are available in each State, or other location, for you to contact about Social Security disability programs. Find a Professional Relations Officer in your Area Disability Related Publications For Health & School Professionals Publications written for persons in the health care or school field who may be involved in the Social Security disability determination process. View the List of Publications",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": ""
      },
      {
        "level": 2,
        "text": "Consultative Examination (CE) Guide (also known as the \"Green Book\")"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security (also known as the \"Blue Book\")"
      },
      {
        "level": 2,
        "text": "Professional/Medical Relations Officers"
      },
      {
        "level": 2,
        "text": "Disability Related Publications For Health & School Professionals"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/index.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/retirement",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/eligibility",
      "https://www.ssa.gov/disability/amount",
      "https://www.ssa.gov/disability/work",
      "https://www.ssa.gov/disability/reporting",
      "https://www.ssa.gov/disability/restart",
      "https://www.ssa.gov/benefits/survivors/",
      "https://www.ssa.gov/ssi",
      "https://www.ssa.gov/disability/professionals/greenbook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/procontacts.htm",
      "https://www.ssa.gov/disability/professionals/publications.htm",
      "https://www.ssa.gov/disability/professionals/index.htm"
    ],
    "html_file": "ssa_bluebook_data/html/907292134b8780149b8396d47af0f6a6.html",
    "fetched_at": 1762482609.455653
  },
  {
    "url": "https://www.ssa.gov/disability/eligibility",
    "url_hash": "6d4a155bce3b6d1004b780d5515a4f0a",
    "title": "Who can get Disability | SSA",
    "text_content": "Who can get Disability | SSA Skip to main content An official website of the United States government Here's how you know Here's how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. Social Security and SSI Payments will Continue during the Government Shutdown. Visit my Social Security for Online Services. Get a benefit verification letter. Social Security English Español Account Sign in Account Menu Menu Benefits Medicare Card & record Benefits By Phase Prepare Apply Manage benefits By Type Retirement Disability Survivor Family Supplemental Security Income (SSI) Benefits overview Medicare Plan for Medicare Sign up for Medicare Request to lower IRMAA Apply for Part D Extra Help Manage Medicare benefits Card & record Number & card Personal record Search English Español Sign in My account Account home Sign out Breadcrumb Home Disability Who can get Disability Retirement Disability Who can get Disability What you could get from Disability Try returning to work without losing Disability What you must report while on Disability Get Disability back if your benefit ended Survivor Family Supplemental Security Income (SSI) Who can get Disability You may be eligible for Disability if you have: A disability or blindness, and Enough work history. Learn how to apply 1. You have a disability or blindness You must have a disability that affects your ability to work for a year or more, or will result in death. If you continue to work, your condition must also limit you from earning income above an amount we call “substantial gainful activity” (SGA). In 2025, SGA is $1,620 per month, or $2,700 if you’re considered blind under our rules . We use different rules to determine SGA if you're self-employed . 2. You have enough work history Generally, you must have worked for at least 5 of the last 10 years to qualify for Disability. People under the age of 24 may not need to have worked as long. Sign in and look under “More Benefits” to see if you’ve worked long enough to qualify. Extra benefits for family members If you’re the spouse, ex-spouse, or child of someone getting Disability, you may qualify for Family Benefits. Learn more about Family Benefits Return to top Support Contact us Find an office Forms Publications Report fraud Languages Español Other languages Plain language Services for Employers & businesses Representatives Government agencies Other groups About About Social Security Communications Careers Initiatives Research & policy Financial reports SSA.gov An official website of the Social Security Administration. Secondary Footer Accessibility support Privacy policy FOIA requests Civil Rights/Compliance Office of the Inspector General Office of the Chief Actuary Performance reports Looking for U.S. government information and services? Visit USA.gov",
    "headings": [
      {
        "level": 1,
        "text": "Who can get Disability"
      },
      {
        "level": 2,
        "text": "Breadcrumb"
      },
      {
        "level": 2,
        "text": ""
      },
      {
        "level": 2,
        "text": "Secondary Footer"
      },
      {
        "level": 3,
        "text": ""
      },
      {
        "level": 3,
        "text": ""
      },
      {
        "level": 3,
        "text": "1. You have a disability or blindness"
      },
      {
        "level": 3,
        "text": "2. You have enough work history"
      },
      {
        "level": 3,
        "text": "Extra benefits for family members"
      },
      {
        "level": 3,
        "text": ""
      },
      {
        "level": 4,
        "text": "Support"
      },
      {
        "level": 4,
        "text": "Languages"
      },
      {
        "level": 4,
        "text": "Services for"
      },
      {
        "level": 4,
        "text": "About"
      },
      {
        "level": 5,
        "text": "By Phase"
      },
      {
        "level": 5,
        "text": "By Type"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/eligibility#main-content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov/",
      "https://www.ssa.gov/disability/eligibility",
      "https://www.ssa.gov/es/disability/eligibility",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/SiView.action",
      "https://secure.ssa.gov/myssa/myhub",
      "https://www.ssa.gov/menu",
      "https://www.ssa.gov/menu#benefits",
      "https://www.ssa.gov/menu#medicare",
      "https://www.ssa.gov/menu#card-record",
      "https://www.ssa.gov/prepare",
      "https://www.ssa.gov/apply",
      "https://www.ssa.gov/manage-benefits",
      "https://www.ssa.gov/retirement",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/survivor",
      "https://www.ssa.gov/family",
      "https://www.ssa.gov/ssi",
      "https://www.ssa.gov/benefits",
      "https://www.ssa.gov/medicare",
      "https://www.ssa.gov/medicare/sign-up",
      "https://www.ssa.gov/medicare/lower-irmaa",
      "https://www.ssa.gov/medicare/part-d-extra-help",
      "https://www.ssa.gov/medicare/manage",
      "https://www.ssa.gov/number-card",
      "https://www.ssa.gov/personal-record",
      "https://www.ssa.gov/disability/eligibility",
      "https://www.ssa.gov/es/disability/eligibility",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/SiView.action",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/logout",
      "https://www.ssa.gov/",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/retirement",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/eligibility",
      "https://www.ssa.gov/disability/amount",
      "https://www.ssa.gov/disability/work",
      "https://www.ssa.gov/disability/reporting",
      "https://www.ssa.gov/disability/restart",
      "https://www.ssa.gov/survivor",
      "https://www.ssa.gov/family",
      "https://www.ssa.gov/ssi",
      "https://www.ssa.gov/apply?benefits=disability&age=adult",
      "https://www.ssa.gov/ssi/text-eligibility-ussi.htm#blind",
      "https://www.ssa.gov/redbook/eng/definedisability.htm?tl=3",
      "https://secure.ssa.gov/RIL/SiView.action",
      "https://www.ssa.gov/benefits/disability/family.html",
      "https://www.ssa.gov/disability/eligibility",
      "https://www.ssa.gov/agency/contact/",
      "https://www.ssa.gov/locator/",
      "https://www.ssa.gov/forms/",
      "https://www.ssa.gov/pubs/",
      "https://secure.ssa.gov/oig/fraud/",
      "https://www.ssa.gov/es",
      "https://www.ssa.gov/site/languages/en/",
      "https://www.ssa.gov/agency/plain-language",
      "https://www.ssa.gov/employer/",
      "https://www.ssa.gov/about-ssa/agency-resources#representatives",
      "https://www.ssa.gov/about-ssa/agency-resources#government-agencies",
      "https://www.ssa.gov/about-ssa/agency-resources#other-groups",
      "https://www.ssa.gov/about-ssa",
      "https://www.ssa.gov/about-ssa/agency-resources#communications",
      "https://www.ssa.gov/careers/",
      "https://www.ssa.gov/about-ssa/agency-resources#initiatives",
      "https://www.ssa.gov/about-ssa/agency-resources#research-policy",
      "https://www.ssa.gov/finance/",
      "https://ssa.gov",
      "https://www.facebook.com/socialsecurity",
      "https://x.com/socialsecurity",
      "https://www.youtube.com/user/socialsecurityonline",
      "https://www.instagram.com/socialsecurity",
      "https://www.linkedin.com/company/ssa",
      "https://www.ssa.gov/accessibility/",
      "https://www.ssa.gov/agency/privacy.html",
      "https://www.ssa.gov/foia/",
      "https://www.ssa.gov/eeo",
      "https://oig.ssa.gov/",
      "https://www.ssa.gov/OACT/",
      "https://ssa.gov/agency/performance/",
      "https://usa.gov"
    ],
    "html_file": "ssa_bluebook_data/html/6d4a155bce3b6d1004b780d5515a4f0a.html",
    "fetched_at": 1762482613.8611224
  },
  {
    "url": "https://www.ssa.gov/es/disability/eligibility",
    "url_hash": "5f74fb90a5c6beecc3edcb584206c251",
    "title": "Quién puede recibir Incapacidad | SSA",
    "text_content": "Quién puede recibir Incapacidad | SSA Saltar al contenido principal Un sitio oficial del Gobierno de Estados Unidos Así es como usted puede verificarlo Así es como usted puede verificarlo Los sitios de internet oficiales usan .gov Un sitio de internet de .gov pertenece a una organización gubernamental oficial en los EE. UU. Los sitios de internet de .gov que son seguros usan HTTPS Un lock ( Lock A locked padlock ) o https:// significa que se conectó de manera segura al sitio de internet de .gov. Comparta información confidencial solo en sitios de internet oficiales y seguros. Obtener una carta de verificación de beneficios. Seguro Social English Español Cuenta Ingresar Cuenta Menú Menú Beneficios Medicare Tarjeta y registro Beneficios POR FASE Cómo prepararse Cómo solicitar Cómo administrar los beneficios POR TIPO Jubilación Incapacidad Sobreviviente Familia Seguridad de Ingreso Suplementario (SSI) Descripción general de los beneficios Medicare Planifique para Medicare Inscríbase en Medicare Solicite disminuir su IRMAA Solicite el programa de Ayuda Adicional de Medicare Parte D Administre sus beneficios de Medicare Tarjeta y registro Número y tarjeta Registro personal Buscar English Español Ingresar Mi cuenta Página de inicio de la cuenta (en inglés) Cerrar sesión Árbol de navegación Inicio Incapacidad Quién puede recibir Incapacidad Jubilación Incapacidad Quién puede recibir Incapacidad Lo que podría obtener de la Incapacidad Trate de regresar al trabajo sin perder la Incapacidad Lo que debe informarnos mientras que está en Incapacidad Recupere Incapacidad si su beneficio terminó Sobreviviente Familia Seguridad de Ingreso Suplementario (SSI) Quién puede recibir Incapacidad Usted puede tener derecho a la Incapacidad si tiene: Una incapacidad o ceguera, y Suficiente historial de trabajo. Aprenda cómo solicitar 1. Usted tiene una incapacidad o ceguera Debe tener una incapacidad que afecte su capacidad para trabajar durante un año o más, o que resulte en la muerte. Si continúa trabajando, su padecimiento también debe limitarle la posibilidad de obtener ingresos superiores a una cantidad que llamamos “trabajo sustancial y lucrativo” (SGA). En 2025, el SGA es de $1,620 al mes, o $2,700 si se le considera ciego según nuestras reglas (en inglés). Usamos reglas diferentes para determinar el SGA si trabaja por cuenta propia (en inglés). 2. Tiene suficiente historial de trabajo Por lo general, debe haber trabajado durante al menos 5 de los últimos 10 años para calificar para Incapacidad. Es posible que las personas menores de 24 años no necesiten haber trabajado tanto tiempo. Ingrese (en inglés) y busque bajo “Más beneficios” (“More Benefits” en inglés) para ver si ha trabajado lo suficiente para calificar. Beneficios extras para familiares Si usted es cónyuge, excónyuge o hijo de alguien que recibe Incapacidad, puede calificar para Beneficios Familiares. Aprenda más sobre Beneficios Familiares Volver a la parte superior Apoyo Comuníquese Encontrar una oficina (en inglés) Formularios (en inglés) Publicaciones Informe fraude (en inglés) Idiomas English Otros idiomas Lenguaje sencillo (en inglés) Servicios para Empleadores y empresas Representantes Agencias federales Otros grupos Sobre Acerca del Seguro Social Comunicaciones Carreras (en inglés) Iniciativas Estudios y política Reportes financieros (en inglés) SeguroSocial.gov Un sitio de internet oficial de la Administración del Seguro Social. Pie de página secundario Informe de accesibilidad (en inglés) Política de confidencialidad FOIA (en inglés) Derechos Civiles/Cumplimiento (en inglés) Oficina del Inspector General Oficina del Actuario Principal (en inglés) Informes de rendimiento (en inglés) ¿Busca información y servicios del gobierno de los EE.UU.? Visite USA.gov/espanol",
    "headings": [
      {
        "level": 1,
        "text": "Quién puede recibir Incapacidad"
      },
      {
        "level": 2,
        "text": "Árbol de navegación"
      },
      {
        "level": 2,
        "text": ""
      },
      {
        "level": 2,
        "text": "Pie de página secundario"
      },
      {
        "level": 3,
        "text": ""
      },
      {
        "level": 3,
        "text": ""
      },
      {
        "level": 3,
        "text": "1. Usted tiene una incapacidad o ceguera"
      },
      {
        "level": 3,
        "text": "2. Tiene suficiente historial de trabajo"
      },
      {
        "level": 3,
        "text": "Beneficios extras para familiares"
      },
      {
        "level": 3,
        "text": ""
      },
      {
        "level": 4,
        "text": "Apoyo"
      },
      {
        "level": 4,
        "text": "Idiomas"
      },
      {
        "level": 4,
        "text": "Servicios para"
      },
      {
        "level": 4,
        "text": "Sobre"
      },
      {
        "level": 5,
        "text": "POR FASE"
      },
      {
        "level": 5,
        "text": "POR TIPO"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/es/disability/eligibility#main-content",
      "https://www.ssa.gov/es/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov/es",
      "https://www.ssa.gov/disability/eligibility",
      "https://www.ssa.gov/es/disability/eligibility",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/SiView.action",
      "https://secure.ssa.gov/myssa/myhub",
      "https://www.ssa.gov/es/menu",
      "https://www.ssa.gov/es/menu#beneficios",
      "https://www.ssa.gov/es/menu#medicare",
      "https://www.ssa.gov/es/menu#tarjeta-y-registro",
      "https://www.ssa.gov/es/prepare",
      "https://www.ssa.gov/es/apply",
      "https://www.ssa.gov/es/manage-benefits",
      "https://www.ssa.gov/es/retirement",
      "https://www.ssa.gov/es/disability",
      "https://www.ssa.gov/es/survivor",
      "https://www.ssa.gov/es/family",
      "https://www.ssa.gov/es/ssi",
      "https://www.ssa.gov/espanol/beneficios/",
      "https://www.ssa.gov/es/medicare",
      "https://www.ssa.gov/es/medicare/sign-up",
      "https://www.ssa.gov/es/medicare/lower-irmaa",
      "https://www.ssa.gov/es/medicare/part-d-extra-help",
      "https://www.ssa.gov/es/medicare/manage",
      "https://www.ssa.gov/es/number-card",
      "https://www.ssa.gov/es/personal-record",
      "https://www.ssa.gov/disability/eligibility",
      "https://www.ssa.gov/es/disability/eligibility",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/SiView.action",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/logout",
      "https://www.ssa.gov/es",
      "https://www.ssa.gov/es/disability",
      "https://www.ssa.gov/es/retirement",
      "https://www.ssa.gov/es/disability",
      "https://www.ssa.gov/es/disability/eligibility",
      "https://www.ssa.gov/es/disability/amount",
      "https://www.ssa.gov/es/disability/work",
      "https://www.ssa.gov/es/disability/reporting",
      "https://www.ssa.gov/es/disability/restart",
      "https://www.ssa.gov/es/survivor",
      "https://www.ssa.gov/es/family",
      "https://www.ssa.gov/es/ssi",
      "https://www.ssa.gov/es/apply?benefits=disability&age=adult",
      "https://www.ssa.gov/ssi/text-eligibility-ussi.htm#blind",
      "https://www.ssa.gov/redbook/eng/definedisability.htm?tl=3",
      "https://secure.ssa.gov/RIL/SiView.action",
      "https://wwwtest.ssa.gov/espanol/beneficios/incapacidad/familia.html",
      "https://www.ssa.gov/es/disability/eligibility",
      "https://www.ssa.gov/espanol/agencia/contacto/",
      "https://www.ssa.gov/locator/",
      "https://www.ssa.gov/forms/",
      "https://www.ssa.gov/espanol/publicaciones/",
      "https://secure.ssa.gov/oig/fraud/",
      "https://www.ssa.gov/",
      "https://www.ssa.gov/site/languages/es/",
      "https://www.ssa.gov/agency/plain-language",
      "https://www.ssa.gov/espanol/bso/bso-bienvenido.htm",
      "https://www.ssa.gov/es/about-ssa/agency-resources#representantes",
      "https://www.ssa.gov/es/about-ssa/agency-resources#agencias-federales",
      "https://www.ssa.gov/es/about-ssa/agency-resources#otros-grupos",
      "https://www.ssa.gov/es/about-ssa",
      "https://www.ssa.gov/es/about-ssa/agency-resources#comunicaciones",
      "https://www.ssa.gov/careers/",
      "https://www.ssa.gov/es/about-ssa/agency-resources#iniciativas",
      "https://www.ssa.gov/es/about-ssa/agency-resources#estudios-y-política",
      "https://www.ssa.gov/finance/",
      "https://segurosocial.gov",
      "https://www.facebook.com/segurosocial",
      "https://x.com/segurosocial",
      "https://www.ssa.gov/accessibility/",
      "https://www.ssa.gov/espanol/agencia/confidencialidad.html",
      "https://www.ssa.gov/foia/",
      "https://www.ssa.gov/eeo",
      "https://oig.ssa.gov/espanol/",
      "https://www.ssa.gov/OACT/",
      "https://ssa.gov/agency/performance/",
      "https://usa.gov/espanol"
    ],
    "html_file": "ssa_bluebook_data/html/5f74fb90a5c6beecc3edcb584206c251.html",
    "fetched_at": 1762482618.2514098
  },
  {
    "url": "https://www.ssa.gov/disability/amount",
    "url_hash": "4266f3a15a9c36908b7afda3ccc7c8fa",
    "title": "What you could get from Disability | SSA",
    "text_content": "What you could get from Disability | SSA Skip to main content An official website of the United States government Here's how you know Here's how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. Social Security and SSI Payments will Continue during the Government Shutdown. Visit my Social Security for Online Services. Get a benefit verification letter. Social Security English Español Account Sign in Account Menu Menu Benefits Medicare Card & record Benefits By Phase Prepare Apply Manage benefits By Type Retirement Disability Survivor Family Supplemental Security Income (SSI) Benefits overview Medicare Plan for Medicare Sign up for Medicare Request to lower IRMAA Apply for Part D Extra Help Manage Medicare benefits Card & record Number & card Personal record Search English Español Sign in My account Account home Sign out Breadcrumb Home Disability What you could get from Disability Retirement Disability Who can get Disability What you could get from Disability Try returning to work without losing Disability What you must report while on Disability Get Disability back if your benefit ended Survivor Family Supplemental Security Income (SSI) What you could get from Disability Disability benefits may include a monthly payment and Medicare health insurance. See your payment estimate See your payment estimate View your estimated monthly payment based on your work history. Disability benefits are under the “More Benefits” heading after you sign in. Sign in View Estimate Create account Medicare coverage We’ll automatically enroll you in Medicare 2 years after the date you became entitled to Disability. You’ll get a welcome package in the mail 3 months before your coverage starts. You can opt out of Part B (medical insurance) if you don’t want it. Learn more about getting started on Medicare.gov Special rules if you have ESRD or ALS If you have end-stage renal disease (ESRD), you can get Medicare: The month you begin at-home dialysis treatments. The month you get a kidney transplant. 3 months after you start outpatient dialysis treatments. If you have ALS (Lou Gehrig’s disease), you can get Medicare as soon as you become entitled to Disability. See if you can increase your payment amount with SSI Supplemental Security Income (SSI) provides monthly payments of up to $967 for people with limited income and resources. If you're eligible, you may be able to get Disability and SSI at the same time. If you choose not to apply for SSI when you file for Disability, you’ll get a letter from us saying, \"You're not eligible for SSI.\" This won't affect your Disability application. Find out if you might be eligible for SSI Learn how to apply Return to top Support Contact us Find an office Forms Publications Report fraud Languages Español Other languages Plain language Services for Employers & businesses Representatives Government agencies Other groups About About Social Security Communications Careers Initiatives Research & policy Financial reports SSA.gov An official website of the Social Security Administration. Secondary Footer Accessibility support Privacy policy FOIA requests Civil Rights/Compliance Office of the Inspector General Office of the Chief Actuary Performance reports Looking for U.S. government information and services? Visit USA.gov",
    "headings": [
      {
        "level": 1,
        "text": "What you could get from Disability"
      },
      {
        "level": 2,
        "text": "Breadcrumb"
      },
      {
        "level": 2,
        "text": "See your payment estimateSee your payment estimate"
      },
      {
        "level": 2,
        "text": ""
      },
      {
        "level": 2,
        "text": "Medicare coverage"
      },
      {
        "level": 2,
        "text": "Special rules if you have ESRD or ALS"
      },
      {
        "level": 2,
        "text": "See if you can increase your payment amount with SSI"
      },
      {
        "level": 2,
        "text": ""
      },
      {
        "level": 2,
        "text": "Secondary Footer"
      },
      {
        "level": 3,
        "text": ""
      },
      {
        "level": 4,
        "text": "Support"
      },
      {
        "level": 4,
        "text": "Languages"
      },
      {
        "level": 4,
        "text": "Services for"
      },
      {
        "level": 4,
        "text": "About"
      },
      {
        "level": 5,
        "text": "By Phase"
      },
      {
        "level": 5,
        "text": "By Type"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/amount#main-content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov/",
      "https://www.ssa.gov/disability/amount",
      "https://www.ssa.gov/es/disability/amount",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/SiView.action",
      "https://secure.ssa.gov/myssa/myhub",
      "https://www.ssa.gov/menu",
      "https://www.ssa.gov/menu#benefits",
      "https://www.ssa.gov/menu#medicare",
      "https://www.ssa.gov/menu#card-record",
      "https://www.ssa.gov/prepare",
      "https://www.ssa.gov/apply",
      "https://www.ssa.gov/manage-benefits",
      "https://www.ssa.gov/retirement",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/survivor",
      "https://www.ssa.gov/family",
      "https://www.ssa.gov/ssi",
      "https://www.ssa.gov/benefits",
      "https://www.ssa.gov/medicare",
      "https://www.ssa.gov/medicare/sign-up",
      "https://www.ssa.gov/medicare/lower-irmaa",
      "https://www.ssa.gov/medicare/part-d-extra-help",
      "https://www.ssa.gov/medicare/manage",
      "https://www.ssa.gov/number-card",
      "https://www.ssa.gov/personal-record",
      "https://www.ssa.gov/disability/amount",
      "https://www.ssa.gov/es/disability/amount",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/SiView.action",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/logout",
      "https://www.ssa.gov/",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/retirement",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/eligibility",
      "https://www.ssa.gov/disability/amount",
      "https://www.ssa.gov/disability/work",
      "https://www.ssa.gov/disability/reporting",
      "https://www.ssa.gov/disability/restart",
      "https://www.ssa.gov/survivor",
      "https://www.ssa.gov/family",
      "https://www.ssa.gov/ssi",
      "https://secure.ssa.gov/RIL/SiView.action",
      "https://secure.ssa.gov/RIL/SiView.action",
      "https://secure.ssa.gov/acu/FIS/ap?idp=logingov&app=rir&target=/myssa/myhub",
      "https://www.medicare.gov/basics/get-started-with-medicare/before-65",
      "https://www.ssa.gov/ssi/eligibility",
      "https://www.ssa.gov/apply?benefits=disability&age=adult",
      "https://www.ssa.gov/disability/amount",
      "https://www.ssa.gov/agency/contact/",
      "https://www.ssa.gov/locator/",
      "https://www.ssa.gov/forms/",
      "https://www.ssa.gov/pubs/",
      "https://secure.ssa.gov/oig/fraud/",
      "https://www.ssa.gov/es",
      "https://www.ssa.gov/site/languages/en/",
      "https://www.ssa.gov/agency/plain-language",
      "https://www.ssa.gov/employer/",
      "https://www.ssa.gov/about-ssa/agency-resources#representatives",
      "https://www.ssa.gov/about-ssa/agency-resources#government-agencies",
      "https://www.ssa.gov/about-ssa/agency-resources#other-groups",
      "https://www.ssa.gov/about-ssa",
      "https://www.ssa.gov/about-ssa/agency-resources#communications",
      "https://www.ssa.gov/careers/",
      "https://www.ssa.gov/about-ssa/agency-resources#initiatives",
      "https://www.ssa.gov/about-ssa/agency-resources#research-policy",
      "https://www.ssa.gov/finance/",
      "https://ssa.gov",
      "https://www.facebook.com/socialsecurity",
      "https://x.com/socialsecurity",
      "https://www.youtube.com/user/socialsecurityonline",
      "https://www.instagram.com/socialsecurity",
      "https://www.linkedin.com/company/ssa",
      "https://www.ssa.gov/accessibility/",
      "https://www.ssa.gov/agency/privacy.html",
      "https://www.ssa.gov/foia/",
      "https://www.ssa.gov/eeo",
      "https://oig.ssa.gov/",
      "https://www.ssa.gov/OACT/",
      "https://ssa.gov/agency/performance/",
      "https://usa.gov"
    ],
    "html_file": "ssa_bluebook_data/html/4266f3a15a9c36908b7afda3ccc7c8fa.html",
    "fetched_at": 1762482620.699479
  },
  {
    "url": "https://www.ssa.gov/disability/work",
    "url_hash": "9af5e11d583febad894ff5681845dad8",
    "title": "Try returning to work without losing Disability | SSA",
    "text_content": "Try returning to work without losing Disability | SSA Skip to main content An official website of the United States government Here's how you know Here's how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. Social Security and SSI Payments will Continue during the Government Shutdown. Visit my Social Security for Online Services. Get a benefit verification letter. Social Security English Español Account Sign in Account Menu Menu Benefits Medicare Card & record Benefits By Phase Prepare Apply Manage benefits By Type Retirement Disability Survivor Family Supplemental Security Income (SSI) Benefits overview Medicare Plan for Medicare Sign up for Medicare Request to lower IRMAA Apply for Part D Extra Help Manage Medicare benefits Card & record Number & card Personal record Search English Español Sign in My account Account home Sign out Breadcrumb Home Disability Try returning to work without losing Disability Retirement Disability Who can get Disability What you could get from Disability Try returning to work without losing Disability What you must report while on Disability Get Disability back if your benefit ended Survivor Family Supplemental Security Income (SSI) Try returning to work without losing Disability You must report your work activity if you get Disability benefits. The first 9 months of work You can return to work for at least 9 months and still get your full Disability payment. We call this a “trial work period.” In 2025, any month you earn over $1,160 before taxes will count towards this trial. The months don't need to be consecutive, just within a rolling 5-year period. There's no limit on how much you can earn during the 9 months. The next 3 years of work After your 9-month work trial, there's a 36-month period called an “extended period of eligibility” (EPE) where you can work and still get Disability. The EPE earnings limit in 2025 is $1,620 per month, or $2,700 if you get Disability due to blindness. If you exceed the earnings limit in any month, you won’t be eligible for a Disability payment for that month. After your EPE, if you keep earning over the limit, your benefit will typically end. Learn how to restart your benefits if you can’t continue to work. Your earnings limit can increase in certain circumstances During the 3-year extended period of eligibility, if you have work expenses due to your disability, you may be able to earn more than the monthly limit without affecting your benefits, up to the value of those costs. For example, if you have to spend $250 per month on specific transportation needs, you can earn an extra $250 each month. Also during that time, your earnings limit could increase if your job offers a subsidy. We define a subsidy as extra support due to your disability, like paid breaks or less work than your peers. We’ll talk to your employer to determine the value of your subsidy. For example, they might tell us they give you extra paid breaks every week, worth $100. This would be your subsidy and you could earn up to that amount more than the earnings limit without reducing your benefit. When you report your work activity , be sure to report these expenses and subsidies as well. Keep your Medicare coverage During the 9-month trial and the following 93 months You can typically keep Part A (hospital insurance) at no cost but can’t withdraw unless you pay a premium. If you have Part B (medical insurance), you can keep it by continuing to pay the premium. After that You can pay for both Parts A and B and keep your coverage as long as you still have a disability. Part A usually becomes free again after age 65. Explore our Ticket to Work program, which can help you find or keep a job Return to top Support Contact us Find an office Forms Publications Report fraud Languages Español Other languages Plain language Services for Employers & businesses Representatives Government agencies Other groups About About Social Security Communications Careers Initiatives Research & policy Financial reports SSA.gov An official website of the Social Security Administration. Secondary Footer Accessibility support Privacy policy FOIA requests Civil Rights/Compliance Office of the Inspector General Office of the Chief Actuary Performance reports Looking for U.S. government information and services? Visit USA.gov",
    "headings": [
      {
        "level": 1,
        "text": "Try returning to work without losing Disability"
      },
      {
        "level": 2,
        "text": "Breadcrumb"
      },
      {
        "level": 2,
        "text": ""
      },
      {
        "level": 2,
        "text": ""
      },
      {
        "level": 2,
        "text": "Your earnings limit can increase in certain circumstances"
      },
      {
        "level": 2,
        "text": "Keep your Medicare coverage"
      },
      {
        "level": 2,
        "text": "Secondary Footer"
      },
      {
        "level": 3,
        "text": "The first 9 months of work"
      },
      {
        "level": 3,
        "text": "The next 3 years of work"
      },
      {
        "level": 3,
        "text": ""
      },
      {
        "level": 3,
        "text": "During the 9-month trial and the following 93 months"
      },
      {
        "level": 3,
        "text": "After that"
      },
      {
        "level": 3,
        "text": ""
      },
      {
        "level": 4,
        "text": "Support"
      },
      {
        "level": 4,
        "text": "Languages"
      },
      {
        "level": 4,
        "text": "Services for"
      },
      {
        "level": 4,
        "text": "About"
      },
      {
        "level": 5,
        "text": "By Phase"
      },
      {
        "level": 5,
        "text": "By Type"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/work#main-content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov/",
      "https://www.ssa.gov/disability/work",
      "https://www.ssa.gov/es/disability/work",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/SiView.action",
      "https://secure.ssa.gov/myssa/myhub",
      "https://www.ssa.gov/menu",
      "https://www.ssa.gov/menu#benefits",
      "https://www.ssa.gov/menu#medicare",
      "https://www.ssa.gov/menu#card-record",
      "https://www.ssa.gov/prepare",
      "https://www.ssa.gov/apply",
      "https://www.ssa.gov/manage-benefits",
      "https://www.ssa.gov/retirement",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/survivor",
      "https://www.ssa.gov/family",
      "https://www.ssa.gov/ssi",
      "https://www.ssa.gov/benefits",
      "https://www.ssa.gov/medicare",
      "https://www.ssa.gov/medicare/sign-up",
      "https://www.ssa.gov/medicare/lower-irmaa",
      "https://www.ssa.gov/medicare/part-d-extra-help",
      "https://www.ssa.gov/medicare/manage",
      "https://www.ssa.gov/number-card",
      "https://www.ssa.gov/personal-record",
      "https://www.ssa.gov/disability/work",
      "https://www.ssa.gov/es/disability/work",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/SiView.action",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/logout",
      "https://www.ssa.gov/",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/retirement",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/eligibility",
      "https://www.ssa.gov/disability/amount",
      "https://www.ssa.gov/disability/work",
      "https://www.ssa.gov/disability/reporting",
      "https://www.ssa.gov/disability/restart",
      "https://www.ssa.gov/survivor",
      "https://www.ssa.gov/family",
      "https://www.ssa.gov/ssi",
      "https://www.ssa.gov/disability/reporting/wages",
      "https://www.ssa.gov/disability/restart",
      "https://www.ssa.gov/disability/reporting/wages",
      "https://www.ssa.gov/work/",
      "https://www.ssa.gov/disability/work",
      "https://www.ssa.gov/agency/contact/",
      "https://www.ssa.gov/locator/",
      "https://www.ssa.gov/forms/",
      "https://www.ssa.gov/pubs/",
      "https://secure.ssa.gov/oig/fraud/",
      "https://www.ssa.gov/es",
      "https://www.ssa.gov/site/languages/en/",
      "https://www.ssa.gov/agency/plain-language",
      "https://www.ssa.gov/employer/",
      "https://www.ssa.gov/about-ssa/agency-resources#representatives",
      "https://www.ssa.gov/about-ssa/agency-resources#government-agencies",
      "https://www.ssa.gov/about-ssa/agency-resources#other-groups",
      "https://www.ssa.gov/about-ssa",
      "https://www.ssa.gov/about-ssa/agency-resources#communications",
      "https://www.ssa.gov/careers/",
      "https://www.ssa.gov/about-ssa/agency-resources#initiatives",
      "https://www.ssa.gov/about-ssa/agency-resources#research-policy",
      "https://www.ssa.gov/finance/",
      "https://ssa.gov",
      "https://www.facebook.com/socialsecurity",
      "https://x.com/socialsecurity",
      "https://www.youtube.com/user/socialsecurityonline",
      "https://www.instagram.com/socialsecurity",
      "https://www.linkedin.com/company/ssa",
      "https://www.ssa.gov/accessibility/",
      "https://www.ssa.gov/agency/privacy.html",
      "https://www.ssa.gov/foia/",
      "https://www.ssa.gov/eeo",
      "https://oig.ssa.gov/",
      "https://www.ssa.gov/OACT/",
      "https://ssa.gov/agency/performance/",
      "https://usa.gov"
    ],
    "html_file": "ssa_bluebook_data/html/9af5e11d583febad894ff5681845dad8.html",
    "fetched_at": 1762482623.063434
  },
  {
    "url": "https://www.ssa.gov/disability/reporting",
    "url_hash": "a1630792a8fff3ae44491bfb8c918b8f",
    "title": "What you must report while on Disability | SSA",
    "text_content": "What you must report while on Disability | SSA Skip to main content An official website of the United States government Here's how you know Here's how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. Social Security and SSI Payments will Continue during the Government Shutdown. Visit my Social Security for Online Services. Get a benefit verification letter. Social Security English Español Account Sign in Account Menu Menu Benefits Medicare Card & record Benefits By Phase Prepare Apply Manage benefits By Type Retirement Disability Survivor Family Supplemental Security Income (SSI) Benefits overview Medicare Plan for Medicare Sign up for Medicare Request to lower IRMAA Apply for Part D Extra Help Manage Medicare benefits Card & record Number & card Personal record Search English Español Sign in My account Account home Sign out Breadcrumb Home Disability What you must report while on Disability Retirement Disability Who can get Disability What you could get from Disability Try returning to work without losing Disability What you must report while on Disability Report changes to work and income Get Disability back if your benefit ended Survivor Family Supplemental Security Income (SSI) What you must report while on Disability Report changes to your work and income Let us know right away if your work status or income changes, or if there’s a big improvement in your medical condition. Report work and income changes Tell us about changes to your personal record Update the following to make sure you get timely and accurate payments: Direct deposit account Contact information Citizenship and immigration status Return to top Support Contact us Find an office Forms Publications Report fraud Languages Español Other languages Plain language Services for Employers & businesses Representatives Government agencies Other groups About About Social Security Communications Careers Initiatives Research & policy Financial reports SSA.gov An official website of the Social Security Administration. Secondary Footer Accessibility support Privacy policy FOIA requests Civil Rights/Compliance Office of the Inspector General Office of the Chief Actuary Performance reports Looking for U.S. government information and services? Visit USA.gov",
    "headings": [
      {
        "level": 1,
        "text": "What you must report while on Disability"
      },
      {
        "level": 2,
        "text": "Breadcrumb"
      },
      {
        "level": 2,
        "text": ""
      },
      {
        "level": 2,
        "text": "Secondary Footer"
      },
      {
        "level": 3,
        "text": "Report changes to your work and income"
      },
      {
        "level": 3,
        "text": "Tell us about changes to your personal record"
      },
      {
        "level": 3,
        "text": ""
      },
      {
        "level": 4,
        "text": "Support"
      },
      {
        "level": 4,
        "text": "Languages"
      },
      {
        "level": 4,
        "text": "Services for"
      },
      {
        "level": 4,
        "text": "About"
      },
      {
        "level": 5,
        "text": "By Phase"
      },
      {
        "level": 5,
        "text": "By Type"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/reporting#main-content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov/",
      "https://www.ssa.gov/disability/reporting",
      "https://www.ssa.gov/es/disability/reporting",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/SiView.action",
      "https://secure.ssa.gov/myssa/myhub",
      "https://www.ssa.gov/menu",
      "https://www.ssa.gov/menu#benefits",
      "https://www.ssa.gov/menu#medicare",
      "https://www.ssa.gov/menu#card-record",
      "https://www.ssa.gov/prepare",
      "https://www.ssa.gov/apply",
      "https://www.ssa.gov/manage-benefits",
      "https://www.ssa.gov/retirement",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/survivor",
      "https://www.ssa.gov/family",
      "https://www.ssa.gov/ssi",
      "https://www.ssa.gov/benefits",
      "https://www.ssa.gov/medicare",
      "https://www.ssa.gov/medicare/sign-up",
      "https://www.ssa.gov/medicare/lower-irmaa",
      "https://www.ssa.gov/medicare/part-d-extra-help",
      "https://www.ssa.gov/medicare/manage",
      "https://www.ssa.gov/number-card",
      "https://www.ssa.gov/personal-record",
      "https://www.ssa.gov/disability/reporting",
      "https://www.ssa.gov/es/disability/reporting",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/SiView.action",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/logout",
      "https://www.ssa.gov/",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/retirement",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/eligibility",
      "https://www.ssa.gov/disability/amount",
      "https://www.ssa.gov/disability/work",
      "https://www.ssa.gov/disability/reporting",
      "https://www.ssa.gov/disability/reporting/wages",
      "https://www.ssa.gov/disability/restart",
      "https://www.ssa.gov/survivor",
      "https://www.ssa.gov/family",
      "https://www.ssa.gov/ssi",
      "https://www.ssa.gov/disability/reporting/wages",
      "https://www.ssa.gov/manage-benefits/update-direct-deposit",
      "https://www.ssa.gov/personal-record/update-contact-information",
      "https://www.ssa.gov/personal-record/update-citizenship-or-immigration-status",
      "https://www.ssa.gov/disability/reporting",
      "https://www.ssa.gov/agency/contact/",
      "https://www.ssa.gov/locator/",
      "https://www.ssa.gov/forms/",
      "https://www.ssa.gov/pubs/",
      "https://secure.ssa.gov/oig/fraud/",
      "https://www.ssa.gov/es",
      "https://www.ssa.gov/site/languages/en/",
      "https://www.ssa.gov/agency/plain-language",
      "https://www.ssa.gov/employer/",
      "https://www.ssa.gov/about-ssa/agency-resources#representatives",
      "https://www.ssa.gov/about-ssa/agency-resources#government-agencies",
      "https://www.ssa.gov/about-ssa/agency-resources#other-groups",
      "https://www.ssa.gov/about-ssa",
      "https://www.ssa.gov/about-ssa/agency-resources#communications",
      "https://www.ssa.gov/careers/",
      "https://www.ssa.gov/about-ssa/agency-resources#initiatives",
      "https://www.ssa.gov/about-ssa/agency-resources#research-policy",
      "https://www.ssa.gov/finance/",
      "https://ssa.gov",
      "https://www.facebook.com/socialsecurity",
      "https://x.com/socialsecurity",
      "https://www.youtube.com/user/socialsecurityonline",
      "https://www.instagram.com/socialsecurity",
      "https://www.linkedin.com/company/ssa",
      "https://www.ssa.gov/accessibility/",
      "https://www.ssa.gov/agency/privacy.html",
      "https://www.ssa.gov/foia/",
      "https://www.ssa.gov/eeo",
      "https://oig.ssa.gov/",
      "https://www.ssa.gov/OACT/",
      "https://ssa.gov/agency/performance/",
      "https://usa.gov"
    ],
    "html_file": "ssa_bluebook_data/html/a1630792a8fff3ae44491bfb8c918b8f.html",
    "fetched_at": 1762482625.5868104
  },
  {
    "url": "https://www.ssa.gov/disability/restart",
    "url_hash": "de06cd892cfd0e62da8991c97238d3bb",
    "title": "Get Disability back if your benefit ended | SSA",
    "text_content": "Get Disability back if your benefit ended | SSA Skip to main content An official website of the United States government Here's how you know Here's how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. Social Security and SSI Payments will Continue during the Government Shutdown. Visit my Social Security for Online Services. Get a benefit verification letter. Social Security English Español Account Sign in Account Menu Menu Benefits Medicare Card & record Benefits By Phase Prepare Apply Manage benefits By Type Retirement Disability Survivor Family Supplemental Security Income (SSI) Benefits overview Medicare Plan for Medicare Sign up for Medicare Request to lower IRMAA Apply for Part D Extra Help Manage Medicare benefits Card & record Number & card Personal record Search English Español Sign in My account Account home Sign out Breadcrumb Home Disability Get Disability back if your benefit ended Retirement Disability Who can get Disability What you could get from Disability Try returning to work without losing Disability What you must report while on Disability Get Disability back if your benefit ended Survivor Family Supplemental Security Income (SSI) Get Disability back if your benefit ended If your benefit ended due to work If your Disability benefit ended because you returned to work and have been earning above the limits for too long, you might be able to restart it later if needed. Within 5 years of your benefits ending Call us and tell the representative you want to file for “expedited reinstatement” of your Disability benefit. You’ll answer a series of questions but won't need to file a new application. You might also get benefits for up to 6 months while we review your request. Call +1 800-772-1213 Call TTY +1 800-325-0778 if you're deaf or hard of hearing. Available in most U.S. time zones Monday through Friday, 8 a.m. to 7 p.m., in English, Spanish, and other languages. After 5 years of your benefit ending You’ll need to file a new application to get back on Disability. If your benefit ended for any other reason You’ll need to file a new application to get back on Disability. Return to top Support Contact us Find an office Forms Publications Report fraud Languages Español Other languages Plain language Services for Employers & businesses Representatives Government agencies Other groups About About Social Security Communications Careers Initiatives Research & policy Financial reports SSA.gov An official website of the Social Security Administration. Secondary Footer Accessibility support Privacy policy FOIA requests Civil Rights/Compliance Office of the Inspector General Office of the Chief Actuary Performance reports Looking for U.S. government information and services? Visit USA.gov",
    "headings": [
      {
        "level": 1,
        "text": "Get Disability back if your benefit ended"
      },
      {
        "level": 2,
        "text": "Breadcrumb"
      },
      {
        "level": 2,
        "text": "If your benefit ended due to work"
      },
      {
        "level": 2,
        "text": "If your benefit ended for any other reason"
      },
      {
        "level": 2,
        "text": "Secondary Footer"
      },
      {
        "level": 3,
        "text": ""
      },
      {
        "level": 3,
        "text": "Within 5 years of your benefits ending"
      },
      {
        "level": 3,
        "text": "After 5 years of your benefit ending"
      },
      {
        "level": 3,
        "text": ""
      },
      {
        "level": 3,
        "text": ""
      },
      {
        "level": 4,
        "text": "Support"
      },
      {
        "level": 4,
        "text": "Languages"
      },
      {
        "level": 4,
        "text": "Services for"
      },
      {
        "level": 4,
        "text": "About"
      },
      {
        "level": 5,
        "text": "By Phase"
      },
      {
        "level": 5,
        "text": "By Type"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/restart#main-content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov/",
      "https://www.ssa.gov/disability/restart",
      "https://www.ssa.gov/es/disability/restart",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/SiView.action",
      "https://secure.ssa.gov/myssa/myhub",
      "https://www.ssa.gov/menu",
      "https://www.ssa.gov/menu#benefits",
      "https://www.ssa.gov/menu#medicare",
      "https://www.ssa.gov/menu#card-record",
      "https://www.ssa.gov/prepare",
      "https://www.ssa.gov/apply",
      "https://www.ssa.gov/manage-benefits",
      "https://www.ssa.gov/retirement",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/survivor",
      "https://www.ssa.gov/family",
      "https://www.ssa.gov/ssi",
      "https://www.ssa.gov/benefits",
      "https://www.ssa.gov/medicare",
      "https://www.ssa.gov/medicare/sign-up",
      "https://www.ssa.gov/medicare/lower-irmaa",
      "https://www.ssa.gov/medicare/part-d-extra-help",
      "https://www.ssa.gov/medicare/manage",
      "https://www.ssa.gov/number-card",
      "https://www.ssa.gov/personal-record",
      "https://www.ssa.gov/disability/restart",
      "https://www.ssa.gov/es/disability/restart",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/SiView.action",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/logout",
      "https://www.ssa.gov/",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/retirement",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/eligibility",
      "https://www.ssa.gov/disability/amount",
      "https://www.ssa.gov/disability/work",
      "https://www.ssa.gov/disability/reporting",
      "https://www.ssa.gov/disability/restart",
      "https://www.ssa.gov/survivor",
      "https://www.ssa.gov/family",
      "https://www.ssa.gov/ssi",
      "https://www.ssa.gov/disability/work",
      "tel:+1-800-772-1213",
      "tel:+1-800-325-0778",
      "https://secure.ssa.gov/iClaim/dib",
      "https://secure.ssa.gov/iClaim/dib",
      "https://www.ssa.gov/disability/restart",
      "https://www.ssa.gov/agency/contact/",
      "https://www.ssa.gov/locator/",
      "https://www.ssa.gov/forms/",
      "https://www.ssa.gov/pubs/",
      "https://secure.ssa.gov/oig/fraud/",
      "https://www.ssa.gov/es",
      "https://www.ssa.gov/site/languages/en/",
      "https://www.ssa.gov/agency/plain-language",
      "https://www.ssa.gov/employer/",
      "https://www.ssa.gov/about-ssa/agency-resources#representatives",
      "https://www.ssa.gov/about-ssa/agency-resources#government-agencies",
      "https://www.ssa.gov/about-ssa/agency-resources#other-groups",
      "https://www.ssa.gov/about-ssa",
      "https://www.ssa.gov/about-ssa/agency-resources#communications",
      "https://www.ssa.gov/careers/",
      "https://www.ssa.gov/about-ssa/agency-resources#initiatives",
      "https://www.ssa.gov/about-ssa/agency-resources#research-policy",
      "https://www.ssa.gov/finance/",
      "https://ssa.gov",
      "https://www.facebook.com/socialsecurity",
      "https://x.com/socialsecurity",
      "https://www.youtube.com/user/socialsecurityonline",
      "https://www.instagram.com/socialsecurity",
      "https://www.linkedin.com/company/ssa",
      "https://www.ssa.gov/accessibility/",
      "https://www.ssa.gov/agency/privacy.html",
      "https://www.ssa.gov/foia/",
      "https://www.ssa.gov/eeo",
      "https://oig.ssa.gov/",
      "https://www.ssa.gov/OACT/",
      "https://ssa.gov/agency/performance/",
      "https://usa.gov"
    ],
    "html_file": "ssa_bluebook_data/html/de06cd892cfd0e62da8991c97238d3bb.html",
    "fetched_at": 1762482627.9879284
  },
  {
    "url": "https://www.ssa.gov/benefits/disability/family.html",
    "url_hash": "f4dd6d96d23d1889475c9c6e0178e4f7",
    "title": "Family benefits | SSA",
    "text_content": "Family benefits | SSA Skip to main content An official website of the United States government Here's how you know Here's how you know Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. Social Security and SSI Payments will Continue during the Government Shutdown. Visit my Social Security for Online Services. Get a benefit verification letter. Social Security English Español Account Sign in Account Menu Menu Benefits Medicare Card & record Benefits By Phase Prepare Apply Manage benefits By Type Retirement Disability Survivor Family Supplemental Security Income (SSI) Benefits overview Medicare Plan for Medicare Sign up for Medicare Request to lower IRMAA Apply for Part D Extra Help Manage Medicare benefits Card & record Number & card Personal record Search English Español Sign in My account Account home Sign out Breadcrumb Home Family benefits Retirement Disability Survivor Family Who can get Family benefits What you could get from Family benefits What you must report while on Family benefits Supplemental Security Income (SSI) Family benefits Family benefits provide monthly payments to certain family members of people who are eligible for Retirement or Disability. Family benefits are also commonly called “spousal” or “child” benefits. Learn how to apply Who can get Family benefits Spouses, ex-spouses, children, and some grandchildren may be eligible for Family benefits. We consider age, marital status, and other factors when we determine eligibility. See if you’re eligible for Family benefits What you could get You could get up to half of your family member’s benefit amount and may be eligible for Medicare based on their work history. Find out what you could get What you need to report To make sure you get the right payments, tell us about updates, like marriage, school, and income changes. Learn what to report Return to top Support Contact us Find an office Forms Publications Report fraud Languages Español Other languages Plain language Services for Employers & businesses Representatives Government agencies Other groups About About Social Security Communications Careers Initiatives Research & policy Financial reports SSA.gov An official website of the Social Security Administration. Secondary Footer Accessibility support Privacy policy FOIA requests Civil Rights/Compliance Office of the Inspector General Office of the Chief Actuary Performance reports Looking for U.S. government information and services? Visit USA.gov",
    "headings": [
      {
        "level": 1,
        "text": "Family benefits"
      },
      {
        "level": 2,
        "text": "Breadcrumb"
      },
      {
        "level": 2,
        "text": ""
      },
      {
        "level": 2,
        "text": ""
      },
      {
        "level": 2,
        "text": ""
      },
      {
        "level": 2,
        "text": "Who can get Family benefits"
      },
      {
        "level": 2,
        "text": "What you could get"
      },
      {
        "level": 2,
        "text": "What you need to report"
      },
      {
        "level": 2,
        "text": "Secondary Footer"
      },
      {
        "level": 3,
        "text": ""
      },
      {
        "level": 4,
        "text": "Support"
      },
      {
        "level": 4,
        "text": "Languages"
      },
      {
        "level": 4,
        "text": "Services for"
      },
      {
        "level": 4,
        "text": "About"
      },
      {
        "level": 5,
        "text": "By Phase"
      },
      {
        "level": 5,
        "text": "By Type"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/benefits/disability/family.html#main-content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov/",
      "https://www.ssa.gov/family",
      "https://www.ssa.gov/es/family",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/SiView.action",
      "https://secure.ssa.gov/myssa/myhub",
      "https://www.ssa.gov/menu",
      "https://www.ssa.gov/menu#benefits",
      "https://www.ssa.gov/menu#medicare",
      "https://www.ssa.gov/menu#card-record",
      "https://www.ssa.gov/prepare",
      "https://www.ssa.gov/apply",
      "https://www.ssa.gov/manage-benefits",
      "https://www.ssa.gov/retirement",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/survivor",
      "https://www.ssa.gov/family",
      "https://www.ssa.gov/ssi",
      "https://www.ssa.gov/benefits",
      "https://www.ssa.gov/medicare",
      "https://www.ssa.gov/medicare/sign-up",
      "https://www.ssa.gov/medicare/lower-irmaa",
      "https://www.ssa.gov/medicare/part-d-extra-help",
      "https://www.ssa.gov/medicare/manage",
      "https://www.ssa.gov/number-card",
      "https://www.ssa.gov/personal-record",
      "https://www.ssa.gov/family",
      "https://www.ssa.gov/es/family",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/SiView.action",
      "https://secure.ssa.gov/myssa/myhub",
      "https://secure.ssa.gov/RIL/logout",
      "https://www.ssa.gov/",
      "https://www.ssa.gov/retirement",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/survivor",
      "https://www.ssa.gov/family",
      "https://www.ssa.gov/family/eligibility",
      "https://www.ssa.gov/family/amount",
      "https://www.ssa.gov/family/reporting",
      "https://www.ssa.gov/ssi",
      "https://www.ssa.gov/apply?benefits=family_adult&age=adult",
      "https://www.ssa.gov/family/eligibility",
      "https://www.ssa.gov/family/amount",
      "https://www.ssa.gov/family/reporting",
      "https://www.ssa.gov/benefits/disability/family.html",
      "https://www.ssa.gov/agency/contact/",
      "https://www.ssa.gov/locator/",
      "https://www.ssa.gov/forms/",
      "https://www.ssa.gov/pubs/",
      "https://secure.ssa.gov/oig/fraud/",
      "https://www.ssa.gov/es",
      "https://www.ssa.gov/site/languages/en/",
      "https://www.ssa.gov/agency/plain-language",
      "https://www.ssa.gov/employer/",
      "https://www.ssa.gov/about-ssa/agency-resources#representatives",
      "https://www.ssa.gov/about-ssa/agency-resources#government-agencies",
      "https://www.ssa.gov/about-ssa/agency-resources#other-groups",
      "https://www.ssa.gov/about-ssa",
      "https://www.ssa.gov/about-ssa/agency-resources#communications",
      "https://www.ssa.gov/careers/",
      "https://www.ssa.gov/about-ssa/agency-resources#initiatives",
      "https://www.ssa.gov/about-ssa/agency-resources#research-policy",
      "https://www.ssa.gov/finance/",
      "https://ssa.gov",
      "https://www.facebook.com/socialsecurity",
      "https://x.com/socialsecurity",
      "https://www.youtube.com/user/socialsecurityonline",
      "https://www.instagram.com/socialsecurity",
      "https://www.linkedin.com/company/ssa",
      "https://www.ssa.gov/accessibility/",
      "https://www.ssa.gov/agency/privacy.html",
      "https://www.ssa.gov/foia/",
      "https://www.ssa.gov/eeo",
      "https://oig.ssa.gov/",
      "https://www.ssa.gov/OACT/",
      "https://ssa.gov/agency/performance/",
      "https://usa.gov"
    ],
    "html_file": "ssa_bluebook_data/html/f4dd6d96d23d1889475c9c6e0178e4f7.html",
    "fetched_at": 1762482630.7163854
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/greenbook/index.htm",
    "url_hash": "0672978f86d30c3831f7b26681dd4ce1",
    "title": "Consultative Examinations: A Guide for Health Professionals | Disability | SSA",
    "text_content": "Consultative Examinations: A Guide for Health Professionals | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Consultative Examinations: A Guide for Health Professionals Professionals Home CE Overview General Information Evidence Requirements Consultative Examination Guidelines Adult CE Report Content Guidelines Pediatric CE Report Content Guidelines How Claims are Evaluated-The Medical Listings Consultative Examinations: A Guide for \n        Health Professionals Overview This Consultative Examination (CE) guide (also known as the \"Green \n     Book\") has been developed to give physicians and other health professionals \n     basic information about the CE process. This guide explains: The \n       Social Security Disability programs; How the Disability Determination Services (DDS) requests CEs; What to look for in reviewing CEs; The essential elements of CE reports for specialties most often involved \n       in CEs for adult and pediatric disability cases. November 2020",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Consultative Examinations: A Guide for \n        Health Professionals"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/greenbook/index.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-general.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-evidence.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-guidelines.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/index.htm"
    ],
    "html_file": "ssa_bluebook_data/html/0672978f86d30c3831f7b26681dd4ce1.html",
    "fetched_at": 1762482632.9717007
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/greenbook/ce-general.htm",
    "url_hash": "8c0b166089d14228e0fed2b9209797ca",
    "title": "Part I - General Information | Disability | SSA",
    "text_content": "Part I - General Information | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Part I - General Information Professionals Home CE Overview General Information Evidence Requirements Consultative Examination Guidelines Adult CE Report Content Guidelines Pediatric CE Report Content Guidelines How Claims are Evaluated-The Medical Listings Consultative Examinations: A Guide for \n        Health Professionals Part I - General Information The Social Security Administration \n        (SSA) administers two programs that provide benefits based on disability: \n        the Social Security disability insurance program (title II of the Social \n        Security Act (the Act) and the supplemental security income (SSI) program \n        (title XVI of the Act). Title II provides for payment of disability benefits \n        to individuals who are \"insured\" under the Act by virtue of their contributions \n        to the Social Security trust fund through the Social Security tax on their \n        earnings, as well as to certain disabled dependents of insured individuals. \n        Title XVI provides for SSI payments to individuals (including children \n        under age 18) who are disabled and have limited income and resources. The Act and SSA's implementing regulations \n        prescribe rules for deciding if an individual is \"disabled.\" SSA's criteria \n        for deciding if someone is disabled are not necessarily the same as the \n        criteria applied in other Government and private disability programs. Definition of Disability For all individuals applying for disability benefits under title II, and \n        for adults applying under title XVI, the definition of disability is the \n        same. The law defines disability as the inability to engage in any substantial \n        gainful activity (SGA) by reason of any medically determinable physical \n        or mental impairment(s) which can be expected to result in death or which \n        has lasted or can be expected to last for a continuous period of not less \n        than 12 months. Disability in Children Under title XVI, a child under age 18 will be considered disabled if he \n        or she has a medically determinable physical or mental impairment or combination \n        of impairments that causes marked and severe functional limitations, and \n        that can be expected to cause death or that has lasted or can be expected \n        to last for a continuous period of not less than 12 months. What is a \"Medically Determinable \n        Impairment\" To establish the  existence of a medically determinable impairment, we need objective medical  evidence from an acceptable medical source. Objective medical evidence means  “signs, laboratory findings, or both”. We never establish a medically  determinable impairment based on an individual’s statement of symptoms, a  diagnosis, or a medical opinion. Signs are defined as  one or more anatomical, physiological, or psychological abnormalities that can  be observed, apart from your statements (symptoms). Signs must be shown by  medically acceptable clinical diagnostic techniques. Psychiatric signs are medically  demonstrable phenomena that indicate specific psychological abnormalities,  e.g., abnormalities of behavior, mood, thought, memory, orientation,  development, or perception, and must also be shown by observable facts that can  be medically described and evaluated. Laboratory findings  are defined as one or more anatomical, physiological, or psychological  phenomena that can be shown by the use of medically acceptable laboratory  diagnostic techniques. Diagnostic techniques include chemical tests (such as blood  tests), electrophysiological studies (such as electrocardiograms and  electroencephalograms). The Disability Determination Process Most disability claims are initially processed through a network of local \n        Social Security field offices and State agencies (usually called the Disability Determination Services or DDSs). Subsequent appeals of unfavorable determinations \n        may be decided in the DDSs or by administrative law judges in SSA's Office of Hearings  Operations. Social Security Field Offices SSA representatives in the field \n        offices usually obtain applications for disability benefits, either in \n        person, by telephone, or by mail. The application and related forms ask \n        for a description of the claimant's impairment(s), names, addresses, and \n        telephone numbers of treatment sources, and other information that relates \n        to the alleged disability. (The \"claimant\" is the person who is requesting \n        disability benefits.) The field office is responsible \n        for verifying non-medical eligibility requirements, which may include \n        age, employment, marital status, or Social Security coverage information. \n        The field office sends the case to a DDS for evaluation of disability. Back to Top Disability Determination Services The DDSs, which are fully funded \n        by the Federal Government, are State agencies responsible for developing \n        medical evidence and rendering the initial determination on whether the \n        claimant is or is not disabled or blind under the law. Usually, the DDS tries to obtain \n        evidence from the claimant's own medical sources first. If that evidence \n        is unavailable or insufficient to make a determination, the DDS will arrange \n        for a CE in order to obtain the additional information needed. The claimant's \n        treating source is the preferred source for the CE; however, the DDS may \n        also obtain the CE from an independent source. (See Part III for more \n        information about CEs.) After completing its initial development, \n        the DDS makes the disability determination. The determination is made \n        by a two-person adjudicative team consisting of a medical or psychological \n        consultant (who is a physician or psychologist) and a disability examiner. \n        If the adjudicative team finds that additional evidence is still needed, \n        the consultant or examiner may recontact a medical source (s) and ask \n        for supplemental information. The DDS also makes a determination \n        whether the claimant is a candidate for vocational rehabilitation (VR). \n        If so, the DDS makes a referral to the State VR agency. After the DDS makes the disability \n        determination, it returns the case to the field office for appropriate \n        action depending on whether the claim is allowed or denied. If the DDS \n        finds the claimant disabled, SSA will complete any outstanding non-disability \n        development, compute the benefit amount, and begin paying benefits. If \n        the claimant is found not disabled, the file is retained in the field \n        office in case the claimant decides to appeal the determination. If the claimant files an appeal of an initial unfavorable determination, \n        the appeal is usually handled much the same as the initial claim, except \n        that the disability determination is made by a different adjudicative \n        team in the DDS than the one that handled the original case. Office of Hearings Operations Claimants dissatisfied with the first  appeal of a determination may file subsequent appeals. A hearing office within  the Office of Hearings Operations (OHO) processes the second appeal. An  administrative law judge makes the second appeal decision, usually after  conducting a hearing and receiving any additional evidence from the claimant's  medical sources or other sources. Medical development by OHO is frequently  conducted through the DDS. However, hearing offices may also contact medical  sources directly. In rare circumstances, an administrative law judge may issue  a subpoena requiring production of evidence or testimony at a hearing. The Role of the Health Professional Health professionals play a vital role \n          in the disability determination process and participate in the process \n          in a variety of ways: As the medical sources who provide healthcare to their patients, they provide documentation of an individual’s medical conditions, treatment, and impairment-related limitations; As CE sources to perform, for a fee, examinations \n          and/or tests that are needed; As full-time or part-time medical or psychological \n          consultants reviewing claims in a DDS, in one of SSA's regional offices, \n          or in SSA central office; or As medical experts who testify at administrative \n          law judge hearings. Back to Top Medical Sources A medical source is a claimant's own  physician, psychologist, or other acceptable medical source that can provide  SSA with objective or other medical evidence, or medical opinions. If an additional examination or testing is  needed, SSA usually considers a claimant’s own medical source to be the  preferred source for performing the examination or test. The medical source is neither asked nor  expected to make a decision whether the claimant is disabled. However, a  medical source will usually be asked to provide a statement about the  claimant's ability, despite his or her impairments, to do work-related physical  or mental activities. Program Medical Professionals Physicians of virtually all specialties and psychologists \n        at the State, regional or national levels review claims for disability \n        benefits. The review work is performed in the State DDSs or SSA's regional \n        office or headquarters. It is strictly a paper review in which the program \n        physician or psychologist usually has no contact with the claimant. Medical Experts Because there is no direct involvement of medical \n        professionals in the disability decisions made by administrative law judges \n        in the Office of Hearing Operations, administrative law judges sometimes \n        request expert testimony on complex medical issues. Each hearing office \n        maintains a roster of medical experts who are called to testify as expert \n        witnesses at hearings. The experts are paid a fee for their services. Confidentiality of Records Two separate laws, the Freedom of \n        Information Act and the Privacy Act, have special significance for Federal \n        agencies. Under the Freedom of Information Act, Federal agencies are required \n        to provide the public with access to their files and records. This means \n        the public has the right, with certain exceptions, to examine records \n        pertaining to the functions, procedures, final opinions, and policy of \n        these Federal agencies. The Privacy Act permits an individual \n        or his or her authorized representative to examine records pertaining \n        to him or her in a Federal agency. For disability applicants, this means \n        that an individual may request to see the medical or other evidence used \n        to evaluate his or her application for disability benefits under the Social \n        Security or the SSI programs. (This evidence, however, is not available \n        to the general public.) SSA screens all requests to see \n        medical evidence in a claim file to determine if release of the evidence \n        directly to the individual might have an adverse effect on that individual. \n        If so, the report will be released only to an authorized representative \n        designated by the individual. Back to Top",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Consultative Examinations: A Guide for \n        Health Professionals"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/greenbook/ce-general.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/index.htm",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-general.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-evidence.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-guidelines.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-general.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-general.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-general.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-general.htm"
    ],
    "html_file": "ssa_bluebook_data/html/8c0b166089d14228e0fed2b9209797ca.html",
    "fetched_at": 1762482637.29351
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/greenbook/ce-evidence.htm",
    "url_hash": "1fc88e255982a8e71f46d39f60a1d4d6",
    "title": "Part II - Evidence Requirements | Disability | SSA",
    "text_content": "Part II - Evidence Requirements | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Part II - Evidence Requirements Professionals Home CE Overview General Information Evidence Requirements Consultative Examination Guidelines Adult CE Report Content Guidelines Pediatric CE Report Content Guidelines How Claims are Evaluated-The Medical Listings Consultative Examinations: A Guide for \n        Health Professionals Part II - Evidence Requirements Medical Evidence Under both the title II and title XVI programs, \n        medical evidence is the cornerstone for the determination of disability. Each person who files a disability \n        claim is responsible for providing medical evidence showing that he or \n        she has an impairment (s) and how severe the impairment (s) is. However, \n        SSA will help claimants get medical reports from their own medical sources \n        when the claimants gives SSA permission to do so. This medical evidence \n        generally comes from sources that have treated or evaluated the claimant \n        for his or her \n        impairment (s). Acceptable Medical Sources Documentation of the existence of a claimant's impairment must come from \n        medical professionals defined by SSA's regulation as \"acceptable medical \n        sources.\" Once the existence of an impairment is established, all of the \n        medical and non-medical evidence is considered in assessing impairment \n      severity. \"Acceptable medical sources\" are: Licensed physicians (medical or osteopathic doctors). Licensed psychologists, which include: A licensed or certified psychologist at the independent practice level; and A licensed or certified school psychologist, or other licensed or certified individual with another title who performs the same function as a school psychologist in a school setting, for impairments of intellectual disability, learning disabilities, and borderline intellectual functioning only. Licensed optometrists for impairments of visual disorders, or measurement of visual acuity and visual fields only, depending on the scope of practice in the State in which the optometrist practices. Licensed podiatrists for impairments of the foot, or foot and ankle only, depending on whether the State in which the podiatrist practices permits the practice of podiatry on the foot only, or the foot and ankle. Qualified speech-language pathologists for speech or language impairments only. For this source, qualified means that the speech-language pathologist must be licensed by the State professional licensing agency, or be fully certified by the State education agency in the State in which he or she practices, or hold a Certificate of Clinical Competence in Speech-Language Pathology from the American Speech-Language-Hearing Association. Licensed audiologists for impairments of hearing loss, auditory processing disorders, and balance disorders within the licensed scope of practice only. NOTE: Audiologists scope of practice generally includes evaluation, examination, and treatment of certain balance impairments that result from the audio-vestibular system. However, some impairments involving balance involve several body systems that are outside the scope of practice for audiologists, such as those involving muscles, bones, joints, vision, nerves, heart, and blood vessels. Licensed advanced practice registered nurses (APRN), also known in some States as advanced practice nurses (APN), and advanced registered nurse practitioners (ARNP) for impairments within his or her licensed scope of practice. There are four types of APRNs with a handful of State variations: Certified nurse midwife (CNM); Nurse practitioner (NP); Certified registered nurse anesthetist (CRNA); and Clinical nurse specialist (CNS). Licensed physician assistants for impairments within his or her licensed scope of practice only. Medical Evidence from Treating \n        Sources Currently, many disability claims are decided on the basis of medical\n         evidence from \"treating sources.\" ”Treating source” means\n         the claimant’s own “acceptable medical source” who\n         provides, or has provided, the claimant with medical treatment or evaluation\n         and who has, or has had, an ongoing treatment relationship with the\n         claimant.  SSA regulations place special emphasis\n         on evidence from treating sources because they are likely to be the\n        medical  professionals most able to provide a detailed longitudinal picture\n        of  the claimant's impairments and they may bring a unique perspective\n        to  the medical evidence that cannot be obtained from the medical findings\n         alone or from reports of individual examinations or brief hospitalizations.\n         Therefore, timely, accurate, and adequate medical reports from treating\n         sources may accelerate the processing of the claim because they can\n        greatly  reduce or eliminate the need for additional medical evidence\n        to complete  the claim. Other Evidence Sources Information from other sources may also help show the extent to which\n         a person's impairment(s) affects his or her ability to function. Other\n         sources include public and private social welfare agencies, non-medical\n         sources such as teachers, day care providers, social workers and employers,\n         and other health care professionals such as naturopaths, chiropractors,\n        and audiologists. Medical Reports SSA frequently asks physicians, psychologists, and other health care\n        professionals to submit reports about an\n        individual's impairment. Therefore, it is important to know what evidence\n        SSA needs. Medical reports should include: Medical history; Clinical findings (such as the results of physical \n          or mental status examinations); Laboratory findings (such as blood pressure, \n          x-rays); Diagnosis; Treatment prescribed with response and prognosis; \n          and a Statement providing an opinion about what \n          the claimant can still do despite his or her impairment(s) based on \n          the medical source's findings on the above factors. This statement should \n          describe, but is not limited to, the individual's ability to perform \n          work-related activities, such as sitting, standing, walking, lifting, \n          carrying, handling objects, hearing, speaking, and traveling. In cases \n          involving mental impairments, it should describe the individual's ability \n          to understand, to carry out and remember instructions, and to respond \n          appropriately to supervision, coworkers, and work pressures in a work \n          setting. For a child, the statement should describe the child's ability \n          to function in an age-appropriate manner in the areas of functioning \n          appropriate for the child's age. Back to Top Evidence Relating to Symptoms In developing evidence of the effects of \n        symptoms, such as pain, shortness of breath, or fatigue, on a claimant's \n        ability to function, SSA investigates all avenues presented that relate \n        to the complaints. These include information provided by treating and \n        other sources regarding: The claimant's daily activities; Location, duration, frequency, and intensity \n          of the pain or other symptom; precipitating and aggravating factors; \n          the type, dosage, effectiveness, and side effects of any medication; Treatments, other than medications, for the \n          relief of pain or other symptoms; Any measures the claimant uses or has used to \n          relieve pain or other symptoms; and Other factors concerning the claimant's \n          functional limitations due to pain or other symptoms. In assessing the claimant's pain or other symptoms, \n          the decision-maker(s) must give full consideration to all of the above-mentioned \n          factors. It is important that medical sources address these factors \n          in the reports they provide. Back to Top",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Consultative Examinations: A Guide for \n        Health Professionals"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/greenbook/ce-evidence.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/index.htm",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-general.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-evidence.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-guidelines.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-evidence.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-evidence.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-evidence.htm"
    ],
    "html_file": "ssa_bluebook_data/html/1fc88e255982a8e71f46d39f60a1d4d6.html",
    "fetched_at": 1762482639.5230696
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/greenbook/ce-guidelines.htm",
    "url_hash": "450df48d03dd6cc554ac9e3b43d08db2",
    "title": "Part III - Consultative Examination Guidelines | Disability | SSA",
    "text_content": "Part III - Consultative Examination Guidelines | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Part III - Consultative Examination Guidelines Professionals Home CE Overview General Information Evidence Requirements Consultative Examination Guidelines Adult CE Report Content Guidelines Pediatric CE Report Content Guidelines How Claims are Evaluated-The Medical Listings Consultative Examinations: A Guide for \n        Health Professionals Part III - Consultative Examination Guidelines If the evidence provided by the claimant's own medical sources is inadequate \n        to determine if he or she is disabled, additional medical information \n        may be sought by recontacting the treating source for additional information \n        or clarification, or by arranging for a CE. The treating source is the preferred \n        source of purchased examinations when the treating source is qualified, \n        equipped and willing to perform the additional examination or tests for \n        the fee schedule payment and generally furnishes complete and timely reports. \n        Even if only a supplemental test is required, the treating source is ordinarily \n        the preferred source for this service. SSA's rules provide for using an \n        independent source (other than the treating source) for a CE or diagnostic \n        study if: The treating source prefers not to perform \n        the examination; There are conflicts or inconsistencies \n        in the file that cannot be resolved by going back to the treating source; The claimant prefers another source and \n        has a good reason for doing\n   so; or Prior experience indicates that the treating \n        source may not be a productive source. The type of examination and/or\n          test  (s) purchased depends upon the specific additional evidence needed\n          for  adjudication. If an ancillary test (e.g., X-ray, PFS or EKG) will\n          furnish  the additional evidence needed for adjudication, the DDS will\n          not request  or authorize a more comprehensive examination. If the\n          examination indicates  that additional testing may be warranted, the\n          medical source must contact the  DDS for approval before performing\n          such testing. Fees for CEs are set by each State \n        and may vary from State to State. Each State agency is responsible for \n        comprehensive oversight management of its CE program. Social Security is committed to providing fair and  equitable service to the American public, regardless of an individual’s  inability to communicate effectively in English. Social Security recognizes that using qualified interpreters efficiently facilitates the Agency’s processes, deters fraud, and assures that  individuals with limited English proficiency (LEP) are not disadvantaged. Therefore, the DDS will provide an interpreter free of charge, to any individual requesting language assistance, or  when it is evident that such assistance is necessary to ensure that the  individual is not disadvantaged. Individuals  have the option of using their own interpreter, such as a family member,  friend, or third party, providing the interpreter meets the Agency’s criteria  for interpreters. A qualified  interpreter is an individual or  vendor who is able to read, write, and speak fluently in English and the  language or dialect of the individual needing language assistance, and who  meets the following criteria: Provides an accurate interpretation of questions  and responses by both the individual being interviewed and the CE provider;  i.e., does not self-initiate follow-up questions or infer facts or dates not  provided by the individual or the CE provider; Demonstrates familiarity with basic terminology  used in the disability determination process, including medical and social  welfare terminology when necessary; Agrees to comply with Social Security's  disclosure and confidentiality of information requirements; and Has no personal stake in the outcome of the case  that would create a conflict of interest. An individual who is a potential or  actual claimant or beneficiary on the same record as the individual needing  language assistance can act as an interpreter, providing that there is no other  conflict of interest. Selection of a Consultative \n        Examination Source The DDS purchases consultative examinations \n        only from qualified medical sources. The medical source may be the individual's \n        own physician or psychologist, or another source. In the case of a child, \n        the medical source may be a pediatrician. By \"qualified,\" we mean that the \n        medical source must be currently licensed in the State and have the training \n        and experience to perform the type of examination or test we request. \n        Also, the medical source must not be barred from participation in our \n        programs. The medical source must also have the equipment required to \n        provide an adequate assessment and record of the existence and level of \n        severity of the individual's alleged impairments. Medical sources who perform \n        CEs must have a good understanding of SSA's disability programs and their\n           evidence requirements. The medical source chosen may use\n          support  staff to help perform the consultative examination. Any such\n          support staff  (e.g., X-ray technician, nurse, etc.) must meet appropriate\n          licensing  or certification requirements of the State. Generally, medical sources are\n          selected based on appointment availability, distance from a claimant's\n          home and ability to perform specific examinations and tests. Back to Top Consultative Examination Report Content The examination report should include \n        the claimant's  non-SSN case identifier and a physical description of the claimant, \n        to help ensure that the person being examined is the claimant. The detail and format for reporting \n        the results of the medical history, physical examination, laboratory findings, \n        and discussion of conclusions should follow the standard reporting principles \n        for a complete medical examination. The report should be complete enough \n        to enable an independent reviewer to determine the nature, severity and \n        duration of the impairment, and, in adults, the claimant's ability to \n        perform basic work-related functions. The history and physical examination \n        must be provided as a narrative of the findings. Conclusions in the report must\n          be  consistent with the objective clinical findings found on examination\n          and  the claimant's symptoms, laboratory studies, and demonstrated\n          response  to treatment and on all available information, including\n          the history.  The report, for adults, should include a description,\n          based on the medical source's  \n        own findings, of the individual's ability to do basic work-related activities.\n         It should not include an opinion as to whether the claimant is disabled\n         under the meaning of the law. Signature Requirements All CE reports must be personally\n           reviewed and signed by the medical source who actually performed the\n          examination. The medical source  doing the examination or testing is\n          solely responsible for the report contents and for the conclusions,\n          explanations or comments provided. The source's signature on a report\n          annotated \"not\n          proofed\" or \n        \"dictated but not read\" is not acceptable. A rubber stamp signature or\n         signature entered by another person, such as a nurse or secretary, is\n         not acceptable. How the DDS Reviews Consultative \n        Examination Reports The DDS is obligated to review the CE report\n      to determine whether the specific information requested has been\n      furnished. The CE report must: Provide evidence that serves as an adequate basis for disability decision making in terms of the impairment it assesses. Be internally consistent. Are all the diseases, impairments and complaints described in the history adequately assessed and \n          reported in the clinical findings? Do the conclusions correlate the medical history, the clinical examination and laboratory tests, and explain all abnormalities? Be consistent with the other information available within the specialty \n          of the examination requested. Did the report fail to mention an important or relevant complaint within\n          that specialty that is noted in other evidence in the file \n          (e.g., blindness in one eye, amputations, pain, alcoholism, depression)? Be adequate as compared to the standards set  out in the course of\n           a medical education. Be properly signed. If the report is inadequate or\n          incomplete, the DDS will contact the medical source and ask the medical\n          source to furnish the missing information or prepare a revised report. Back to Top",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 3,
        "text": "Consultative Examinations: A Guide for \n        Health Professionals"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/greenbook/ce-guidelines.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/index.htm",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-general.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-evidence.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-guidelines.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-guidelines.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-guidelines.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-guidelines.htm"
    ],
    "html_file": "ssa_bluebook_data/html/450df48d03dd6cc554ac9e3b43d08db2.html",
    "fetched_at": 1762482641.7775266
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm",
    "url_hash": "b07539b9c923f2c31927900fd1cc4537",
    "title": "Part IV - Adult Consultative Examination Report Content Guidelines | Disability | SSA",
    "text_content": "Part IV - Adult Consultative Examination Report Content Guidelines | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Part IV - Adult Consultative Examination Report Content Guidelines Professionals Home CE Overview General Information Evidence Requirements Consultative Examination Guidelines Adult CE Report Content Guidelines Pediatric CE Report Content Guidelines How Claims are Evaluated-The Medical Listings Consultative Examinations: A Guide for \n        Health Professionals Part IV - Adult Physical Consultative Examination (CE) Report Content The following are guidelines to provide minimum content for CE reports for adult claimants. Each Disability Determination Services (DDS) will notify medical sources of any additional requirements. Section Musculoskeletal Special Senses and Speech Respiratory System Cardiovascular System Digestive Disorders Genitourinary Impairments Hematological Disorders Skin Disorders Endocrine Disorders Neurological Disorders Mental Disorders Cancer Immune System Disorders General Consultative Examination and Report Identification The CE provider will include the claimant's name, date of birth and/or claim number and; The CE provider will indicate that the claimant provided proof of identity by showing a   valid and current government photographic identification (for example, U.S. State-issued driver’s license, U.S. State-issued non-driver identity card, U.S. passport, U.S. military ID, student or school ID, etc.); or provide a physical description of the claimant to verify that the person being examined is the claimant, except if the claimant’s medical source with a treating relationship is the CE provider. Medical history Longitudinal Medical History The CE provider will cite and describe the medical records and any other documents reviewed during the course of the evaluation, and The CE provider will identify the person(s) providing the oral medical history, as well as an assessment of the validity and reliability of such information. Current Medical History The CE provider will describe and discuss as appropriate: The primary impairment(s) alleged as the reason for not working. This information must be in a narrative, rather than a “questionnaire” or “check-off” form, and pertinent descriptive statements by the claimant should be recorded in the claimant’s own words. This description must include: History of the onset and progress of the disorder(s) and/or impairment(s); The claimant’s statement of current symptoms; Type and resultant effect of any treatment; Factors which increase the problem or impairment or that may provide relief; and The claimant’s typical daily activities and the claimant’s description of how their disorder(s) and/or impairment(s) limit their ability to function. Dates and results of relevant hospitalizations, surgical operations, and diagnostic procedures (for example, audiometry, tympanography, MRI). Past Medical History The CE provider will describe and discuss, as appropriate, any other significant past illnesses, injuries, operations, hospitalizations, and diagnostic procedures with dates of the events, and when possible, the names of the treatment providers or facilities. Current Medications The CE provider will list the name, dose, and frequency of medication(s), including both beneficial and adverse effects, and plans for continued drug administration, schedule, and extent of any therapy. Review of systems The CE provider will describe and discuss other symptoms the claimant has experienced relative to any specific organ systems; and the pertinent negative findings considered in making a differential diagnosis of the current illness or in evaluating the severity of this or any other alleged impairment. Social history The CE provider will include pertinent findings about use of tobacco products, alcohol, and nonprescription drugs, etc., as well as relevant work history such as occupations with exposure to hazards. Family history The CE provider will include the relevant information. Physical examination and other objective findings Physical examination The CE provider will describe and discuss as appropriate: General observations, such as how the claimant arrived at the examination, whether they were alone or accompanied, the distance they traveled, and if they arrived by automobile, who drove; General appearance (including any obvious vision or hearing loss, and facial, skeletal, or other abnormalities); Blood pressure, pulse rate and rhythm, respiratory rate; Nutritional status (including height and weight without shoes, including the presence and impact of obesity, if appropriate); Behavior (such as cooperativeness and effort on testing, as appropriate); and A thorough and complete physical examination, with aspects of the examination focusing on the claimant’s major and minor complaints in detail, describing both pertinent positive and negative findings. Laboratory and imaging tests (for example, x-ray) The CE provider will obtain only after proper authorization from the DDS. The CE provider will provide an interpretation of laboratory and imaging tests. The CE provider will provide interpretation that takes into account, and correlates with, the history and physical examination findings. If the interpretation is provided separately, or if a medical source other than the person signing the CE report is providing the formal interpretation of the results, the report sheet should state the interpreting medical source’s name and address. Medical opinion The medical source should provide a medical opinion The CE provider will assess the claimant’s ability to perform the demands of work activities, and any limitations based upon the claimant’s medical history, medical signs and observation during the examination, and results of relevant laboratory and imaging tests. The CE provider will specify the nature and extent of the condition(s) or disorder(s); The CE provider will discuss any apparent discrepancies in the medical history and/or in the examination findings; and The CE provider will specify any limitations in functioning that result from the condition(s) or disorder(s), including: Lifting, carrying, pushing, pulling; Sitting, standing, walking; Postural (for example: climbing, stooping, bending, balancing, crawling, kneeling and/or crouching); Fine or gross motor skills (for example; handling, fingering, gripping, and/or feeling); Overhead, lateral, and forward reaching: Vision, hearing, and speech; and Environmental exposures (for example: extreme heat, extreme cold, wetness, humidity, noise, vibration, and hazards). Back to Top Report content by Specific Impairment Musculoskeletal Disorders Use the following guidelines to provide minimum content for CE reports for adult claimants with musculoskeletal disorders. Each Disability Determination Services (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content The CE report guidelines for adult musculoskeletal disorders in this section are in addition to the general CE report content guidelines. See General Consultative Examination and Report . Report content specific to musculoskeletal disorders The CE provider will use the specific requirements below to complete the CE report for a musculoskeletal disorder. Current medical history The CE provider will describe and discuss, as appropriate: Character, location, and radiation of pain; Factors that incite and relieve the pain as well as attempted treatment modalities such as medication, physical therapy, and/or surgical intervention, as well as their effect; Any history of fractures of bones (traumatic), dates and frequency of fractures, imaging (if available), and the status of any fractures (including clinical evidence of union or non-union) at the time of the examination; Symptoms of weakness, other motor loss, and/or any sensory abnormalities; and Dates and results of any relevant diagnostic procedures, such as x-rays, myelography, CT scan, MRI, and radio-nuclear bone scan. Physical examination The CE provider will describe and discuss, as appropriate: Any apparent abnormalities such as gait or the need for any type of assistive device: If the claimant uses an assistive device(s), note the type of, and medical need for, the device, the medical impairment the device is needed for, and examination findings that support the medical need for the assistive device. Also, note whether the assistive device was prescribed, how frequently it is used, the date it was prescribed, and the medical source who prescribed it. For lower extremity assistive devices, describe the claimant’s gait with and without use of the device. Describe the claimant's ability to bend, squat, arise from a squatting position, tandem walk, walk on their heels and toes, get up from a chair, get on and off the examining table, and dress and undress. Extremities and peripheral joints: Active and passive range of motion. If active range of motion is abnormal, describe passive range of motion and how active range of motion differs from passive range of motion; Effusion; Peri-articular swelling; Pain, if any, and its distribution; Tenderness; Redness or heat; Thickening; Structural deformities; Instability; Grip, pinch, ability to close the fist or perform fine and gross manipulations, and strength (measured either by dynamometer or 0-5 scale); Extremity strength (measured either by dynamometer or 0-5 scale); Atrophy; and Ability to use, and effective use of, any orthoses. Spine Distribution of pain, tenderness, and sensory and/or motor loss; Muscle spasms, when present; Intensity and symmetry of deep tendon reflexes; Active range of spinal motion; When the lumbar spine is an issue, straight-leg raising (lumbar spine, both sitting and supine); and When the cervical spine is an issue, provocation test for radiculopathy, such as the Spurling Test (cervical spine). Amputated extremities: Description of stump, including integrity of skin flap; Tenderness; and Ability to use, and effective use of any prostheses, as well as the functional level of the contralateral extremity. It is not necessary to evaluate the individual’s ability to walk without the prostheses in place. Fractures of bones of extremities or pelvis: Review of imaging such as x-rays or MRI; and Clinical evidence of union or non-union. Soft tissue injuries/burns: Nature and extent of the injury; Skin sensitivity; and Effect the injury has on joint motion. Back to Top Special Senses & Speech Disorders Use the following guidelines to provide minimum content for CE reports for adult claimants with special senses and speech disorders. Each Disability Determination Services (DDS) will notify medical sources of any additional requirements. General guidelines for adult special senses and speech disorders CE report content The CE report guidelines for adult special senses and speech disorders in this section are in addition to the general CE report content guidelines. See General Consultative Examination and Report . Report content specific to visual disorders The CE provider will use the specific requirements below to complete the CE report for a visual disorder. Current medical history The CE provider will describe and discuss, as appropriate: Character and severity of visual loss; and Dates and results of relevant diagnostic procedures, such as imaging studies, visual acuity testing, and visual field testing. Physical examination The CE provider will describe and discuss, as appropriate: Best corrected visual acuity for each eye, and the lens correction for each eye (manifest refraction, correction of own lenses is not sufficient for \"best corrected\"); If there is a loss of visual acuity, document the cause of the loss. If the vision loss is due to a cortical visual disorder, it must be confirmed by documenting the cause of the brain lesion. Examination of pupils, external examination, and extraocular motions; Visual field -- confrontation visual fields; If confrontation fields are not normal, or if there is a history of glaucoma or other conditions resulting in visual field loss, visual fields are needed; Confrontation fields are acceptable evidence that the fields are normal. Restricted fields must be confirmed either by acceptable automated static threshold perimetry, measuring the central 24 to 30 degrees of the visual field performed on an acceptable perimeter (acceptable tests include the Humphrey Field Analyzer (HFA) 30-2, Octopus 32, Octopus 30-2, and HFA 24-2); or an acceptable manual or automated kinetic perimetry (for example, Goldmann perimetry); Include a printout of any visual field testing (perimetry) results; and If there is a loss of visual fields, document the cause of the loss. Intraocular pressure for each eye; Slit lamp examination: include detailed description of the cornea and lens; Fundus examination: include detailed description of the discs, vessels, maculae, and peripheral retina; and Describe any observed visual behaviors, such as the ability to navigate in the office, reaching for items handed to them, using a cellphone in the waiting room, etc. Report content specific to hearing loss The CE provider will use the specific requirements below to complete the CE report for a hearing disorder. Current medical history The CE provider will describe and discuss, as appropriate: Character and severity of hearing loss; and Dates and results of relevant diagnostic procedures, such as audiometry, typanography, and MRI. Physical examination The CE provider will describe and discuss, as appropriate: Examination of the ears, nose, and throat; An otologic examination; The external ears (pinnae and external ear canals) and the tympanic membranes; and Any middle ear abnormalities. Hearing loss; The condition that causes the hearing loss, including any related speech impairments; and Whether the hearing loss is sensorineural, conductive, or mixed. Claimants without a cochlear implant(s); and Pure tone air conduction and bone conduction testing, speech reception threshold (SRT) testing, and word recognition testing; Testing must be done in a sound-treated booth or room; Testing must be done in accordance with the most recently published standards of the American National Standards Institute (ANSI); Each ear must be tested separately; and If the SRT is not within 10dB of the average pure tone air conduction thresholds at 500, 1,000, and 2,000 Hz, document the medical basis for the discrepancy. Claimants with a cochlear implant(s) Sentences presented at 60 dB hearing level and without any visual cues; In a quiet sound field; and With the cochlear implant in place, functioning properly, and adjusted to the claimant’s normal settings. Report content specific to labyrinthine-vestibular disorders The CE provider will use the specific requirements below to complete the CE report for a labyrinthine-vestibular disorder. Current medical history The CE provider will describe and discuss, as appropriate: Episodes of vertigo, including frequency, severity, and duration of the attacks; Nausea and vomiting; Ataxia; Tinnitus; Progressive hearing loss; and Dates and results of relevant diagnostic procedures such as x-rays, CT scan, MRI, or radio-nuclear bone scan. Physical examination The CE provider will describe and discuss, as appropriate: Examination of the ears, nose, and throat; An otologic examination; Describe the external ears (pinnae and external ear canals) and the tympanic membranes; and Assess any middle ear abnormalities. Report the presence of absence of nystagmus, Romberg results, and cerebellar signs; The results of any caloric and other vestibular tests; and Pure tone audiometry showing progressive hearing loss with special examinations such as Bekesy audiometry. Report content specific to speech sound disorders The CE provider will use the specific requirements below to complete the CE report for a speech sound disorder. Current medical history The CE provider will describe and discuss, as appropriate: Duration, onset, and cause of the speech sound disorder(s), if known; Dates and results of any relevant diagnostic procedures or testing; and Treatment modalities, dates of treatments, and responses to treatments. Physical examination The CE provider will describe and discuss, as appropriate: The claimant's ability to produce and sustain speech; The use of, or need for, any voice modulation or amplification devices; The claimant's speech articulation and volume for sustained speech; and The presence of abnormalities such as aphasia, dysarthia, stuttering, or involuntary vocalizations. Back to Top Respiratory Disorders Use the following guidelines to provide minimum content for CE reports for adult claimants with respiratory disorders. Each Disability Determination Services (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for adult respiratory disorders The CE report guidelines for adult respiratory disorders in this section are in addition to the general CE report content guidelines. See General Consultative Examination and Report. Report content specific to respiratory disorders The CE provider will use the specific requirements below to complete the CE report for a respiratory disorder: Current medical history The CE provider will describe and discuss, as appropriate: Dyspnea at rest and/or with exertion; How much activity causes dyspnea (for example, distance the claimant can walk and how many flights of stairs they can climb before resting); Palpations, wheezing, cough, sputum production, chest discomfort, paroxysmal nocturnal dyspnea, and orthopnea; Characteristics of severe respiratory attack or persistent pulmonary infection; History of hospital admissions or emergency department visits; and Episodic disorders, such as asthma: Onset and precipitating factors; Frequency and intensity; Duration; Mode of treatment and response; Compliance with therapy including frequency of inhaler use; and Description of a severe attack. Social history The CE provider will describe and discuss, as appropriate, any tobacco use, substance use, or any employment history relevant to the condition such as exposure to fibrotic agents, chemicals, or irritants. Physical examination The CE provider will describe and discuss, as appropriate: Assistive devices: presence of tracheostomy, central venous catheter, or gastrostomy; The presence of, or need for supplemental oxygen and for what period (for example, all the time, with exercise, at night, etc.); Respiratory rate: whether respirations are labored, and use of accessory muscles of respiration; Lungs: Occurrence of cough, audible wheezing, pallor cyanosis, hoarseness, clubbing of fingers, chest wall deformity, and any abnormal curvature of the spine; Whether there is prolongation of the expiration phase or respiration; Quality of breath sounds (or air exchange), whether normal or diminished; Presence of adventitious sounds (such as wheezing, rhonchi, or rales); and Diaphragmatic motion. Heart and vascular: Description of heart sounds; Presence of any lifts, heaves, or thrills; Heart size; Point of maximal impulse of cardiac apex; Presence of any murmurs, rubs, or gallops; Presence and location of any bruits; Distention of neck veins; and Presence, type, and extent of any peripheral edema and any associated skin discoloration or ulceration. Pulmonary Function Tests The CE provider will obtain pulmonary function tests only after receiving proper authorization from the DDS. Spirometry: Perform as specified in section 3.00E of the respiratory listings (see https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm ). Diffusing capacity of the lungs (DLCO) test: Perform as specified in section 3.00F of the respiratory listings listings (see https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm ). Arterial blood gas (ABG) test: Perform as specified in section 3.00G of the respiratory listings listings (see https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm ). Pulse oximetry: Perform as specified in section 3.00H of the respiratory listings listings (see https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm ). Back to Top Cardiovascular Disorders Use the following guidelines to provide minimum content for CE reports for adult claimants with cardiovascular disorders. Each Disability Determination Services (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for adult cardiovascular disorders The CE report content guidelines for adult cardiovascular disorders in this section are in addition to the general CE report content guidelines. See General Consultative Examination and Report . Report content specific to cardiovascular disorders The CE provider will use the specific requirements below to complete the CE report for a cardiovascular disorder. Current medical history The CE provider will describe and discuss, as appropriate: Dyspnea, orthopnea, fatigue, and exercise intolerance; Chest pain (angina, angina equivalents, or variant angina) and reduced cerebral perfusion (for example, confusion, difficulty walking); The quality, location, radiation, and duration of the chest pain noted, along with factors that exacerbate the chest pain (for example, continued activity, deep breathing, etc.); and factors that relieve the chest pain (for example, rest, nitroglycerin, food, etc.); Any associated symptoms such as shortness of breath, diaphoresis, nausea, dizziness, lightheadedness, near syncope, or syncope; Intermittent claudication, swelling, and skin changes in the lower extremities; and Dates and results of relevant diagnostic procedures, such as electrocardiography, exercise-tolerance stress testing, angiography, echocardiography, Doppler tests, and any other imaging studies. Social history The CE provider will describe and discuss, as appropriate, any employment history relevant to the alleged condition(s) such as exposure to chemicals or irritants. Include pertinent findings about use of tobacco products, alcohol, and nonprescription drugs. Physical examination The CE provider will describe and discuss, as appropriate: Lungs: Whether respiratory rate is labored or unlabored and diaphragmatic motion; Occurrence of cough, audible wheezing, pallor cyanosis, hoarseness, clubbing of fingers, chest wall deformity, any abnormal curvature of the spine; and Breath sounds (air exchange), whether there is prolongation of the exhalatory phase of respiration, and the presence or absence of adventitious sounds (such as rales or rhonchi). Heart and vascular: Presence of any lifts, heaves, or thrills; Heart size; Point of maximal impact of cardiac apex; Presence of any murmurs, rubs, or gallups; Presence and location of any bruits; Distention of neck veins; Presence, type, and extent of any peripheral edema and any associated skin discoloration or ulceration; Quality of peripheral pulses in extremities; Presence and quality of carotid pulses; and Presence of any abdominal pulsation or bruit. Electrocardiogram (ECG), exercise tolerance test (ETT), and Doppler test Obtain ECG, ETT, and Doppler test only after receiving proper authorization from the DDS. ECG: Perform as specified in section 4.00C of the cardiovascular listings (see https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm ) and provide ECG tracings. ETT: Perform as specified in section 4.00C of the cardiovascular listings (see https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm ). Doppler tests: Perform as specified in section 4.00C of the cardiovascular listings (see https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm ). Back to Top Digestive Disorders Use the following guidelines to provide minimum content for CE reports for adult claimants with digestive disorders. Each Disability Determination Services (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for adult digestive disorders The CE report guidelines for adult digestive disorders in this section are in addition to the general CE report content guidelines. See General Consultative Examination and Report . Report content specific to digestive disorders The CE provider will use the specific requirements below to complete the CE report for a digestive disorder. Current medical history The CE provider will describe and discuss, as appropriate: Fatigue, muscle weakness, sensory abnormalities, cognitive impairment, malaise, loss of appetite; Sleep disturbance and any other nocturnal symptoms; Pain, if present, and its location; Recent (involuntary) weight loss and the amount; Bowel and bladder patterns; Nausea; and Dates and results of relevant diagnostic procedures (such as diagnostic imaging, endoscopy, biopsy, aspiration of ascetic fluid, and clinical laboratory test). Physical examination The CE provider will describe and discuss, as appropriate: Presence of jaundice and pallor; Liver and spleen size; Muscle wasting; Presence of edema, ascites, and asterixis; Presence of any abdominal masses; Rectal bleeding (if the claimant allows the physician to observe the claimant's rectum); Evidence of perianal disease; and Superficial manifestations of liver disease, such as, spider angiomas, caput medusae, and/or altered venous flow on the abdomen. Laboratory tests or findings The CE provider will obtain laboratory testing only after receiving proper authorization from the DDS. Describe and discuss the results of such tests as appropriate: Serum creatinine; Serum total bilirubin; International normalized ratio (INR); Serum sodium; Serum albumin; and Hemoglobin. Back to Top Genitourinary Disorders Use the following guidelines to provide minimum content for CE reports for adult claimants with genitourinary disorders. Each Disability Determination Services (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for adult genitourinary disorders The CE report guidelines for adult genitourinary disorders in this section are in addition to the general CE report content guidelines. See General Consultative Examination and Report . Report content specific to genitourinary disorders The CE provider will use the specific requirements below to complete the CE report for a genitourinary disorder. Current medical history The CE provider will describe and discuss, as appropriate: Frequency of any renal dialysis, as well as the date of first dialysis; Fatigue; Dyspnea; Motor weakness and/or sensory abnormalities; Loss of appetite; and Dates and results of relevant diagnostic procedures, such as imaging studies, renal biopsy, and clinical laboratory tests. Physical examination The CE provider will describe and discuss, as appropriate: Renal osteodystrophy; Ascites or anasarca; Pleural effusions; Type and location of any edema; and Any signs of cardiac involvement. Back to Top Hematological Disorders Use the following guidelines to provide minimum content for CE reports for adult claimants with hematological disorders. Each Disability Determination Services (DDS) will notify medical sources of any additional requirements. General guidelines for CE report for adult hematological disorders The CE report guidelines for adult hematological disorders in this section are in addition to the general CE report content guidelines. See General Consultative Examination and Report . Report content specific to hematological disorders The CE provider will use the specific requirements below to complete the CE report for a hematological disorder. Current medical history The CE provider will describe and discuss, as appropriate: Dates and results of relevant diagnostic procedures such as complete blood count (CBC), mean corpuscular volume (MCV), platelets, reticulocyte count, serial hemoglobin, hemoglobin electrophoresis, blood smears, and bone marrow examination; and A detailed description of the following: Abnormal blood clotting; Pain crises; Infections; and Frequency of red blood cell (RBC) or other blood component transfusions or infusions. Physical examination The CE provider will describe and discuss, as appropriate: Any apparent abnormalities such as pallor, jaundice, abnormal bruising, petechiae, ecchymoses, edema, fatigue level, or enlarged lymph nodes; Joint examination including swelling, tenderness, and range of motion; Abdominal examination including liver, spleen, or abnormal masses; General and focal neurologic examinations; and Mental status examination. Back to Top Skin Disorders Use the following guidelines to provide minimum content for CE reports for adult claimants with skin disorders. Each Disability Determination Services (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for adult skin disorders The CE report guidelines for adult skin disorders in this section are in addition to the general CE report content guidelines. See General Consultative Examination and Report . Report content specific to skin disorders The CE provider will use the specific requirements below to complete the CE report for a skin disorder. Current medical history The CE provider will describe and discuss, as appropriate: Dates and results of relevant diagnostic procedures such as biopsy and genetic testing; Treatment modalities, dates of treatments, and responses to treatments; Frequency, severity, and duration of skin lesion exacerbations; and If the claimant uses a lower extremity assistive device, note whether the assistive device was prescribed, how frequently it is used, the date it was prescribed, and the medical source who prescribed it. Physical examination The CE provider will describe and discuss, as appropriate: Location and size of skin lesion(s) and contractures, associated symptoms such as pain or tenderness, and extent of the body affected (e.g., one or both extremities); Joint function including range of motion of the affected joint(s); If at least one extremity is affected (including involvement of the perineum or inguinal region affecting lower extremity functioning), describe ability to: Perform gross (e.g., reaching, lifting, carrying, handling, and gripping) and fine (e.g., picking, pinching, manipulating, and fingering) movements; Stand up from a seated position; and Maintain an upright position while standing or walking. Provide a description of the claimant’s gait. If the claimant uses a lower extremity assistive device, describe: Claimant’s gait with and without use of the device; and The device and how it is used by the claimant, the medical need for the device, the medical impairment the device is needed for, and the examination findings that support the medical need for the assistive device; and Optional with consent of the claimant: a digital photograph to document the severity of the skin lesion(s). Back to Top Endocrine Disorders Use the following guidelines to provide minimum content for CE reports for adult claimants with endocrine disorders. Each Disability Determination Services (DDS) will notify medical sources of any additional requirements. General guidelines for CE report for adult endocrine disorders The CE report guidelines for adult endocrine disorders are in addition to the general CE report content guidelines. See General Consultative Examination and Report . Report content specific to endocrine disorders The CE provider will use the specific requirements below to complete the CE report for an endocrine disorder. Current medical history The CE provider will describe and discuss, as appropriate: Heat or cold intolerance; Sensory aberrations; Any vision loss; Convulsions, tetany, or episodes of alteration of consciousness; Bone pain or localization of pain; Abnormal bowel or urinary pattern; and Dates and results of relevant diagnostic procedures, such as CBC, liver enzymes, adrenal function, serum electrolytes, calcium and phosphorus, fasting blood glucose; glucose tolerance testing, Hb1AC, blood chemistries, T3, TSH, urinalysis, and relevant imaging studies. Physical examination The CE provider will describe and discuss, as appropriate: Abnormal sweating, dry skin, or changes in color or texture of skin; Abnormal eye changes, such as exophthalmia, cataracts, visual field loss, extra ocular muscle movement, and fundus changes (retinitis proliferens); Abnormal masses of neck or abdomen; Peripheral neuropathy – sensory or motor; Presence of Chvostek or Trousseau signs; and Mental status examination. Back to Top Neurological Disorders Use the following guidelines to provide minimum content for CE reports for adult claimants with neurological disorders. Each Disability Determination Services (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for adult neurological disorders The CE report guidelines for adult neurological disorders in this section are in addition to the general CE report content guidelines. See General Consultative Examination and Report . Report content specific to neurological disorders The CE provider will use the specific requirements below to complete the CE report for a neurological disorder. Current medical history The CE provider will describe and discuss, as appropriate: Cognitive impairment; Motor weakness; Sensory abnormalities; Problems with speech; Problems with swallowing; Problems with voiding and defecation; Complete description of seizures including type and severity, auras, behavior prior to seizure, diurnal or nocturnal, frequency per month during the past year, duration of episodes, postictal phenomena, and date of last three seizures; Cooperation with taking medication as prescribed and response to treatment; Blood levels, if available; Dates and results of relevant electrodiagnostic studies, such as EMG, NCV, evoked potentials, or EEG; and Headaches, including known triggers, frequency, length, and response to treatment. Physical examination The CE provider will describe and discuss, as appropriate: Any apparent abnormalities in gait: Gait (including timed walking speed, when appropriate), or Need for any type of assistive device and the reason such device is needed. Mobility (including hand dominance) – ability to: Use the upper extremities effectively for gross and fine movements; Get up from a seated position and stand; Walk with and without assistance; Get on and off the examination table; Tandem walk; and Walk on heels and toes. Coordination – abnormal movements, especially tremors and incoordination Motor function: Strength – 0-5/5 (MRC scale) or dynamometer, when appropriate; Atrophy or flaccidity; Spasticity; Rigidity; Limitation of movement; Fatigability of extremities; and Reflexes – deep tendon and superficial. Myasthenia gravis or cases in which fatigue is alleged: Test for ability to fatigue the claimant by exercise (for example, ptosis develops after 1 minute of attempted up gaze or strength declines from 5/5 at rest to 2/5 after 10 minutes of exercise of a particular muscle). Cranial nerve functions: Visual acuity and confrontation visual fields; Pupillary response to light and accommodation; Examination of extraocular movements or presence of nystagmus; Facial sensation including corneal reflex and masseter strength and bulk; Facial muscle strength and symmetry; Hearing test; and Other functions, as appropriate, such as gag reflex, neck muscle strength, ability to detect odors, and tongue movement (strength or atrophy). Sensory function: Pattern – anatomic or non-anatomic; and Characteristics of any pain and relationship to underlying disorder. Mental status examination: Orientation; Memory; Calculation; Insight; General understanding; Fund of knowledge; and Mood and behavior during examination. Speech and language functioning: Intelligibility and fluency; Aphasia including ability to comprehend language or produce language either spoken or written; Dysarthria; Stuttering; and Involuntary vocalizations. Back to Top Mental Disorders Use the following guidelines to provide minimum content for CE reports for adult claimants with mental disorders. Each Disability Determinations Service (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for adult mental disorders The CE report guidelines for adult mental disorders in this section are in addition to the general CE report content guidelines. See General Consultative Examination and Report . Identification The CE provider will include the claimant’s name, date of birth, and/or claim number; and The CE provider will indicate that the claimant provided proof of identity by showing a valid and current government photo identification (for example, U.S. State-issued driver’s license, U.S. State-issued non-driver identity card, U.S. passport, U.S. military ID, or Student or school ID, etc.), or provide a physical description of the claimant to verify that the person being examined is the claimant, except if the claimant's medical source with a treating relationship is the CE provider. Medical history Longitudinal medical history The CE provider will cite and describe the medical records and any other documents reviewed during the course of the evaluation; The CE provider will identify the person(s) providing the oral medical history and an assessment of the validity and reliability of such information; and If the person providing the oral medical history is someone other than the claimant, the CE provider will indicate whether the person was interviewed separately or in the presence of the claimant. Current medical history The primary impairment(s) alleged as the reason for not working. This information must be in a narrative, rather than a “questionnaire” or “check-off” form, and pertinent descriptive statements by the claimant, should be recorded in the claimant’s own words. This description must include: History of the onset and progress of the disorder; The claimant’s statement of current symptom(s); Type and resultant effect of any treatment; Factors which increase the problem or impairment or that may provide relief; and The claimant’s typical daily activities and the claimant’s description of how their disorder(s) and or impairment(s) limit their ability to function. Information provided by the claimant, or other source. This report should provide a detailed description of the claimant’s: Ability to understand, remember, and apply information; Ability to interact with others; Ability to concentrate, persist, and maintain pace; Ability to adapt and manage oneself; Ability to function in personal, social, and occupational situations; Attempts to return to work and the results; and Daily activities. Past medical history Outpatient evaluations and treatment for mental and emotional problems, including: Names of medical sources providing treatment; Dates of treatment; Types of treatment (names and dosages of medications, if prescribed); and Response to treatment. Hospitalization for the disorder, including: Names of hospitals; Dates; and Treatment and response. Current medications The CE provider will list the name, dose, and frequency of medication(s), including both beneficial and adverse effects, and plans for continued drug administration, schedule, and extent of any therapy. Longitudinal account of the claimant's personal life The CE provider will describe and discuss, as appropriate: Relevant educational, medical, social, legal, military, marital, and occupational data; and any associated problems in adjustment; Details (dates, places, etc.) of any past history of outpatient treatment and hospitalizations for mental/emotional conditions; and History, if any, of substance use or treatment in detoxification and rehabilitation centers. Mental status examination The CE provider will describe and discuss, as appropriate: Appearance, behavior, and speech (if not already described). For example, dress, grooming, and appearance of invalidism; Thought process. For example, loosening of associations; Thought content. For example, delusions; Perceptual abnormalities. For example, hallucinations; Mood and affect. For example, depression or mania; Sensorium and cognition. For example, orientation, concentration, remote memory, recall of new information, fund of information, and estimated intelligence; Judgment and insight; NOTE: The description of the claimant’s mental status must not be an enumeration of the symptoms reported by the claimant (or other source) in DI 22510.112C.2, rather the description must be the examining source’s description of the above items. Further, the CE provider will describe and discuss general observations, as appropriate; How the claimant came to the examination; Alone or accompanied; Distance and mode of transportation; and If by automobile, who drove. Attitude and degree of cooperation; Posture and gait; and Involuntary movements. Diagnosis The report should include the American Psychiatric Association standard nomenclature as set forth in the current edition of the Diagnostic and Statistical Manual of Mental Disorders. Prognosis The CE report should include prognosis and recommendations for treatment, if indicated. The report should also include recommendations for any other medical evaluation (for example, neurological, general physical), if indicated. Capability The report should include information about whether the claimant can manage his or her funds. Additional requirements for specific mental disorders Schizophrenia spectrum and other psychotic disorders If the claimant has alleged a disorder on the schizophrenia spectrum or other psychotic disorders the medical source must provide a detailed description of the following, as appropriate: Periods of residence in structured settings such as half-way houses and group homes; Frequency and duration of episodes of illness and periods of remission; and Side effects of medications. Neurocognitive disorders If the claimant has alleged a neurocognitive disorder, the medical source must provide a detailed description of the following, as appropriate: The etiology of the disorder and onset date (if known), the prognosis, and: Whether there is an acute or chronic process; Whether stable or progressive; Changes at various points in time; and Whether there has been a clinically significant decline in cognitive functioning and, if so, the basis for the conclusion that there has been a decline. The results of any psychological or neuropsychological testing that may have been performed that could serve to further document an organic process and its severity. Information regarding the results of any neurological evaluations. Intellectual disability The report of intellectual disability should include the following: Current documentation of IQ by a standardized test of general intelligence; Acceptable test instruments (for example, the Wechsler scales) are those that: Meet contemporary psychometric standards for validity, reliability, normative data, and scope of measurement; Are individually administered according to all pre-requisite testing conditions; and Have a mean of 100 and a standard deviation of 15. Summary of composite scores; For example, Full Scale IQ, Verbal Comprehension Index, Perceptual Reasoning Index together with the individual subtest scores. Interpretation of the obtained scores; The medical source should indicate whether the scores are representative of the claimant’s present level of intellectual functioning. Any factors that may have influenced the results, such as the claimant’s attitude and degree of cooperation, the presence of visual, hearing, or other physical problems, and recent prior exposure to the same or similar test; and Consistency of the obtained test results with the claimant’s education, vocational background, and social adjustment, especially in the area of personal self-sufficiency. Provide a medical opinion The CE provider will specify the nature and extent of the condition(s) or disorder(s); The CE provider will discuss any apparent discrepancies in the medical history or in the examination findings; The CE provider will specify any limitations in functioning that result for the condition(s) or disorder(s), including the claimant’s ability to: Understand, carry out, and remember instructions (both complex and one-two step); Sustain concentration and persist in work-related activity at a reasonable pace; Maintain effective social interaction on a consistent and independent basis, with supervisors, co-workers, and the public; and Deal with normal pressures in a competitive work setting. Back to Top Cancer Use the following guidelines to provide minimum content for CE reports for adult claimants with cancer. Each Disability Determinations Service (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for adult cancer The CE report guidelines for adult cancer in this section are in addition to the general CE report content guidelines. See General Consultative Examination and Report . Report content specific to cancer The CE provider will use the specific requirements below to complete the CE report for cancer. Current medical history The CE provider will describe and discuss, as appropriate: Fatigue, malaise, affected organ systems; Type of therapy received or planned; Response to therapy – surgical, radiation, and chemotherapy (for each cancer condition if more than one). If multimodal therapy, dates each completed/scheduled and performed by which physician; Effects of any post-therapeutic residuals; Planned treatment; Weight loss; Prognosis, if available; and Dates and results of relevant diagnostic procedures, such as biopsy or tissue pathologic examination and imaging studies. Physical examination The CE provider will describe and discuss, as appropriate: Review any biopsy or tissue pathologic examination; Imaging studies; and Other body systems affected by adverse effects of treatment. Back to Top Immune System Disorders Use the following guidelines to provide minimum content for CE reports for adult claimants with immune system disorders. Each Disability Determinations Service (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for immune system disorders The CE report guidelines for immune system disorders in this section are in addition to the general CE report content guidelines. See General Consultative Examination and Report . Report content specific to immune system disorders The CE provider will use the specific requirements below to complete the CE report for an immune system disorder. Current medical history The CE provider will describe and discuss, as appropriate: Weight loss; Fever; Pain; Fatigue; Malaise; Degree of limitation in: Activities of daily living; Maintaining social functioning; and Completing tasks in a timely manner due to deficiencies in concentration, persistence, and pace; and Effects in other organ systems. Physical examination The CE provider will describe and discuss, as appropriate: Signs of affected body systems, such as heart, lungs, kidneys, eyes, digestive system, skin, etc.; Any apparent abnormalities such as gait or the need for any type of assistive device; If the claimant uses an assistive device(s), note the type of, and medical need for, the device. For lower extremity assistive devices, describe the claimant’s gait with and without use of the device. Ability to: Tandem walk; Walk on heels and toes; Bend; Squat; Get up from a seated position; Grasp or shake hands; Write; and Turn door handles. Extremities and peripheral joints: If active range of motion is abnormal, describe passive range of motion and how active range of motion differs from passive range of motion; Effusion; Peri-articular swelling; Tenderness; Redness; Heat; Thickening; Structural deformities; Instability; Grip, pinch, and ability to fully close the fist (either by dynamometer or 0-5 scale); Extremity strength (either by dynamometer or 0-5 scale); Atrophy; and Ability to use, and effective use of, any orthoses. Spine: Distribution of pain, tenderness, sensory or motor loss; and Active range of spinal motion; Back to Top",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Consultative Examinations: A Guide for \n        Health ProfessionalsPart IV - Adult Physical Consultative Examination (CE) Report Content"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/index.htm",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-general.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-evidence.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-guidelines.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Musculoskeletal",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Special",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Respiratory",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Cardiovascular",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Digestive",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Genitourinary",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Hematological",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Skin",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Endocrine",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Neurological",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Mental",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Cancer",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Immune System",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#GeneralConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#GeneralConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#GeneralConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#GeneralConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#GeneralConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#GeneralConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#GeneralConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#GeneralConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#GeneralConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#GeneralConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#GeneralConsultativeExamReport",
      "http://policynet.ba.ssa.gov/poms.nsf/lnx/0422510112",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#GeneralConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#GeneralConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm"
    ],
    "html_file": "ssa_bluebook_data/html/b07539b9c923f2c31927900fd1cc4537.html",
    "fetched_at": 1762482644.0868828
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm",
    "url_hash": "1a2313c9f67866f19244520e848cc830",
    "title": "Pediatric Physical Consultative Examination Report Content | Disability | SSA",
    "text_content": "Pediatric Physical Consultative Examination Report Content | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Pediatric Physical Consultative Examination Report Content Professionals Home CE Overview General Information Evidence Requirements Consultative Examination Guidelines Adult CE Report Content Guidelines Pediatric CE Report Content Guidelines How Claims are Evaluated-The Medical Listings Consultative Examinations: A Guide for \n        Health Professionals Pediatric Physical Consultative Examination Report Content Section Musculoskeletal System Special Senses and Speech Respiratory System Cardiovascular System Digestive Disorders Genitourinary Impairments Hematological Disorders Skin Disorders Endocrine Disorders Neurological Disorders Mental Disorders Pediatric Cancer Immune System Disorders Pediatric Speech and Languages Impairments Under 3 Years Pediatric Speech and Languages Impairments in Children 3 and Older General Pediatric Consultative Examination and Report The following are guidelines to provide minimum content for CE reports on child claimants. Each Disability Determination Services (DDS) will notify medical sources of any additional requirements. Identification The CE provider will include the claimant's name, date of birth, and/or claim number; and, Indicate that the claimant and/or caregiver provided proof of identity by showing an original document proving age and identity (social security card, U.S. passport, birth certificate, student or school ID, daycare center or school record); or, Provide a physical description of the claimant to verify that the person being examined is the claimant, except if the claimant's medical source with a treating relationship is the CE provider. Medical History Longitudinal medical history The CE provider will cite and describe the medical records and any other documents reviewed during the course of the evaluation, and Identify the person(s) providing the oral medical history, as well as an assessment of the validity and reliability of such information. Current medical history The CE provider will describe and discuss, as appropriate: The primary impairment(s) alleged for the current child disability claim and explanation of how the child functions. This information must be in a narrative, rather than a “questionnaire” or “check-off” form, and pertinent descriptive statements by the claimant and/or caregiver, should be recorded in the claimant’s own words. This description must include: Onset, frequency, symptoms, and duration of the impairment(s); Current treatment plan including medicines and dosages, role of child and caregiver in administration of treatment plan, and need for periodic adjustments in medication regimen; Special therapy, equipment, or devices; Response to treatment, including medications and any side effects, and overall extent of control of the impairment(s); and Source(s) of medical care including specialist(s) or specialty clinic(s). Dates and results of relevant hospitalization, surgical operations, and diagnostic procedures. Past medical history The CE provider will describe and discuss, as appropriate: prenatal, delivery, and neonatal course; other significant events including past illnesses, injuries, operations, hospitalizations, prior developmental therapies, and urgent care encounters; and when possible, the dates of the events and names of facilities that provided treatment. Information about the child's growth and development Any delay(s) in length, height, measurement of head circumference for children under age 3, or weight growth, when impairment(s) would be expected to affect growth; Early infant or preschool intervention services; For children who have not attained age 6, developmental milestones (for example, the results of a formalized developmental screening test) For children age 6 and older, usual daily activities; and Current grade, type of class, limitations of activities, and need for special assistance or extra care. Review of body systems The CE provider will describe and discuss other symptoms the claimant has experienced relative to any specific organ systems; and the pertinent negative findings considered in making a differential diagnosis of the current illness or in evaluating the severity of this or any other alleged impairment. Social history The CE provider will include pertinent findings about use of tobacco products, alcohol, and nonprescription drugs, etc. Family history The CE provider will include relevant information, including role of primary caretaker(s) in providing for child’s medical care and daily activity needs. Current Medication(s) The CE provider will list the child's current medication(s) by name of drug, and dose. Physical examination and other objective findings Physical examination The CE provider will describe and discuss, as appropriate: Length, height, and weight measurements (without shoes), as well as impact of obesity, if appropriate, head circumference for children under age 3, and percentiles based on the most recent Centers for Disease Control and Prevention growth standards; Blood pressure, pulse rate and rhythm, and respiratory rate; General appearance including any obvious vision or hearing loss, and facial, skeletal, or other abnormalities; The interaction with the CE provider, including the ability to understand directions and communicate clearly with content appropriate for age; General pediatric examination and body system specific examination as needed; A thorough and complete physical examination addressing the child’s major and minor complaints in detail, with both pertinent positive and negative findings; and, Cooperation and/or effort as appropriate. Laboratory and imaging tests (for example, x-ray) The CE provider will obtain only after proper authorization from the DDS; and Provide an interpretation of laboratory and imaging tests. Provide interpretation that takes into account, and correlates with, the history and physical examination findings. If the interpretation is provided separately, or if a medical source other than the person signing the CE report is providing the formal interpretation of the results, the report sheet should state the interpreting medical source's name and address. Medical Opinion Provide a medical opinion The CE provider will assess the child’s abilities and limitations based upon the child’s medical history, observation during the examination, and results of relevant signs, laboratory and imaging tests. The CE provider will: Specify the nature and extent of the condition or disorder; Discuss any apparent discrepancies in the medical history or in the examination findings; and Specify any limitations in functioning that result from the condition(s) or disorder(s). Back to Top Pediatric - Musculoskeletal Disorders Use the following guidelines to provide the minimum content in a CE report for a child disability case. Each Disability Determination Service (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for pediatric musculoskeletal disorders The guidelines in this section are in addition to the Pediatric CE report content as stated in General Pediatric Consultation Examination Report . Report content specific to pediatric musculoskeletal disorders The CE provider will use the specific requirements below to complete the CE report for a musculoskeletal disorder. Current medical history The CE provider will describe and discuss, as appropriate: Character, location, and radiation of pain; Factors that incite and relieve the pain; Symptoms of weakness, other motor loss, and/or any sensory abnormalities; and Dates and results of any relevant diagnostic procedures, such as x-rays, myelography, CT scan, MRI, and radionuclide bone scan. Physical examination The CE provider will describe and discuss, as appropriate: Any apparent abnormalities such as gait, or the need for any type of assistive device; Extremities and peripheral joints: Active and passive range of motion; If active range of motion is abnormal, describe passive range of motion and how active range of motion differs from passive range of motion; Effusion; Peri-articular swelling; Pain, if any, and its distribution; Tenderness; Redness or heat; Thickening; Structural deformities; Instability; Grip, pinch, ability to close the fist or perform fine and gross manipulations (measured either by dynamometer or 0-5 scale); Extremity strength (measured either by dynamometer or 0-5 scale); Atrophy; and Ability to use, and effective use of, any orthoses. Spine: Distribution of pain, tenderness, and sensory and/or motor loss; Intensity and symmetry of deep tendon reflexes; Muscle spasms, when present; Active range of spinal motion; When the lumbar spine is an issue, straight-leg raising (lumbar spine, both sitting and supine); and, When the cervical spine is an issue, provocation test for radiculopathy, such as the Sperling test. Amputated extremities: Description of stump, including integrity of skin flap; Tenderness; and Ability to use, and effective use of, any prostheses. It is not necessary to evaluate the child’s ability to walk without the prostheses in place. If an upper extremity is involved, the CE provider should comment on the functional level of the contralateral extremity. Fractures of bones of extremities or pelvis: Review of imaging such as x-rays or MRI; and Clinical evidence of union or non-union. Soft tissue injuries/burns: Nature and extent of the injury; Skin sensitivity; and Effect the injury has on joint motion. Back to Top Pediatric - Special Senses and Speech Use the following guidelines to provide the minimum content in a CE report for a child disability case. Each Disability Determination Service (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for pediatric special senses and speech disorders The CE report content guidelines in this section are in addition to the general pediatric CE report content guidelines. See General Pediatric Consultation Examination Report . For pediatric CE report content guidelines for speech disorders and language disorders, see Pediatric - Speech and Language (SL) Impairments in Children from Birth to Attainment of Age 3 and See Pediatric - Speech and Language (SL) Impairments in Children Age 3 and Older Report content specific to pediatric visual disorders The CE provider will use the specific requirements below to complete the CE report for a visual disorder. Current medical history The CE provider will describe and discuss, as appropriate: Character and severity of visual loss; Dates and results of relevant diagnostic procedures, such as imaging studies, visual acuity testing, and visual field testing. Physical examination The CE provider will describe and discuss, as appropriate: Best corrected visual acuity for each eye, and the manifest refraction for each eye. If there is a loss of visual acuity, document the cause of the loss. If the vision loss is due to a cortical visual disorder, it must be confirmed by documenting the cause of the brain lesion. For children who do not have the ability to participate in visual acuity testing using Snellen methodology or other comparable testing, clinical findings of fixation and visual-following behavior. Examination of pupils, external exam, and extraocular motions. Visual fields – confrontation visual fields. If confrontation fields are not normal, or if there is a history of glaucoma, visual field testing is needed; Confrontation fields are acceptable evidence that the fields are normal. Restricted fields must be confirmed either by acceptable automated static threshold perimetry, measuring the central 24 to 30 degrees of the visual field performed on an acceptable perimeter (acceptable test include the Humphrey Field Analyzer (HFA) 30-2, Octopus 32, Octopus 30-2, and HFA 24-2); or an acceptable manual or automated kinetic perimetry (for example, Goldmann perimetry); Include a printout of any visual field testing (perimetry) results; and If there is a loss of visual fields, document the cause of the loss. Intraocular pressure for each eye; Slit lamp exam – cornea and lens, at least; Fundus exam – discs, vessels, and maculae, and peripheral retina; and, Any observed visual behaviors (for example, ability to navigate in the office, reaching for items, using cell phone in waiting room, etc.). Report content specific to pediatric hearing loss Current medical history The CE provider will describe and discuss, as appropriate: Character and severity of hearing loss; and Dates and results of relevant diagnostic procedures, such as audiometry, tympanogram/tympanometry, and MRI. Physical examination The CE provider will describe and discuss as appropriate: Examination of the ears, nose, and throat; An otologic examination: The external ears (pinnae and external ear canals) and the tympanic membranes; and Any middle ear abnormalities Hearing loss: The condition that causes the hearing loss; and Whether the hearing loss is sensorineural, conductive, or mixed. All audiometric testing performed where no cochlear implant or bone-anchored hearing aid (BAHA) is present should be conducted unaided. For children without a cochlear implant(s) from birth to the attainment of age 6 months, physiologic testing, such as auditory brainstem response (ABR) testing. For children without a cochlear implant(s) who are age 6 months to the attainment of age 2, air conduction thresholds determined by a behavioral assessment, usually visual reinforcement audiometry (VRA) or ABR testing, if the behavioral assessment cannot be completed. For children without a cochlear implant(s) who are age 2 to the attainment of age 5, air conduction thresholds determined by a behavioral assessment, such as conditioned play audiometry (CPA), tangible or visually reinforced operant conditioning audiometry (TROCA, VROCA), or VRA. For children without a cochlear implant(s) who are age 5 and older: Pure tone air conduction and bone conduction testing, speech recognition threshold (SRT) testing, and word recognition testing; Testing must be done in a sound-treated booth or room; Testing must be done in accordance with the most recently published standards of the American National Standards Institute (ANSI); Each ear must be tested separately; and If the SRT is not within 10 dB of the average pure tone air conduction thresholds at 500, 1,000, and 2,000 Hz, document the medical basis for the discrepancy. For children with a cochlear implant(s) who are age 5 and older: Sentences presented at 60 dB hearing level and without any visual cues; In a quiet and sound field; and With the cochlear implant in place, functioning properly, and adjusted to the child's normal settings. Back to Top Pediatric - Respiratory Disorders Use the following guidelines to provide the minimum content in a CE report for a child disability case. Each Disability Determination Service (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for pediatric respiratory disorders The CE report content guidelines in this section are in addition to the general pediatric CE report content guidelines. See General Pediatric Consultation Examination Report . Report content specific to pediatric respiratory disorders The CE provider will use the specific requirements below to complete the CE report for a respiratory disorder. Current medical history The CE provider will describe and discuss, as appropriate: Dyspnea at rest and with exertion; Palpation, wheezing, cough, sputum production, chest discomfort, symptoms of hyperventilation, paroxysmal nocturnal dyspnea, and orthopnea; Characteristics of severe respiratory attack or persistent pulmonary infection; History of hospitalizations or emergency department visits; and Episodic disorders, such as asthma: Onset and precipitating factors; Frequency and intensity; Duration; Mode of treatment and response; and Description of severe attack(s). Physical examination The CE provider will describe and discuss, as appropriate: Assistive devices: presence of tracheostomy, central venous catheter, supplemental oxygen, or gastrostomy; Respiratory rate: whether respirations are labored, and use of any accessory muscles of respiration; Lungs: Occurrence of cough, audible wheezing, pallor cyanosis, hoarseness, clubbing of fingers, chest wall deformity, and any abnormal curvature of the spine; Whether there is prolongation of the expiration phase of respiration; Quality of breath sounds (or air exchange), whether normal or diminished; Presence or absence of adventitious sounds (such as wheezing, rhonchi, or rales); and Diaphragmatic motion. Heart and vascular: Description of heart sounds; Presence of any lifts, heaves, or thrills; Heart size; Point of maximal impact of cardiac apex; Presence of any murmurs, rubs or gallops; Distention of neck veins; and Presence, type, and extent of any peripheral edema and any associated skin discoloration or ulceration; Pulmonary Function Tests. The CE provider will obtain pulmonary function tests only after receiving proper authority from the DDS. Perform spirometry testing for children age six and older as specified in section 103.00E of the respiratory listing (see https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm .) Back to Top Pediatric - Cardiovascular Disorders Use the following guidelines to provide the minimum content in a CE report for a child disability case. Each Disability Determination Service (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for pediatric cardiovascular disorders The CE report content guidelines in this section are in addition to the general pediatric CE report content guidelines. See General Pediatric Consultation Examination Report . Report content specific to pediatric cardiovascular disorders The CE provider will use the specific requirements below to complete the CE report for a cardiovascular disorder. Current medical history The CE provider will describe and discuss, as appropriate: Dyspnea; Orthopnea; Exercise intolerance; Hypercyanotic spells; Slow feeding; Squatting; Syncope; and Growth failure. Physical examination The CE provider will describe and discuss, as appropriate: Whether respiratory rate is labored or unlabored; O2 saturation level; Evidence of cyanosis (perioral, peripheral), pallor, and clubbing; Heart sounds and murmurs; Presence of hepatomegaly and edema; and, Exercise tolerance test (ETT). The CE provider will obtain ETT only after receiving proper authorization from DDS. Use ETT for children age 6 and older, and perform as specified in section 104.00B7 of the cardiovascular listing (see https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm .) Back to Top Pediatric - Digestive Disorders Use the following guidelines to provide the minimum content in a CE report for a child disability case. Each Disability Determination Service (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for pediatric digestive disorders The CE report content guidelines in this section are in addition to the general pediatric CE report content guidelines. See General Pediatric Consultation Examination Report . Report content specific to pediatric digestive disorders The CE provider will use the specific requirements below to complete the CE report for a digestive disorder. Current medical history The CE provider will describe and discuss, as appropriate: Fatigue, muscle weakness, sensory abnormalities, cognitive impairment, malaise, and/or loss of appetite; Sleep disturbance and any other nocturnal symptoms; Pain, if present, and its location; Eating habits, and unusual weight loss or gain; Bowel and bladder patterns; Rectal bleeding, if the claimant allows the physician to observe the rectum; Nausea; Growth failure; and Dates and results of relevant diagnostic procedures (such as diagnostic imaging, endoscopy, biopsy, aspiration of ascetic fluid, and clinical laboratory test). Physical examination The CE provider will describe and discuss, as appropriate: Length, height, and weight; Nutritional status; Presence of jaundice and pallor; Liver and spleen size; Muscle wasting; Presence of edema, ascites, and asterixis; Presence of any abdominal masses; and Evidence of perianal disease. Laboratory tests or findings The CE provider will describe and discuss, as appropriate. Laboratory testing should include, if appropriate: Serum creatinine; Serum total bilirubin; International normalized ratio (INR); Serum albumin; and Hemoglobin. Back to Top Pediatric - Genitourinary Disorders Use the following guidelines to provide the minimum content in a CE report for a child disability case. Each Disability Determination Service (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for pediatric genitourinary disorders The CE report content guidelines in this section are in addition to the general pediatric CE report content guidelines. See General Pediatric Consultation Examination Report . Report content specific to pediatric genitourinary disorders The CE provider will use the specific requirements below to complete the CE report for a genitourinary disorder. Current medical history The CE provider will describe and discuss, as appropriate: Malaise; Fatigue; Poor appetite; Edema; Headaches; Bone pain; Urinary frequency, dysuria, hematuria, and/or incontinence; Renal ultrasound results; Type and frequency of urological procedures; and Acute weight gain or loss. Physical examination The CE provider will describe and discuss, as appropriate: Pallor; Fundoscopic and any retinal change; Edema – type and location; Anasarca; Congenital abnormalities; and Neurological findings – irritability and hypotonia. Back to Top Pediatric - Hematological Disorders Use the following guidelines to provide the minimum content in a CE report for a child disability case. Each Disability Determination Service (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content to pediatric hematological disorders The CE report content guidelines in this section are in addition to the general pediatric CE report content guidelines. See General Pediatric Consultation Examination Report . Report content specific to pediatric hematological disorders Use the specific requirements below to complete the CE report for a hematological disorder. Current medical history The CE provider will describe and discuss, as appropriate: Fatigue; Anorexia; Pain crises; Headaches; Weight loss or gain; Edema; Jaundice; Ecchymoses bleeding; Frequency of hospitalizations; Hemoglobin values; Infections; and Frequency of red blood cell (RBC) or other blood component transfusions or infusions. Physical examination The CE provider will describe and discuss, as appropriate: Any apparent abnormalities such as enlarged lymph nodes, edema, fatigue level, abnormal bruising, pallor, scleral icterus, and jaundice; Evidence of bleeding – ecchymoses, petechiae, and hemarthrosis; Liver and spleen size; and Abnormal neurological findings. Back to Top Pediatric - Skin Disorders Use the following guidelines to provide the minimum content in a CE report for a child disability case. Each Disability Determination Service (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for pediatric skin disorders The CE report content guidelines in this section are in addition to the general pediatric CE report content guidelines. See General Pediatric Consultation Examination Report . Report content specific to pediatric skin disorders The CE provider will use the specific requirements below to complete the CE report for a skin disorder. Current medical history The CE provider will describe and discuss, as appropriate: Dates of relevant diagnostic procedures such as biopsy and genetic testing; Results of relevant diagnostic procedures; Treatment modalities, dates of treatments, and responses to treatments; Frequency, severity, and duration of skin lesion exacerbations; Effects on age-appropriate activity, especially social behavior, because of disfigurement; and If the claimant uses a lower extremity assistive device, note whether the assistive device was prescribed, how frequently it is used, the date it was prescribed, and the medical source who prescribed it. Physical examination The CE provider will describe and discuss, as appropriate: Location, size, and appearance of skin lesion(s) and contractures, associated symptoms such as pain or tenderness, and extent of the body affected (e.g., one or both extremities ). Joint function including range of motion of the affected joint(s); and If at least one extremity is affected (including involvement of the perineum or inguinal region affecting lower extremity functioning), describe ability to: Perform age-appropriate gross (e.g., reaching, lifting, carrying, handling, and gripping) and fine (e.g., picking, pinching, manipulating, and fingering) movements; Stand up from a seated position; and Maintain an upright position while standing or walking. Provide a description of the claimant’s gait. If the claimant uses a lower extremity assistive device, describe: Claimant’s gait with and without use of the device; and The device and how it is used by the claimant, the medical need for the device, the medical impairment the device is needed for, and the examination findings that support the medical need for the assistive device; and Optional with consent of the claimant/guardian: a digital photograph to document the severity of the skin lesion(s). Back to Top Pediatric - Endocrine Disorders Use the following guidelines to provide the minimum content in a CE report for a child disability case. Each Disability Determination Service (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for pediatric endocrine disorders The CE report content guidelines in this section are in addition to the general pediatric CE report content guidelines. See General Pediatric Consultation Examination Report . Report content specific to pediatric endocrine disorders The CE provider will use the specific requirements below to complete the CE report for an endocrine disorder. Current medical history The CE provider will describe and discuss, as appropriate: Fatigue; Drowsiness; Gastroparesis; Any vision loss or other visual changes; Heat or cold intolerance; Sensory aberrations; Hypoglycemia unawareness; Convulsions, tetany, or episodes of alteration of consciousness; Bone pain or localization of pain; Increased thirst; Abdominal pain; Abnormal bowel or urinary tract changes, including change in frequency; Growth failure or weight loss; Hospitalizations due to diabetic ketoacidosis; and Dates and results of relevant diagnostic procedures, such as CBC, liver enzymes, adrenal function, serum electrolytes, calcium and phosphorus, fasting blood glucose, glucose tolerance testing, Hb1AC, blood chemistries, T3, TSH, urinalysis, and relevant imaging studies. Physical examination The CE provider will describe and discuss, as appropriate: Abnormal sweating, dry skin, or changes in color or texture of skin; Abnormal eye changes, such as exophthalmia, visual field loss, extra ocular muscle movement, and fundus changes (retinitis proliferans ); Abnormal masses of neck or abdomen; Assessment of reflex activity and muscle strength; Presence of tremulousness, Chvostek, or Trousseau signs; and Mental status. Back to Top Pediatric - Neurological Disorders Use the following guidelines to provide the minimum content in a CE report for a child disability case. Each Disability Determination Service (DDS) will notify medical sources of any additional requirements. General guidelines for the CE report content for pediatric neurological disorders The CE report content guidelines in this section are in addition to the general pediatric CE report content guidelines. See General Pediatric Consultation Examination Report . Report content specific to pediatric neurological disorders The CE provider will use the specific requirements below to complete the CE report for a neurological disorder. Current medical history The CE provider will describe and discuss, as appropriate: Use of assistive devices(s) or brace(s) being used, when they are used, and who prescribed their use; Complete description of seizures including type and severity, aura, behavior prior to seizure, diurnal or nocturnal, frequency per month during the past year, duration of episodes, postictal phenomena, and date of last three seizures; Cognitive impairment; For children under age 6, a history of developmental milestones; Motor weakness; Sensory aberrations; Problems with speech; Problems with swallowing; Problems with voiding and defecation; and Headaches including known triggers, frequency, length and response to treatment. Physical examination The CE provider will describe and discuss, as appropriate: Hand dominance; Cranial nerve evaluation, including the ability to fix and follow for vision; Motor strength and how tested, reflexes, muscle bulk, and tone; For children who cannot participate in muscle strength testing, record observations of abilities such as rolling over, sitting, pulling, and standing; Abnormal movements; Gait and fine motor coordination; Sensation and how tested; Assistive device(s) or brace(s) brought to examination with description and opinion regarding its medical necessity; Mental status examination: details about the mental status examination, as appropriate based on child's age; and Speech functioning, including: Intelligibility and fluency; Aphasia; Dysarthria; Stuttering; and Involuntary vocalizations. Back to Top Pediatric - Mental Disorders Use the following guidelines to provide the minimum content in a CE report for a child disability case. Each Disability Determination Service (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for pediatric mental disorders The CE report content guidelines in this section are in addition to the general pediatric CE report content guidelines. See General Pediatric Consultation Examination Report . Identification The CE provider will include the claimant's name, date of birth, and/or claim number; and Indicate that the claimant and/or caregiver provided proof of identity by showing an original document proving age and identity (social security card, U.S. passport, birth certificate, student or school ID, daycare center or school record); or Provide a physical description of the claimant to verify that the person being examined is the claimant, except if the claimant's medical source with a treating relationship is the CE provider. Medical History Longitudinal medical history The CE provider will describe and discuss, as appropriate: Cite the specific medical records and any other documents reviewed during the course of the evaluation; and Identify the person(s) providing the oral medical history and an assessment of the validity and reliability of such information. Current medical history The CE provider will describe and discuss, as appropriate: The primary impairment(s) alleged for which the disability claim is being filed; Onset, frequency, and duration of the impairment(s); Current treatment plan including medicines and dosages, role of child and caregiver in administration of treatment plan, need for periodic adjustments in medication regimen; Special therapy, equipment or devices; Response to treatment and overall extent of control of the impairment(s); and Source(s) of medical care including specialist(s) or specialty  clinic(s). Past medical history The CE provider will describe and discuss, as appropriate: Prenatal, delivery, and neonatal course; and Other significant events including past illnesses, injuries, operations, hospitalizations, and urgent care encounters. When possible provide the dates of events and names of facilities that provided treatment. Information about the child's development The CE provider will describe and discuss, as appropriate: For children who have not attained age 6, developmental milestones – the results of a formalized developmental screening test is one method to meet this requirement; Early infant or preschool intervention services; For children age 6 and older, usual daily activities; and Current grade, type of class, limitations of activities, and need for special assistance or extra care. Provide a list of current medications The CE provider will list the name, dose, and frequency of medication(s), including both beneficial and adverse effects, and plans for continued drug administration, schedule, and extent of any therapy. Infants and toddlers (birth up to age 3) Information on the mental assessment for infants and toddlers must include the following: Motor coordination and responsiveness to visual, auditory, and tactile stimuli (birth to 12 months) Communicative behaviors, including pre-speech behaviors (for example, sucking, swallowing, imitation of sounds) and early language behaviors (for example, jargon, single words, phrases, turn-taking); Manner of relating to and interacting with parent or caregiver, and ability to separate from parent or caregiver; Manner of relating to and interacting with sibling or peer group, if observed; Any stereotypical movements; Perceptual functioning; and Other pathology. Children age 3 and older Information on the mental assessment for children age 3 and older must include the following: History, including adjustment in school and home (daily activities, social functioning, concentration, persistence, pace); Appearance and grooming; Behavior; Attention and concentration; Affect; Communicative abilities and behavior; Thought processes (with verbatim examples); Cognitive functioning, including psychological test findings; Any indication of self-injury; and Any indication of substance use. Mental status examination for children age 12 and older The mental status examination for individuals in this age range must include the information for children age 3 and older. The case facts emphasized will determine the specific areas of mental status during the examination, but the report must include a detailed description of the child's: Judgment and insight; Impulse control; Orientation; Memory; and Homicidal and suicidal ideation. Diagnosis The CE report should include the American Psychiatric Association standard nomenclature as set forth in the current edition of the Diagnostic and Statistical Manual of Mental Disorders. NOTE: The description of the claimant's mental status must not be an enumeration of the symptoms reported by the claimant (or other source); rather the description must be the examining source's description of the above item. Prognosis The CE report should include prognosis and recommendations for treatment, if indicated. The report should also include recommendations for any other medical evaluation (for example, neurological, general physical), if indicated. Additional requirements for intellectual disability The CE report must describe the following: Current documentation of IQ score by a standardized, well-recognized measure. Acceptable instruments will have a representative normative sample, a mean of approximately 100 and standard deviation of approximately 15 in the general population, and cover a broad range of cognitive and perceptual-motor functions (for example, the Wechsler scales); Summary of composite scores (for example, Full Scale IQ, Verbal Comprehension Index, Perceptual Reasoning Index) together with the individual subtest scores; Interpretation of the scores and assessment of the validity of the obtained scores, indicating any factors that may have influenced the results, such as the child's attitude and degree of cooperation, the presence of visual, hearing, or other physical problems, and recent prior exposure to the same or similar test; and Consistency of the obtained test results with the child’s education and social adjustment, especially in the area of personal self-sufficiency. Provide a medical opinion The medical source should provide a medical opinion that includes the following: Assessment of the child’s abilities and limitations based upon the child’s medical history, observations during the examination, and results of relevant signs or tests, or both; Specify the nature and extent of the condition or disorder; Discuss any apparent discrepancies in the medical history or in the examination findings; and Specify any limitations in age-appropriate functioning that result from the condition or disorder, including the child’s ability to: Acquire and use information; Interact and relate with others; Attend and complete tasks; and Care for himself or herself. Back to Top Pediatric - Cancer Use the following guidelines to provide the minimum content in a CE report for a child disability case. Each Disability Determination Service (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for pediatric cancer The CE report content guidelines in this section are in addition to the general pediatric CE report content guidelines. See General Pediatric Consultation Examination Report . Report content specific to pediatric cancer The CE provider will use the specific requirements below to complete the CE report specific to cancer. Current medical history The CE provider will describe and discuss as appropriate: Fatigue, malaise, and/or affected organ systems; Type of therapy received or planned, including prescribed medications and their side effects (for each cancer condition if more than one). If multimodal therapy, dates each therapy was completed/scheduled and performed by which physician; Effects of any post-therapeutic residuals; Planned treatment; Weight loss; Prognosis, if available; and Dates and results of relevant diagnostic procedures, such as biopsy or tissue pathologic examination and imaging studies, as these results relate to information on cancer stage, when possible. Physical examination The CE provider will describe and discuss as appropriate: Review of any biopsy or tissue pathologic examination; Imaging studies; and Other body systems affected by adverse effects of treatment. Back to Top Pediatric - Immune System Disorders Use the following guidelines to provide the minimum content in a CE report for a child disability case. Each Disability Determination Service (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for pediatric immune system disorders The CE report content guidelines in this section are in addition to the general pediatric CE report content guidelines. See General Pediatric Consultation Examination Report . Report content specific to pediatric immune system disorders The CE provider will use the specific requirements below to complete the CE report for an immune system disorder. Current medical history The CE provider will describe and discuss, as appropriate: Weight loss; Fever; Pain; Fatigue; Malaise; Type, frequency, and severity of any infections, especially systemic infections – sepsis, meningitis, endocarditis, osteomyelitis; Stem cell transplantation and any adverse effects; and Difficult to control dermatologic conditions. Physical examination The CE provider will describe and discuss, as appropriate: Signs of affected body systems, such as heart, lungs, kidneys, eyes, digestive system, skin, etc.; Temperature; Joint pain, swelling, tenderness, contractures, deformities; Muscle weakness, atrophy, pain; Skin abnormalities; and Extra-articular findings. Back to Top Pediatric - Speech and Language (SL) Impairments in Children from Birth to Attainment of Age 3 Use the following guidelines to provide the minimum content in a CE report for a child disability case. Each Disability Determination Service (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for pediatric speech and language disorders The CE report content guidelines in this section are in addition to the general pediatric CE report content guidelines. See General Pediatric Consultation Examination Report . Report content specific to pediatric speech disorders and language disorders The CE provider will describe and discuss, as appropriate: The alleged speech or language problems; The ages at which the child babbled, produced first words, and spoke in phrases or sentences; NOTE: The DDS will provide the speech language pathologist (SLP) vendor with the child’s corrected chronological age for prematurity for any child who has not attained age 1 and for any child age 1 and older for whom the DDS continues to regard prematurity as a relevant factor to the case. The characteristics of any unusual early feeding and eating behavior (for example, difficulty chewing, swallowing, or tolerating various food textures or temperatures); Significant history of: Ear infections or hearing loss; Whether the child has had pressure equalizing (PE) tubes inserted and, if so, when; Other developmental problems; and Oro-maxillo-facial abnormalities and relevant surgeries. Participation in previous or current speech and language therapy and progress made; and The child's native language and the language(s) spoken in the home, the percentage of each language spoken in the home (and how many hours a week the child is with a daycare provider), and any exposure to language in a preschool program (and how many hours in a week in the program). Report content specific to a speech assessment On the CE report specific to the speech assessment, the CE provider will provide data about the child’s level of functioning and select one of two approaches to the speech assessment: A statement indicating that the child’s functioning in sound production and articulation and voice is within normal limits; or Information in b.1 or b.2 below, according to the component(s) of speech requiring detailed evaluation: When sound production and articulation is evaluated in detail, the report should include information (as age-appropriate) regarding: Structure and functioning of the oral mechanism. The child’s typical mode of communication (for example, uses gestures only, uses verbalization only, uses a combination of gestures and spoken language and, if so, what percentage of time for each). Sounds in the child’s repertoire, frequency, and ease of use. Sound play (such as pitch variations, “raspberry” productions, or producing animal sounds). The stage of the child’s sound making (such as cooing, reduplicative babbling, or word approximations). Test results, if applicable (full test title, test and subtest means and standard deviations, child’s standard score and subtest scores). Articulation errors or phonological processes (with examples), based on either a formal assessment tool or a speech sample. Whether sound patterns are typical, atypical, or delayed for chronological age. Level of stimulability for error sounds. Overall intelligibility percentage (not a range) as judged by the SLP (generally an unfamiliar, trained listener) if the child is using words, and whether it is within expectancy for age. A parent’s or caregiver’s estimate of the child’s intelligibility for single words in context, single words out of context, phrases or short utterances in context, and phrases or short utterances out of context. The extent to which any motor-based speech disorders (such as dyspraxia or dysarthria) limit intelligibility, as appropriate. Brief clinical observations, descriptions of voice, and speech fluency. When voice is evaluated in detail, the report should include information regarding: Structure and functioning of the oral mechanism. The child’s typical mode of communication (for example, uses gesture only, uses verbalization only, uses a combination of gesture and spoken language and, if so, what percentage of time for each). Any otolaryngological findings provided by the DDS (briefly), to keep internal consistency (per 20 CFR 404.1519(a)(2)) or a statement regarding unavailability of this information. The SLP’s assessment of vocal pitch, quality, resonance, and intensity (including whether the child is able to sustain phonation and whether conversational speech is audible). The SLP’s judgment regarding the clinical severity of the voice disorder. Brief clinical observations and descriptions of sound production and articulation. Any effect of other medical conditions (for example, allergies) on voice Report content specific to a language assessment On the CE report specific to a language assessment, the CE provider will provide data about the child’s level of functioning and the following, as appropriate: Administer a current, standardized, comprehensive language battery that is appropriate for the child’s age (such as the Preschool Language Scale-5). “Current” means the most recently published version of the test instrument. The test report should: State the full title of the test(s) and include the test and subtest means and standard deviations. List the child’s total language standard score (SS), area composite SSs, or age equivalents when SSs are not available. Indicate when the child’s score falls below the lowest SS provided. State whether the test results are a true representation of the child’s capabilities given their cooperation, interest, attention and concentration. NOTE: Our general expectation is that the transition to using the latest version of a test occurs no more than one year after publication. Supplement formal test results with a parent report instrument (such as the MacArthur-Bates Communicative Development Inventories). Document clinical observations and descriptions of the child’s: Typical mode of communication (for example, uses gesture only, uses verbalization only, uses a combination of gesture and spoken language and, if so, what percentage of time for each). Use of gestures (such as communicative pointing or showing objects). Ability to initiate and maintain social gaze or eye contact, joint attention, and turn-taking. Mean length of utterances (MLU). Obtain a language sample of at least 20 utterances, if possible, and then determine the MLU (in terms of morphemes, not words). Total number of words and word approximations in expressive vocabulary (regardless of clarity). Frequency and type (novel, stereotypic) of multi-word utterances. Range of communicative intentions (such as labeling, requesting, or socializing). Document relevant information obtained through parent or caregiver report regarding the child’s language understanding and production. Compare the child’s receptive and expressive language skills to those of typically developing, same-age peers, using substantive descriptions (versus a general, single statement of age-appropriateness) and provide examples. NOTE: The CE will provide any other pertinent information and observations that may be helpful in evaluating the child (for example, include information on the child’s level of cooperation, compliance, and social interaction). SLP conclusions The CE provider will include the following information on the CE report: State conclusions and correlate them with information from the history, clinical observations, and formal assessment. Explain any discrepancies between the test data and observed behaviors or, if you cannot explain the discrepancies, then comment on them. Provide: A diagnosis, and A statement of whether and to what extent the SLP may reasonably expect the identified speech disorder or language disorder to impact how the child functions every day and in all settings compared to other children the same age who do not have the impairment, currently and over the next 12 months. State whether norm-referenced test scores (or detailed parent or caregiver interview, if the child was reluctant to talk with the SLP) are generally consistent with observations and impressions about the child’s conversational skills (for example, oral language or social interaction) and school language skills (for example, narrative discourse). Sign the report and identify their educational degree and certification or licensure credentials. Back to Top Pediatric - Speech and Language (SL) Impairments in Children Age 3 and Older Use the following guidelines to provide the minimum content in a CE report for a child disability case. Each Disability Determination Service (DDS) will notify medical sources of any additional requirements. General guidelines for CE report content for pediatric for speech and language disorders The CE report content guidelines in this section are in addition to the general pediatric CE report content guidelines. See General Pediatric Consultation Examination Report . Report content specific to pediatric speech disorders and language disorders The CE provider will describe and discuss, as appropriate: The alleged speech or language problems; Significant history of: Ear infections or hearing loss; Whether the child has had pressure equalizing (PE) tubes inserted and, if so, when; Other developmental problems; and Oro-maxillo-facial abnormalities and relevant surgeries. Participation in previous or current speech-language therapy and progress made; and Indicate the child’s native language and the language(s) spoken in the home, the percentage of each language spoken in the home (and how many hours a week the child is with a daycare provider), and any exposure to language in a school program (and how many hours a week in the program). Report content specific to a speech assessment On the CE report specific to the speech assessment, the CE provider will provide data about the child’s level of functioning and select one of two approaches to the speech assessment: A statement indicating that the child’s functioning in sound production and articulation and voice is within normal limits; or The information in b.1, b.2, or b.3 below, according to the component(s) of speech requiring detailed evaluation: When articulation and phonological development is evaluated in detail, the report should include information (as age-appropriate) regarding: Structure and functioning of the oral mechanism (for example, diadochokinetic rates, tongue mobility and strength). Articulation errors or phonological process, usually based on a formal assessment tool, and a variety of sampling procedures (for example, connected speech sampling). Whether sound patterns are typical, atypical, or delayed for chronological age. Level of stimulability for error sounds at word or sentence level. Overall intelligibility percentage (not a range) as judged by the SLP (an unfamiliar, trained listener) if the child is using words in known or unknown context, and whether it is within expectancy for age. A parent’s or caregiver’s estimate (elicited by asking how many of ten typical utterances he or she understands) of the child’s conversational speech intelligibility on first attempt when communicating about familiar and unfamiliar topics. A parent’s or caregiver’s estimate of conversational speech intelligibility upon repetition (either spontaneously or by request). The extent to which any motor-based speech disorders (such as dyspraxia or dysarthria) limit intelligibility, as appropriate. The influence of dialectal variations on the speech pattern, as appropriate. Brief clinical observations, descriptions of voice, and speech fluency. When voice is evaluated in detail, the report should include information regarding: Structure and functioning of the oral mechanism (for example, diadochokinetic rates, tongue mobility and strength). The otolaryngologist’s findings provided by the DDS (briefly) or a statement regarding unavailability of this information. The SLP’s assessment (as guided by a clearly specified, commercially available protocol or manual) of vocal pitch, quality, and intensity (including whether the child is able to sustain phonation and whether conversational speech is audible). Observed or reported voice used patterns and how these may contribute to any identified disorder. The SLP’s judgment regarding the clinical severity of the voice disorder. Brief clinical observations and descriptions of articulation and phonology and fluency. Whether the voice is better at different times of day. Any effect of other medical conditions (for example, allergies) on voice. Effect of the voice disorder on intelligibility. When fluency is evaluated in detail, the report should include information regarding: Structure and functioning of the oral mechanism (for example, diadochokinetic rates, tongue mobility and strength). Severity rating as determined using a nationally published stuttering assessment instrument. Typical and atypical disfluencies based on parent or caregiver interview (or child interview, if appropriate), including parent and child reports regarding how often they note the two types of disfluencies in conversation with familiar and with unfamiliar listeners. (We expect that parent/child reports will more often be qualitative than quantitative.) Atypical disfluencies include part-word repetitions, audible sound prolongations, silent fixations or blockages, sound repetitions, and syllable repetitions. Observed and reported, and frequency of, secondary behaviors. How the child responds to their stuttering (such as avoiding other children during playtime or being overly anxious or fearful when interacting with others). The approximate onset date of disfluency at its current level and any changes noted over time. Brief clinical observations and descriptions (as well as the parent’s or caregiver’s report) of articulation and phonology and voice. Effect of the fluency (stuttering) disorder on intelligibility. Report content specific to a language assessment On the CE report specific to the language assessment, the CE provider will provide accurate data about the child’s level of functioning and the following, as appropriate: Administer a current, standardized, comprehensive language battery that is appropriate for the child’s age. “Current” means the most recently published version of the test instrument. The test report should: State the full title of the test(s) and include the test and subtest means and standard deviations. List the child’s total language standard score (SS), area composite SSs, and individual subtest SSs. When a test provides quotients rather than SSs, report these instead. Indicate when the child’s score falls below the lowest SS provided. Indicate if the child needed repetition of items for tests that allow for repetition and, if so, how often. Provide an analysis, while also addressing and providing an account for any unusual scores, of the errors in the interpretation section and discuss the potential effect on school performance involving language comprehension and expression. State whether the test results are a true representation of the child’s capabilities given their cooperation, interest, attention and concentration, and any other variables that might affect performance (for example, other medical conditions, medication use or nonuse, energy and motivation). NOTE: Our general expectation is that the transition to using the latest version of a test occurs no more than one year after publication. Supplement formal test results with a parent report instrument (such as the MacArthur-Bates Communicative Development Inventories), when the child’s language age falls below 36 months. Based on a spontaneous language sample, document clinical observations and descriptions of the child’s overall receptive and expressive language skills. In the report, include: Information on language content and form, such as the child’s ability to follow multi-step directions, express ideas with age-appropriate mean length of utterance, use and maintain social gaze or eye contact, provide comments relevant to the discussion, ask or answer questions, and produce grammatically correct sentences for age. A description of pragmatic skills, such as the child’s ability to: Engage in verbal and nonverbal turn-taking; Initiate and maintain conversational topics; Identify and repair miscommunications; Request, respond, direct, and comment; and Retell experiences and events. Information about development of narrative skills as it relates to the child’s chronological age. For example, does a child age 6 or older produce narratives that have intact basic story structure? Does a child age 12 or older generate coherent stories using the appropriate language (such as pronouns or conjunctions) to associate elements of one sentence to those of another? Document relevant information obtained through parent or caregiver report regarding the child’s language understanding and production. Compare the child’s receptive and expressive language skills to those of typically developing, same-age peers, using substantive descriptions (versus a general, single statement of age-appropriateness) and provide examples. SLP conclusions The CE provider will include the following information on the CE report: State conclusions and correlate them with information from the history, clinical observations, and formal assessment. Explain any discrepancies between the test data and observed behaviors or, if you cannot explain the discrepancies, then comment on them. Provide: A diagnosis, and A statement of whether and to what extent the SLP may reasonably expect the identified speech disorder or language disorder to affect the child’s ability to learn and use information and the child’s ability to interact and maintain relationships with others currently and over the next 12 months. State whether norm-referenced test scores (or detailed parent or caregiver interview, if the child was reluctant to talk with the SLP) are generally consistent with observations and impressions about the child’s conversational skills (for example, oral language or social interaction) and school language skills (for example, narrative discourse). Sign the report and identify their educational degree and certification or licensure credentials. Back to Top",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 3,
        "text": "Consultative Examinations: A Guide for \n        Health ProfessionalsPediatric Physical Consultative Examination Report Content"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/index.htm",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-general.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-evidence.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-guidelines.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-adult.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Musculoskeletal",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Special",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Respiratory",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Cardiovascular",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Digestive",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Genitourinary",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Hematological",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Skin",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Endocrine",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Neurological",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Mental",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Cancer",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Immune System",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#ImpairmentsUnderThree",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#ImpairmentsAboveThree",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#GeneralPediatricConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#GeneralPediatricConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#ImpairmentsUnderThree",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#ImpairmentsAboveThree",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#GeneralPediatricConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#GeneralPediatricConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#GeneralPediatricConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#GeneralPediatricConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#GeneralPediatricConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#GeneralPediatricConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#GeneralPediatricConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#GeneralPediatricConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#GeneralPediatricConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#GeneralPediatricConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#GeneralPediatricConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#GeneralPediatricConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#GeneralPediatricConsultativeExamReport",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm#Top",
      "https://www.ssa.gov/disability/professionals/greenbook/ce-pediatric.htm"
    ],
    "html_file": "ssa_bluebook_data/html/1a2313c9f67866f19244520e848cc830.html",
    "fetched_at": 1762482646.3844485
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
    "url_hash": "9410734e438db40ba951ed5c5d1956fa",
    "title": "Disability Evaluation Under Social Security | Disability | SSA",
    "text_content": "Disability Evaluation Under Social Security | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security Disability Evaluation Under Social  Security provides physicians and other health professionals with an  introduction to the disability programs administered by the Social Security  Administration. General Information describes our  programs, the disability determination process, and the role of health care  professionals in the process. Evidentiary Requirements explains the  information that medical sources can furnish to help ensure sound and prompt  determinations and decisions on disability claims. Listing of Impairments (Overview)  introduces Parts A and B of the Listing of Impairments, which contain medical  criteria that are usually sufficient to establish disability.  Parts A and B of the Listing of Impairments appear  in appendix 1 to subpart P of part 404 of the Code of Federal Regulations, but  we also provide them here.  See Adult  Listings (Part A) and Childhood Listings (Part B). Revisions to Rules Regarding the  Evaluation of Medical Evidence provides resources to help understand our rules  that became effective on March 27, 2017, related to medical sources and medical  evidence.",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm"
    ],
    "html_file": "ssa_bluebook_data/html/9410734e438db40ba951ed5c5d1956fa.html",
    "fetched_at": 1762482648.622868
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/procontacts.htm",
    "url_hash": "c4b0d12c33109b0d5261b6457e6f2240",
    "title": "Professional/Medical Relations Officers In Your Area | Disability | SSA",
    "text_content": "Professional/Medical Relations Officers In Your Area | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Professional/Medical Relations Officers In Your Area Professionals Home Publications for Health & School Professionals Disability Publications for the General Public Professional/Medical Relations Officers In Your Area Professional Relations Officers are available in each State, or other location,   for you to contact about Social Security disability programs. They make   informational presentations to the professional community about Social   Security's need for timely, accurate, and complete medical information,   educating doctors, hospital staff, and other health professionals about how that   information is used to evaluate disability. Professional Relations   Officers also recruit and train physicians (medical or osteopathic doctors),   psychologists, and other health professionals to become consultative examination   (CE) providers for States. They can answer your questions about performing CEs   or reviewing disability claims for the disability determination services in your area. If you would like more information on performing CEs for the State DDS, please reach out to the appropriate contact in the state(s) for which you are licensed. The Professional Relations Officers at your state's DDS can assist you with signing on to use Social Security's Electronic Records Express secure website for sending health or school records related to disability claims. You can also fax records to your state DDS or Social Security following the instructions in the letter you received  requesting information. Select a \n          Location Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Guam Hawaii Headquarters/OMVE Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Virgin Islands Washington West Virginia Wisconsin Wyoming Alabama (AL) Disability Determination Services P.O. Box 830300 Birmingham, AL 35283-0300 Medical Relations Coordinator 800-292-8106 Disability Determination Services Post Office Box 2371 Mobile, AL 36652-2371 Medical Relations Officer 800-292-6743 Top of  page Alaska (AK) Disability Determination Services 619 E. Ship Creek Avenue, Suite    305 Anchorage, AK 99501 Professional Relations Officer 907-777-8100 800-577-3334 Top of  page Arizona (AZ) Disability Determination Services 4000 North Central Avenue, Suite 1800 Phoenix, AZ 85012 Professional Relations Officer 800-352-0409 Disability Determination Services 4710 South Palo Verde Road Tucson, AZ 85714 Professional Relations Officer 800-362-6368 Top of  page Arkansas (AR) Disability Determinations for SSA 701 Pulaski Street Little Rock, AR   72201 Professional Relations Manager 501-682-3030 Top of  page California (CA) Disability Determination Service Division Central Support Services Branch PO Box 997119 Sacramento, CA 95899-7119 Professional Relations Officer 916-285-8900 Disability Determination Service  Division Central Valley Branch P.O. Box 3045 Clovis, CA 93613-3045 Professional Relations Officer 559-297-2610 Disability Determination Service  Division Covina Branch P.O. Box 6118 Covina, CA 91722-6118 Professional Relations Officer (626) 732-8100 Disability Determination Service Division Glendale Branch P.O. Box 29002 Glendale, CA 91209-9002 Professional Relations Officer (818) 550-4200 Disability Determination Service Division La Jolla Branch P.O. Box 85501 San Diego, CA 92186-5501 Professional Relations Officer 619-278-4550 Disability Determination Service Division Oakland Branch P.O. Box 24225 Oakland, CA 94623-1225 Professional Relations Officer 510-622-3506 Disability Determination Service  Division Rancho Bernardo Branch P.O. Box 509135 San Diego, CA 92150 Professional Relations Officer 858-674-3300 Disability Determination Service Division Roseville Branch P.O. Box 619020 Roseville, CA 95661-9020 Professional Relations Officer 916-774-4100 Disability Determination Service Division Sacramento Branch P.O. Box 997121 Sacramento, CA 95899-7120 Professional Relations Officer 916-515-4400 Disability Determination Service Division San Diego Branch P.O. Box 85273 San Diego, CA 92186-9516 Professional  Relations Officer 619-278-4300 Disability Determination Service Division Sierra Branch P.O. Box 3060 Clovis, CA 93613-9920 Professional Relations Officer 559-440-5200 Disability Determination Service Division Stockton Branch P.O. Box 207015 Stockton, CA 95267-9515 Professional Relations Officer 209-472-2391 Top of page Colorado (CO) Disability Determination Services 3190 S Vaughn Way, Suite 500 Aurora, CO  80014 Professional Relations Officer 303-368-4100 800-332-8087 Top of  page Connecticut (CT) Disability Determination Services 309 Wawarme Avenue Hartford, CT 06114 Professional Relations  Coordinator 860-466-6100 Top of  page Delaware (DE) Disability Determination Services 920 W Basin Rd. Suite 300 New Castle, DE 19720 Medical Relations Officer 302-324-7600 Top of  page District of Columbia   (DC) Disability Determination Division 1227 25th Street NW – 4th Floor Washington, DC  20037 Medical Relations Officer 202-442-8519 Top of  page Florida (FL) Department  of Health Division  of Disability Determinations Administrative  Office P.O. Box 7118 Tallahassee, FL 32314-5270 Professional  Relations Coordinator 800-499-6590,  ext. 5238 Department of Health Division of Disability Determinations PO BOX 10375 JACKSONVILLE FL 32247-0375 Professional Relations Officer 800-821-8122, ext. 4017 Department of Health Division of Disability Determinations P.O. BOX 839001 MIAMI FL 33283-9001 Professional Relations Officer 305-596-3020, ext. 6017 Department of Health Division of Disability Determinations PO BOX 15550 TAMPA FL 33684-5550 Professional Relations Officer 813-806-8950, ext. 8017 Department of Health Division of Disability Determinations PO BOX 9860 PENSACOLA FL 32513-9860 Professional Relations Officer 866-209-2095, ext. 3017 Division of Disability Determinations PO BOX 144040 ORLANDO FL 32814-4040 Professional Relations Officer 800-342-2065, ext. 7017 Top of  page Georgia (GA) Disability Adjudication Services Division of Georgia Vocational Rehabilitation Agency 1551 Juliette Road Stone Mountain, GA 300-86-1519 Professional Relations Coordinator 800-252-7485, ext. 2759 678-639-2759 Disability Adjudication Services 450 Mall Boulevard, Suite C Savannah, GA 31406-4823 Professional Relations Officer 800-992-3511, ext. 3233 912-652-3027 Disability Adjudication Services 14250 Highway 19 South Thomasville, GA 31792-4800 Professional Relations Officer 800-282-7485, ext. 2758 678-639-2758 Disability Adjudication Services 125 Athens West Parkway Athens, GA 30606-6942 Professional Relations Officer 800-282-7485, ext. 2761 678-639-2761 Georgia Vocational Rehabilitation Agency Disability Adjudication Section 500 East Walnut Avenue Building 2, Suite 101 Dalton, GA 30271 Professional Relations Officer 855-706-1128 706-281-8834 Top of  page Guam (includes American Samoa & Northern Mariana Islands) Federal Disability Office - Guam 770 East Sunset Boulevard Suite 155 Barrigada, Guam 96913-1506 Top of  page Hawaii (HI) Disability Determination Branch P.O. Box 2458 Honolulu, HI 96804 Professional Relations Officer 808-979-7000 Top of  page Headquarters/OMVE Headquarters/Office of Medical  and Vocational Expertise Oak Meadows   Building 6340 Security Blvd Baltimore, MD   21207 Professional Relations Officer Top of  page Idaho (ID) Disability Determination Services P.O. Box 21 Boise, ID 83707 Professional Relations Officer 208-327-7333 800-626-2681 Top of  page Illinois (IL) Illinois Department of  Rehabilitation Services Bureau of Disability Services P.O. Box 19250 Springfield, IL   62794-9250 Professional Relations Officer 800-225-3607 Top of  page Indiana (IN) Indiana Disability Determination  Bureau P.O. Box 7069 Indianapolis, IN   46207-7069 Professional Relations Officer 317-396-2000 Top of  page Iowa (IA) Disability Determination Services Bureau 535 SW 7th Street Des Moines, IA 50309-4535 Professional Relations Officer 515-725-0702 800-532-1223 Top of  page Kansas (KS) Disability Determination Services 2820 SW Fairlawn Rd Ste 100 Topeka, KS   66614-1509 Medical Relations Officer Medical Services Administrator 785-267-4440 800-685-0122 Top of  page Kentucky (KY) Kentucky Disability Determination Services Cabinet for Health and Family Services 102 Athletic Drive Frankfort, KY 40601 Professional Relations Coordinator 502-595-4404 502-782-1576 Department of Income Support Kentucky Disability Determination Services Cabinet for Health and Family Services Chestnut Center, Grauman Building 10510 LaGrange Road Louisville, KY 40223 Professional Relations Officer 502-782-1575 Top of  page Louisiana (LA) LA State Office Disability Determination Services 5825 Florida Blvd., Room 2065 Baton Rouge, LA 70806 800-256-2288 LA DDS—New Orleans Area Office 2150 West Bank Expressway, Suite 709 Harvey, LA 70058 Medical Relations Officer 504-838-5000 LA DDS—Baton Rouge Area Office 5905 Florida Blvd., Suite 2110 Baton Rouge, LA 70806 Medical Relations Officer 225-925-3522 LA DDS—Shreveport Area Office 2920 Knight Street, Suite 232 Shreveport, LA 71134-0446 Medical Relations Officer 318-869-6400 Top of  page Maine (ME) Carleton Mills Building 1705 US Rte 202 Winthrop, ME 04364 Professional Relations Officer 207-287-9600 Top of  page Maryland (MD) Disability Determination Services P.O. BOX 1810 Cockeysville, MD 21030-7810 Medical Relations Director 410-308-4336 Top of  page Massachusetts  (MA) Disability Determination Services 135 Santilli Highway Suite 310 Everett, MA 02149 Director, Medical Relations Program 617-727-1600 800-882-2040 Disability Determination Services 18 Chestnut Street 3rd Floor Worcester, MA 01608 Medical Relations Officer 508-752-5001 800-551-5532 Top of  page Michigan (MI) Lansing DDS Disability Determination Services PO Box 30011 Lansing, MI 48909-7511 800-366-3404 Detroit DDS Disability Determination Services P.O. Box 345 Detroit, MI 48231-0345 800-383-7155 Kalamazoo DDS Disability Determination Services P.O. Box 4020 Kalamazoo, MI 49003 Professional Relations Officer 800-829-7763 Traverse City DDS Disability Determination Service PO Box 1200 Traverse City, MI 49685 800-632-1097 Top of  page Minnesota (MN) Disability Determination Services P.O. Box 64709 St. Paul, MN   55164 Medical Relations Officer 651-259-7700 800-937-6469 Top of  page Mississippi (MS) Mississippi Disability Determination Services Department of Rehabilitation Services 1281 Highway 51 North Madison, MS 39110 Medical Relations Officer 601-853-5577 Top of  page Missouri (MO) Disability Determination Services 3014 Blattner Drive Cape Girardeau, MO 63703 Professional Relations Officer 573-290-5710 Disability Determination Services 1500 Southridge Drive, Suite 100 Jefferson City, MO 65109 Professional Relations Officer 573-751-2929 Disability Determination Services Governor Joseph P. Teasdale State Office Building 8800 East 63rd St., Suite 320 Raytown, MO  64133 Professional Relations Officer 816-743-8800 Disability Determination Services 1900 E. Division Street Springfield, MO 65803 Professional Relations Officer 417-888-4070 Disability Determinations Central Office 3024 Dupont Circle Jefferson City, MO 65109 Director for Medical Services 573-751-3251 Disability Determination Services 7545 S. Lindbergh, Suite 220 St. Louis, MO 63125 Professional Relations Officer 314-416-2803 Top of  page Montana (MT) Disability Determination Bureau P.O. Box 4189 Helena, MT 59604-4189 Professional Relations Officer 406-444-3054 800-545-3054 Top of  page Nebraska (NE) Disability Determinations Section 500 S 84th Street Lincoln, NE 68510 Medical Services Officer 402-471-2961 Top of  page Nevada (NV) Bureau of Disability Adjudication 2527 North Carson Street, Room 215 Carson City, NV  89706 Professional Relations Officer 800-882-4430 Top of  page New Hampshire (NH) Disability Determination Service 21 South Fruit Street, Suite 30 Concord, NH   03301-2453 Professional Relations Officer 603-271-3341 Top of  page New Jersey (NJ) Division of Disability Determinations P.O. Box 649 Newark, NJ 07101 Tel: 973-648-6971 Fax: 973-648-3886 Division of Disability Determinations P.O. Box 649 Newark, NJ 07101-0649 Tel: 973-648-4578 Fax: 973-648-7892 Covering Counties: Union Warren, Hunterdon, Somerset, Hudson, Monmouth Division of Disability Determinations P.O. Box 649 Newark, NJ 07010-0649 Tel: 973-648-4062 Fax: 973-648-7981 Covering Counties: Essex, Passaic, Sussex, Bergen, Morris, Mercer Division of Disability Determinations P.O. Box 378 Trenton, NJ 08625-0378 Labor Building - 10th Floor Tel: 609-943-4421 Fax: 609-943-5827 Top of  page New Mexico (NM) Disability Determination Services P.O. Box 4588 Albuquerque, NM   87196 Professional Relations Officer 505-841-5600 Top of  page New York (NY) Disability Determination Services P.O. Box 165 Albany, NY 12260-0165 Medical Relations Officer 518-473-9320 800-522-5511 Division of Disability  Determinations PO Box 5191 Bowling Green Station, NY 10274-5191 Medical Relations Officer 212-240-3456 800-522-5511 Office of Disability  Determination Services P.O. Box 5030 Buffalo, NY 14205-5030 Medical Relations Officer 716-847-5007 800-522-5511 Division of Disability  Determinations P.O. Box 9009 Endicott, NY 13761-9009 Medical Relations Officer 607-741-4195 800-522-5511 Top of  page North Carolina (NC) Disability Determination Services P.O. Box 243 2802 Mail Service Center Raleigh, NC 27602-0243 Professional Relations 919-814-3222 For Claim Status Information call 1-866-542-8113 Top of  page North Dakota (ND) Disability Determination Services 1237 W. Divide Avenue, Suite 4 Bismarck, ND   58501 Professional Relations Officer 800-543-2048 701-328-8700 Top of  page Ohio (OH) Opportunities for Ohioans with Disabilities Division of Disability Determination P.O. Box 359001 Columbus, OH 43235-9001 Professional Relations Officer 800-282-2695 Top of  page Oklahoma (OK) Disability Determination Division P.O. Box 24400 Oklahoma City, OK   73124-0400 Professional Relations Officer 800-877-9977 405- 419-2200 Top of  page Oregon (OR) Disability Determination Services 3150 Lancaster Drive NE Salem, OR 97305-1350 Professional Relations Officer 503-986-5100 800-452-2147 Top of  page Pennsylvania (PA) Bureau of Disability  Determination 144 N Main Street Greensburg, PA 15601 Medical Relations Program Manager 724-836-5100 Bureau of Disability Determination 1171 S. Cameron Street, Room 200 Harrisburg, PA 17104 Assistant Administrator Medical Relations Program Manager 717-783-3620 Bureau of Disability Determination Department of Labor and Industry 3rd Floor 901 North 7th Street,  Rear Harrisburg, PA 17102 717-425-7900 Bureau of Disability Determination P.O. Box R Wilkes-Barre, PA 18703 Medical Relations Program Director 570-301-5629 800-432-8039 Top of  page Puerto Rico (PR) Disability Determination Services P.O. Box 71301 San Juan, PR 00936-8401 Professional  Relations Officer 787-763-8989 787-754-6455 Top of  page Rhode Island (RI) Disability Determination Services 40 Fountain Street,  6th Floor Providence, RI 02903 Professional Relations  Officer 401-222-3182 Top of  page South Carolina (SC) Disability Determination Services P.O. Box 60 West Columbia, SC 29171-0060 Professional Relations Coordinator 803-896-6400 803-896-6799 Columbia Region Disability Determination Division P.O. Box 80 West Columbia, SC 29171-0060 Professional Relations Officer 803-896-6700 803-896-6708 Greenville Region Disability Determination Division P.O. Box 3090 Greenville, SC 29602 Professional Relations Officer 864-242-1950 864-282-4056 Charleston Region Disability Determination Division P.O. Box 190029 Charleston, SC 29602 Professional Relations Officer 843-953-0335 Top of  page South Dakota (SD) Disability Determination Services 3109 W 41st St, Ste. 100 Sioux Falls, SD 57105-8155 Professional Relations Officer 605-367-5499 800-658-2272 Top of  page Tennessee (TN) Tennessee Disability Determinations Services P.O. Box 775 Nashville, TN 37202 Professional Relations Coordinator 800-342-1117 (In State) 615-743-7774 800-342-1117 ERE.TN@ssa.gov Top of  page Texas (TX) Department of Assistive and  Rehabilitative Services Disability Determination Services P.O. Box 149198 Austin, TX 78714-9198 800-252-9627 Top of  page Utah (UT) Disability Determination Services P.O. Box 144032 Salt Lake City, UT   84111-4032 Professional Relations Officer 801-321-6500 800-221-3493 Top of  page Vermont (VT) Disability Determination Services 93 Pilgrim Park Road, Suite 6 Waterbury, VT 05676 Professional Relations Office 802-241-2463 800-734-2463 Top of  page Virginia (VA) Disability Determination Services 11150 Fairfax Blvd, Suite 200 Fairfax, VA 22030 703-934-7408 Disability  Determination Services Southwest Regional Office 612 S. Jefferson Street, Suite 300 Roanoke, VA 24011 540-857-7754 Disability Determination Services Central Regional Office 9960 Mayland Dr., Suite 200 Richmond, VA 23233 804-367-4707 Disability Determination Services Tidewater Regional Office 5850 Lake Herbert Dr., Suite 200 Norfolk, VA 23502 757-466-3312 Disability Determination Services Administrative Office 8004 Franklin Farms Dr. Richmond, VA 23229 540-613-0344 Top of  page Virgin Islands (VI) SSA Disability Center  - VI Nisky Center, 1st Floor, Suite 14 St. Thomas, VI 00802 Top of  page Washington (WA) Division of Disability Determination Services P.O. Box 9303-MS-45550 Olympia, WA 98507-9303 Professional Relations Officer 1-800-562-6074 Division of Disability Determination Services 1330 N Washington #2080 Spokane, WA 99201-2314 1-800-562-6074 Top of  page West Virginia(WV) Division of Rehabilitation  Services Disability Determination Section 500 Quarrier Street, Suite 500 Charleston, WV 25301-2913 Professional Relations Officer 304-343-5055 800-344-5033 (in-state only) Division of Rehabilitation  Services Disability Determination Section 320 West Pike Street, Suite 120 Clarksburg, WV 26301-2913 Professional Relations Officer 304-624-0200 800-344-7813 (in-state only) Top of  page Wisconsin (WI) Disability Determination Bureau Division of Medicaid Services Department of Health State of Wisconsin P.O. Box 7886 Madison, WI 53707-7886 608-266-1565 Top of  page Wyoming (WY) Disability Determination Services 5221 Yellowstone Road Cheyenne, WY 82002 Disability Hearings  Officer/Professional Relations Officer/ Medical Relations Officer 307-777-7341 800-438-5788 For information about registering for SSA’s Electronic Records Express , please contact us at ERE.NC@ssa.gov. Please do not send medical records directly to this email address. Top of  page",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/procontacts.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/publications.htm",
      "https://www.ssa.gov/pubs/englist.html#Disability",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Alabama",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Alaska",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Arizona",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Arkansas",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#California",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Colorado",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Connecticut",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Delaware",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#District of Columbia",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Florida",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Georgia",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Guam",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Hawaii",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#HQ",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Idaho",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Illinois",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Indiana",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Iowa",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Kansas",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Kentucky",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Louisiana",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Maine",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Maryland",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Massachusetts",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Michigan",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Minnesota",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Mississippi",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Missouri",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Montana",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Nebraska",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Nevada",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#New Hampshire",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#NewJersey",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#NewMexico",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#NewYork",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#NorthCarolina",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#North Dakota",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Ohio",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Oklahoma",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Oregon",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Pennsylvania",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Puerto Rico",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#RhodeIsland",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#SouthCarolina",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#SouthDakota",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Tennessee",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Texas",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Utah",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Vermont",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Virginia",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Virgin Islands",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Washington",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#WestVirginia",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Wisconsin",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Wyoming",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "mailto:ERE.TN@ssa.gov",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/ere/",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm"
    ],
    "html_file": "ssa_bluebook_data/html/c4b0d12c33109b0d5261b6457e6f2240.html",
    "fetched_at": 1762482650.9432337
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/publications.htm",
    "url_hash": "bc824e0a16f1d75f1e536ddc8f96b00e",
    "title": "Disability-Related Publications for Health & School Professionals | Disability | SSA",
    "text_content": "Disability-Related Publications for Health & School Professionals | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Related Publications For Health & School Professionals Professionals Home Publications for Health & School Professionals Disability Publications for the General Public Disability\nRelated Publications For Health & School Professionals The following publications are written for persons in\nthe health care or school field who may be involved in the Social Security disability\ndetermination process. As such, they may contain medical terminology and technical\ninformation confusing to the general public. Health and school professionals may obtain these publications, free of charge,\nfrom the SSA Supply System. How to Order Outside Organizations: You may view, print, or order publications on SSA’s Publications webpage . List of publications: Answers\nfor Doctors and Other Health Professionals , (Pub. No. 64-042, ICN 953635, September 1998) Childhood Disability\nUnder the Social Security Administration’s Supplemental Security Income:\nA Guide for Physicians and Other Health Professionals (Pub. No. 64-048, ICN 436930) Childhood\nDisability Under the Social Security Administration’s Supplemental Security\nIncome: A Guide for School Professionals (Pub. No. 64-049, ICN 436935) Consultative\nExaminations: A Guide for Health Professionals (Pub No. 64-025, ICN 954095, November 1999) Disability\nEvaluation Under Social Security (Pub. No. 64-039, ICN 468600, September 2008) Fact Sheet for Mental Health Care Professionals: Supporting\n  Individuals' Social Security Disability Claims (Pub. No. 64-103, January 2008,\n  ICN available Spring 2008) pdf\n  version (189 KB) HIPAA and the Social Security Disability Programs: Information for Consultative Examination Providers (Pub. No. 64-092, Fact Sheet) Long COVID: A Guide for Health Professionals on Providing Medical Evidence for Social Security Disability (Pub. No. 64-128, June 2023) Providing\nMedical Evidence for Individuals with HIV Infection: A Guide for Health Professionals (Pub. No. 64-037, ICN 953600, August 1993) Providing\nMedical Evidence to the Social Security Administration for Individuals with Chronic\nFatigue Syndrome: A Guide for Health Professionals (Pub. No. 64-063, ICN 953800, Fact Sheet) Red\nBook on Work Incentives: A Summary Guide to Social Security and Supplemental\nSecurity Income Work Incentives for People with Disabilities (Pub. No. 64-030, ICN 436900) Back to Top",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability\nRelated Publications For Health & School Professionals"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/publications.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/publications.htm",
      "https://www.ssa.gov/pubs/englist.html#Disability",
      "https://www.ssa.gov/pubs/",
      "https://www.ssa.gov/disability/professionals/answers-pub042.htm",
      "https://www.ssa.gov/disability/professionals/childhoodssi-pub048.htm",
      "https://www.ssa.gov/disability/professionals/childhoodssi-pub049.htm",
      "https://www.ssa.gov/disability/professionals/greenbook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/mentalhealthproffacts.htm",
      "https://www.ssa.gov/disability/Documents/64-103_Supporting Individuals Social Security Disability Claims_factsheet.pdf",
      "https://www.ssa.gov/disability/professionals/hipaa-cefactsheet.htm",
      "https://www.ssa.gov/disability/professionals/hipaa-cefactsheet.htm",
      "https://www.ssa.gov/disability/professionals/documents/EN-64-128.pdf",
      "https://www.ssa.gov/disability/professionals/documents/64-037.pdf",
      "https://www.ssa.gov/disability/professionals/documents/64-063.pdf",
      "https://www.ssa.gov/redbook/",
      "https://www.ssa.gov/disability/professionals/publications.htm#Top",
      "https://www.ssa.gov/disability/professionals/publications.htm"
    ],
    "html_file": "ssa_bluebook_data/html/bc824e0a16f1d75f1e536ddc8f96b00e.html",
    "fetched_at": 1762482655.3415318
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/procontacts.htm#Alabama",
    "url_hash": "76926d1bd230fd07e77f3fd243bb1fb0",
    "title": "Professional/Medical Relations Officers In Your Area | Disability | SSA",
    "text_content": "Professional/Medical Relations Officers In Your Area | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Professional/Medical Relations Officers In Your Area Professionals Home Publications for Health & School Professionals Disability Publications for the General Public Professional/Medical Relations Officers In Your Area Professional Relations Officers are available in each State, or other location,   for you to contact about Social Security disability programs. They make   informational presentations to the professional community about Social   Security's need for timely, accurate, and complete medical information,   educating doctors, hospital staff, and other health professionals about how that   information is used to evaluate disability. Professional Relations   Officers also recruit and train physicians (medical or osteopathic doctors),   psychologists, and other health professionals to become consultative examination   (CE) providers for States. They can answer your questions about performing CEs   or reviewing disability claims for the disability determination services in your area. If you would like more information on performing CEs for the State DDS, please reach out to the appropriate contact in the state(s) for which you are licensed. The Professional Relations Officers at your state's DDS can assist you with signing on to use Social Security's Electronic Records Express secure website for sending health or school records related to disability claims. You can also fax records to your state DDS or Social Security following the instructions in the letter you received  requesting information. Select a \n          Location Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Guam Hawaii Headquarters/OMVE Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Virgin Islands Washington West Virginia Wisconsin Wyoming Alabama (AL) Disability Determination Services P.O. Box 830300 Birmingham, AL 35283-0300 Medical Relations Coordinator 800-292-8106 Disability Determination Services Post Office Box 2371 Mobile, AL 36652-2371 Medical Relations Officer 800-292-6743 Top of  page Alaska (AK) Disability Determination Services 619 E. Ship Creek Avenue, Suite    305 Anchorage, AK 99501 Professional Relations Officer 907-777-8100 800-577-3334 Top of  page Arizona (AZ) Disability Determination Services 4000 North Central Avenue, Suite 1800 Phoenix, AZ 85012 Professional Relations Officer 800-352-0409 Disability Determination Services 4710 South Palo Verde Road Tucson, AZ 85714 Professional Relations Officer 800-362-6368 Top of  page Arkansas (AR) Disability Determinations for SSA 701 Pulaski Street Little Rock, AR   72201 Professional Relations Manager 501-682-3030 Top of  page California (CA) Disability Determination Service Division Central Support Services Branch PO Box 997119 Sacramento, CA 95899-7119 Professional Relations Officer 916-285-8900 Disability Determination Service  Division Central Valley Branch P.O. Box 3045 Clovis, CA 93613-3045 Professional Relations Officer 559-297-2610 Disability Determination Service  Division Covina Branch P.O. Box 6118 Covina, CA 91722-6118 Professional Relations Officer (626) 732-8100 Disability Determination Service Division Glendale Branch P.O. Box 29002 Glendale, CA 91209-9002 Professional Relations Officer (818) 550-4200 Disability Determination Service Division La Jolla Branch P.O. Box 85501 San Diego, CA 92186-5501 Professional Relations Officer 619-278-4550 Disability Determination Service Division Oakland Branch P.O. Box 24225 Oakland, CA 94623-1225 Professional Relations Officer 510-622-3506 Disability Determination Service  Division Rancho Bernardo Branch P.O. Box 509135 San Diego, CA 92150 Professional Relations Officer 858-674-3300 Disability Determination Service Division Roseville Branch P.O. Box 619020 Roseville, CA 95661-9020 Professional Relations Officer 916-774-4100 Disability Determination Service Division Sacramento Branch P.O. Box 997121 Sacramento, CA 95899-7120 Professional Relations Officer 916-515-4400 Disability Determination Service Division San Diego Branch P.O. Box 85273 San Diego, CA 92186-9516 Professional  Relations Officer 619-278-4300 Disability Determination Service Division Sierra Branch P.O. Box 3060 Clovis, CA 93613-9920 Professional Relations Officer 559-440-5200 Disability Determination Service Division Stockton Branch P.O. Box 207015 Stockton, CA 95267-9515 Professional Relations Officer 209-472-2391 Top of page Colorado (CO) Disability Determination Services 3190 S Vaughn Way, Suite 500 Aurora, CO  80014 Professional Relations Officer 303-368-4100 800-332-8087 Top of  page Connecticut (CT) Disability Determination Services 309 Wawarme Avenue Hartford, CT 06114 Professional Relations  Coordinator 860-466-6100 Top of  page Delaware (DE) Disability Determination Services 920 W Basin Rd. Suite 300 New Castle, DE 19720 Medical Relations Officer 302-324-7600 Top of  page District of Columbia   (DC) Disability Determination Division 1227 25th Street NW – 4th Floor Washington, DC  20037 Medical Relations Officer 202-442-8519 Top of  page Florida (FL) Department  of Health Division  of Disability Determinations Administrative  Office P.O. Box 7118 Tallahassee, FL 32314-5270 Professional  Relations Coordinator 800-499-6590,  ext. 5238 Department of Health Division of Disability Determinations PO BOX 10375 JACKSONVILLE FL 32247-0375 Professional Relations Officer 800-821-8122, ext. 4017 Department of Health Division of Disability Determinations P.O. BOX 839001 MIAMI FL 33283-9001 Professional Relations Officer 305-596-3020, ext. 6017 Department of Health Division of Disability Determinations PO BOX 15550 TAMPA FL 33684-5550 Professional Relations Officer 813-806-8950, ext. 8017 Department of Health Division of Disability Determinations PO BOX 9860 PENSACOLA FL 32513-9860 Professional Relations Officer 866-209-2095, ext. 3017 Division of Disability Determinations PO BOX 144040 ORLANDO FL 32814-4040 Professional Relations Officer 800-342-2065, ext. 7017 Top of  page Georgia (GA) Disability Adjudication Services Division of Georgia Vocational Rehabilitation Agency 1551 Juliette Road Stone Mountain, GA 300-86-1519 Professional Relations Coordinator 800-252-7485, ext. 2759 678-639-2759 Disability Adjudication Services 450 Mall Boulevard, Suite C Savannah, GA 31406-4823 Professional Relations Officer 800-992-3511, ext. 3233 912-652-3027 Disability Adjudication Services 14250 Highway 19 South Thomasville, GA 31792-4800 Professional Relations Officer 800-282-7485, ext. 2758 678-639-2758 Disability Adjudication Services 125 Athens West Parkway Athens, GA 30606-6942 Professional Relations Officer 800-282-7485, ext. 2761 678-639-2761 Georgia Vocational Rehabilitation Agency Disability Adjudication Section 500 East Walnut Avenue Building 2, Suite 101 Dalton, GA 30271 Professional Relations Officer 855-706-1128 706-281-8834 Top of  page Guam (includes American Samoa & Northern Mariana Islands) Federal Disability Office - Guam 770 East Sunset Boulevard Suite 155 Barrigada, Guam 96913-1506 Top of  page Hawaii (HI) Disability Determination Branch P.O. Box 2458 Honolulu, HI 96804 Professional Relations Officer 808-979-7000 Top of  page Headquarters/OMVE Headquarters/Office of Medical  and Vocational Expertise Oak Meadows   Building 6340 Security Blvd Baltimore, MD   21207 Professional Relations Officer Top of  page Idaho (ID) Disability Determination Services P.O. Box 21 Boise, ID 83707 Professional Relations Officer 208-327-7333 800-626-2681 Top of  page Illinois (IL) Illinois Department of  Rehabilitation Services Bureau of Disability Services P.O. Box 19250 Springfield, IL   62794-9250 Professional Relations Officer 800-225-3607 Top of  page Indiana (IN) Indiana Disability Determination  Bureau P.O. Box 7069 Indianapolis, IN   46207-7069 Professional Relations Officer 317-396-2000 Top of  page Iowa (IA) Disability Determination Services Bureau 535 SW 7th Street Des Moines, IA 50309-4535 Professional Relations Officer 515-725-0702 800-532-1223 Top of  page Kansas (KS) Disability Determination Services 2820 SW Fairlawn Rd Ste 100 Topeka, KS   66614-1509 Medical Relations Officer Medical Services Administrator 785-267-4440 800-685-0122 Top of  page Kentucky (KY) Kentucky Disability Determination Services Cabinet for Health and Family Services 102 Athletic Drive Frankfort, KY 40601 Professional Relations Coordinator 502-595-4404 502-782-1576 Department of Income Support Kentucky Disability Determination Services Cabinet for Health and Family Services Chestnut Center, Grauman Building 10510 LaGrange Road Louisville, KY 40223 Professional Relations Officer 502-782-1575 Top of  page Louisiana (LA) LA State Office Disability Determination Services 5825 Florida Blvd., Room 2065 Baton Rouge, LA 70806 800-256-2288 LA DDS—New Orleans Area Office 2150 West Bank Expressway, Suite 709 Harvey, LA 70058 Medical Relations Officer 504-838-5000 LA DDS—Baton Rouge Area Office 5905 Florida Blvd., Suite 2110 Baton Rouge, LA 70806 Medical Relations Officer 225-925-3522 LA DDS—Shreveport Area Office 2920 Knight Street, Suite 232 Shreveport, LA 71134-0446 Medical Relations Officer 318-869-6400 Top of  page Maine (ME) Carleton Mills Building 1705 US Rte 202 Winthrop, ME 04364 Professional Relations Officer 207-287-9600 Top of  page Maryland (MD) Disability Determination Services P.O. BOX 1810 Cockeysville, MD 21030-7810 Medical Relations Director 410-308-4336 Top of  page Massachusetts  (MA) Disability Determination Services 135 Santilli Highway Suite 310 Everett, MA 02149 Director, Medical Relations Program 617-727-1600 800-882-2040 Disability Determination Services 18 Chestnut Street 3rd Floor Worcester, MA 01608 Medical Relations Officer 508-752-5001 800-551-5532 Top of  page Michigan (MI) Lansing DDS Disability Determination Services PO Box 30011 Lansing, MI 48909-7511 800-366-3404 Detroit DDS Disability Determination Services P.O. Box 345 Detroit, MI 48231-0345 800-383-7155 Kalamazoo DDS Disability Determination Services P.O. Box 4020 Kalamazoo, MI 49003 Professional Relations Officer 800-829-7763 Traverse City DDS Disability Determination Service PO Box 1200 Traverse City, MI 49685 800-632-1097 Top of  page Minnesota (MN) Disability Determination Services P.O. Box 64709 St. Paul, MN   55164 Medical Relations Officer 651-259-7700 800-937-6469 Top of  page Mississippi (MS) Mississippi Disability Determination Services Department of Rehabilitation Services 1281 Highway 51 North Madison, MS 39110 Medical Relations Officer 601-853-5577 Top of  page Missouri (MO) Disability Determination Services 3014 Blattner Drive Cape Girardeau, MO 63703 Professional Relations Officer 573-290-5710 Disability Determination Services 1500 Southridge Drive, Suite 100 Jefferson City, MO 65109 Professional Relations Officer 573-751-2929 Disability Determination Services Governor Joseph P. Teasdale State Office Building 8800 East 63rd St., Suite 320 Raytown, MO  64133 Professional Relations Officer 816-743-8800 Disability Determination Services 1900 E. Division Street Springfield, MO 65803 Professional Relations Officer 417-888-4070 Disability Determinations Central Office 3024 Dupont Circle Jefferson City, MO 65109 Director for Medical Services 573-751-3251 Disability Determination Services 7545 S. Lindbergh, Suite 220 St. Louis, MO 63125 Professional Relations Officer 314-416-2803 Top of  page Montana (MT) Disability Determination Bureau P.O. Box 4189 Helena, MT 59604-4189 Professional Relations Officer 406-444-3054 800-545-3054 Top of  page Nebraska (NE) Disability Determinations Section 500 S 84th Street Lincoln, NE 68510 Medical Services Officer 402-471-2961 Top of  page Nevada (NV) Bureau of Disability Adjudication 2527 North Carson Street, Room 215 Carson City, NV  89706 Professional Relations Officer 800-882-4430 Top of  page New Hampshire (NH) Disability Determination Service 21 South Fruit Street, Suite 30 Concord, NH   03301-2453 Professional Relations Officer 603-271-3341 Top of  page New Jersey (NJ) Division of Disability Determinations P.O. Box 649 Newark, NJ 07101 Tel: 973-648-6971 Fax: 973-648-3886 Division of Disability Determinations P.O. Box 649 Newark, NJ 07101-0649 Tel: 973-648-4578 Fax: 973-648-7892 Covering Counties: Union Warren, Hunterdon, Somerset, Hudson, Monmouth Division of Disability Determinations P.O. Box 649 Newark, NJ 07010-0649 Tel: 973-648-4062 Fax: 973-648-7981 Covering Counties: Essex, Passaic, Sussex, Bergen, Morris, Mercer Division of Disability Determinations P.O. Box 378 Trenton, NJ 08625-0378 Labor Building - 10th Floor Tel: 609-943-4421 Fax: 609-943-5827 Top of  page New Mexico (NM) Disability Determination Services P.O. Box 4588 Albuquerque, NM   87196 Professional Relations Officer 505-841-5600 Top of  page New York (NY) Disability Determination Services P.O. Box 165 Albany, NY 12260-0165 Medical Relations Officer 518-473-9320 800-522-5511 Division of Disability  Determinations PO Box 5191 Bowling Green Station, NY 10274-5191 Medical Relations Officer 212-240-3456 800-522-5511 Office of Disability  Determination Services P.O. Box 5030 Buffalo, NY 14205-5030 Medical Relations Officer 716-847-5007 800-522-5511 Division of Disability  Determinations P.O. Box 9009 Endicott, NY 13761-9009 Medical Relations Officer 607-741-4195 800-522-5511 Top of  page North Carolina (NC) Disability Determination Services P.O. Box 243 2802 Mail Service Center Raleigh, NC 27602-0243 Professional Relations 919-814-3222 For Claim Status Information call 1-866-542-8113 Top of  page North Dakota (ND) Disability Determination Services 1237 W. Divide Avenue, Suite 4 Bismarck, ND   58501 Professional Relations Officer 800-543-2048 701-328-8700 Top of  page Ohio (OH) Opportunities for Ohioans with Disabilities Division of Disability Determination P.O. Box 359001 Columbus, OH 43235-9001 Professional Relations Officer 800-282-2695 Top of  page Oklahoma (OK) Disability Determination Division P.O. Box 24400 Oklahoma City, OK   73124-0400 Professional Relations Officer 800-877-9977 405- 419-2200 Top of  page Oregon (OR) Disability Determination Services 3150 Lancaster Drive NE Salem, OR 97305-1350 Professional Relations Officer 503-986-5100 800-452-2147 Top of  page Pennsylvania (PA) Bureau of Disability  Determination 144 N Main Street Greensburg, PA 15601 Medical Relations Program Manager 724-836-5100 Bureau of Disability Determination 1171 S. Cameron Street, Room 200 Harrisburg, PA 17104 Assistant Administrator Medical Relations Program Manager 717-783-3620 Bureau of Disability Determination Department of Labor and Industry 3rd Floor 901 North 7th Street,  Rear Harrisburg, PA 17102 717-425-7900 Bureau of Disability Determination P.O. Box R Wilkes-Barre, PA 18703 Medical Relations Program Director 570-301-5629 800-432-8039 Top of  page Puerto Rico (PR) Disability Determination Services P.O. Box 71301 San Juan, PR 00936-8401 Professional  Relations Officer 787-763-8989 787-754-6455 Top of  page Rhode Island (RI) Disability Determination Services 40 Fountain Street,  6th Floor Providence, RI 02903 Professional Relations  Officer 401-222-3182 Top of  page South Carolina (SC) Disability Determination Services P.O. Box 60 West Columbia, SC 29171-0060 Professional Relations Coordinator 803-896-6400 803-896-6799 Columbia Region Disability Determination Division P.O. Box 80 West Columbia, SC 29171-0060 Professional Relations Officer 803-896-6700 803-896-6708 Greenville Region Disability Determination Division P.O. Box 3090 Greenville, SC 29602 Professional Relations Officer 864-242-1950 864-282-4056 Charleston Region Disability Determination Division P.O. Box 190029 Charleston, SC 29602 Professional Relations Officer 843-953-0335 Top of  page South Dakota (SD) Disability Determination Services 3109 W 41st St, Ste. 100 Sioux Falls, SD 57105-8155 Professional Relations Officer 605-367-5499 800-658-2272 Top of  page Tennessee (TN) Tennessee Disability Determinations Services P.O. Box 775 Nashville, TN 37202 Professional Relations Coordinator 800-342-1117 (In State) 615-743-7774 800-342-1117 ERE.TN@ssa.gov Top of  page Texas (TX) Department of Assistive and  Rehabilitative Services Disability Determination Services P.O. Box 149198 Austin, TX 78714-9198 800-252-9627 Top of  page Utah (UT) Disability Determination Services P.O. Box 144032 Salt Lake City, UT   84111-4032 Professional Relations Officer 801-321-6500 800-221-3493 Top of  page Vermont (VT) Disability Determination Services 93 Pilgrim Park Road, Suite 6 Waterbury, VT 05676 Professional Relations Office 802-241-2463 800-734-2463 Top of  page Virginia (VA) Disability Determination Services 11150 Fairfax Blvd, Suite 200 Fairfax, VA 22030 703-934-7408 Disability  Determination Services Southwest Regional Office 612 S. Jefferson Street, Suite 300 Roanoke, VA 24011 540-857-7754 Disability Determination Services Central Regional Office 9960 Mayland Dr., Suite 200 Richmond, VA 23233 804-367-4707 Disability Determination Services Tidewater Regional Office 5850 Lake Herbert Dr., Suite 200 Norfolk, VA 23502 757-466-3312 Disability Determination Services Administrative Office 8004 Franklin Farms Dr. Richmond, VA 23229 540-613-0344 Top of  page Virgin Islands (VI) SSA Disability Center  - VI Nisky Center, 1st Floor, Suite 14 St. Thomas, VI 00802 Top of  page Washington (WA) Division of Disability Determination Services P.O. Box 9303-MS-45550 Olympia, WA 98507-9303 Professional Relations Officer 1-800-562-6074 Division of Disability Determination Services 1330 N Washington #2080 Spokane, WA 99201-2314 1-800-562-6074 Top of  page West Virginia(WV) Division of Rehabilitation  Services Disability Determination Section 500 Quarrier Street, Suite 500 Charleston, WV 25301-2913 Professional Relations Officer 304-343-5055 800-344-5033 (in-state only) Division of Rehabilitation  Services Disability Determination Section 320 West Pike Street, Suite 120 Clarksburg, WV 26301-2913 Professional Relations Officer 304-624-0200 800-344-7813 (in-state only) Top of  page Wisconsin (WI) Disability Determination Bureau Division of Medicaid Services Department of Health State of Wisconsin P.O. Box 7886 Madison, WI 53707-7886 608-266-1565 Top of  page Wyoming (WY) Disability Determination Services 5221 Yellowstone Road Cheyenne, WY 82002 Disability Hearings  Officer/Professional Relations Officer/ Medical Relations Officer 307-777-7341 800-438-5788 For information about registering for SSA’s Electronic Records Express , please contact us at ERE.NC@ssa.gov. Please do not send medical records directly to this email address. Top of  page",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/procontacts.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/publications.htm",
      "https://www.ssa.gov/pubs/englist.html#Disability",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Alabama",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Alaska",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Arizona",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Arkansas",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#California",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Colorado",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Connecticut",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Delaware",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#District of Columbia",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Florida",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Georgia",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Guam",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Hawaii",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#HQ",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Idaho",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Illinois",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Indiana",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Iowa",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Kansas",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Kentucky",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Louisiana",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Maine",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Maryland",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Massachusetts",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Michigan",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Minnesota",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Mississippi",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Missouri",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Montana",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Nebraska",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Nevada",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#New Hampshire",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#NewJersey",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#NewMexico",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#NewYork",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#NorthCarolina",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#North Dakota",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Ohio",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Oklahoma",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Oregon",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Pennsylvania",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Puerto Rico",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#RhodeIsland",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#SouthCarolina",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#SouthDakota",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Tennessee",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Texas",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Utah",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Vermont",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Virginia",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Virgin Islands",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Washington",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#WestVirginia",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Wisconsin",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#Wyoming",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "mailto:ERE.TN@ssa.gov",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/ere/",
      "https://www.ssa.gov/disability/professionals/procontacts.htm#top",
      "https://www.ssa.gov/disability/professionals/procontacts.htm"
    ],
    "html_file": "ssa_bluebook_data/html/76926d1bd230fd07e77f3fd243bb1fb0.html",
    "fetched_at": 1762482657.719734
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
    "url_hash": "47f8cfc76a2b484d5c865ad4408d7e16",
    "title": "Listing of Impairments - Child Listings (Part B) | Disability | SSA",
    "text_content": "Listing of Impairments - Child Listings (Part B) | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Listing of Impairments - Childhood Listings (Part B) Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security Listing of Impairments - Childhood \n        Listings (Part B) The following sections contain medical  criteria that apply only to the evaluation of impairments in children under age  18. 100.00 Low Birth Weight and Failure to Thrive 101.00 Musculoskeletal Disorders 102.00 Special Senses and Speech 103.00 Respiratory Disorders 104.00 Cardiovascular System 105.00 Digestive Disorders 106.00 Genitourinary Disorders 107.00 Hematological Disorders 108.00 Skin Disorders 109.00 Endocrine Disorders 110.00 Congenital Disorders that Affect Multiple Body Systems 111.00 Neurological Disorders 112.00 Mental Disorders 113.00 Cancer (Malignant Neoplastic Diseases) 114.00 Immune System Disorders",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social SecurityListing of Impairments - Childhood \n        Listings(Part B)"
      }
    ],
    "tables": [
      [
        [
          "100.00Low Birth Weight and Failure to Thrive",
          "101.00Musculoskeletal Disorders",
          "102.00Special Senses and Speech"
        ],
        [
          "103.00Respiratory Disorders",
          "104.00Cardiovascular System",
          "105.00Digestive Disorders"
        ],
        [
          "106.00Genitourinary Disorders",
          "107.00Hematological Disorders",
          "108.00Skin Disorders"
        ],
        [
          "109.00Endocrine Disorders",
          "110.00Congenital Disorders that Affect Multiple Body Systems",
          "111.00Neurological Disorders"
        ],
        [
          "112.00Mental Disorders",
          "113.00Cancer (Malignant Neoplastic Diseases)",
          "114.00Immune System Disorders"
        ]
      ]
    ],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/106.00-Genitourinary-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/107.00-HematologicalDisorders-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/109.00-Endocrine-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/110.00-MultipleBody-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm"
    ],
    "html_file": "ssa_bluebook_data/html/47f8cfc76a2b484d5c865ad4408d7e16.html",
    "fetched_at": 1762482770.7157197
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
    "url_hash": "c04e48402a545959569176c515bc44f1",
    "title": "Part I - General Information | Disability | SSA",
    "text_content": "Part I - General Information | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Part I - General Information Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social \n        Security Part I - General Information Program Description The Social Security  Administration (SSA) administers two programs that provide benefits based on  disability: the Social Security disability insurance program (title II of the  Social Security Act (Act)) and the Supplemental Security Income (SSI) program  (title XVI of the Act). Title II provides for  payment of disability benefits to disabled individuals who are  \"insured\" under the Act by virtue of their contributions to the  Social Security trust fund through the Social Security tax on their earnings,  as well as to certain disabled dependents of insured individuals. Title XVI  provides SSI payments to disabled individuals (including children under age 18)  who have limited income and resources. The Act and SSA's  implementing regulations prescribe rules for deciding if an individual is  \"disabled.\" SSA's criteria for deciding disability may differ from  the criteria applied in other government and private disability programs. Definition of Disability For all individuals  applying for disability benefits under title II, and for adults applying under  title XVI, the definition of disability is the same. The law defines disability  as the inability to engage in any substantial gainful activity (SGA) by reason  of any medically determinable physical or mental impairment(s) which can be  expected to result in death or which has lasted or can be expected to last for  a continuous period of not less than 12 months. Disability in Children Under title XVI, a child  under age 18 will be considered disabled if he or she has a medically  determinable physical or mental impairment or combination of impairments that  causes marked and severe functional limitations, and that can be expected to  cause death or that has lasted or can be expected to last for a continuous  period of not less than 12 months. What is a \"Medically  Determinable Impairment\"? A medically determinable  physical or mental impairment is an impairment that results from anatomical,  physiological, or psychological abnormalities that can be shown by medically  acceptable clinical and laboratory diagnostic techniques. The medical evidence  must establish that an individual has a physical or mental impairment; a  statement about the individual's symptoms is not enough. The Disability  Determination Process Most disability claims  are initially processed through a network of local Social Security field  offices and State agencies (usually called Disability Determination Services,  or DDSs). Subsequent appeals of unfavorable determinations may be decided in  the DDSs or by administrative law judges in SSA's Office of Hearing Operations (OHO). Social Security Field  Offices When an individual  applies for disability benefits, whether online, in person, by telephone, or by  mail, the application is initially processed at an SSA field office. The  completed application and related forms provide information about the  claimant's impairment(s); names, addresses, and telephone numbers of medical  sources; and other information that relates to the alleged disability. (The  \"claimant\" is the person who is requesting disability benefits.) The field office is  responsible for verifying nonmedical eligibility requirements, which may  include age, employment, marital status, citizenship and residency, and Social  Security coverage information.   For SSI eligibility, the field  office verifies income, resources, and living arrangement information. The  field office sends the case to a DDS for disability evaluation. State Disability  Determination Services The DDSs are State  agencies responsible for developing medical evidence and making the initial  determination about whether the claimant is or is not disabled or blind under  the law.  These State agencies are fully funded by the Federal Government. Usually, the DDS obtains  evidence from the claimant's own medical sources first. When the evidence is  unavailable or insufficient to make a determination, the DDS may arrange a  consultative examination (CE) to obtain additional evidence. The individual's own  medical source(s) is the preferred source for the CE; however, the DDS may also  obtain the CE from an independent source. ( See Part II, Evidentiary Requirements,  for more information about CEs .) After completing its  development, the DDS makes the disability determination. An adjudicative team  consisting of a medical or psychological consultant and a disability examiner usually  makes the determination. If the adjudicative team finds that additional  evidence is still needed, the consultant or examiner may recontact a medical  source and ask for additional information. The DDS will refer the case  to the State vocational rehabilitation (VR) agency if the claimant is a  candidate for VR. The DDS returns the case  to the field office after making a disability determination.  The field  office takes appropriate action depending on whether the claim is allowed or  denied.  If the DDS finds the claimant is disabled, SSA will complete  any outstanding non-disability development, compute the benefit amount, and  begin paying benefits. If the claimant is found to be not disabled, the file is  retained in the field office in case he or she decides to appeal the  determination. If the claimant appeals an  initial determination, the appeal is usually handled much the same as the  initial claim  except that a different adjudicative team in the DDS  than the one that handled the original case makes the reconsideration determination. Office of Hearing Operations Claimants who are  dissatisfied with the reconsideration determination may request a hearing  before an administrative law judge (ALJ) in OHO.  The claimant may submit additional  information and evidence to the ALJ, and the ALJ will issue a decision based on  all the evidence of record, including evidence obtained at the hearing. When an ALJ needs  additional evidence, the hearing office frequently coordinates with the DDS to  obtain the evidence. However, hearing offices may also contact medical sources  directly. In some circumstances, an ALJ may issue a subpoena requiring  production of evidence or testimony at a hearing. Back to Top The Role of the Health Professional Health professionals play  a vital role in the disability determination process and participate in the  process in a variety of ways: As medical       sources who provide medical evidence on behalf of their patients; As CE       sources who perform, for a fee, examinations or tests that are needed; As       full-time or part-time medical or psychological consultants reviewing       claims in a DDS, in one of SSA's regional offices, or in SSA’s central       office; or As medical       experts who testify at ALJ hearings or respond to written interrogatories       from the ALJ. Claimant’s Own Medical  Sources A medical source who has  evaluated, examined, or treated a claimant is usually the best source of  medical evidence about the nature and severity of a claimant's impairment(s). If an additional  examination or testing is needed, SSA usually considers a claimant’s own  medical source to be the preferred source for performing a CE. Consultative Examiners  for the DDS In the absence of  sufficient medical evidence from a claimant’s own medical sources, SSA, through  the State DDS, may request an additional CE(s) to be performed by licensed medical  sources (such as physicians and psychologists). All CE sources must be  currently licensed in the State and have the training and experience to perform  the type of examination or test SSA requests. Each State establishes  the set fee for CEs, and fees may vary from State to State. Each State agency  is responsible for comprehensive oversight of its CE program. Medical professionals who  perform CEs must have a good understanding of SSA's disability programs and  their evidentiary requirements. In addition, these medical professionals are  made fully aware of their responsibilities and obligations regarding  confidentiality and: CE scheduling intervals; CE report content; Elements of a complete CE; When a complete CE is not required; and Signature requirements. See Part II of this guide for more information about CEs. Program Medical Consultants  and Psychological Consultants Medical consultants, who  are physicians, and psychological consultants, who are psychiatrists and  psychologists, review disability claims at the State, regional, or national  levels.  During a case review, a medical  or psychological consultant usually has no contact with the claimant. Medical Experts Administrative law judges  may request medical expert testimony on complex medical issues.  Each  hearing office maintains a roster of medical experts who are called to testify  as expert witnesses at hearings or to respond to written interrogatories. The  experts are paid a fee for their services. Confidentiality of  Records Two separate laws, the  Freedom of Information Act and the Privacy Act, have special significance for  Federal agencies. Under the Freedom of Information Act, Federal agencies are  required to provide the public with access to their files and records. This  means the public has the right, with certain exceptions, to examine records  pertaining to the functions, procedures, final opinions, and policy of these  Federal agencies. The Privacy Act permits  an individual or his or her authorized representative to examine records  pertaining to him or her in a Federal agency. For disability applicants, this  means that an individual may request to see the medical or other evidence used  to evaluate his or her application for disability benefits under the Social  Security or the SSI programs. (This evidence, however, is not available to the  general public.) SSA screens all requests  to see medical evidence in a claim file to determine if release of the evidence  directly to the individual might have an adverse effect on that individual. If  so, the report will be released only to an authorized representative designated  by the individual. Back to Top Questions and Answers about Social Security Disability Programs This information is  designed to provide a more thorough understanding of the disability programs that  SSA administers. Following are some of the most frequently asked questions  about these programs. Q. Who can get disability  benefits under Social Security? A. Under the Social  Security disability insurance program (title II of the Act), there are three  basic categories of individuals who can qualify for benefits on the basis of  disability: A disabled insured worker less than full retirement age. An individual disabled since childhood (before age 22) who is a dependent of a parent entitled to title II disability or retirement benefits or was a dependent of a deceased insured parent. A disabled widow or widower, age 50-60 if the deceased spouse was insured under Social Security. Under title XVI, or SSI, adults  and children under age 18 who have limited income and resources can receive  payments based on disability or blindness. Q. How is the disability determination made? A. SSA’s regulations provide  a procedure known as the \"sequential evaluation process\" for  disability evaluation.   For adults, this is a five-step process that  requires sequential review of: the claimant's current work activity (if any), the severity of his or her impairment(s), a determination of whether his or her impairment(s) meets or medically equals a listing (see Part III of this guide), the claimant's ability to perform his or her past relevant work, and his or her ability to do other work based on age, education, and work experience. For children applying for  SSI, the process requires sequential review of: the child's current work activity (if any), the severity of his or her impairment(s), and an  assessment of whether his or her impairment(s) meets, medically equals, or  functionally equals a listing. If  SSA can find an adult or child either disabled or not disabled at any step, the  evaluation is complete. Q. When do disability  benefits start? A. Disability benefits  for workers and widows usually cannot begin for 5 months after the established  onset of the disability. Therefore, Social Security disability benefits will begin the sixth full month after the date the disability began. The 5-month  waiting period does not apply to individuals filing as children of workers. The 5-month waiting period also does not apply if a worker’s disability results from amyotrophic lateral sclerosis (ALS) and he or she is approved for Social Security disability benefits on or after July 23, 2020. Under SSI, disability payments may begin as early as the first full month after the individual applied or became eligible for SSI. In addition, under the  SSI disability program, an applicant may be found \"presumptively disabled  or blind,\" and receive cash payments for up to 6 months while the formal  disability determination is made. The presumptive payment is designed to allow  an individual with limited income and resources to meet his or her basic living  expenses during the time it takes to process the application. If it is later  determined that the individual is not disabled, he or she is not required to  refund the payments. There is no provision for a finding of presumptive  disability or blindness under the Title II program. Q. What can an individual  do if he or she disagrees with the determination? A. If an individual  disagrees with the initial determination in the case, he or she may appeal it. Usually,  the first administrative appeal is a reconsideration.  At the  reconsideration appeal level, generally the case is reviewed at the State level  by an adjudicative team that was not involved in the original determination. If  dissatisfied with the reconsideration determination, the individual may request  a hearing before an administrative law judge. If the individual is dissatisfied  with the hearing decision, he or she may request review by the Appeals Council.  In general, a claimant has 60 days to appeal an unfavorable determination or  decision. Appeals must be filed in writing and may be submitted by mail, in  person to any Social Security office, or online where available. After an individual has  completed the administrative appeals process, he or she may seek judicial  review by filing a civil action in Federal district court. Q. Can individuals  receiving disability benefits or payments get Medicare or Medicaid coverage? A. Medicare helps pay  hospital and doctor bills of disabled or retired people who have worked long  enough under Social Security to be insured for Social Security benefits. It  generally covers people who are 65 and over; people who have been determined to  be disabled and have been receiving benefits for at least 24 months or have  amyotrophic lateral sclerosis (ALS); and people who need long‑term dialysis treatment  for chronic kidney disease or require a kidney transplant. In general, Medicare  pays 80 percent of reasonable charges. In most States, individuals who qualify for SSI disability payments also qualify for Medicaid.  States may refer to the Medicaid program by different names. The program covers  all of the approved charges of the Medicaid patient. Medicaid is financed by  Federal and State matching funds, but eligibility rules may vary from State to  State. Q. Can someone work and  still receive disability benefits? A. Social Security’s “work  incentive” rules make it possible for people to test their ability to work  without losing their eligibility for cash benefits and Medicare or Medicaid.  The rules are different for title II and title XVI, but under both programs  they may provide: continued cash benefits; continued help with medical bills; help with work expenses or; vocational training. For more information about work incentives,  ask any Social Security Office for the publication entitled the \"Red  Book,\" A Summary Guide to Employment Supports for Persons with  Disabilities under the Social Security Disability Insurance (SSDI) and  Supplemental Security Income (SSI) Programs. You can access the Red Book  online at: https://www.ssa.gov/redbook/index.html .",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social \n        Security"
      },
      {
        "level": 3,
        "text": "Part I - General Information"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm#Top",
      "https://www.ssa.gov/redbook/",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm"
    ],
    "html_file": "ssa_bluebook_data/html/c04e48402a545959569176c515bc44f1.html",
    "fetched_at": 1762482774.977954
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
    "url_hash": "b787b3e406728b4c032e5f87f9a4db20",
    "title": "Part II - Evidentiary Requirements | Disability | SSA",
    "text_content": "Part II - Evidentiary Requirements | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Part II - Evidentiary Requirements Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security Part II - Evidentiary Requirements Medical Evidence Medical evidence is the  cornerstone of the disability determination under both the title II and title  XVI programs. Each person who files a  disability claim is responsible for providing medical evidence showing he or  she has an impairment(s) and the severity of the impairment(s). However, the  Social Security Administration (SSA), with the claimant’s permission, will help  the claimant get medical evidence from his or her own medical sources who have evaluated,  examined, or treated the claimant for his or her impairment(s). SSA also  requests copies of medical evidence from hospitals, clinics, or other health  facilities when appropriate. Claimants who provide SSA  with timely, accurate, and complete information and evidence can help accelerate  the processing of their claims. Existence of an  impairment By law, SSA needs  specific medical evidence to establish that a claimant has an impairment.  SSA regulations require “objective medical  evidence” from an “acceptable medical source” to establish that a claimant has  a medically determinable impairment.  The  regulations define these terms. Severity Once the existence of an  impairment is established, SSA considers all evidence from all medical and  nonmedical sources to assess the extent to which a claimant's impairment(s)  affects his or her ability to function in a work setting; or in the case of a  child, the ability to function compared to that of children the same age who do  not have impairments.  Nonmedical sources include, but are not limited to:  the claimant, educational personnel, public and private social welfare agency  personnel, family members, caregivers, friends, neighbors, employers, and  clergy. Claimant’s Responsibilities A claimant must inform SSA  about or submit all evidence known to him or her that relates to whether or not  he or she is blind or disabled.  This  duty is ongoing and requires the claimant to disclose any additional related  evidence about which he or she becomes aware throughout the administrative  review process.  The evidence must be complete  and detailed enough for SSA to determine: The nature and severity of the claimant’s  impairment(s), How long the claimant has experienced the  impairment(s), and Whether the claimant can still do  work-related physical and mental activities with the impairment(s). Consultative Examinations If the evidence provided by the claimant's own medical sources is inadequate to  determine if he or she is disabled, additional medical information may be  sought by recontacting the medical source for additional information or  clarification, or by arranging for a consultative examination (CE). Generally, a claimant’s own medical source(s) is the preferred source to perform the needed examination or test, and SSA will  pay the authorized fee for the CE. However, SSA may use an independent medical  source other than the claimant’s own medical source(s) to conduct the CE in  several situations, such as: the claimant’s own medical source(s)  prefers not to perform the examination; the claimant’s       own medical source(s) does not have the equipment to provide the specific       data needed; there are       conflicts or inconsistencies in the file that cannot be resolved by going       back to the claimant’s own medical source(s); the       claimant prefers another source and has good reason for doing so; SSA knows       from prior experience that the claimant’s own medical source(s) may not be       a productive source; or the claimant’s       own medical source(s) is not qualified, as is defined by regulation. Consultative Examination  Report Content A complete CE report will involve all the elements of a standard examination in  the applicable medical specialty and should include the following elements: the       claimant's major or chief complaint(s); a detailed       description, within the area of specialty of the examination, of the       history of the major complaint(s); a       description, and disposition, of pertinent \"positive\" and       \"negative\" detailed findings based on the history, examination,       and laboratory tests related to the major complaint(s), and any other       abnormalities or lack thereof reported or found during examination or       laboratory testing; results of       laboratory and other tests (for example, X-rays) performed according to       the requirements stated in the Listing of Impairments ( see Part III of       this guide ); the       diagnosis and prognosis for the claimant's impairment(s); in claims       for adults, a statement about what a claimant can still do despite his or       her impairment(s) and whether the claimant has one or more       impairment-related limitations or restrictions in the following abilities: The        ability to perform physical demands of work activities, such as sitting,        standing, walking, lifting, carrying, pushing, pulling, or other physical        functions (including manipulative or postural functions, such as        reaching, handling, stooping, or crouching); The        ability to perform mental demands of work activities, such as        understanding; remembering; maintaining concentration, persistence, or        pace; carrying out instructions; or responding appropriately to        supervision, co-workers, or work pressures in a work setting; The        ability to perform other demands of work, such as seeing, hearing, or        using other senses; and The        ability to adapt to environmental conditions, such as temperature        extremes or fumes; in claims       for children under age 18, a statement about the child’s impairment-related       limitations and restrictions (as compared to children his or her age who       do not have impairments) in: acquiring and using information; attending and       completing tasks; interacting and relating with others; moving about and       manipulating objects; caring for yourself; and heath and physical well-being;       and the       consultant 's consideration, and some explanation or comment on, the       claimant's major complaint(s) and any other abnormalities found during the       history and examination or reported from the laboratory tests. The       history, examination, evaluation of laboratory test results, and the       conclusions will represent the information provided by the consultant who       signs the report. Evidence Relating to  Symptoms In developing evidence of the effects of symptoms, such as pain, shortness of  breath, or fatigue, on a claimant's ability to function, SSA investigates all  avenues presented that relate to the complaints. These include evidence about: the       claimant's daily activities; the       location, duration, frequency, and intensity of the pain or other symptom; precipitating       and aggravating factors; the type,       dosage, effectiveness, and side effects of any medication; treatments,       other than medications, for the relief of pain or other symptoms; any       measures the claimant uses or has used to relieve pain or other symptoms;       and other       factors concerning the claimant's functional limitations due to pain or       other symptoms. In assessing the claimant's pain or other symptoms, SSA considers all of the  above-mentioned factors. It is important that medical sources address these  factors in the reports they provide.",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security"
      },
      {
        "level": 3,
        "text": "Part II - Evidentiary Requirements"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm"
    ],
    "html_file": "ssa_bluebook_data/html/b787b3e406728b4c032e5f87f9a4db20.html",
    "fetched_at": 1762482779.2634108
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
    "url_hash": "2b132247acdb17deab54e3fe69bee2c0",
    "title": "Part III - Listing of Impairments (Overview) | Disability | SSA",
    "text_content": "Part III - Listing of Impairments (Overview) | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Part III - Listing Of Impairments Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security Part III - Listing Of Impairments The Listing of  Impairments describes, for each major body system, impairments considered  severe enough to prevent an individual from doing any gainful activity (or in  the case of children under age 18 applying for SSI, severe enough to cause  marked and severe functional limitations). Most of the listed impairments are  permanent or expected to result in death, or the listing includes a specific  statement of duration. For all other listings, the evidence must show that the  impairment has lasted or is expected to last for a continuous period of at  least 12 months. The criteria in the Listing of Impairments are applicable to  evaluation of claims for disability benefits under the Social Security  disability insurance program or payments under the SSI program. Part A of the Listing of Impairments contains medical criteria that apply to  the evaluation of impairments in adults age 18 and over. The medical criteria  in Part A may also be applied in evaluating impairments in children under age 18 if  the disease processes have a similar effect on adults and younger children. Part B of  the Listing of Impairments contains additional medical criteria that apply only  to the evaluation of impairments of persons under age 18. Certain  criteria in Part A do not give appropriate consideration to the particular  effects of the disease processes in childhood; that is, when the disease  process is generally found only in children or when the disease process differs  in its effect on children and adults. Additional criteria are included in Part B , and the impairment categories are, to the extent  possible, numbered to maintain a relationship with their counterparts in Part  A. In evaluating disability for child under age 18, part B will be used first.  If the medical criteria in part B do not apply, then the medical criteria in  part A will be used. The criteria in the Listing of Impairments apply only  to one step of the multi-step sequential evaluation process. At that step, the  presence of an impairment that meets the criteria in the Listing of Impairments  (or that is of equal severity) is usually sufficient to establish that an  individual who is not working is disabled. However, the absence of a listing-level impairment does  not mean the individual is not disabled. Rather, it merely requires the  adjudicator to move on to the next step of the process and apply other rules in  order to resolve the issue of disability.",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security"
      },
      {
        "level": 3,
        "text": "Part III - Listing Of Impairments"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm"
    ],
    "html_file": "ssa_bluebook_data/html/2b132247acdb17deab54e3fe69bee2c0.html",
    "fetched_at": 1762482781.5472994
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
    "url_hash": "d94e0a4b740c961a0940f240e764ec05",
    "title": "Revisions to Rules Regarding the Evaluation of Medical Evidence | Disability | SSA",
    "text_content": "Revisions to Rules Regarding the Evaluation of Medical Evidence | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Revisions  to Rules Regarding the Evaluation of Medical Evidence Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Revisions  to Rules Regarding the Evaluation of Medical Evidence On January 18, 2017, SSA published the final rules  “Revisions to Rules Regarding the Evaluation of Medical Evidence” in the  Federal Register (82 FR 5844). A correction to the final rules was published on  March 27, 2017 (82 FR 15132). The final rules became  effective on March 27, 2017. This page provides information for the public to  become familiar with the rules.  Additional  resources  are found at the bottom of this page. Q1: What revisions did we make? A1: The  revisions to our medical evidence rules include redefining several  key terms related to evidence, revising our list of acceptable medical sources  (AMS), revising how we consider and articulate our consideration of medical  opinions and prior administrative medical findings, revising who can be a  medical consultant (MC) and psychological consultant (PC), revising our rules  about treating sources, and reorganizing our evidence regulations for ease of  use. Q2:  Why did  we make these revisions? A2: These  revisions conform our rules with the requirements of the Bipartisan Budget Act  of 2015 (BBA), reflect changes in the national healthcare workforce and in the  manner that individuals receive primary medical care, simplify and reorganize  our rules to make them easier to understand and apply,  allow us to continue to make accurate and  consistent decisions, and emphasize the need for objective medical evidence in  disability and blindness claims. Q3:  How do we determine which set of rules to  use? A3 : Some of  the rules we use to evaluate evidence will depend on a claim’s filing  date.   For a claim   filed on or after March 27, 2017, we will  adjudicate  the claim using the rules in place on or after March 27, 2017 (“current  rules”).    For  a claim   filed before March 27, 2017, we will  adjudicate  the claim using    the rules in  place before March 27, 2017 (“prior  rules”).   We   maintain subregulatory guidance about how to determine the filing  date of a claim and filing date scenarios at  POMS DI  24503.050 Determining the Filing Date for Evaluating Evidence. Q4: What  changes did we make to our rules about categorizing evidence? A4: We  reorganized and redefined categories of evidence to make them easier to  understand and apply in the  disability adjudicative process.  The  categories of evidence are: (1) objective medical evidence, (2) medical  opinions, (3) other medical evidence, (4) evidence from nonmedical sources, and  (5) prior administrative medical findings.  This chart summarizes the  categories of evidence: Category    of Evidence Source Summary    of Definition Objective    medical evidence Medical    sources Signs,    laboratory findings, or both Medical    opinion Medical    sources A    statement about what an individual can still do despite his or her    impairment(s) and whether the individual has one or more impairment-related    limitations or restrictions in one or more specified abilities Other    medical evidence Medical    sources All other    evidence from medical sources that is not objective medical evidence or a    medical opinion Evidence    from nonmedical sources Nonmedical    sources All    evidence from nonmedical sources Prior    administrative medical finding MCs and    PCs A    finding, other    than the ultimate determination about whether the individual is disabled,    about a medical issue made by an MC or PC at a prior administrative level in    the current claim Q5: What changes did we make to the list of acceptable  medical sources (AMS)? A5: For  claims filed on or after March 27, 2017, we   recognize three    new  AMSs.   These  include Advanced Practice Registered Nurses (APRN), or other  licensed advanced practice nurse with another title, for impairments within his  or her scope of practice;  audiologists for impairments  of hearing loss, auditory processing disorders, and balance disorders within his  or her licensed scope of practice;   and P hysician  A ssistants  (PA) for impairments within  his or her licensed  scope of practice. We also updated rules about existing  AMSs    to reflect current  licensing, scope of practice, and credentialing requirements. Q6: Why  did we not recognize additional medical sources as AMSs? A6: Upon investigation of licensing requirements for other  medical sources, we did not find a similar level of  consistency  or rigor in terms of education, training, certification, and scope of practice. However, we will  continue to consider evidence from  these medical sources when we evaluate the severity of an individual’s  impairment(s) and its effect on an individual. Q7: What  changes did we make to our rules about establishing the existence of an  impairment? A7: We still require objective medical evidence from  an AMS to establish the existence of a medically determinable impairment(s) .   We revised the definition of objective medical  evidence to clarify that it means signs, laboratory findings, or both.  We   now recognize APRNs, audiologists, and  PAs as AMSs who can provide us with this objective medical evidence for claims  filed on or after March 27, 2017.  We also clarified that we cannot  establish an impairment based on a diagnosis, symptoms, or a medical opinion.  Finally, we made clarifying  revisions to the existing definitions of signs and laboratory findings. Q8: What  changes did we make to our rules about medical consultants (MC) and  psychological consultants (PC)? A8: We  revised our rules to conform  with requirements  of  BBA section 832.  This law  states that we must make every reasonable effort to ensure that a qualified  physician ( where evidence  indicates the existence of a physical impairment) or a  qualified  psychiatrist or psychologist  ( where evidence indicates the  existence of a mental impairment) completes    the medical portion of the case review  and any applicable residual  functional capacity assessment . Q9: What changes  did we make to the definition of a medical opinion? A9: For  claims filed on or after March 27, 2017,  the   definition focuses  on  perspectives from medical sources  about  an individual’s  functional  abilities and limitations.  This makes our evidence rules easier to understand  and use  and improves our  adjudicative process.  Under the new rules, all medical sources other than  MCs and PCs, not just AMSs, can create evidence that we categorize as  medical opinions. Q10: Why  did we change our rules about considering medical opinions? A10: We  revised how we consider medical opinions to reflect a modern  healthcare delivery model that involves many types of medical  sources.  We also  address  several  adjudicative issues resulting from our prior rules for  weighing medical opinions.  For example,              the treating source rule   resulted in reviewing courts focusing more on whether we sufficiently  articulated the weight we gave treating source opinions rather than  on whether substantial evidence supported   the Commissioner’s final decision.  In addition,  the Ninth Circuit’s  use of a “credit-as-true” rule  sometimes  resulted  in the court  ordering us to award benefits instead of remanding  cases,  preventing us from reconsidering the evidence in  the record as a whole and correcting any errors that may have existed,  effectively supplanting the judgment of our decision makers. Q11: What changes did we make to  our rules about considering medical opinions? A11: For claims filed on or after  March 27, 2017,  we  no longer  defer  or give any specific evidentiary weight, including controlling  weight, to medical opinions .  Instead, we   focus on the  persuasiveness of medical opinions from all medical sources  equally using  factors specified in our  rules.   We   emphasize   supportability and consistency as the most important factors  for considering the value  and persuasiveness of medical opinions. Q12: What changes did we make to  our rules about providing written explanations about how we consider medical  opinions? A12: For  claims filed on or after March 27, 2017,  we  articulate in our  determination or decision how persuasive we find all of the medical opinions from all  medical sources.  When a  medical source provides multiple medical opinions, we articulate how we  considered the medical opinions from that medical source  together in a single analysis using specified factors, as appropriate.  We are not required to articulate how we  considered each medical opinion from one medical source individually.    We   explain  how we considered the  supportability  and consistency factors for a medical source’s opinions because  those are the most important factors we consider when we  determine how persuasive we find a medical source’s medical opinions.    W e  may,  but are not required to,  explain how we considered the other specified  factors, as appropriate, when we articulate how we  consider medical opinions in the case record .    When we find that two or more medical  opinions  about  the same issue are equally well-supported and consistent with the record but  are not exactly the same, we  articulate how we considered the  other most persuasive factors. Q13: What changes did we make to  our rules about considering and providing written explanations about how we  consider evidence from MCs and PCs? A13 :  For claims filed on  our after March 27, 2017, w e   use the same rules for considering and articulating  prior administrative medical findings as we do  for medical opinions, which we discuss above in questions 11 and 12. Q14: What changes did we make to  our rules about how we consider decisions from other governmental agencies and  nongovernmental entities? A14 : For  claims filed on or after March 27, 2017, we  do not  provide any written analysis in our determination   or decision about a  decision  made  by any  other governmental  agency or a nongovernmental   entity about whether   an individual is disabled, blind, or  employable, or  entitled to any benefits.      However, we   consider all of the supporting  evidence  underlying  the other governmental  agency or  nongovernmental  entity’s decision   that we receive as evidence in a claim in accordance with  our rules  about how we consider evidence. Q15: What changes did we make to  our rules about how we consider statements on issues reserved to the  Commissioner? A15: For  claims filed on or after March 27, 2017, we do not  provide any written analysis in our determination or decision about  statements on  issues  reserved to the Commissioner because   we are  responsible for making the determination or decision about whether an  individual  is disabled or blind under  the Act. Q16: What training are we  providing to our adjudicators about the final rules? A16: To help  adjudicators understand and apply the revised medical  evidence rules,  we  provide    written training materials,  several training videos, and training sessions  targeted to adjudicators at each level of administrative  review. Additional Resources Policy Guide Notice of Proposed Rulemaking Final Rules Final Rules, correction",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Revisions  to Rules Regarding the Evaluation of Medical Evidence"
      }
    ],
    "tables": [
      [
        [
          "Category    of Evidence",
          "Source",
          "Summary    of Definition"
        ],
        [
          "Objective    medical evidence",
          "Medical    sources",
          "Signs,    laboratory findings, or both"
        ],
        [
          "Medical    opinion",
          "Medical    sources",
          "A    statement about what an individual can still do despite his or her    impairment(s) and whether the individual has one or more impairment-related    limitations or restrictions in one or more specified abilities"
        ],
        [
          "Other    medical evidence",
          "Medical    sources",
          "All other    evidence from medical sources that is not objective medical evidence or a    medical opinion"
        ],
        [
          "Evidence    from nonmedical sources",
          "Nonmedical    sources",
          "All    evidence from nonmedical sources"
        ],
        [
          "Prior    administrative medical finding",
          "MCs and    PCs",
          "A    finding, other    than the ultimate determination about whether the individual is disabled,    about a medical issue made by an MC or PC at a prior administrative level in    the current claim"
        ]
      ]
    ],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://secure.ssa.gov/apps10/poms.nsf/lnx/0424503050",
      "https://www.ssa.gov/disability/professionals/bluebook/documents/Medical Evidence Regulation Public Desk Guide.docx",
      "https://www.ssa.gov/disability/professionals/bluebook/documents/Medical Evidence NPRM published.9.9.16.pdf",
      "https://www.ssa.gov/disability/professionals/bluebook/documents/Medical Evidence Final Published.1.18.17.pdf",
      "https://www.ssa.gov/disability/professionals/bluebook/documents/Medical Evidence.final correction.3.27.17.pdf",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html"
    ],
    "html_file": "ssa_bluebook_data/html/d94e0a4b740c961a0940f240e764ec05.html",
    "fetched_at": 1762482784.0069516
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm#Top",
    "url_hash": "e32059f453fd9a2adc561a5336cb309c",
    "title": "Part I - General Information | Disability | SSA",
    "text_content": "Part I - General Information | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Part I - General Information Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social \n        Security Part I - General Information Program Description The Social Security  Administration (SSA) administers two programs that provide benefits based on  disability: the Social Security disability insurance program (title II of the  Social Security Act (Act)) and the Supplemental Security Income (SSI) program  (title XVI of the Act). Title II provides for  payment of disability benefits to disabled individuals who are  \"insured\" under the Act by virtue of their contributions to the  Social Security trust fund through the Social Security tax on their earnings,  as well as to certain disabled dependents of insured individuals. Title XVI  provides SSI payments to disabled individuals (including children under age 18)  who have limited income and resources. The Act and SSA's  implementing regulations prescribe rules for deciding if an individual is  \"disabled.\" SSA's criteria for deciding disability may differ from  the criteria applied in other government and private disability programs. Definition of Disability For all individuals  applying for disability benefits under title II, and for adults applying under  title XVI, the definition of disability is the same. The law defines disability  as the inability to engage in any substantial gainful activity (SGA) by reason  of any medically determinable physical or mental impairment(s) which can be  expected to result in death or which has lasted or can be expected to last for  a continuous period of not less than 12 months. Disability in Children Under title XVI, a child  under age 18 will be considered disabled if he or she has a medically  determinable physical or mental impairment or combination of impairments that  causes marked and severe functional limitations, and that can be expected to  cause death or that has lasted or can be expected to last for a continuous  period of not less than 12 months. What is a \"Medically  Determinable Impairment\"? A medically determinable  physical or mental impairment is an impairment that results from anatomical,  physiological, or psychological abnormalities that can be shown by medically  acceptable clinical and laboratory diagnostic techniques. The medical evidence  must establish that an individual has a physical or mental impairment; a  statement about the individual's symptoms is not enough. The Disability  Determination Process Most disability claims  are initially processed through a network of local Social Security field  offices and State agencies (usually called Disability Determination Services,  or DDSs). Subsequent appeals of unfavorable determinations may be decided in  the DDSs or by administrative law judges in SSA's Office of Hearing Operations (OHO). Social Security Field  Offices When an individual  applies for disability benefits, whether online, in person, by telephone, or by  mail, the application is initially processed at an SSA field office. The  completed application and related forms provide information about the  claimant's impairment(s); names, addresses, and telephone numbers of medical  sources; and other information that relates to the alleged disability. (The  \"claimant\" is the person who is requesting disability benefits.) The field office is  responsible for verifying nonmedical eligibility requirements, which may  include age, employment, marital status, citizenship and residency, and Social  Security coverage information.   For SSI eligibility, the field  office verifies income, resources, and living arrangement information. The  field office sends the case to a DDS for disability evaluation. State Disability  Determination Services The DDSs are State  agencies responsible for developing medical evidence and making the initial  determination about whether the claimant is or is not disabled or blind under  the law.  These State agencies are fully funded by the Federal Government. Usually, the DDS obtains  evidence from the claimant's own medical sources first. When the evidence is  unavailable or insufficient to make a determination, the DDS may arrange a  consultative examination (CE) to obtain additional evidence. The individual's own  medical source(s) is the preferred source for the CE; however, the DDS may also  obtain the CE from an independent source. ( See Part II, Evidentiary Requirements,  for more information about CEs .) After completing its  development, the DDS makes the disability determination. An adjudicative team  consisting of a medical or psychological consultant and a disability examiner usually  makes the determination. If the adjudicative team finds that additional  evidence is still needed, the consultant or examiner may recontact a medical  source and ask for additional information. The DDS will refer the case  to the State vocational rehabilitation (VR) agency if the claimant is a  candidate for VR. The DDS returns the case  to the field office after making a disability determination.  The field  office takes appropriate action depending on whether the claim is allowed or  denied.  If the DDS finds the claimant is disabled, SSA will complete  any outstanding non-disability development, compute the benefit amount, and  begin paying benefits. If the claimant is found to be not disabled, the file is  retained in the field office in case he or she decides to appeal the  determination. If the claimant appeals an  initial determination, the appeal is usually handled much the same as the  initial claim  except that a different adjudicative team in the DDS  than the one that handled the original case makes the reconsideration determination. Office of Hearing Operations Claimants who are  dissatisfied with the reconsideration determination may request a hearing  before an administrative law judge (ALJ) in OHO.  The claimant may submit additional  information and evidence to the ALJ, and the ALJ will issue a decision based on  all the evidence of record, including evidence obtained at the hearing. When an ALJ needs  additional evidence, the hearing office frequently coordinates with the DDS to  obtain the evidence. However, hearing offices may also contact medical sources  directly. In some circumstances, an ALJ may issue a subpoena requiring  production of evidence or testimony at a hearing. Back to Top The Role of the Health Professional Health professionals play  a vital role in the disability determination process and participate in the  process in a variety of ways: As medical       sources who provide medical evidence on behalf of their patients; As CE       sources who perform, for a fee, examinations or tests that are needed; As       full-time or part-time medical or psychological consultants reviewing       claims in a DDS, in one of SSA's regional offices, or in SSA’s central       office; or As medical       experts who testify at ALJ hearings or respond to written interrogatories       from the ALJ. Claimant’s Own Medical  Sources A medical source who has  evaluated, examined, or treated a claimant is usually the best source of  medical evidence about the nature and severity of a claimant's impairment(s). If an additional  examination or testing is needed, SSA usually considers a claimant’s own  medical source to be the preferred source for performing a CE. Consultative Examiners  for the DDS In the absence of  sufficient medical evidence from a claimant’s own medical sources, SSA, through  the State DDS, may request an additional CE(s) to be performed by licensed medical  sources (such as physicians and psychologists). All CE sources must be  currently licensed in the State and have the training and experience to perform  the type of examination or test SSA requests. Each State establishes  the set fee for CEs, and fees may vary from State to State. Each State agency  is responsible for comprehensive oversight of its CE program. Medical professionals who  perform CEs must have a good understanding of SSA's disability programs and  their evidentiary requirements. In addition, these medical professionals are  made fully aware of their responsibilities and obligations regarding  confidentiality and: CE scheduling intervals; CE report content; Elements of a complete CE; When a complete CE is not required; and Signature requirements. See Part II of this guide for more information about CEs. Program Medical Consultants  and Psychological Consultants Medical consultants, who  are physicians, and psychological consultants, who are psychiatrists and  psychologists, review disability claims at the State, regional, or national  levels.  During a case review, a medical  or psychological consultant usually has no contact with the claimant. Medical Experts Administrative law judges  may request medical expert testimony on complex medical issues.  Each  hearing office maintains a roster of medical experts who are called to testify  as expert witnesses at hearings or to respond to written interrogatories. The  experts are paid a fee for their services. Confidentiality of  Records Two separate laws, the  Freedom of Information Act and the Privacy Act, have special significance for  Federal agencies. Under the Freedom of Information Act, Federal agencies are  required to provide the public with access to their files and records. This  means the public has the right, with certain exceptions, to examine records  pertaining to the functions, procedures, final opinions, and policy of these  Federal agencies. The Privacy Act permits  an individual or his or her authorized representative to examine records  pertaining to him or her in a Federal agency. For disability applicants, this  means that an individual may request to see the medical or other evidence used  to evaluate his or her application for disability benefits under the Social  Security or the SSI programs. (This evidence, however, is not available to the  general public.) SSA screens all requests  to see medical evidence in a claim file to determine if release of the evidence  directly to the individual might have an adverse effect on that individual. If  so, the report will be released only to an authorized representative designated  by the individual. Back to Top Questions and Answers about Social Security Disability Programs This information is  designed to provide a more thorough understanding of the disability programs that  SSA administers. Following are some of the most frequently asked questions  about these programs. Q. Who can get disability  benefits under Social Security? A. Under the Social  Security disability insurance program (title II of the Act), there are three  basic categories of individuals who can qualify for benefits on the basis of  disability: A disabled insured worker less than full retirement age. An individual disabled since childhood (before age 22) who is a dependent of a parent entitled to title II disability or retirement benefits or was a dependent of a deceased insured parent. A disabled widow or widower, age 50-60 if the deceased spouse was insured under Social Security. Under title XVI, or SSI, adults  and children under age 18 who have limited income and resources can receive  payments based on disability or blindness. Q. How is the disability determination made? A. SSA’s regulations provide  a procedure known as the \"sequential evaluation process\" for  disability evaluation.   For adults, this is a five-step process that  requires sequential review of: the claimant's current work activity (if any), the severity of his or her impairment(s), a determination of whether his or her impairment(s) meets or medically equals a listing (see Part III of this guide), the claimant's ability to perform his or her past relevant work, and his or her ability to do other work based on age, education, and work experience. For children applying for  SSI, the process requires sequential review of: the child's current work activity (if any), the severity of his or her impairment(s), and an  assessment of whether his or her impairment(s) meets, medically equals, or  functionally equals a listing. If  SSA can find an adult or child either disabled or not disabled at any step, the  evaluation is complete. Q. When do disability  benefits start? A. Disability benefits  for workers and widows usually cannot begin for 5 months after the established  onset of the disability. Therefore, Social Security disability benefits will begin the sixth full month after the date the disability began. The 5-month  waiting period does not apply to individuals filing as children of workers. The 5-month waiting period also does not apply if a worker’s disability results from amyotrophic lateral sclerosis (ALS) and he or she is approved for Social Security disability benefits on or after July 23, 2020. Under SSI, disability payments may begin as early as the first full month after the individual applied or became eligible for SSI. In addition, under the  SSI disability program, an applicant may be found \"presumptively disabled  or blind,\" and receive cash payments for up to 6 months while the formal  disability determination is made. The presumptive payment is designed to allow  an individual with limited income and resources to meet his or her basic living  expenses during the time it takes to process the application. If it is later  determined that the individual is not disabled, he or she is not required to  refund the payments. There is no provision for a finding of presumptive  disability or blindness under the Title II program. Q. What can an individual  do if he or she disagrees with the determination? A. If an individual  disagrees with the initial determination in the case, he or she may appeal it. Usually,  the first administrative appeal is a reconsideration.  At the  reconsideration appeal level, generally the case is reviewed at the State level  by an adjudicative team that was not involved in the original determination. If  dissatisfied with the reconsideration determination, the individual may request  a hearing before an administrative law judge. If the individual is dissatisfied  with the hearing decision, he or she may request review by the Appeals Council.  In general, a claimant has 60 days to appeal an unfavorable determination or  decision. Appeals must be filed in writing and may be submitted by mail, in  person to any Social Security office, or online where available. After an individual has  completed the administrative appeals process, he or she may seek judicial  review by filing a civil action in Federal district court. Q. Can individuals  receiving disability benefits or payments get Medicare or Medicaid coverage? A. Medicare helps pay  hospital and doctor bills of disabled or retired people who have worked long  enough under Social Security to be insured for Social Security benefits. It  generally covers people who are 65 and over; people who have been determined to  be disabled and have been receiving benefits for at least 24 months or have  amyotrophic lateral sclerosis (ALS); and people who need long‑term dialysis treatment  for chronic kidney disease or require a kidney transplant. In general, Medicare  pays 80 percent of reasonable charges. In most States, individuals who qualify for SSI disability payments also qualify for Medicaid.  States may refer to the Medicaid program by different names. The program covers  all of the approved charges of the Medicaid patient. Medicaid is financed by  Federal and State matching funds, but eligibility rules may vary from State to  State. Q. Can someone work and  still receive disability benefits? A. Social Security’s “work  incentive” rules make it possible for people to test their ability to work  without losing their eligibility for cash benefits and Medicare or Medicaid.  The rules are different for title II and title XVI, but under both programs  they may provide: continued cash benefits; continued help with medical bills; help with work expenses or; vocational training. For more information about work incentives,  ask any Social Security Office for the publication entitled the \"Red  Book,\" A Summary Guide to Employment Supports for Persons with  Disabilities under the Social Security Disability Insurance (SSDI) and  Supplemental Security Income (SSI) Programs. You can access the Red Book  online at: https://www.ssa.gov/redbook/index.html .",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social \n        Security"
      },
      {
        "level": 3,
        "text": "Part I - General Information"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm#Top",
      "https://www.ssa.gov/redbook/",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm"
    ],
    "html_file": "ssa_bluebook_data/html/e32059f453fd9a2adc561a5336cb309c.html",
    "fetched_at": 1762482786.419726
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm",
    "url_hash": "4c65307ed5c00ae1c384e8bbbf2bd1fe",
    "title": "100.00 Low Birth Weight and Failure to Thrive - Childhood | Disability | SSA",
    "text_content": "100.00 Low Birth Weight and Failure to Thrive - Childhood | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Listing of Impairments - Child Listings (Part B) 100.00 Low Birth Weight and Failure to Thrive - Childhood Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security 100.00 Low Birth Weight and Failure to Thrive\n - Childhood Section 100.01 Category of Impairments, Low Birth Weight and Failure to Thrive 100.04 Low birth weight in infants from birth to attainment of age 1 100.05 Failure to thrive in children from birth to attainment of age 3 100.00 Low  Birth Weight and Failure to Thrive A. What conditions do we evaluate under these listings? We evaluate low birth weight (LBW) in infants from birth to attainment of age 1 and failure to thrive (FTT) in infants and toddlers from birth to attainment of age 3. B. How do we evaluate disability based on LBW under  100.04? In 100.04A and 100.04B ,\n    we use an infant’s birth weight as documented by an original or certified copy of the infant’s birth certificate or by a medical record signed by a physician. Birth weight means the first weight  recorded after birth.\n    In 100.04B , gestational age is the infant’s age based on the date of conception as recorded in the medical record.\n    If the infant’s impairment meets the requirements for listing 100.04A or 100.04B , \n      we will follow the rules in § 416.990(b)(11) of this chapter. C. How do we evaluate disability under 100.05 ? 1. General. We establish FTT with or without a known cause when we have documentation of an infant’s or toddler’s growth failure and developmental delay from an acceptable medical source(s) \n        as defined in § 416.913(a) of this chapter.\n    We require documentation of growth measurements in 100.05A and developmental delay in 100.05B or 100.05C within the same consecutive 12-month period.\n    The dates of developmental testing and reports may be different from  the dates of the growth measurements. After the attainment of age 3, we evaluate growth failure under the affected body system(s). 2. Growth failure. Under 100.05A ,\n    we use the appropriate table(s) under 105.08B in the digestive system to determine whether a child’s growth is less than the third percentile.\n    The child does not need to have a digestive disorder for the purposes of 100.05 . a.  For children from birth to attainment of age 2, we use the weight-for-length table corresponding to the child’s gender (Table I or Table II). b.  For children age 2 to the attainment of age 3, we use the body mass index (BMI)-for-age table corresponding to the child’s gender (Table III or Table IV). c.  BMI is the ratio of a child’s weight to the square of his or her height.\n          We calculate BMI using the formulas in the digestive disorders body system ( 105.00 ). d. Growth measurements. The weight-for-length measurements for children from birth to attainment of age 2 and BMI-for-age measurements in children age 2 to attainment of age 3 that are required for this listing must be obtained  within a 12-month period and at least 60 days apart. If a child attains 2  during the evaluation period, additional measurements are not needed. Any  measurements taken before the child attains age 2 can be used to evaluate the  impairment under the appropriate listing for the child’s age. If the child  attains age 3 during the evaluation period, the measurements can be used to  evaluate the impairment in the affected body system. 3. Developmental Delay. a.  Under 100.05B and C , \n      we use reports from acceptable medical sources to  establish delay in a child’s development. b.  Under 100.05B , \n      we document the severity of developmental delay with results from a standardized developmental assessment, \n      which compares a child’s level of development to the level typically expected for his or her chronological age.  \n      If the child was born prematurely, we may use the corrected chronological age (CCA) for comparison. \n      (See § 416.924b(b) of this chapter.)\n    CCA is the chronological age adjusted by a period of gestational prematurity. CCA=  (chronological age) – (number of weeks premature).\n    Acceptable medical sources or early intervention specialists, physical or occupational therapists, and other sources may conduct standardized developmental assessments and developmental screenings.\n    The results of these tests and screening must be accompanied by a statement or records from an acceptable medical source who established the child has a developmental delay. c. Under 100.05C , \n      when there are no results from a standardized developmental assessment in the case record, \n      we need narrative developmental reports from the child’s medical sources in sufficient detail to assess the severity of his or her developmental delay. \n      A narrative developmental report is based on clinical observations, progress notes, and well-baby check-ups. To meet the requirements for 100.05C ,\n    the report must include: the child’s developmental history; examination findings (with abnormal findings noted on repeated examinations); \n      and an overall assessment of the child’s development (that is, more than one or two  isolated skills) by the medical source. \n      Some narrative developmental reports may include results from developmental screening tests, which can identify a child who is not developing or achieving skills within expected timeframes. \n      Although medical sources may refer to screening test results as supporting evidence in the narrative developmental report, \n      screening test results alone cannot establish a diagnosis or the severity of developmental delay. D. How do we evaluate disorders that do not meet one  of our listings? 1.  We may find infants disabled due to other disorders when their birth weights are greater than 1200 grams but less than 2000 grams and their \n      weight and gestational age do not meet listing 100.04 . The most common disorders of prematurity and LBW include retinopathy of prematurity (ROP),\n    chronic lung disease of infancy (CLD, previously known as bronchopulmonary dysplasia, or  BPD), intraventricular hemorrhage (IVH), necrotizing enterocolitis (NEC),\n    and periventricular leukomalacia (PVL). Other disorders include poor nutrition and growth failure, hearing disorders, seizure disorders, cerebral palsy, and developmental disorders.\n    We evaluate these disorders under the affected body systems. 2.  We may evaluate infants and toddlers with growth failure that is associated  with a known medical disorder under the body system of that medical disorder,  for example, the respiratory or digestive body systems. 3. If an infant or toddler has a severe medical  determinable impairment(s) that does not meet the criteria of any listing, \n      we must also consider whether the child has an impairment(s) that medically equals a listing \n      (see § 416.926 of this chapter).\n    If the child’s impairment(s) does not meet or medically equal a listing, we will determine whether the child’s  impairment(s) functionally equals the listings\n    (see § 416.926a of this chapter)\n    considering the factors in § 416.924a of this chapter.\n    We use the rules in § 416.994a of this chapter when we decide whether a child continues to be disabled. 100.01 Category of Impairments, Low Birth Weight and Failure to Thrive 100.04 Low birth weight in infants from birth to attainment of age 1. A. Birth weight (see 100.00B ) of less than 1200 grams. OR B. The following gestational age and birth weight: Gestational Age (in weeks) Birth Weight 37-40 2000 grams or less 36 1875 grams or less 35 1700 grams or less 34 1500 grams or less 33 1325 grams or less 32 1250 grams or less 100.05 Failure to thrive in children from birth to attainment of age 3 (see 100.00C ), documented by A and B, or A and C. A.  Growth failure as required in 1 or 2: 1. For children from birth to attainment of age 2, three weight-for-length measurements that are: a.  Within a consecutive 12-month period; and b.  At least 60 days apart; and c.  Less than the third percentile on the appropriate weight-for-length table under 105.08B1 ; or 2. For children age 2 to attainment of age 3, three BMI-for-age measurements that are: a.  Within a consecutive 12-month period; and b.  At least 60 days apart; and c.  Less than the third percentile on the appropriate BMI-for-age table under 105.08B2 . AND B.  Developmental delay (see 100.00C1 and C3 ), \n      established by an acceptable medical source and documented by findings from one current report of a standardized developmental assessment (see 100.00C3b ) that: 1.  Shows development not more than two-thirds of the level typically expected for the child’s age; or 2.  Results in a valid score that is at least two standard deviations below the mean. OR C.  Developmental delay (see 100.00C3 ), \n      established by an acceptable medical source and documented by findings from two narrative developmental reports (see 100.00C3c ) that: 1.  Are dated at least 120 days apart (see 100.00C1 ); and 2. Indicate current development not more than two-thirds of the level typically expected for the child’s age. Back to Top",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security100.00 Low Birth Weight and Failure to Thrive\n - Childhood"
      }
    ],
    "tables": [
      [
        [
          "Gestational Age (in weeks)",
          "Birth Weight"
        ],
        [
          "37-40",
          "2000 grams or less"
        ],
        [
          "36",
          "1875 grams or less"
        ],
        [
          "35",
          "1700 grams or less"
        ],
        [
          "34",
          "1500 grams or less"
        ],
        [
          "33",
          "1325 grams or less"
        ],
        [
          "32",
          "1250 grams or less"
        ]
      ]
    ],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_01",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04A",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04B",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04B",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04A",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04B",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0990.htm#b11",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0913.htm#a",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05A",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05B",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05C",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05A",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05B",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05C",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05B",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0924b.htm#b",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05C",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05C",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0924a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0994a.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00B",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B1",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B2",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C1",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C3b",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C3c",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C1",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm"
    ],
    "html_file": "ssa_bluebook_data/html/4c65307ed5c00ae1c384e8bbbf2bd1fe.html",
    "fetched_at": 1762482788.6530955
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B",
    "url_hash": "aef645e9ead3a0431bcbb40144a4cd79",
    "title": "105.00 Digestive Disorders - Childhood | Disability | SSA",
    "text_content": "105.00 Digestive Disorders - Childhood | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Listing of Impairments - Child Listings (Part B) 105.00 Digestive Disorders - Childhood Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security 105.00 Digestive Disorders - Childhood Section 105.01 Category of Impairments, Digestive Disorders 105.02 Gastrointestinal hemorrhaging from any cause, requiring three blood transfusions 105.05 Chronic liver disease (CLD) 105.06 Inflammatory bowel disease (IBD) 105.07 Intestinal failure 105.08 Growth failure due to any digestive disorder 105.09 Liver transplantation 105.10 Need for supplemental daily enteral feeding via a gastrostomy, duodenostomy, or jejunostomy 105.11 Small intestine transplantation 105.12 Pancreas transplantation 105.00 Digestive Disorders A. Which digestive disorders do we evaluate in this body system? We evaluate digestive disorders that result in severe dysfunction of the liver, pancreas, and gastrointestinal tract (the large, muscular tube that extends from the mouth to the anus, \n                            where the movement of muscles, along with the release of hormones and enzymes, allows for the digestion of food) in this body system. \n                            Examples of these disorders and the listings we use to evaluate them include chronic liver disease ( 105.05 ), \n                            inflammatory bowel disease ( 105.06 ), and intestinal failure ( 105.07 ). \n                            We also use this body system to evaluate gastrointestinal hemorrhaging from any cause ( 105.02 ), \n                            growth failure due to any digestive disorder ( 105.08 ), liver transplantation ( 105.09 ), \n                            need for supplemental daily enteral feeding via a gastrostomy, duodenostomy, or jejunostomy due to any cause for children who have not attained age 3 ( 105.10 ), \n                            small intestine transplantation ( 105.11 ), and pancreas transplantation ( 105.12 ). \n                            We evaluate cancers affecting the digestive system under the listings in 113.00 . B. What evidence do we need to evaluate your digestive disorder? 1. General. To establish that you have a digestive disorder, we need medical evidence about the existence of your digestive disorder and its severity. Medical evidence should include your medical history, physical examination findings, operative reports, and relevant laboratory findings. 2. Laboratory findings. We need laboratory reports such as results of imaging (see 105.00B3 ), \n                            endoscopy, and other diagnostic procedures. We may also need clinical laboratory and pathology results. 3. Imaging refers to medical imaging techniques, such as x-ray, ultrasound, magnetic resonance imaging, and computerized tomography. The imaging must be consistent with the prevailing state of medical knowledge and clinical practice as a proper technique to support the evaluation of the disorder. Back to Top C. What is chronic liver disease (CLD), and how do we evaluate it under 105.05 ? 1. General. CLD is loss of liver function with cell necrosis (cell death), inflammation, or scarring of the liver that persists for more than 6 months. Common causes of CLD in children include chronic infection with hepatitis B virus or hepatitis C virus, autoimmune hepatitis, and metabolic disease. a. We will evaluate your signs of CLD, such as jaundice, changes in size of the liver and spleen, ascites, peripheral edema, and altered mental status. \n                            We will also evaluate your symptoms of CLD, such as pruritus (itching), fatigue, nausea, loss of appetite, and sleep disturbances when we assess the severity of your impairment(s) \n                            and how it affects your ability to function. In the absence of evidence of a chronic liver impairment, \n                            episodes of acute liver disease do not meet the requirements of 105.05 . b. Laboratory findings of your CLD may include decreased serum albumin, increased International Normalized Ratio (INR), arterial deoxygenation (hypoxemia), increased serum creatinine, oliguria (reduced urine output), or sodium retention. Another laboratory finding that may be included in the evidence is a liver biopsy. If you have had a liver biopsy, we will make every reasonable effort to obtain the results; however, we will not purchase a liver biopsy. 2. Manifestations of CLD. a. Gastrointestinal hemorrhaging ( 105.05A ), as a consequence of cirrhosis and high pressure in the liver's portal venous system, \n                            may occur from varices (dilated veins in the esophagus or the stomach) or from portal hypertensive gastropathy (abnormal mucosal changes in the stomach). \n                            When gastrointestinal hemorrhaging is due to a cause other than CLD, we evaluate it under 105.02 . \n                            The phrase \"consider under a disability for 1 year\" in 105.02 and 105.05A does not refer to the date on which your disability began, \n                            only to the date on which we must reevaluate whether your impairment(s) continues to meet a listing or is otherwise disabling. \n                            We determine the onset of your disability based on the facts of your case. b. Ascites or hydrothorax ( 105.05B ) is a pathologic accumulation of fluid in the peritoneal cavity (ascites) or pleural space (hydrothorax). \n                            Ascites or hydrothorax may be diagnosed by removing some of the fluid with needle aspiration (paracentesis or thoracentesis), physical examination, or imaging. \n                            The most common causes of ascites are portal hypertension and low serum albumin resulting from CLD. \n                            We evaluate other causes of ascites and hydrothorax that are unrelated to CLD, such as congestive heart failure and cancer, under the listings in the affected body systems. c. Spontaneous bacterial peritonitis (SBP) ( 105.05C ) is an acute bacterial infection of peritoneal fluid and is most commonly associated with CLD. \n                            SBP is diagnosed by laboratory analysis of peritoneal fluid (obtained by paracentesis) that contains a neutrophil count (also called absolute neutrophil count) of at least 250 cells/mm 3 . 105.05C is satisfied with one evaluation documenting peritoneal infection. We evaluate other causes of peritonitis that are unrelated to CLD, \n                            such as tuberculosis, malignancy, and perforated bowel, under the listings in the affected body systems. d. Hepatorenal syndrome ( 105.05D ) is renal failure associated with CLD in the absence of underlying kidney pathology. \n                            Findings associated with hepatorenal syndrome include elevation of serum creatinine, sodium retention with low urinary sodium excretion, and oliguria. \n                            We evaluate renal dysfunction with known underlying kidney pathology, such as glomerulonephritis, tubular necrosis, and renal infections, \n                            under the listings in 106.00 . e. Hepatopulmonary syndrome ( 105.05E ) is arterial deoxygenation due to intrapulmonary vascular dilation and arteriovenous shunting associated with CLD. \n                            Clinical findings of hepatopulmonary syndrome include platypnea (shortness of breath relieved when lying down) and orthodeoxia (low arterial blood oxygen while in the upright position), \n                            when presenting in the context of CLD. We evaluate pulmonary dysfunction with known underlying respiratory pathology, such as asthma, pneumonia, and pulmonary infections, \n                            under the listings in 103.00 . (i) Under 105.05E1 , we require a resting arterial blood gas (ABG) measurement obtained while you are breathing room air;\n                            that is, without oxygen supplementation. The ABG report must include the P a O 2 value, your name, the date of the test, and either the altitude or both the city and State of the test site. (ii) We will not purchase the specialized imaging techniques described in 105.05E2 ; \n                            however, if you have had the test(s) at a time relevant to your claim, we will make every reasonable effort to obtain the report. f. Hepatic encephalopathy ( 105.05F ), also known as portosystemic encephalopathy, \n                            is a recurrent or chronic neuropsychiatric disorder associated with CLD. (i) Under 105.05F2 , we require documentation of a mental impairment associated with hepatic encephalopathy. \n                            A mental impairment can include abnormal behavior, changes in mental status, or an altered state of consciousness. Reports of abnormal behavior may show that you are experiencing delusions, \n                            paranoia, or hallucinations. Reports of changes in mental status may show change in sleep patterns, personality or mood changes, poor concentration, or poor judgment or cognitive dysfunction \n                            (for example, impaired memory, poor problem-solving ability, or attention deficits). Reports of altered state of consciousness may show that you are experiencing confusion, delirium, or stupor. (ii) Signs and laboratory findings that document the severity of hepatic encephalopathy when not attributable to other causes may include a \"flapping tremor\" (asterixis), \n                            characteristic abnormalities found on an electroencephalogram (EEG), or abnormal serum albumin or coagulation values. We will not purchase an EEG; however, if you have had this test at a time relevant to your claim, \n                            we will make every reasonable effort to obtain the report for the purpose of establishing whether your impairment meets the criteria of 105.05F . (iii) We will not evaluate acute encephalopathy under 105.05F if it results from conditions other than CLD. \n                            For example, we will evaluate acute encephalopathy caused by vascular events under the listings in 111.00 and acute encephalopathy caused by cancer under the listings in 113.00 . 3. SSA Chronic Liver Disease (SSA CLD) and SSA Chronic Liver Disease-Pediatric (SSA CLD–P) scores ( 105.05G ). \n                            Listing 105.05G1 requires two SSA CLD scores, each requiring three or four laboratory values. \n                            Listing 105.05G2 requires one SSA CLD–P score, which requires four parameters (three laboratory values and growth failure). \n                            The \"date of the SSA CLD score\" is the date of the earliest of the three or four laboratory values used for its calculation. \n                            The \"date of the SSA CLD–P score\" is the date of the earliest of the three laboratory values used for its calculation. \n                            For 105.05G1 , the date of the second SSA CLD score must be at least 60 days after the date of the first SSA CLD score and both scores must be within the required 12-month period. \n                            If you have the two SSA CLD scores required by 105.05G1 , we will find that your impairment meets the criteria of the listing from at least the date of the first SSA CLD score. [We provide the SSA CLD Calculato r to calculate the SSA CLD scores as described in 105.00C3a below and the SSA CLD-P Calculator to calculate the SSA CLD-P score as described in 105.00C3b below.] a. SSA CLD score. (i) If you are age 12 or older, we will calculate the SSA CLD score using a formula that includes up to four laboratory values: \n                            Serum creatinine (mg/dL), total bilirubin (mg/dL), INR, and under certain conditions, serum sodium (mmol/L). \n                            The SSA CLD score calculation contains at least one, and sometimes two, parts, as described in (a) and (b). (a) The initial calculation is: SSA CLD i = 9.57 × [log e (serum creatinine mg/dL)] + 3.78 × [log e (serum total bilirubin mg/dL)] + 11.2 × [log e (INR)] + 6.43 rounded to the nearest whole integer. (b) If the value from the initial calculation is 11 or below, the SSA CLD score will be the SSA CLD i value. If the value from the initial calculation is greater than 11, the SSA CLD score will be re-calculated as: SSA CLD = SSA CLD i + 1.32 × (137−serum sodium mmol/L) −[0.033 × SSA CLD i × (137−serum sodium mmol/L)] (c) We round the results of your SSA CLD score calculation to the nearest whole integer to arrive at your SSA CLD score. (ii) For any SSA CLD score calculation, all of the required laboratory values (serum creatinine, serum total bilirubin, INR, and serum sodium) must have been obtained within a continuous 30-day period. (a) We round values for serum creatinine (mg/dL), serum total bilirubin (mg/dL), or INR less than 1.0 up to 1.0 to calculate your SSA CLD score. (b) We round values for serum creatinine (mg/dL) greater than 4.0 down to 4.0 to calculate your SSA CLD score. (c) If there are multiple laboratory values within the 30-day interval for serum creatinine (mg/dL), serum total bilirubin (mg/dL), or INR, we use the highest value to calculate your SSA CLD score. \n                            We will not use any INR values derived from testing done while you are on anticoagulant treatment in our SSA CLD calculation. (d) If there are multiple laboratory values within the 30-day interval for serum sodium (mmol/L), we use the lowest value to calculate your SSA CLD score. (e) If you are in renal failure or on renal dialysis within a week of any serum creatinine test in the period used for the SSA CLD calculation, we will use a serum creatinine value of 4.0, which is the maximum serum creatinine level allowed in the calculation, to calculate your SSA CLD score. (f) If your serum sodium is less than 125 mmol/L, we will set your serum sodium to 125 mmol/L for purposes of calculation of the SSA CLD score. If your serum sodium is higher than 137 mmol/L, we will set your serum sodium to 137 mmol/L for purposes of calculation of the SSA CLD score. (iii) When we indicate \"log e \" (also abbreviated \"ln\") in the formula for the SSA CLD score calculation, \n                            we mean the \"base e logarithm\" or \"natural logarithm\" of the numerical laboratory value, not the “base 10 logarithm” or “common logarithm” (log) of the laboratory value, \n                            and not the actual laboratory value. For example, if a person has laboratory values of serum creatinine 1.4 mg/dL, serum total bilirubin 1.3 mg/dL, INR 1.32, and serum sodium 119 mmol/L, \n                            we compute the SSA CLD score as follows: SSA CLD i = 9.57 × [log e (serum creatinine 1.4 mg/dL) = 0.336] + 3.78 × [log e (serum total bilirubin 1.3 mg/dL) = 0.262] + 11.2 × [log e (INR 1.32) = .278] + 6.43 = 3.22 + 0.99 + 3.11 + 6.43 = 13.75, which we round to an SSA CLD i score of 14. Because the SSA CLD i score is over 11, we then move to the second step of calculating the SSA CLD: SSA CLD = 14 + 1.32 × (137−serum sodium 125 mmol/L) −[0.033 × SSA CLD i 14 × (137−serum sodium 125 mmol/L) = 14 + 15.84−5.54 = 24.3, which we round to an SSA CLD score of 24. b. SSA CLD–P score (i) We calculate the SSA CLD–P score using a formula that includes four parameters: Serum total bilirubin (mg/dL), INR, serum albumin (g/dL), and whether you have growth failure. The formula for the SSA CLD–P score calculation is: 4.80 × [log e (serum total bilirubin mg/dL)] + 18.57 × [log e (INR)] −6.87 × [log e (serum albumin g/dL)] + 6.67 if you have growth failure (<−2 standard deviations for weight or height) (ii)When we indicate \"log e \" in the formula for the SSA CLD–P score calculation, we mean the \"base e logarithm\" or \"natural logarithm\" (log e ) of a numerical laboratory value, not the “base 10 logarithm” or “common logarithm” (log) of the laboratory value, and not the actual laboratory value. For example, if a female child is 4.0 years old, has growth failure, and has laboratory values of serum total bilirubin 2.2 mg/dL, INR 1.0, and serum albumin 3.5 g/dL, we compute the SSA CLD–P score as follows: 4.80 × [log e (serum total bilirubin 2.2 mg/dL) = 0.788] + 18.57 × [log e (INR 1.0) = 0] −6.87 × [log e (serum albumin 3.5 g/dL) = 1.253] + 6.67 = 3.78 + 0−8.61 + 6.67 = 1.84, which we round to an SSA CLD–P score of 2. (iii) For an SSA CLD–P score calculation, all of the required laboratory values (serum total bilirubin, INR, and serum albumin) must have been obtained within a continuous 30-day period. \n                            We round any of the required laboratory values less than 1.0 up to 1.0 to calculate your SSA CLD–P score. If there are multiple laboratory values within the 30-day interval for any given laboratory test, \n                            we use the highest serum total bilirubin and INR values and the lowest serum albumin value to calculate the SSA CLD–P score. \n                            We will not use any INR values derived from testing done while you are on anticoagulant treatment in our SSA CLD–P calculation. \n                            We will not purchase INR values for children who have not attained age 12. If there is no INR value for a child under 12 within the applicable period, \n                            we will use an INR value of 1.1 to calculate the SSA CLD–P score. We round the results of your SSA CLD–P score calculation to the nearest whole integer to arrive at your SSA CLD–P score. (iv) The weight and length/height measurements used for the calculation must be obtained within the same 30-day period as the laboratory values. 4. Extrahepatic biliary atresia ( 105.05H ) presents itself in the first 2 months of life with persistent jaundice. \n                            To satisfy 105.05H , the diagnosis of extrahepatic biliary atresia must be confirmed by liver biopsy or intraoperative cholangiogram that shows obliteration of the extrahepatic biliary tree. \n                            Biliary atresia is usually treated surgically by portoenterostomy (for example, Kasai procedure). If this surgery is not performed in the first months of life or is not completely successful, \n                            liver transplantation is indicated. If you have received a liver transplant, we will evaluate your impairment under 105.09 . \n                            The phrase \"consider under a disability for 1 year\" in 105.05H does not refer to the date on which your disability began, \n                            only to the date on which we must reevaluate whether your impairment(s) continues to meet a listing or is otherwise disabling. We determine the onset of your disability based on the facts of your case. Back to Top D. What is inflammatory bowel disease (IBD), and how do we evaluate it under 105.06 ? 1. IBD is a group of inflammatory conditions of the small intestine and colon. The most common IBD disorders are Crohn's disease and ulcerative colitis. Remissions and exacerbations of variable duration are a hallmark of IBD. 2. We evaluate your signs and symptoms of IBD, such as diarrhea, fecal incontinence, rectal bleeding, abdominal pain, fatigue, fever, nausea, vomiting, arthralgia, \n                            abdominal tenderness, palpable abdominal mass (usually inflamed loops of bowel), and perianal disease (for example, fissure, fistulas, abscesses, or anal canal stenosis), \n                            when we assess the severity of your impairment(s). You may require supplemental daily nutrition due to IBD. \n                            There are two forms of supplemental daily nutrition we consider under 105.06B5 : \n                            enteral nutrition (delivered directly to a part of your digestive system) via a gastrostomy, duodenostomy, or jejunostomy, \n                            and parenteral nutrition delivered via a central venous catheter. \n                            Enteral tube feedings delivered via nasal or oral tubes do not satisfy the requirement in 105.06B5 . 3. Surgical diversion of the intestinal tract, including ileostomy and colostomy, \n                            does not very seriously interfere with age-appropriate functioning if you are able to maintain adequate nutrition and function of the stoma. \n                            However, if you are not able to maintain adequate nutrition, we will evaluate your impairment under 105.08 . 4. IBD may be associated with significant extraintestinal manifestations in a variety of body systems. These include, but are not limited to, involvement of the eye \n                            (for example, uveitis, episcleritis, or iritis); hepatobiliary disease (for example, gallstones or primary sclerosing cholangitis); \n                            urologic disease (for example, kidney stones or obstructive hydronephrosis); skin involvement (for example, erythema nodosum or pyoderma gangrenosum); \n                            or non-destructive inflammatory arthritis. You may also have associated thromboembolic disorders or vascular disease. These manifestations may not correlate with the severity of your IBD. \n                            If your impairment does not meet any of the criteria of 105.06 , \n                            we will consider the effects of your extraintestinal manifestations in determining whether you have an impairment(s) that meets or medically equals another listing, \n                            and when we determine whether your impairment(s) functionally equals the listings. 5. Examples of complications of IBD that may result in hospitalization include abscesses, intestinal perforation, toxic megacolon, infectious colitis, pyoderma gangrenosum, ureteral obstruction, primary sclerosing cholangitis, and hypercoagulable state (which may lead to thromboses or embolism). Back to Top E. What is intestinal failure, and how do we evaluate it under 105.07 ? 1. Intestinal failure is a condition resulting in gut function below the minimum necessary for the absorption of macronutrients or water and electrolytes, \n                            resulting in a requirement for intravenous supplementation ( i.e., parenteral nutrition) to maintain health. Examples of conditions that may result in intestinal failure include short bowel syndrome, \n                            extensive small bowel mucosal disease, and chronic motility disorders. 2. Short bowel syndrome is a malabsorption disorder that occurs when ischemic vascular insults (caused, for example, by volvulus or necrotizing enterocolitis), trauma, or IBD complications require(s) surgical resection of any amount of the small intestine, resulting in chronic malnutrition. 3. Extensive small bowel mucosal disease means that the mucosal surface of the small bowel does not efficiently absorb nutrients or loses nutrients. Common causes of small bowel mucosal disease include microvillous inclusion disease and tufting enteropathy. 4. Chronic motility disorder refers to a chronic disorder of the propulsion of gut content without fixed obstructions, causing intolerance to oral nutrition and inadequate nutritional intake. This type of disorder may also be known as a chronic intestinal pseudo-obstruction (CIPO), because the gut dysfunction mimics that of an obstructed intestine, but without evidence of an actual obstruction. Primary CIPO may have an unknown underlying cause. Chronic motility disorders may also result from congenital, neuromuscular, or autoimmune conditions, such as gastroschisis, omphalocele, long segment Hirschprung's disease, Crohn's disease, and mitochondrial disorders. 5. For short bowel syndrome, we require a copy of the operative report that includes details of the surgical findings, or postoperative imaging indicating a resection of the small intestine. \n                            If we cannot get one of these reports, we need other medical reports that include details of the surgical findings. For other chronic motility disorders or extensive small bowel mucosal disease, \n                            we need medical reports that include details of your intestinal dysfunction. For any impairment evaluated under 105.07 , \n                            we also need medical documentation that you are dependent on daily parenteral nutrition to provide most of your nutritional requirements. Back to Top F. How do we evaluate growth failure due to any digestive disorder under 105.08 ? 1. To evaluate growth failure due to any digestive disorder, \n                            we require documentation of the laboratory findings of chronic nutritional deficiency described in 105.08A and the growth measurements in 105.08B within the same consecutive 12-month period. \n                            The dates of laboratory findings may be different from the dates of growth measurements. \n                            Impairments other than digestive disorders that cause weight loss should be evaluated under the appropriate body system. \n                            For instance, weight loss as a result of chronic kidney disease should be evaluated under our rules for genitourinary disorders \n                            (see 106.00 ), and weight loss as the result of an eating disorder should be evaluated under our rules for mental disorders \n                            (see 112.00 ). However, if you develop a digestive disorder as the result of your other impairment, \n                            we will evaluate the acquired digestive disorder under our rules for digestive disorders. 2. Under 105.08B , we evaluate a child's growth failure by using the appropriate table for age and gender. a. For children from birth to attainment of age 2, we use the weight-for-length table (see Table I or Table II). b. For children age 2 to attainment of age 18, we use the body mass index (BMI)-for-age table (see Table III or Table IV). c. BMI is the ratio of your weight to the square of your height. We calculate BMI using one of the following formulas: English Formula BMI = [Weight in Pounds/(Height in Inches × Height in Inches)] × 703 Metric Formulas BMI = Weight in Kilograms/(Height in Meters × Height in Meters) BMI = [Weight in Kilograms/(Height in Centimeters × Height in Centimeters)] × 10,000 Back to Top G . How do we evaluate digestive organ transplantation? If you receive a liver ( 105.09 ), small intestine ( 105.11 ), \n                            or pancreas ( 105.12 ) transplant, we will consider you disabled under the listing for 1 year from the date of the transplant. After that, \n                            we evaluate your residual impairment(s) by considering the adequacy of your post-transplant function, the frequency and severity of any rejection episodes you have, \n                            complications in other body systems, and adverse treatment effects. \n                            People who receive digestive organ transplants generally have impairments that meet our definition of disability before they undergo transplantation. \n                            The phrase \"consider under a disability for 1 year\" in 105.09 , 105.11 , \n                            and 105.12 does not refer to the date on which your disability began, \n                            only to the date on which we must reevaluate whether your impairment(s) continues to meet a listing or is otherwise disabling. \n                            We determine the onset of your disability based on the facts of your case. H. How do we evaluate the need for supplemental daily enteral feeding via a gastrostomy, duodenostomy, or jejunostomy? We evaluate the need for supplemental daily enteral feeding via a gastrostomy, duodenostomy, \n                            or jejunostomy in children who have not attained age 3 under 105.10 regardless of the medical reason for the stoma. \n                            Enteral tube feedings delivered via nasal or oral tubes do not satisfy the requirement in 105.10 . \n                            After a child attains age 3, we evaluate growth failure due to any digestive disorder under 105.08 , \n                            IBD requiring supplemental daily enteral or parenteral nutrition under 105.06 , \n                            or other medical or developmental disorders under another digestive disorders listing or under a listing in an affected body system(s). I. How do we evaluate esophageal stricture or stenosis? Esophageal stricture or stenosis (narrowing) from congenital atresia (absence or abnormal closure of a tubular body organ) or destructive esophagitis may result in malnutrition \n                            or the need for gastrostomy placement, which we evaluate under 105.08 or 105.10 . \n                            Esophageal stricture or stenosis may also result in complications such as pneumonias due to frequent aspiration, or difficulty in maintaining nutritional status short of listing level severity. \n                            While these individual complications usually do not meet the listing criteria, a combination of your impairments may medically equal a listing or functionally equal the listings. Back to Top J. How do we evaluate your digestive disorder if there is no record of ongoing treatment? If there is no record of ongoing treatment despite the existence of a severe impairment(s), we will assess the severity and duration of your digestive disorder based on the current medical and other evidence in your case record. If there is no record of ongoing treatment, you may not be able to show an impairment that meets a digestive disorders listing, but your impairment may medically equal a listing, or be disabling based on our rules for functional equivalence. K. How do we evaluate your digestive disorder if there is evidence establishing a substance use disorder? If we find that you are disabled and there is medical evidence in your case record establishing that you have a substance use disorder,\n                            we will determine whether your substance use disorder is a contributing factor material to the determination of disability.\n                            See § 416.935 of this chapter.\n                            Digestive disorders resulting from drug or alcohol use are often chronic in nature and will not necessarily improve with cessation in drug or alcohol use. L. How do we evaluate digestive disorders that do not meet one of these listings? 1. These listings are only examples of common digestive disorders that we consider severe enough to result in marked and severe functional limitations. If your impairment(s) does not meet the criteria of any of these listings, we must also consider whether you have an impairment(s) that satisfies the criteria of a listing in another body system. 2. If you have a severe medically determinable impairment(s) that does not meet a listing, we will determine whether your impairment(s) medically equals a listing.\n                            See  § 416.926 of this chapter.\n                            Digestive disorders may be associated with disorders in other body systems, and we consider the combined effects of multiple impairments when we determine whether they medically equal a listing.\n                            If your impairment(s) does not meet or medically equal a listing, we will also consider whether it functionally equals the listings.\n                            See § 416.926a of this chapter.\n                            We use the rules in § 416.994a of this chapter when we decide whether you continue to be disabled. Back to Top 105.01  Category of Impairments, Digestive Disorders 105.02 Gastrointestinal hemorrhaging from any cause, requiring three blood transfusions of at least 10 cc of blood/kg of body weight per transfusion, within a consecutive 12-month period and at least 30 days apart. Consider under a disability for 1 year following the last documented transfusion; after that, evaluate the residual impairment(s). 105.03 [Reserved] 105.04 [Reserved] Back to Top 105.05 Chronic liver disease (CLD) (see 105.00C ) with A, B, C, D, E, F, G, or H: A. Hemorrhaging from esophageal, gastric, or ectopic varices, or from portal hypertensive gastropathy (see 105.00C2a ), \n                            documented by imaging (see 105.00B3 ); resulting in 1 and 2: 1. Hemodynamic instability indicated by signs such as pallor (pale skin), diaphoresis (profuse perspiration), rapid pulse, low blood pressure, postural hypotension (pronounced fall in blood pressure when arising to an upright position from lying down), or syncope (fainting); and 2. Requiring hospitalization for transfusion of at least 10 cc of blood/kg of body weight. Consider under a disability for 1 year following the documented transfusion; after that, evaluate the residual impairment(s). OR B. Ascites or hydrothorax not attributable to other causes (see 105.00C2b ), \n                            present on two evaluations within a consecutive 12-month period and at least 60 days apart. Each evaluation must document the ascites or hydrothorax by 1, 2, or 3: 1. Paracentesis; or 2. Thoracentesis; or 3. Imaging or physical examination with a or b: a. Serum albumin of 3.0 g/dL or less; or b. INR of at least 1.5. OR C. Spontaneous bacterial peritonitis (see 105.00C2c ) documented by peritoneal fluid containing a neutrophil count of at least 250 cells/mm 3 . OR D. Hepatorenal syndrome (see 105.00C2d ) documented by 1, 2, or 3: 1. Serum creatinine elevation of at least 2 mg/dL; or 2. Oliguria with 24-hour urine output less than 1 mL/kg/hr; or 3. Sodium retention with urine sodium less than 10 mEq per liter. OR E. Hepatopulmonary syndrome (see 105.00C2e ) documented by 1 or 2: 1. Arterial P a O 2 measured by an ABG test, while at rest, breathing room air, less than or equal to: a. 60 mm Hg, at test sites less than 3,000 feet above sea level; or b. 55 mm Hg, at test sites from 3,000 through 6,000 feet above sea level; or c. 50 mm Hg, at test sites over 6,000 feet above sea level; or 2. Intrapulmonary arteriovenous shunting as shown on contrast-enhanced echocardiography or macroaggregated albumin lung perfusion scan. OR F. Hepatic encephalopathy (see 105.00C2f ) with documentation of abnormal behavior, \n                            cognitive dysfunction, changes in mental status, or altered state of consciousness (for example, confusion, delirium, stupor, or coma), \n                            present on two evaluations within a consecutive 12-month period and at least 60 days apart and either 1 or 2: 1. History of transjugular intrahepatic portosystemic shunt (TIPS) or other surgical portosystemic shunt; or 2.  One of the following on at least two evaluations at least 60 days apart within the same consecutive 12-month period as in F: a. Asterixis or other fluctuating physical neurological abnormalities; or b. EEG demonstrating triphasic slow wave activity; or c. Serum albumin of 3.0 g/dL or less; or d. INR of 1.5 or greater. OR G. SSA CLD or SSA CLD–P scores (see 105.00C3 ) [ SSA CLD Calculator and SSA CLD-P Calculator ]: 1. For children age 12 or older, two SSA CLD scores of at least 20 within a consecutive 12-month period and at least 60 days apart. Consider under a disability from at least the date of the first score; or 2. For children who have not attained age 12, one SSA CLD–P score of at least 11. OR H. Extrahepatic biliary atresia as diagnosed on liver biopsy or intraoperative cholangiogram (see 105.00C4 ). \n                            Consider under a disability for 1 year following diagnosis; after that, evaluate the residual impairment(s). Back to Top 105.06 Inflammatory bowel disease (IBD) (see 105.00D ) documented by endoscopy, biopsy, imaging, or operative findings and demonstrated by A or B: A. Obstruction of stenotic areas (not adhesions) in the small intestine or colon with proximal dilatation, confirmed by imaging or in surgery, requiring two hospitalizations for intestinal decompression or for surgery, within a consecutive 12-month period and at least 60 days apart. OR B. Two of the following occurring within a consecutive 12-month period and at least 60 days apart: 1. Anemia with hemoglobin less than 10.0 g/dL, present on at least two evaluations at least 60 days apart; or 2. Serum albumin of 3.0 g/dL or less, present on at least two evaluations at least 60 days apart; or 3. Clinically documented tender abdominal mass palpable on physical examination with abdominal pain or cramping; or 4. Perianal disease with a draining abscess or fistula; or 5. Need for supplemental daily enteral nutrition via a gastrostomy, duodenostomy, or jejunostomy, or daily parenteral nutrition via a central venous catheter \n                            (see 105.10 for children who have not attained age 3). Back to Top 105.07 Intestinal failure (see 105.00E ) due to short bowel syndrome, chronic motility disorders, or extensive small bowel mucosal disease, \n                            resulting in dependence on daily parenteral nutrition via a central venous catheter for at least 12 months. 105.08 Growth failure due to any digestive disorder (see 105.00F ), documented by A and B: A. Chronic nutritional deficiency present on two evaluations within a consecutive 12-month period and at least 60 days apart documented by 1 or 2: 1. Anemia with hemoglobin less than 10.0 g/dL; or 2. Serum albumin of 3.0 g/dL or less AND B. Growth failure as required in 1 or 2: 1. For children from birth to attainment of age 2, three weight-for-length measurements that are: a. Within a consecutive 12-month period; and b. At least 60 days apart; and c. Less than the third percentile values in Table I or Table II; or Third Percentile Values for Weight-for Length Length\n                                         \n                                        (Centimeters) Weight\n                                         \n                                        (kilograms) Table I –  Males Birth to Attainment of Age 2 Table II –  Females Birth to Attainment of Age 2 45.0 1.597 1.613 45.5 1.703 1.724 46.5 1.919 1.946 47.5 2.139 2.171 48.5 2.364 2.397 49.5 2.592 2.624 50.5 2.824 2.852 51.5 3.058 3.081 52.5 3.294 3.310 53.5 3.532 3.538 54.5 3.771 3.767 55.5 4.010 3.994 56.5 4.250 4.220 57.5 4.489 4.445 58.5 4.728 4.669 59.5 4.966 4.892 60.5 5.203 5.113 61.5 5.438 5.333 62.5 5.671 5.552 63.5 5.903 5.769 64.5 6.132 5.985 65.5 6.359 6.200 66.5 6.584 6.413 67.5 6.807 6.625 68.5 7.027 6.836 69.5 7.245 7.046 70.5 7.461 7.254 71.5 7.674 7.461 72.5 7.885 7.667 73.5 8.094 7.871 74.5 8.301 8.075 75.5 8.507 8.277 76.5 8.710 8.479 77.5 8.913 8.679 78.5 9.113 8.879 79.5 9.313 9.078 80.5 9.512 9.277 81.5 9.710 9.476 82.5 9.907 9.674 83.5 10.104 9.872 84.5 10.301 10.071 85.5 10.499 10.270 86.5 10.696 10.469 87.5 10.895 10.670 88.5 11.095 10.871 89.5 11.296 11.074 90.5 11.498 11.278 91.5 11.703 11.484 92.5 11.910 11.691 93.5 12.119 11.901 94.5 12.331 12.112 95.5 12.546 12.326 96.5 12.764 12.541 97.5 12.987 12.760 98.5 13.213 12.981 99.5 13.443 13.205 100.5 13.678 13.431 101.5 13.918 13.661 102.5 14.163 13.895 103.5 14.413 14.132 2. For children age 2 to attainment of age 18 , three BMI-for-age measurements that are: a. Within a consecutive 12-month period; and b. At least 60 days apart; and c. Less than the third percentile value in Table III or Table IV. Third Percentile Values for BMI-for-Age Table III –  Males Age 2 to Attainment of Age 18 Table IV –  Females Age 2 to Attainment of Age 18 Age (yrs. and mos.) BMI Age (yrs. and mos.) BMI 2.0 to 2.1 14.5 2.0 to 2.2 14.1 2.2 to 2.4 14.4 2.3 to 2.6 14.0 2.5 to 2.7 14.3 2.7 to 2.10 13.9 2.8 to 2.11 14.2 2.11 to 3.2 13.8 3.0 to 3.2 14.1 3.3 to 3.6 13.7 3.3 to 3.6 14.0 3.7 to 3.11 13.6 3.7 to 3.11 13.9 4.0 to 4.4 13.5 4.0 to 4.5 13.8 4.5 to 4.11 13.4 4.6 to 5.0 13.7 5.0 to 5.9 13.3 5.1 to 6.0 13.6 5.10 to 7.6 13.2 6.1 to 7.6 13.5 7.7 to 8.4 13.3 7.7 to 8.6 13.6 8.5 to 8.10 13.4 8.7 to 9.1 13.7 8.11 to 9.3 13.5 9.2 to 9.6 13.8 9.4 to 9.8 13.6 9.7 to 9.11 13.9 9.9 to 10.0 13.7 10.0 to 10.3 14.0 10.1 to 10.4 13.8 10.4 to 10.7 14.1 10.5 to 10.7 13.9 10.8 to 10.10 14.2 10.8 to 10.10 14.0 10.11 to 11.2 14.3 10.11 to 11.2 14.1 11.3 to 11.5 14.4 11.3 to 11.5 14.2 11.6 to 11.8 14.5 11.6 to 11.7 14.3 11.9 to 11.11 14.6 11.8 to 11.10 14.4 12.0 to 12.1 14.7 11.11 to 12.1 14.5 12.2 to 12.4 14.8 12.2 to 12.4 14.6 12.5 to 12.7 14.9 12.5 to 12.6 14.7 12.8 to 12.9 15.0 12.7 to 12.9 14.8 12.10 to 13.0 15.1 12.10 to 12.11 14.9 13.1 to 13.2 15.2 13.0 to 13.2 15.0 13.3 to 13.4 15.3 13.3 to 13.4 15.1 13.5 to 13.7 15.4 13.5 to 13.7 15.2 13.8 to 13.9 15.5 13.8 to 13.9 15.3 13.10 to 13.11 15.6 13.10 to 14.0 15.4 14.0 to 14.1 15.7 14.1 to 14.2 15.5 14.2 to 14.4 15.8 14.3 to 14.5 15.6 14.5 to 14.6 15.9 14.6 to 14.7 15.7 14.7 to 14.8 16.0 14.8 to 14.9 15.8 14.9 to 14.10 16.1 14.10 to 15.0 15.9 14.11 to 15.0 16.2 15.1 to 15.2 16.0 15.1 to 15.3 16.3 15.3 to 15.5 16.1 15.4 to 15.5 16.4 15.6 to 15.7 16.2 15.6 to 15.7 16.5 15.8 to 15.10 16.3 15.8 to 15.9 16.6 15.11 to 16.0 16.4 15.10 to 15.11 16.7 16.1 to 16.3 16.5 16.0 to 16.1 16.8 16.4 to 16.6 16.6 16.2 to 16.3 16.9 16.7 to 16.9 16.7 16.4 to 16.5 17.0 16.10 to 17.0 16.8 16.6 to 16.8 17.1 17.1 to 17.3 16.9 16.9 to 16.10 17.2 17.4 to 17.7 17.0 16.11 to 17.0 17.3 17.8 to 17.11 17.1 17.1 to 17.2 17.4 17.3 to 17.5 17.5 17.6 to 17.7 17.6 17.8 to 17.9 17.7 17.10 to 17.11 17.8 Back to Top 105.09 Liver transplantation (see 105.00G ). Consider under a disability for 1 year from the date of the transplant; after that, evaluate the residual impairment(s). 105.10 Need for supplemental daily enteral feeding via a gastrostomy, duodenostomy, or jejunostomy (see 105.00H ) due to any cause, for children who have not attained age 3; after that, evaluate the residual impairment(s). 105.11 Small intestine transplantation (see 105.00G ). Consider under a disability for 1 year from the date of the transplant; after that, evaluate the residual impairment(s). 105.12 Pancreas transplantation (see 105.00G ). Consider under a disability for 1 year from the date of the transplant; after that, evaluate the residual impairment(s). Back to Top",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security105.00 Digestive Disorders - Childhood"
      }
    ],
    "tables": [
      [
        [
          "Third Percentile Values for Weight-for Length"
        ],
        [
          "Length\n                                         \n                                        (Centimeters)",
          "Weight\n                                         \n                                        (kilograms)"
        ],
        [
          "Table I –  Males Birth to Attainment of Age 2",
          "Table II –  Females Birth to Attainment of Age 2"
        ],
        [
          "45.0",
          "1.597",
          "1.613"
        ],
        [
          "45.5",
          "1.703",
          "1.724"
        ],
        [
          "46.5",
          "1.919",
          "1.946"
        ],
        [
          "47.5",
          "2.139",
          "2.171"
        ],
        [
          "48.5",
          "2.364",
          "2.397"
        ],
        [
          "49.5",
          "2.592",
          "2.624"
        ],
        [
          "50.5",
          "2.824",
          "2.852"
        ],
        [
          "51.5",
          "3.058",
          "3.081"
        ],
        [
          "52.5",
          "3.294",
          "3.310"
        ],
        [
          "53.5",
          "3.532",
          "3.538"
        ],
        [
          "54.5",
          "3.771",
          "3.767"
        ],
        [
          "55.5",
          "4.010",
          "3.994"
        ],
        [
          "56.5",
          "4.250",
          "4.220"
        ],
        [
          "57.5",
          "4.489",
          "4.445"
        ],
        [
          "58.5",
          "4.728",
          "4.669"
        ],
        [
          "59.5",
          "4.966",
          "4.892"
        ],
        [
          "60.5",
          "5.203",
          "5.113"
        ],
        [
          "61.5",
          "5.438",
          "5.333"
        ],
        [
          "62.5",
          "5.671",
          "5.552"
        ],
        [
          "63.5",
          "5.903",
          "5.769"
        ],
        [
          "64.5",
          "6.132",
          "5.985"
        ],
        [
          "65.5",
          "6.359",
          "6.200"
        ],
        [
          "66.5",
          "6.584",
          "6.413"
        ],
        [
          "67.5",
          "6.807",
          "6.625"
        ],
        [
          "68.5",
          "7.027",
          "6.836"
        ],
        [
          "69.5",
          "7.245",
          "7.046"
        ],
        [
          "70.5",
          "7.461",
          "7.254"
        ],
        [
          "71.5",
          "7.674",
          "7.461"
        ],
        [
          "72.5",
          "7.885",
          "7.667"
        ],
        [
          "73.5",
          "8.094",
          "7.871"
        ],
        [
          "74.5",
          "8.301",
          "8.075"
        ],
        [
          "75.5",
          "8.507",
          "8.277"
        ],
        [
          "76.5",
          "8.710",
          "8.479"
        ],
        [
          "77.5",
          "8.913",
          "8.679"
        ],
        [
          "78.5",
          "9.113",
          "8.879"
        ],
        [
          "79.5",
          "9.313",
          "9.078"
        ],
        [
          "80.5",
          "9.512",
          "9.277"
        ],
        [
          "81.5",
          "9.710",
          "9.476"
        ],
        [
          "82.5",
          "9.907",
          "9.674"
        ],
        [
          "83.5",
          "10.104",
          "9.872"
        ],
        [
          "84.5",
          "10.301",
          "10.071"
        ],
        [
          "85.5",
          "10.499",
          "10.270"
        ],
        [
          "86.5",
          "10.696",
          "10.469"
        ],
        [
          "87.5",
          "10.895",
          "10.670"
        ],
        [
          "88.5",
          "11.095",
          "10.871"
        ],
        [
          "89.5",
          "11.296",
          "11.074"
        ],
        [
          "90.5",
          "11.498",
          "11.278"
        ],
        [
          "91.5",
          "11.703",
          "11.484"
        ],
        [
          "92.5",
          "11.910",
          "11.691"
        ],
        [
          "93.5",
          "12.119",
          "11.901"
        ],
        [
          "94.5",
          "12.331",
          "12.112"
        ],
        [
          "95.5",
          "12.546",
          "12.326"
        ],
        [
          "96.5",
          "12.764",
          "12.541"
        ],
        [
          "97.5",
          "12.987",
          "12.760"
        ],
        [
          "98.5",
          "13.213",
          "12.981"
        ],
        [
          "99.5",
          "13.443",
          "13.205"
        ],
        [
          "100.5",
          "13.678",
          "13.431"
        ],
        [
          "101.5",
          "13.918",
          "13.661"
        ],
        [
          "102.5",
          "14.163",
          "13.895"
        ],
        [
          "103.5",
          "14.413",
          "14.132"
        ]
      ],
      [
        [
          "Third Percentile Values for BMI-for-Age"
        ],
        [
          "Table III –  Males Age 2 to Attainment of Age 18",
          "Table IV –  Females Age 2 to Attainment of Age 18"
        ],
        [
          "Age(yrs. and mos.)",
          "BMI",
          "Age(yrs. and mos.)",
          "BMI"
        ],
        [
          "2.0 to 2.1",
          "14.5",
          "2.0 to 2.2",
          "14.1"
        ],
        [
          "2.2 to 2.4",
          "14.4",
          "2.3 to 2.6",
          "14.0"
        ],
        [
          "2.5 to 2.7",
          "14.3",
          "2.7 to 2.10",
          "13.9"
        ],
        [
          "2.8 to 2.11",
          "14.2",
          "2.11 to 3.2",
          "13.8"
        ],
        [
          "3.0 to 3.2",
          "14.1",
          "3.3 to 3.6",
          "13.7"
        ],
        [
          "3.3 to 3.6",
          "14.0",
          "3.7 to 3.11",
          "13.6"
        ],
        [
          "3.7 to 3.11",
          "13.9",
          "4.0 to 4.4",
          "13.5"
        ],
        [
          "4.0 to 4.5",
          "13.8",
          "4.5 to 4.11",
          "13.4"
        ],
        [
          "4.6 to 5.0",
          "13.7",
          "5.0 to 5.9",
          "13.3"
        ],
        [
          "5.1 to 6.0",
          "13.6",
          "5.10 to 7.6",
          "13.2"
        ],
        [
          "6.1 to 7.6",
          "13.5",
          "7.7 to 8.4",
          "13.3"
        ],
        [
          "7.7 to 8.6",
          "13.6",
          "8.5 to 8.10",
          "13.4"
        ],
        [
          "8.7 to 9.1",
          "13.7",
          "8.11 to 9.3",
          "13.5"
        ],
        [
          "9.2 to 9.6",
          "13.8",
          "9.4 to 9.8",
          "13.6"
        ],
        [
          "9.7 to 9.11",
          "13.9",
          "9.9 to 10.0",
          "13.7"
        ],
        [
          "10.0 to 10.3",
          "14.0",
          "10.1 to 10.4",
          "13.8"
        ],
        [
          "10.4 to 10.7",
          "14.1",
          "10.5 to 10.7",
          "13.9"
        ],
        [
          "10.8 to 10.10",
          "14.2",
          "10.8 to 10.10",
          "14.0"
        ],
        [
          "10.11 to 11.2",
          "14.3",
          "10.11 to 11.2",
          "14.1"
        ],
        [
          "11.3 to 11.5",
          "14.4",
          "11.3 to 11.5",
          "14.2"
        ],
        [
          "11.6 to 11.8",
          "14.5",
          "11.6 to 11.7",
          "14.3"
        ],
        [
          "11.9 to 11.11",
          "14.6",
          "11.8 to 11.10",
          "14.4"
        ],
        [
          "12.0 to 12.1",
          "14.7",
          "11.11 to 12.1",
          "14.5"
        ],
        [
          "12.2 to 12.4",
          "14.8",
          "12.2 to 12.4",
          "14.6"
        ],
        [
          "12.5 to 12.7",
          "14.9",
          "12.5 to 12.6",
          "14.7"
        ],
        [
          "12.8 to 12.9",
          "15.0",
          "12.7 to 12.9",
          "14.8"
        ],
        [
          "12.10 to 13.0",
          "15.1",
          "12.10 to 12.11",
          "14.9"
        ],
        [
          "13.1 to 13.2",
          "15.2",
          "13.0 to 13.2",
          "15.0"
        ],
        [
          "13.3 to 13.4",
          "15.3",
          "13.3 to 13.4",
          "15.1"
        ],
        [
          "13.5 to 13.7",
          "15.4",
          "13.5 to 13.7",
          "15.2"
        ],
        [
          "13.8 to 13.9",
          "15.5",
          "13.8 to 13.9",
          "15.3"
        ],
        [
          "13.10 to 13.11",
          "15.6",
          "13.10 to 14.0",
          "15.4"
        ],
        [
          "14.0 to 14.1",
          "15.7",
          "14.1 to 14.2",
          "15.5"
        ],
        [
          "14.2 to 14.4",
          "15.8",
          "14.3 to 14.5",
          "15.6"
        ],
        [
          "14.5 to 14.6",
          "15.9",
          "14.6 to 14.7",
          "15.7"
        ],
        [
          "14.7 to 14.8",
          "16.0",
          "14.8 to 14.9",
          "15.8"
        ],
        [
          "14.9 to 14.10",
          "16.1",
          "14.10 to 15.0",
          "15.9"
        ],
        [
          "14.11 to 15.0",
          "16.2",
          "15.1 to 15.2",
          "16.0"
        ],
        [
          "15.1 to 15.3",
          "16.3",
          "15.3 to 15.5",
          "16.1"
        ],
        [
          "15.4 to 15.5",
          "16.4",
          "15.6 to 15.7",
          "16.2"
        ],
        [
          "15.6 to 15.7",
          "16.5",
          "15.8 to 15.10",
          "16.3"
        ],
        [
          "15.8 to 15.9",
          "16.6",
          "15.11 to 16.0",
          "16.4"
        ],
        [
          "15.10 to 15.11",
          "16.7",
          "16.1 to 16.3",
          "16.5"
        ],
        [
          "16.0 to 16.1",
          "16.8",
          "16.4 to 16.6",
          "16.6"
        ],
        [
          "16.2 to 16.3",
          "16.9",
          "16.7 to 16.9",
          "16.7"
        ],
        [
          "16.4 to 16.5",
          "17.0",
          "16.10 to 17.0",
          "16.8"
        ],
        [
          "16.6 to 16.8",
          "17.1",
          "17.1 to 17.3",
          "16.9"
        ],
        [
          "16.9 to 16.10",
          "17.2",
          "17.4 to 17.7",
          "17.0"
        ],
        [
          "16.11 to 17.0",
          "17.3",
          "17.8 to 17.11",
          "17.1"
        ],
        [
          "17.1 to 17.2",
          "17.4",
          "",
          ""
        ],
        [
          "17.3 to 17.5",
          "17.5",
          "",
          ""
        ],
        [
          "17.6 to 17.7",
          "17.6",
          "",
          ""
        ],
        [
          "17.8 to 17.9",
          "17.7",
          "",
          ""
        ],
        [
          "17.10 to 17.11",
          "17.8",
          "",
          ""
        ]
      ]
    ],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_01",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_02",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_06",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_07",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_09",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_10",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_11",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_12",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_06",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_07",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_02",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_09",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_10",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_11",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_12",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05A",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_02",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_02",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05A",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05B",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05C",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05C",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05D",
      "https://www.ssa.gov/disability/professionals/bluebook/106.00-Genitourinary-Childhood.htm#106_00",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05E",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05E1",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05E2",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05F",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05F2",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05F",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05F",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05G",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05G",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05G2",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05G1",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05G1",
      "https://www.ssa.gov/disability/professionals/bluebook/impairments_digestive_cld.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/impairments_digestive_cld-p.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05H",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05H",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_09",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05H",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_06",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_06B5",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_06B5",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_06",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_07",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_07",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08A",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B",
      "https://www.ssa.gov/disability/professionals/bluebook/106.00-Genitourinary-Childhood.htm#106_00",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_09",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_11",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_12",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_09",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_11",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_12",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_10",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_10",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_06",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_10",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0935.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0994a.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00C",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00C2a",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00C2b",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00C2c",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00C2d",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00C2e",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00C2f",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/impairments_digestive_cld.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/impairments_digestive_cld-p.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00C4",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00D",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_10",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00E",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00G",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00H",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00G",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00G",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm"
    ],
    "html_file": "ssa_bluebook_data/html/aef645e9ead3a0431bcbb40144a4cd79.html",
    "fetched_at": 1762482809.0617929
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00B",
    "url_hash": "f3c4be30d014f00acc16ff109f09ee90",
    "title": "100.00 Low Birth Weight and Failure to Thrive - Childhood | Disability | SSA",
    "text_content": "100.00 Low Birth Weight and Failure to Thrive - Childhood | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Listing of Impairments - Child Listings (Part B) 100.00 Low Birth Weight and Failure to Thrive - Childhood Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security 100.00 Low Birth Weight and Failure to Thrive\n - Childhood Section 100.01 Category of Impairments, Low Birth Weight and Failure to Thrive 100.04 Low birth weight in infants from birth to attainment of age 1 100.05 Failure to thrive in children from birth to attainment of age 3 100.00 Low  Birth Weight and Failure to Thrive A. What conditions do we evaluate under these listings? We evaluate low birth weight (LBW) in infants from birth to attainment of age 1 and failure to thrive (FTT) in infants and toddlers from birth to attainment of age 3. B. How do we evaluate disability based on LBW under  100.04? In 100.04A and 100.04B ,\n    we use an infant’s birth weight as documented by an original or certified copy of the infant’s birth certificate or by a medical record signed by a physician. Birth weight means the first weight  recorded after birth.\n    In 100.04B , gestational age is the infant’s age based on the date of conception as recorded in the medical record.\n    If the infant’s impairment meets the requirements for listing 100.04A or 100.04B , \n      we will follow the rules in § 416.990(b)(11) of this chapter. C. How do we evaluate disability under 100.05 ? 1. General. We establish FTT with or without a known cause when we have documentation of an infant’s or toddler’s growth failure and developmental delay from an acceptable medical source(s) \n        as defined in § 416.913(a) of this chapter.\n    We require documentation of growth measurements in 100.05A and developmental delay in 100.05B or 100.05C within the same consecutive 12-month period.\n    The dates of developmental testing and reports may be different from  the dates of the growth measurements. After the attainment of age 3, we evaluate growth failure under the affected body system(s). 2. Growth failure. Under 100.05A ,\n    we use the appropriate table(s) under 105.08B in the digestive system to determine whether a child’s growth is less than the third percentile.\n    The child does not need to have a digestive disorder for the purposes of 100.05 . a.  For children from birth to attainment of age 2, we use the weight-for-length table corresponding to the child’s gender (Table I or Table II). b.  For children age 2 to the attainment of age 3, we use the body mass index (BMI)-for-age table corresponding to the child’s gender (Table III or Table IV). c.  BMI is the ratio of a child’s weight to the square of his or her height.\n          We calculate BMI using the formulas in the digestive disorders body system ( 105.00 ). d. Growth measurements. The weight-for-length measurements for children from birth to attainment of age 2 and BMI-for-age measurements in children age 2 to attainment of age 3 that are required for this listing must be obtained  within a 12-month period and at least 60 days apart. If a child attains 2  during the evaluation period, additional measurements are not needed. Any  measurements taken before the child attains age 2 can be used to evaluate the  impairment under the appropriate listing for the child’s age. If the child  attains age 3 during the evaluation period, the measurements can be used to  evaluate the impairment in the affected body system. 3. Developmental Delay. a.  Under 100.05B and C , \n      we use reports from acceptable medical sources to  establish delay in a child’s development. b.  Under 100.05B , \n      we document the severity of developmental delay with results from a standardized developmental assessment, \n      which compares a child’s level of development to the level typically expected for his or her chronological age.  \n      If the child was born prematurely, we may use the corrected chronological age (CCA) for comparison. \n      (See § 416.924b(b) of this chapter.)\n    CCA is the chronological age adjusted by a period of gestational prematurity. CCA=  (chronological age) – (number of weeks premature).\n    Acceptable medical sources or early intervention specialists, physical or occupational therapists, and other sources may conduct standardized developmental assessments and developmental screenings.\n    The results of these tests and screening must be accompanied by a statement or records from an acceptable medical source who established the child has a developmental delay. c. Under 100.05C , \n      when there are no results from a standardized developmental assessment in the case record, \n      we need narrative developmental reports from the child’s medical sources in sufficient detail to assess the severity of his or her developmental delay. \n      A narrative developmental report is based on clinical observations, progress notes, and well-baby check-ups. To meet the requirements for 100.05C ,\n    the report must include: the child’s developmental history; examination findings (with abnormal findings noted on repeated examinations); \n      and an overall assessment of the child’s development (that is, more than one or two  isolated skills) by the medical source. \n      Some narrative developmental reports may include results from developmental screening tests, which can identify a child who is not developing or achieving skills within expected timeframes. \n      Although medical sources may refer to screening test results as supporting evidence in the narrative developmental report, \n      screening test results alone cannot establish a diagnosis or the severity of developmental delay. D. How do we evaluate disorders that do not meet one  of our listings? 1.  We may find infants disabled due to other disorders when their birth weights are greater than 1200 grams but less than 2000 grams and their \n      weight and gestational age do not meet listing 100.04 . The most common disorders of prematurity and LBW include retinopathy of prematurity (ROP),\n    chronic lung disease of infancy (CLD, previously known as bronchopulmonary dysplasia, or  BPD), intraventricular hemorrhage (IVH), necrotizing enterocolitis (NEC),\n    and periventricular leukomalacia (PVL). Other disorders include poor nutrition and growth failure, hearing disorders, seizure disorders, cerebral palsy, and developmental disorders.\n    We evaluate these disorders under the affected body systems. 2.  We may evaluate infants and toddlers with growth failure that is associated  with a known medical disorder under the body system of that medical disorder,  for example, the respiratory or digestive body systems. 3. If an infant or toddler has a severe medical  determinable impairment(s) that does not meet the criteria of any listing, \n      we must also consider whether the child has an impairment(s) that medically equals a listing \n      (see § 416.926 of this chapter).\n    If the child’s impairment(s) does not meet or medically equal a listing, we will determine whether the child’s  impairment(s) functionally equals the listings\n    (see § 416.926a of this chapter)\n    considering the factors in § 416.924a of this chapter.\n    We use the rules in § 416.994a of this chapter when we decide whether a child continues to be disabled. 100.01 Category of Impairments, Low Birth Weight and Failure to Thrive 100.04 Low birth weight in infants from birth to attainment of age 1. A. Birth weight (see 100.00B ) of less than 1200 grams. OR B. The following gestational age and birth weight: Gestational Age (in weeks) Birth Weight 37-40 2000 grams or less 36 1875 grams or less 35 1700 grams or less 34 1500 grams or less 33 1325 grams or less 32 1250 grams or less 100.05 Failure to thrive in children from birth to attainment of age 3 (see 100.00C ), documented by A and B, or A and C. A.  Growth failure as required in 1 or 2: 1. For children from birth to attainment of age 2, three weight-for-length measurements that are: a.  Within a consecutive 12-month period; and b.  At least 60 days apart; and c.  Less than the third percentile on the appropriate weight-for-length table under 105.08B1 ; or 2. For children age 2 to attainment of age 3, three BMI-for-age measurements that are: a.  Within a consecutive 12-month period; and b.  At least 60 days apart; and c.  Less than the third percentile on the appropriate BMI-for-age table under 105.08B2 . AND B.  Developmental delay (see 100.00C1 and C3 ), \n      established by an acceptable medical source and documented by findings from one current report of a standardized developmental assessment (see 100.00C3b ) that: 1.  Shows development not more than two-thirds of the level typically expected for the child’s age; or 2.  Results in a valid score that is at least two standard deviations below the mean. OR C.  Developmental delay (see 100.00C3 ), \n      established by an acceptable medical source and documented by findings from two narrative developmental reports (see 100.00C3c ) that: 1.  Are dated at least 120 days apart (see 100.00C1 ); and 2. Indicate current development not more than two-thirds of the level typically expected for the child’s age. Back to Top",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security100.00 Low Birth Weight and Failure to Thrive\n - Childhood"
      }
    ],
    "tables": [
      [
        [
          "Gestational Age (in weeks)",
          "Birth Weight"
        ],
        [
          "37-40",
          "2000 grams or less"
        ],
        [
          "36",
          "1875 grams or less"
        ],
        [
          "35",
          "1700 grams or less"
        ],
        [
          "34",
          "1500 grams or less"
        ],
        [
          "33",
          "1325 grams or less"
        ],
        [
          "32",
          "1250 grams or less"
        ]
      ]
    ],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_01",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04A",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04B",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04B",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04A",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04B",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0990.htm#b11",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0913.htm#a",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05A",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05B",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05C",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05A",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05B",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05C",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05B",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0924b.htm#b",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05C",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05C",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0924a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0994a.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00B",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B1",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B2",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C1",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C3b",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C3c",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C1",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm"
    ],
    "html_file": "ssa_bluebook_data/html/f3c4be30d014f00acc16ff109f09ee90.html",
    "fetched_at": 1762482813.3560975
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B1",
    "url_hash": "801ff91a68009bf03de2c862fb6f9d22",
    "title": "105.00 Digestive Disorders - Childhood | Disability | SSA",
    "text_content": "105.00 Digestive Disorders - Childhood | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Listing of Impairments - Child Listings (Part B) 105.00 Digestive Disorders - Childhood Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security 105.00 Digestive Disorders - Childhood Section 105.01 Category of Impairments, Digestive Disorders 105.02 Gastrointestinal hemorrhaging from any cause, requiring three blood transfusions 105.05 Chronic liver disease (CLD) 105.06 Inflammatory bowel disease (IBD) 105.07 Intestinal failure 105.08 Growth failure due to any digestive disorder 105.09 Liver transplantation 105.10 Need for supplemental daily enteral feeding via a gastrostomy, duodenostomy, or jejunostomy 105.11 Small intestine transplantation 105.12 Pancreas transplantation 105.00 Digestive Disorders A. Which digestive disorders do we evaluate in this body system? We evaluate digestive disorders that result in severe dysfunction of the liver, pancreas, and gastrointestinal tract (the large, muscular tube that extends from the mouth to the anus, \n                            where the movement of muscles, along with the release of hormones and enzymes, allows for the digestion of food) in this body system. \n                            Examples of these disorders and the listings we use to evaluate them include chronic liver disease ( 105.05 ), \n                            inflammatory bowel disease ( 105.06 ), and intestinal failure ( 105.07 ). \n                            We also use this body system to evaluate gastrointestinal hemorrhaging from any cause ( 105.02 ), \n                            growth failure due to any digestive disorder ( 105.08 ), liver transplantation ( 105.09 ), \n                            need for supplemental daily enteral feeding via a gastrostomy, duodenostomy, or jejunostomy due to any cause for children who have not attained age 3 ( 105.10 ), \n                            small intestine transplantation ( 105.11 ), and pancreas transplantation ( 105.12 ). \n                            We evaluate cancers affecting the digestive system under the listings in 113.00 . B. What evidence do we need to evaluate your digestive disorder? 1. General. To establish that you have a digestive disorder, we need medical evidence about the existence of your digestive disorder and its severity. Medical evidence should include your medical history, physical examination findings, operative reports, and relevant laboratory findings. 2. Laboratory findings. We need laboratory reports such as results of imaging (see 105.00B3 ), \n                            endoscopy, and other diagnostic procedures. We may also need clinical laboratory and pathology results. 3. Imaging refers to medical imaging techniques, such as x-ray, ultrasound, magnetic resonance imaging, and computerized tomography. The imaging must be consistent with the prevailing state of medical knowledge and clinical practice as a proper technique to support the evaluation of the disorder. Back to Top C. What is chronic liver disease (CLD), and how do we evaluate it under 105.05 ? 1. General. CLD is loss of liver function with cell necrosis (cell death), inflammation, or scarring of the liver that persists for more than 6 months. Common causes of CLD in children include chronic infection with hepatitis B virus or hepatitis C virus, autoimmune hepatitis, and metabolic disease. a. We will evaluate your signs of CLD, such as jaundice, changes in size of the liver and spleen, ascites, peripheral edema, and altered mental status. \n                            We will also evaluate your symptoms of CLD, such as pruritus (itching), fatigue, nausea, loss of appetite, and sleep disturbances when we assess the severity of your impairment(s) \n                            and how it affects your ability to function. In the absence of evidence of a chronic liver impairment, \n                            episodes of acute liver disease do not meet the requirements of 105.05 . b. Laboratory findings of your CLD may include decreased serum albumin, increased International Normalized Ratio (INR), arterial deoxygenation (hypoxemia), increased serum creatinine, oliguria (reduced urine output), or sodium retention. Another laboratory finding that may be included in the evidence is a liver biopsy. If you have had a liver biopsy, we will make every reasonable effort to obtain the results; however, we will not purchase a liver biopsy. 2. Manifestations of CLD. a. Gastrointestinal hemorrhaging ( 105.05A ), as a consequence of cirrhosis and high pressure in the liver's portal venous system, \n                            may occur from varices (dilated veins in the esophagus or the stomach) or from portal hypertensive gastropathy (abnormal mucosal changes in the stomach). \n                            When gastrointestinal hemorrhaging is due to a cause other than CLD, we evaluate it under 105.02 . \n                            The phrase \"consider under a disability for 1 year\" in 105.02 and 105.05A does not refer to the date on which your disability began, \n                            only to the date on which we must reevaluate whether your impairment(s) continues to meet a listing or is otherwise disabling. \n                            We determine the onset of your disability based on the facts of your case. b. Ascites or hydrothorax ( 105.05B ) is a pathologic accumulation of fluid in the peritoneal cavity (ascites) or pleural space (hydrothorax). \n                            Ascites or hydrothorax may be diagnosed by removing some of the fluid with needle aspiration (paracentesis or thoracentesis), physical examination, or imaging. \n                            The most common causes of ascites are portal hypertension and low serum albumin resulting from CLD. \n                            We evaluate other causes of ascites and hydrothorax that are unrelated to CLD, such as congestive heart failure and cancer, under the listings in the affected body systems. c. Spontaneous bacterial peritonitis (SBP) ( 105.05C ) is an acute bacterial infection of peritoneal fluid and is most commonly associated with CLD. \n                            SBP is diagnosed by laboratory analysis of peritoneal fluid (obtained by paracentesis) that contains a neutrophil count (also called absolute neutrophil count) of at least 250 cells/mm 3 . 105.05C is satisfied with one evaluation documenting peritoneal infection. We evaluate other causes of peritonitis that are unrelated to CLD, \n                            such as tuberculosis, malignancy, and perforated bowel, under the listings in the affected body systems. d. Hepatorenal syndrome ( 105.05D ) is renal failure associated with CLD in the absence of underlying kidney pathology. \n                            Findings associated with hepatorenal syndrome include elevation of serum creatinine, sodium retention with low urinary sodium excretion, and oliguria. \n                            We evaluate renal dysfunction with known underlying kidney pathology, such as glomerulonephritis, tubular necrosis, and renal infections, \n                            under the listings in 106.00 . e. Hepatopulmonary syndrome ( 105.05E ) is arterial deoxygenation due to intrapulmonary vascular dilation and arteriovenous shunting associated with CLD. \n                            Clinical findings of hepatopulmonary syndrome include platypnea (shortness of breath relieved when lying down) and orthodeoxia (low arterial blood oxygen while in the upright position), \n                            when presenting in the context of CLD. We evaluate pulmonary dysfunction with known underlying respiratory pathology, such as asthma, pneumonia, and pulmonary infections, \n                            under the listings in 103.00 . (i) Under 105.05E1 , we require a resting arterial blood gas (ABG) measurement obtained while you are breathing room air;\n                            that is, without oxygen supplementation. The ABG report must include the P a O 2 value, your name, the date of the test, and either the altitude or both the city and State of the test site. (ii) We will not purchase the specialized imaging techniques described in 105.05E2 ; \n                            however, if you have had the test(s) at a time relevant to your claim, we will make every reasonable effort to obtain the report. f. Hepatic encephalopathy ( 105.05F ), also known as portosystemic encephalopathy, \n                            is a recurrent or chronic neuropsychiatric disorder associated with CLD. (i) Under 105.05F2 , we require documentation of a mental impairment associated with hepatic encephalopathy. \n                            A mental impairment can include abnormal behavior, changes in mental status, or an altered state of consciousness. Reports of abnormal behavior may show that you are experiencing delusions, \n                            paranoia, or hallucinations. Reports of changes in mental status may show change in sleep patterns, personality or mood changes, poor concentration, or poor judgment or cognitive dysfunction \n                            (for example, impaired memory, poor problem-solving ability, or attention deficits). Reports of altered state of consciousness may show that you are experiencing confusion, delirium, or stupor. (ii) Signs and laboratory findings that document the severity of hepatic encephalopathy when not attributable to other causes may include a \"flapping tremor\" (asterixis), \n                            characteristic abnormalities found on an electroencephalogram (EEG), or abnormal serum albumin or coagulation values. We will not purchase an EEG; however, if you have had this test at a time relevant to your claim, \n                            we will make every reasonable effort to obtain the report for the purpose of establishing whether your impairment meets the criteria of 105.05F . (iii) We will not evaluate acute encephalopathy under 105.05F if it results from conditions other than CLD. \n                            For example, we will evaluate acute encephalopathy caused by vascular events under the listings in 111.00 and acute encephalopathy caused by cancer under the listings in 113.00 . 3. SSA Chronic Liver Disease (SSA CLD) and SSA Chronic Liver Disease-Pediatric (SSA CLD–P) scores ( 105.05G ). \n                            Listing 105.05G1 requires two SSA CLD scores, each requiring three or four laboratory values. \n                            Listing 105.05G2 requires one SSA CLD–P score, which requires four parameters (three laboratory values and growth failure). \n                            The \"date of the SSA CLD score\" is the date of the earliest of the three or four laboratory values used for its calculation. \n                            The \"date of the SSA CLD–P score\" is the date of the earliest of the three laboratory values used for its calculation. \n                            For 105.05G1 , the date of the second SSA CLD score must be at least 60 days after the date of the first SSA CLD score and both scores must be within the required 12-month period. \n                            If you have the two SSA CLD scores required by 105.05G1 , we will find that your impairment meets the criteria of the listing from at least the date of the first SSA CLD score. [We provide the SSA CLD Calculato r to calculate the SSA CLD scores as described in 105.00C3a below and the SSA CLD-P Calculator to calculate the SSA CLD-P score as described in 105.00C3b below.] a. SSA CLD score. (i) If you are age 12 or older, we will calculate the SSA CLD score using a formula that includes up to four laboratory values: \n                            Serum creatinine (mg/dL), total bilirubin (mg/dL), INR, and under certain conditions, serum sodium (mmol/L). \n                            The SSA CLD score calculation contains at least one, and sometimes two, parts, as described in (a) and (b). (a) The initial calculation is: SSA CLD i = 9.57 × [log e (serum creatinine mg/dL)] + 3.78 × [log e (serum total bilirubin mg/dL)] + 11.2 × [log e (INR)] + 6.43 rounded to the nearest whole integer. (b) If the value from the initial calculation is 11 or below, the SSA CLD score will be the SSA CLD i value. If the value from the initial calculation is greater than 11, the SSA CLD score will be re-calculated as: SSA CLD = SSA CLD i + 1.32 × (137−serum sodium mmol/L) −[0.033 × SSA CLD i × (137−serum sodium mmol/L)] (c) We round the results of your SSA CLD score calculation to the nearest whole integer to arrive at your SSA CLD score. (ii) For any SSA CLD score calculation, all of the required laboratory values (serum creatinine, serum total bilirubin, INR, and serum sodium) must have been obtained within a continuous 30-day period. (a) We round values for serum creatinine (mg/dL), serum total bilirubin (mg/dL), or INR less than 1.0 up to 1.0 to calculate your SSA CLD score. (b) We round values for serum creatinine (mg/dL) greater than 4.0 down to 4.0 to calculate your SSA CLD score. (c) If there are multiple laboratory values within the 30-day interval for serum creatinine (mg/dL), serum total bilirubin (mg/dL), or INR, we use the highest value to calculate your SSA CLD score. \n                            We will not use any INR values derived from testing done while you are on anticoagulant treatment in our SSA CLD calculation. (d) If there are multiple laboratory values within the 30-day interval for serum sodium (mmol/L), we use the lowest value to calculate your SSA CLD score. (e) If you are in renal failure or on renal dialysis within a week of any serum creatinine test in the period used for the SSA CLD calculation, we will use a serum creatinine value of 4.0, which is the maximum serum creatinine level allowed in the calculation, to calculate your SSA CLD score. (f) If your serum sodium is less than 125 mmol/L, we will set your serum sodium to 125 mmol/L for purposes of calculation of the SSA CLD score. If your serum sodium is higher than 137 mmol/L, we will set your serum sodium to 137 mmol/L for purposes of calculation of the SSA CLD score. (iii) When we indicate \"log e \" (also abbreviated \"ln\") in the formula for the SSA CLD score calculation, \n                            we mean the \"base e logarithm\" or \"natural logarithm\" of the numerical laboratory value, not the “base 10 logarithm” or “common logarithm” (log) of the laboratory value, \n                            and not the actual laboratory value. For example, if a person has laboratory values of serum creatinine 1.4 mg/dL, serum total bilirubin 1.3 mg/dL, INR 1.32, and serum sodium 119 mmol/L, \n                            we compute the SSA CLD score as follows: SSA CLD i = 9.57 × [log e (serum creatinine 1.4 mg/dL) = 0.336] + 3.78 × [log e (serum total bilirubin 1.3 mg/dL) = 0.262] + 11.2 × [log e (INR 1.32) = .278] + 6.43 = 3.22 + 0.99 + 3.11 + 6.43 = 13.75, which we round to an SSA CLD i score of 14. Because the SSA CLD i score is over 11, we then move to the second step of calculating the SSA CLD: SSA CLD = 14 + 1.32 × (137−serum sodium 125 mmol/L) −[0.033 × SSA CLD i 14 × (137−serum sodium 125 mmol/L) = 14 + 15.84−5.54 = 24.3, which we round to an SSA CLD score of 24. b. SSA CLD–P score (i) We calculate the SSA CLD–P score using a formula that includes four parameters: Serum total bilirubin (mg/dL), INR, serum albumin (g/dL), and whether you have growth failure. The formula for the SSA CLD–P score calculation is: 4.80 × [log e (serum total bilirubin mg/dL)] + 18.57 × [log e (INR)] −6.87 × [log e (serum albumin g/dL)] + 6.67 if you have growth failure (<−2 standard deviations for weight or height) (ii)When we indicate \"log e \" in the formula for the SSA CLD–P score calculation, we mean the \"base e logarithm\" or \"natural logarithm\" (log e ) of a numerical laboratory value, not the “base 10 logarithm” or “common logarithm” (log) of the laboratory value, and not the actual laboratory value. For example, if a female child is 4.0 years old, has growth failure, and has laboratory values of serum total bilirubin 2.2 mg/dL, INR 1.0, and serum albumin 3.5 g/dL, we compute the SSA CLD–P score as follows: 4.80 × [log e (serum total bilirubin 2.2 mg/dL) = 0.788] + 18.57 × [log e (INR 1.0) = 0] −6.87 × [log e (serum albumin 3.5 g/dL) = 1.253] + 6.67 = 3.78 + 0−8.61 + 6.67 = 1.84, which we round to an SSA CLD–P score of 2. (iii) For an SSA CLD–P score calculation, all of the required laboratory values (serum total bilirubin, INR, and serum albumin) must have been obtained within a continuous 30-day period. \n                            We round any of the required laboratory values less than 1.0 up to 1.0 to calculate your SSA CLD–P score. If there are multiple laboratory values within the 30-day interval for any given laboratory test, \n                            we use the highest serum total bilirubin and INR values and the lowest serum albumin value to calculate the SSA CLD–P score. \n                            We will not use any INR values derived from testing done while you are on anticoagulant treatment in our SSA CLD–P calculation. \n                            We will not purchase INR values for children who have not attained age 12. If there is no INR value for a child under 12 within the applicable period, \n                            we will use an INR value of 1.1 to calculate the SSA CLD–P score. We round the results of your SSA CLD–P score calculation to the nearest whole integer to arrive at your SSA CLD–P score. (iv) The weight and length/height measurements used for the calculation must be obtained within the same 30-day period as the laboratory values. 4. Extrahepatic biliary atresia ( 105.05H ) presents itself in the first 2 months of life with persistent jaundice. \n                            To satisfy 105.05H , the diagnosis of extrahepatic biliary atresia must be confirmed by liver biopsy or intraoperative cholangiogram that shows obliteration of the extrahepatic biliary tree. \n                            Biliary atresia is usually treated surgically by portoenterostomy (for example, Kasai procedure). If this surgery is not performed in the first months of life or is not completely successful, \n                            liver transplantation is indicated. If you have received a liver transplant, we will evaluate your impairment under 105.09 . \n                            The phrase \"consider under a disability for 1 year\" in 105.05H does not refer to the date on which your disability began, \n                            only to the date on which we must reevaluate whether your impairment(s) continues to meet a listing or is otherwise disabling. We determine the onset of your disability based on the facts of your case. Back to Top D. What is inflammatory bowel disease (IBD), and how do we evaluate it under 105.06 ? 1. IBD is a group of inflammatory conditions of the small intestine and colon. The most common IBD disorders are Crohn's disease and ulcerative colitis. Remissions and exacerbations of variable duration are a hallmark of IBD. 2. We evaluate your signs and symptoms of IBD, such as diarrhea, fecal incontinence, rectal bleeding, abdominal pain, fatigue, fever, nausea, vomiting, arthralgia, \n                            abdominal tenderness, palpable abdominal mass (usually inflamed loops of bowel), and perianal disease (for example, fissure, fistulas, abscesses, or anal canal stenosis), \n                            when we assess the severity of your impairment(s). You may require supplemental daily nutrition due to IBD. \n                            There are two forms of supplemental daily nutrition we consider under 105.06B5 : \n                            enteral nutrition (delivered directly to a part of your digestive system) via a gastrostomy, duodenostomy, or jejunostomy, \n                            and parenteral nutrition delivered via a central venous catheter. \n                            Enteral tube feedings delivered via nasal or oral tubes do not satisfy the requirement in 105.06B5 . 3. Surgical diversion of the intestinal tract, including ileostomy and colostomy, \n                            does not very seriously interfere with age-appropriate functioning if you are able to maintain adequate nutrition and function of the stoma. \n                            However, if you are not able to maintain adequate nutrition, we will evaluate your impairment under 105.08 . 4. IBD may be associated with significant extraintestinal manifestations in a variety of body systems. These include, but are not limited to, involvement of the eye \n                            (for example, uveitis, episcleritis, or iritis); hepatobiliary disease (for example, gallstones or primary sclerosing cholangitis); \n                            urologic disease (for example, kidney stones or obstructive hydronephrosis); skin involvement (for example, erythema nodosum or pyoderma gangrenosum); \n                            or non-destructive inflammatory arthritis. You may also have associated thromboembolic disorders or vascular disease. These manifestations may not correlate with the severity of your IBD. \n                            If your impairment does not meet any of the criteria of 105.06 , \n                            we will consider the effects of your extraintestinal manifestations in determining whether you have an impairment(s) that meets or medically equals another listing, \n                            and when we determine whether your impairment(s) functionally equals the listings. 5. Examples of complications of IBD that may result in hospitalization include abscesses, intestinal perforation, toxic megacolon, infectious colitis, pyoderma gangrenosum, ureteral obstruction, primary sclerosing cholangitis, and hypercoagulable state (which may lead to thromboses or embolism). Back to Top E. What is intestinal failure, and how do we evaluate it under 105.07 ? 1. Intestinal failure is a condition resulting in gut function below the minimum necessary for the absorption of macronutrients or water and electrolytes, \n                            resulting in a requirement for intravenous supplementation ( i.e., parenteral nutrition) to maintain health. Examples of conditions that may result in intestinal failure include short bowel syndrome, \n                            extensive small bowel mucosal disease, and chronic motility disorders. 2. Short bowel syndrome is a malabsorption disorder that occurs when ischemic vascular insults (caused, for example, by volvulus or necrotizing enterocolitis), trauma, or IBD complications require(s) surgical resection of any amount of the small intestine, resulting in chronic malnutrition. 3. Extensive small bowel mucosal disease means that the mucosal surface of the small bowel does not efficiently absorb nutrients or loses nutrients. Common causes of small bowel mucosal disease include microvillous inclusion disease and tufting enteropathy. 4. Chronic motility disorder refers to a chronic disorder of the propulsion of gut content without fixed obstructions, causing intolerance to oral nutrition and inadequate nutritional intake. This type of disorder may also be known as a chronic intestinal pseudo-obstruction (CIPO), because the gut dysfunction mimics that of an obstructed intestine, but without evidence of an actual obstruction. Primary CIPO may have an unknown underlying cause. Chronic motility disorders may also result from congenital, neuromuscular, or autoimmune conditions, such as gastroschisis, omphalocele, long segment Hirschprung's disease, Crohn's disease, and mitochondrial disorders. 5. For short bowel syndrome, we require a copy of the operative report that includes details of the surgical findings, or postoperative imaging indicating a resection of the small intestine. \n                            If we cannot get one of these reports, we need other medical reports that include details of the surgical findings. For other chronic motility disorders or extensive small bowel mucosal disease, \n                            we need medical reports that include details of your intestinal dysfunction. For any impairment evaluated under 105.07 , \n                            we also need medical documentation that you are dependent on daily parenteral nutrition to provide most of your nutritional requirements. Back to Top F. How do we evaluate growth failure due to any digestive disorder under 105.08 ? 1. To evaluate growth failure due to any digestive disorder, \n                            we require documentation of the laboratory findings of chronic nutritional deficiency described in 105.08A and the growth measurements in 105.08B within the same consecutive 12-month period. \n                            The dates of laboratory findings may be different from the dates of growth measurements. \n                            Impairments other than digestive disorders that cause weight loss should be evaluated under the appropriate body system. \n                            For instance, weight loss as a result of chronic kidney disease should be evaluated under our rules for genitourinary disorders \n                            (see 106.00 ), and weight loss as the result of an eating disorder should be evaluated under our rules for mental disorders \n                            (see 112.00 ). However, if you develop a digestive disorder as the result of your other impairment, \n                            we will evaluate the acquired digestive disorder under our rules for digestive disorders. 2. Under 105.08B , we evaluate a child's growth failure by using the appropriate table for age and gender. a. For children from birth to attainment of age 2, we use the weight-for-length table (see Table I or Table II). b. For children age 2 to attainment of age 18, we use the body mass index (BMI)-for-age table (see Table III or Table IV). c. BMI is the ratio of your weight to the square of your height. We calculate BMI using one of the following formulas: English Formula BMI = [Weight in Pounds/(Height in Inches × Height in Inches)] × 703 Metric Formulas BMI = Weight in Kilograms/(Height in Meters × Height in Meters) BMI = [Weight in Kilograms/(Height in Centimeters × Height in Centimeters)] × 10,000 Back to Top G . How do we evaluate digestive organ transplantation? If you receive a liver ( 105.09 ), small intestine ( 105.11 ), \n                            or pancreas ( 105.12 ) transplant, we will consider you disabled under the listing for 1 year from the date of the transplant. After that, \n                            we evaluate your residual impairment(s) by considering the adequacy of your post-transplant function, the frequency and severity of any rejection episodes you have, \n                            complications in other body systems, and adverse treatment effects. \n                            People who receive digestive organ transplants generally have impairments that meet our definition of disability before they undergo transplantation. \n                            The phrase \"consider under a disability for 1 year\" in 105.09 , 105.11 , \n                            and 105.12 does not refer to the date on which your disability began, \n                            only to the date on which we must reevaluate whether your impairment(s) continues to meet a listing or is otherwise disabling. \n                            We determine the onset of your disability based on the facts of your case. H. How do we evaluate the need for supplemental daily enteral feeding via a gastrostomy, duodenostomy, or jejunostomy? We evaluate the need for supplemental daily enteral feeding via a gastrostomy, duodenostomy, \n                            or jejunostomy in children who have not attained age 3 under 105.10 regardless of the medical reason for the stoma. \n                            Enteral tube feedings delivered via nasal or oral tubes do not satisfy the requirement in 105.10 . \n                            After a child attains age 3, we evaluate growth failure due to any digestive disorder under 105.08 , \n                            IBD requiring supplemental daily enteral or parenteral nutrition under 105.06 , \n                            or other medical or developmental disorders under another digestive disorders listing or under a listing in an affected body system(s). I. How do we evaluate esophageal stricture or stenosis? Esophageal stricture or stenosis (narrowing) from congenital atresia (absence or abnormal closure of a tubular body organ) or destructive esophagitis may result in malnutrition \n                            or the need for gastrostomy placement, which we evaluate under 105.08 or 105.10 . \n                            Esophageal stricture or stenosis may also result in complications such as pneumonias due to frequent aspiration, or difficulty in maintaining nutritional status short of listing level severity. \n                            While these individual complications usually do not meet the listing criteria, a combination of your impairments may medically equal a listing or functionally equal the listings. Back to Top J. How do we evaluate your digestive disorder if there is no record of ongoing treatment? If there is no record of ongoing treatment despite the existence of a severe impairment(s), we will assess the severity and duration of your digestive disorder based on the current medical and other evidence in your case record. If there is no record of ongoing treatment, you may not be able to show an impairment that meets a digestive disorders listing, but your impairment may medically equal a listing, or be disabling based on our rules for functional equivalence. K. How do we evaluate your digestive disorder if there is evidence establishing a substance use disorder? If we find that you are disabled and there is medical evidence in your case record establishing that you have a substance use disorder,\n                            we will determine whether your substance use disorder is a contributing factor material to the determination of disability.\n                            See § 416.935 of this chapter.\n                            Digestive disorders resulting from drug or alcohol use are often chronic in nature and will not necessarily improve with cessation in drug or alcohol use. L. How do we evaluate digestive disorders that do not meet one of these listings? 1. These listings are only examples of common digestive disorders that we consider severe enough to result in marked and severe functional limitations. If your impairment(s) does not meet the criteria of any of these listings, we must also consider whether you have an impairment(s) that satisfies the criteria of a listing in another body system. 2. If you have a severe medically determinable impairment(s) that does not meet a listing, we will determine whether your impairment(s) medically equals a listing.\n                            See  § 416.926 of this chapter.\n                            Digestive disorders may be associated with disorders in other body systems, and we consider the combined effects of multiple impairments when we determine whether they medically equal a listing.\n                            If your impairment(s) does not meet or medically equal a listing, we will also consider whether it functionally equals the listings.\n                            See § 416.926a of this chapter.\n                            We use the rules in § 416.994a of this chapter when we decide whether you continue to be disabled. Back to Top 105.01  Category of Impairments, Digestive Disorders 105.02 Gastrointestinal hemorrhaging from any cause, requiring three blood transfusions of at least 10 cc of blood/kg of body weight per transfusion, within a consecutive 12-month period and at least 30 days apart. Consider under a disability for 1 year following the last documented transfusion; after that, evaluate the residual impairment(s). 105.03 [Reserved] 105.04 [Reserved] Back to Top 105.05 Chronic liver disease (CLD) (see 105.00C ) with A, B, C, D, E, F, G, or H: A. Hemorrhaging from esophageal, gastric, or ectopic varices, or from portal hypertensive gastropathy (see 105.00C2a ), \n                            documented by imaging (see 105.00B3 ); resulting in 1 and 2: 1. Hemodynamic instability indicated by signs such as pallor (pale skin), diaphoresis (profuse perspiration), rapid pulse, low blood pressure, postural hypotension (pronounced fall in blood pressure when arising to an upright position from lying down), or syncope (fainting); and 2. Requiring hospitalization for transfusion of at least 10 cc of blood/kg of body weight. Consider under a disability for 1 year following the documented transfusion; after that, evaluate the residual impairment(s). OR B. Ascites or hydrothorax not attributable to other causes (see 105.00C2b ), \n                            present on two evaluations within a consecutive 12-month period and at least 60 days apart. Each evaluation must document the ascites or hydrothorax by 1, 2, or 3: 1. Paracentesis; or 2. Thoracentesis; or 3. Imaging or physical examination with a or b: a. Serum albumin of 3.0 g/dL or less; or b. INR of at least 1.5. OR C. Spontaneous bacterial peritonitis (see 105.00C2c ) documented by peritoneal fluid containing a neutrophil count of at least 250 cells/mm 3 . OR D. Hepatorenal syndrome (see 105.00C2d ) documented by 1, 2, or 3: 1. Serum creatinine elevation of at least 2 mg/dL; or 2. Oliguria with 24-hour urine output less than 1 mL/kg/hr; or 3. Sodium retention with urine sodium less than 10 mEq per liter. OR E. Hepatopulmonary syndrome (see 105.00C2e ) documented by 1 or 2: 1. Arterial P a O 2 measured by an ABG test, while at rest, breathing room air, less than or equal to: a. 60 mm Hg, at test sites less than 3,000 feet above sea level; or b. 55 mm Hg, at test sites from 3,000 through 6,000 feet above sea level; or c. 50 mm Hg, at test sites over 6,000 feet above sea level; or 2. Intrapulmonary arteriovenous shunting as shown on contrast-enhanced echocardiography or macroaggregated albumin lung perfusion scan. OR F. Hepatic encephalopathy (see 105.00C2f ) with documentation of abnormal behavior, \n                            cognitive dysfunction, changes in mental status, or altered state of consciousness (for example, confusion, delirium, stupor, or coma), \n                            present on two evaluations within a consecutive 12-month period and at least 60 days apart and either 1 or 2: 1. History of transjugular intrahepatic portosystemic shunt (TIPS) or other surgical portosystemic shunt; or 2.  One of the following on at least two evaluations at least 60 days apart within the same consecutive 12-month period as in F: a. Asterixis or other fluctuating physical neurological abnormalities; or b. EEG demonstrating triphasic slow wave activity; or c. Serum albumin of 3.0 g/dL or less; or d. INR of 1.5 or greater. OR G. SSA CLD or SSA CLD–P scores (see 105.00C3 ) [ SSA CLD Calculator and SSA CLD-P Calculator ]: 1. For children age 12 or older, two SSA CLD scores of at least 20 within a consecutive 12-month period and at least 60 days apart. Consider under a disability from at least the date of the first score; or 2. For children who have not attained age 12, one SSA CLD–P score of at least 11. OR H. Extrahepatic biliary atresia as diagnosed on liver biopsy or intraoperative cholangiogram (see 105.00C4 ). \n                            Consider under a disability for 1 year following diagnosis; after that, evaluate the residual impairment(s). Back to Top 105.06 Inflammatory bowel disease (IBD) (see 105.00D ) documented by endoscopy, biopsy, imaging, or operative findings and demonstrated by A or B: A. Obstruction of stenotic areas (not adhesions) in the small intestine or colon with proximal dilatation, confirmed by imaging or in surgery, requiring two hospitalizations for intestinal decompression or for surgery, within a consecutive 12-month period and at least 60 days apart. OR B. Two of the following occurring within a consecutive 12-month period and at least 60 days apart: 1. Anemia with hemoglobin less than 10.0 g/dL, present on at least two evaluations at least 60 days apart; or 2. Serum albumin of 3.0 g/dL or less, present on at least two evaluations at least 60 days apart; or 3. Clinically documented tender abdominal mass palpable on physical examination with abdominal pain or cramping; or 4. Perianal disease with a draining abscess or fistula; or 5. Need for supplemental daily enteral nutrition via a gastrostomy, duodenostomy, or jejunostomy, or daily parenteral nutrition via a central venous catheter \n                            (see 105.10 for children who have not attained age 3). Back to Top 105.07 Intestinal failure (see 105.00E ) due to short bowel syndrome, chronic motility disorders, or extensive small bowel mucosal disease, \n                            resulting in dependence on daily parenteral nutrition via a central venous catheter for at least 12 months. 105.08 Growth failure due to any digestive disorder (see 105.00F ), documented by A and B: A. Chronic nutritional deficiency present on two evaluations within a consecutive 12-month period and at least 60 days apart documented by 1 or 2: 1. Anemia with hemoglobin less than 10.0 g/dL; or 2. Serum albumin of 3.0 g/dL or less AND B. Growth failure as required in 1 or 2: 1. For children from birth to attainment of age 2, three weight-for-length measurements that are: a. Within a consecutive 12-month period; and b. At least 60 days apart; and c. Less than the third percentile values in Table I or Table II; or Third Percentile Values for Weight-for Length Length\n                                         \n                                        (Centimeters) Weight\n                                         \n                                        (kilograms) Table I –  Males Birth to Attainment of Age 2 Table II –  Females Birth to Attainment of Age 2 45.0 1.597 1.613 45.5 1.703 1.724 46.5 1.919 1.946 47.5 2.139 2.171 48.5 2.364 2.397 49.5 2.592 2.624 50.5 2.824 2.852 51.5 3.058 3.081 52.5 3.294 3.310 53.5 3.532 3.538 54.5 3.771 3.767 55.5 4.010 3.994 56.5 4.250 4.220 57.5 4.489 4.445 58.5 4.728 4.669 59.5 4.966 4.892 60.5 5.203 5.113 61.5 5.438 5.333 62.5 5.671 5.552 63.5 5.903 5.769 64.5 6.132 5.985 65.5 6.359 6.200 66.5 6.584 6.413 67.5 6.807 6.625 68.5 7.027 6.836 69.5 7.245 7.046 70.5 7.461 7.254 71.5 7.674 7.461 72.5 7.885 7.667 73.5 8.094 7.871 74.5 8.301 8.075 75.5 8.507 8.277 76.5 8.710 8.479 77.5 8.913 8.679 78.5 9.113 8.879 79.5 9.313 9.078 80.5 9.512 9.277 81.5 9.710 9.476 82.5 9.907 9.674 83.5 10.104 9.872 84.5 10.301 10.071 85.5 10.499 10.270 86.5 10.696 10.469 87.5 10.895 10.670 88.5 11.095 10.871 89.5 11.296 11.074 90.5 11.498 11.278 91.5 11.703 11.484 92.5 11.910 11.691 93.5 12.119 11.901 94.5 12.331 12.112 95.5 12.546 12.326 96.5 12.764 12.541 97.5 12.987 12.760 98.5 13.213 12.981 99.5 13.443 13.205 100.5 13.678 13.431 101.5 13.918 13.661 102.5 14.163 13.895 103.5 14.413 14.132 2. For children age 2 to attainment of age 18 , three BMI-for-age measurements that are: a. Within a consecutive 12-month period; and b. At least 60 days apart; and c. Less than the third percentile value in Table III or Table IV. Third Percentile Values for BMI-for-Age Table III –  Males Age 2 to Attainment of Age 18 Table IV –  Females Age 2 to Attainment of Age 18 Age (yrs. and mos.) BMI Age (yrs. and mos.) BMI 2.0 to 2.1 14.5 2.0 to 2.2 14.1 2.2 to 2.4 14.4 2.3 to 2.6 14.0 2.5 to 2.7 14.3 2.7 to 2.10 13.9 2.8 to 2.11 14.2 2.11 to 3.2 13.8 3.0 to 3.2 14.1 3.3 to 3.6 13.7 3.3 to 3.6 14.0 3.7 to 3.11 13.6 3.7 to 3.11 13.9 4.0 to 4.4 13.5 4.0 to 4.5 13.8 4.5 to 4.11 13.4 4.6 to 5.0 13.7 5.0 to 5.9 13.3 5.1 to 6.0 13.6 5.10 to 7.6 13.2 6.1 to 7.6 13.5 7.7 to 8.4 13.3 7.7 to 8.6 13.6 8.5 to 8.10 13.4 8.7 to 9.1 13.7 8.11 to 9.3 13.5 9.2 to 9.6 13.8 9.4 to 9.8 13.6 9.7 to 9.11 13.9 9.9 to 10.0 13.7 10.0 to 10.3 14.0 10.1 to 10.4 13.8 10.4 to 10.7 14.1 10.5 to 10.7 13.9 10.8 to 10.10 14.2 10.8 to 10.10 14.0 10.11 to 11.2 14.3 10.11 to 11.2 14.1 11.3 to 11.5 14.4 11.3 to 11.5 14.2 11.6 to 11.8 14.5 11.6 to 11.7 14.3 11.9 to 11.11 14.6 11.8 to 11.10 14.4 12.0 to 12.1 14.7 11.11 to 12.1 14.5 12.2 to 12.4 14.8 12.2 to 12.4 14.6 12.5 to 12.7 14.9 12.5 to 12.6 14.7 12.8 to 12.9 15.0 12.7 to 12.9 14.8 12.10 to 13.0 15.1 12.10 to 12.11 14.9 13.1 to 13.2 15.2 13.0 to 13.2 15.0 13.3 to 13.4 15.3 13.3 to 13.4 15.1 13.5 to 13.7 15.4 13.5 to 13.7 15.2 13.8 to 13.9 15.5 13.8 to 13.9 15.3 13.10 to 13.11 15.6 13.10 to 14.0 15.4 14.0 to 14.1 15.7 14.1 to 14.2 15.5 14.2 to 14.4 15.8 14.3 to 14.5 15.6 14.5 to 14.6 15.9 14.6 to 14.7 15.7 14.7 to 14.8 16.0 14.8 to 14.9 15.8 14.9 to 14.10 16.1 14.10 to 15.0 15.9 14.11 to 15.0 16.2 15.1 to 15.2 16.0 15.1 to 15.3 16.3 15.3 to 15.5 16.1 15.4 to 15.5 16.4 15.6 to 15.7 16.2 15.6 to 15.7 16.5 15.8 to 15.10 16.3 15.8 to 15.9 16.6 15.11 to 16.0 16.4 15.10 to 15.11 16.7 16.1 to 16.3 16.5 16.0 to 16.1 16.8 16.4 to 16.6 16.6 16.2 to 16.3 16.9 16.7 to 16.9 16.7 16.4 to 16.5 17.0 16.10 to 17.0 16.8 16.6 to 16.8 17.1 17.1 to 17.3 16.9 16.9 to 16.10 17.2 17.4 to 17.7 17.0 16.11 to 17.0 17.3 17.8 to 17.11 17.1 17.1 to 17.2 17.4 17.3 to 17.5 17.5 17.6 to 17.7 17.6 17.8 to 17.9 17.7 17.10 to 17.11 17.8 Back to Top 105.09 Liver transplantation (see 105.00G ). Consider under a disability for 1 year from the date of the transplant; after that, evaluate the residual impairment(s). 105.10 Need for supplemental daily enteral feeding via a gastrostomy, duodenostomy, or jejunostomy (see 105.00H ) due to any cause, for children who have not attained age 3; after that, evaluate the residual impairment(s). 105.11 Small intestine transplantation (see 105.00G ). Consider under a disability for 1 year from the date of the transplant; after that, evaluate the residual impairment(s). 105.12 Pancreas transplantation (see 105.00G ). Consider under a disability for 1 year from the date of the transplant; after that, evaluate the residual impairment(s). Back to Top",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security105.00 Digestive Disorders - Childhood"
      }
    ],
    "tables": [
      [
        [
          "Third Percentile Values for Weight-for Length"
        ],
        [
          "Length\n                                         \n                                        (Centimeters)",
          "Weight\n                                         \n                                        (kilograms)"
        ],
        [
          "Table I –  Males Birth to Attainment of Age 2",
          "Table II –  Females Birth to Attainment of Age 2"
        ],
        [
          "45.0",
          "1.597",
          "1.613"
        ],
        [
          "45.5",
          "1.703",
          "1.724"
        ],
        [
          "46.5",
          "1.919",
          "1.946"
        ],
        [
          "47.5",
          "2.139",
          "2.171"
        ],
        [
          "48.5",
          "2.364",
          "2.397"
        ],
        [
          "49.5",
          "2.592",
          "2.624"
        ],
        [
          "50.5",
          "2.824",
          "2.852"
        ],
        [
          "51.5",
          "3.058",
          "3.081"
        ],
        [
          "52.5",
          "3.294",
          "3.310"
        ],
        [
          "53.5",
          "3.532",
          "3.538"
        ],
        [
          "54.5",
          "3.771",
          "3.767"
        ],
        [
          "55.5",
          "4.010",
          "3.994"
        ],
        [
          "56.5",
          "4.250",
          "4.220"
        ],
        [
          "57.5",
          "4.489",
          "4.445"
        ],
        [
          "58.5",
          "4.728",
          "4.669"
        ],
        [
          "59.5",
          "4.966",
          "4.892"
        ],
        [
          "60.5",
          "5.203",
          "5.113"
        ],
        [
          "61.5",
          "5.438",
          "5.333"
        ],
        [
          "62.5",
          "5.671",
          "5.552"
        ],
        [
          "63.5",
          "5.903",
          "5.769"
        ],
        [
          "64.5",
          "6.132",
          "5.985"
        ],
        [
          "65.5",
          "6.359",
          "6.200"
        ],
        [
          "66.5",
          "6.584",
          "6.413"
        ],
        [
          "67.5",
          "6.807",
          "6.625"
        ],
        [
          "68.5",
          "7.027",
          "6.836"
        ],
        [
          "69.5",
          "7.245",
          "7.046"
        ],
        [
          "70.5",
          "7.461",
          "7.254"
        ],
        [
          "71.5",
          "7.674",
          "7.461"
        ],
        [
          "72.5",
          "7.885",
          "7.667"
        ],
        [
          "73.5",
          "8.094",
          "7.871"
        ],
        [
          "74.5",
          "8.301",
          "8.075"
        ],
        [
          "75.5",
          "8.507",
          "8.277"
        ],
        [
          "76.5",
          "8.710",
          "8.479"
        ],
        [
          "77.5",
          "8.913",
          "8.679"
        ],
        [
          "78.5",
          "9.113",
          "8.879"
        ],
        [
          "79.5",
          "9.313",
          "9.078"
        ],
        [
          "80.5",
          "9.512",
          "9.277"
        ],
        [
          "81.5",
          "9.710",
          "9.476"
        ],
        [
          "82.5",
          "9.907",
          "9.674"
        ],
        [
          "83.5",
          "10.104",
          "9.872"
        ],
        [
          "84.5",
          "10.301",
          "10.071"
        ],
        [
          "85.5",
          "10.499",
          "10.270"
        ],
        [
          "86.5",
          "10.696",
          "10.469"
        ],
        [
          "87.5",
          "10.895",
          "10.670"
        ],
        [
          "88.5",
          "11.095",
          "10.871"
        ],
        [
          "89.5",
          "11.296",
          "11.074"
        ],
        [
          "90.5",
          "11.498",
          "11.278"
        ],
        [
          "91.5",
          "11.703",
          "11.484"
        ],
        [
          "92.5",
          "11.910",
          "11.691"
        ],
        [
          "93.5",
          "12.119",
          "11.901"
        ],
        [
          "94.5",
          "12.331",
          "12.112"
        ],
        [
          "95.5",
          "12.546",
          "12.326"
        ],
        [
          "96.5",
          "12.764",
          "12.541"
        ],
        [
          "97.5",
          "12.987",
          "12.760"
        ],
        [
          "98.5",
          "13.213",
          "12.981"
        ],
        [
          "99.5",
          "13.443",
          "13.205"
        ],
        [
          "100.5",
          "13.678",
          "13.431"
        ],
        [
          "101.5",
          "13.918",
          "13.661"
        ],
        [
          "102.5",
          "14.163",
          "13.895"
        ],
        [
          "103.5",
          "14.413",
          "14.132"
        ]
      ],
      [
        [
          "Third Percentile Values for BMI-for-Age"
        ],
        [
          "Table III –  Males Age 2 to Attainment of Age 18",
          "Table IV –  Females Age 2 to Attainment of Age 18"
        ],
        [
          "Age(yrs. and mos.)",
          "BMI",
          "Age(yrs. and mos.)",
          "BMI"
        ],
        [
          "2.0 to 2.1",
          "14.5",
          "2.0 to 2.2",
          "14.1"
        ],
        [
          "2.2 to 2.4",
          "14.4",
          "2.3 to 2.6",
          "14.0"
        ],
        [
          "2.5 to 2.7",
          "14.3",
          "2.7 to 2.10",
          "13.9"
        ],
        [
          "2.8 to 2.11",
          "14.2",
          "2.11 to 3.2",
          "13.8"
        ],
        [
          "3.0 to 3.2",
          "14.1",
          "3.3 to 3.6",
          "13.7"
        ],
        [
          "3.3 to 3.6",
          "14.0",
          "3.7 to 3.11",
          "13.6"
        ],
        [
          "3.7 to 3.11",
          "13.9",
          "4.0 to 4.4",
          "13.5"
        ],
        [
          "4.0 to 4.5",
          "13.8",
          "4.5 to 4.11",
          "13.4"
        ],
        [
          "4.6 to 5.0",
          "13.7",
          "5.0 to 5.9",
          "13.3"
        ],
        [
          "5.1 to 6.0",
          "13.6",
          "5.10 to 7.6",
          "13.2"
        ],
        [
          "6.1 to 7.6",
          "13.5",
          "7.7 to 8.4",
          "13.3"
        ],
        [
          "7.7 to 8.6",
          "13.6",
          "8.5 to 8.10",
          "13.4"
        ],
        [
          "8.7 to 9.1",
          "13.7",
          "8.11 to 9.3",
          "13.5"
        ],
        [
          "9.2 to 9.6",
          "13.8",
          "9.4 to 9.8",
          "13.6"
        ],
        [
          "9.7 to 9.11",
          "13.9",
          "9.9 to 10.0",
          "13.7"
        ],
        [
          "10.0 to 10.3",
          "14.0",
          "10.1 to 10.4",
          "13.8"
        ],
        [
          "10.4 to 10.7",
          "14.1",
          "10.5 to 10.7",
          "13.9"
        ],
        [
          "10.8 to 10.10",
          "14.2",
          "10.8 to 10.10",
          "14.0"
        ],
        [
          "10.11 to 11.2",
          "14.3",
          "10.11 to 11.2",
          "14.1"
        ],
        [
          "11.3 to 11.5",
          "14.4",
          "11.3 to 11.5",
          "14.2"
        ],
        [
          "11.6 to 11.8",
          "14.5",
          "11.6 to 11.7",
          "14.3"
        ],
        [
          "11.9 to 11.11",
          "14.6",
          "11.8 to 11.10",
          "14.4"
        ],
        [
          "12.0 to 12.1",
          "14.7",
          "11.11 to 12.1",
          "14.5"
        ],
        [
          "12.2 to 12.4",
          "14.8",
          "12.2 to 12.4",
          "14.6"
        ],
        [
          "12.5 to 12.7",
          "14.9",
          "12.5 to 12.6",
          "14.7"
        ],
        [
          "12.8 to 12.9",
          "15.0",
          "12.7 to 12.9",
          "14.8"
        ],
        [
          "12.10 to 13.0",
          "15.1",
          "12.10 to 12.11",
          "14.9"
        ],
        [
          "13.1 to 13.2",
          "15.2",
          "13.0 to 13.2",
          "15.0"
        ],
        [
          "13.3 to 13.4",
          "15.3",
          "13.3 to 13.4",
          "15.1"
        ],
        [
          "13.5 to 13.7",
          "15.4",
          "13.5 to 13.7",
          "15.2"
        ],
        [
          "13.8 to 13.9",
          "15.5",
          "13.8 to 13.9",
          "15.3"
        ],
        [
          "13.10 to 13.11",
          "15.6",
          "13.10 to 14.0",
          "15.4"
        ],
        [
          "14.0 to 14.1",
          "15.7",
          "14.1 to 14.2",
          "15.5"
        ],
        [
          "14.2 to 14.4",
          "15.8",
          "14.3 to 14.5",
          "15.6"
        ],
        [
          "14.5 to 14.6",
          "15.9",
          "14.6 to 14.7",
          "15.7"
        ],
        [
          "14.7 to 14.8",
          "16.0",
          "14.8 to 14.9",
          "15.8"
        ],
        [
          "14.9 to 14.10",
          "16.1",
          "14.10 to 15.0",
          "15.9"
        ],
        [
          "14.11 to 15.0",
          "16.2",
          "15.1 to 15.2",
          "16.0"
        ],
        [
          "15.1 to 15.3",
          "16.3",
          "15.3 to 15.5",
          "16.1"
        ],
        [
          "15.4 to 15.5",
          "16.4",
          "15.6 to 15.7",
          "16.2"
        ],
        [
          "15.6 to 15.7",
          "16.5",
          "15.8 to 15.10",
          "16.3"
        ],
        [
          "15.8 to 15.9",
          "16.6",
          "15.11 to 16.0",
          "16.4"
        ],
        [
          "15.10 to 15.11",
          "16.7",
          "16.1 to 16.3",
          "16.5"
        ],
        [
          "16.0 to 16.1",
          "16.8",
          "16.4 to 16.6",
          "16.6"
        ],
        [
          "16.2 to 16.3",
          "16.9",
          "16.7 to 16.9",
          "16.7"
        ],
        [
          "16.4 to 16.5",
          "17.0",
          "16.10 to 17.0",
          "16.8"
        ],
        [
          "16.6 to 16.8",
          "17.1",
          "17.1 to 17.3",
          "16.9"
        ],
        [
          "16.9 to 16.10",
          "17.2",
          "17.4 to 17.7",
          "17.0"
        ],
        [
          "16.11 to 17.0",
          "17.3",
          "17.8 to 17.11",
          "17.1"
        ],
        [
          "17.1 to 17.2",
          "17.4",
          "",
          ""
        ],
        [
          "17.3 to 17.5",
          "17.5",
          "",
          ""
        ],
        [
          "17.6 to 17.7",
          "17.6",
          "",
          ""
        ],
        [
          "17.8 to 17.9",
          "17.7",
          "",
          ""
        ],
        [
          "17.10 to 17.11",
          "17.8",
          "",
          ""
        ]
      ]
    ],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_01",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_02",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_06",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_07",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_09",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_10",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_11",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_12",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_06",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_07",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_02",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_09",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_10",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_11",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_12",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05A",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_02",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_02",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05A",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05B",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05C",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05C",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05D",
      "https://www.ssa.gov/disability/professionals/bluebook/106.00-Genitourinary-Childhood.htm#106_00",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05E",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05E1",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05E2",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05F",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05F2",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05F",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05F",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05G",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05G",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05G2",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05G1",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05G1",
      "https://www.ssa.gov/disability/professionals/bluebook/impairments_digestive_cld.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/impairments_digestive_cld-p.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05H",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05H",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_09",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_05H",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_06",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_06B5",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_06B5",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_06",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_07",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_07",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08A",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B",
      "https://www.ssa.gov/disability/professionals/bluebook/106.00-Genitourinary-Childhood.htm#106_00",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_09",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_11",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_12",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_09",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_11",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_12",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_10",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_10",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_06",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_10",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0935.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0994a.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00C",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00C2a",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00C2b",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00C2c",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00C2d",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00C2e",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00C2f",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/impairments_digestive_cld.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/impairments_digestive_cld-p.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00C4",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00D",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_10",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00E",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00G",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00H",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00G",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00G",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm"
    ],
    "html_file": "ssa_bluebook_data/html/801ff91a68009bf03de2c862fb6f9d22.html",
    "fetched_at": 1762482817.7548163
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C1",
    "url_hash": "8c901de9df8ae4044b11f56ae48f00f2",
    "title": "100.00 Low Birth Weight and Failure to Thrive - Childhood | Disability | SSA",
    "text_content": "100.00 Low Birth Weight and Failure to Thrive - Childhood | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Listing of Impairments - Child Listings (Part B) 100.00 Low Birth Weight and Failure to Thrive - Childhood Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security 100.00 Low Birth Weight and Failure to Thrive\n - Childhood Section 100.01 Category of Impairments, Low Birth Weight and Failure to Thrive 100.04 Low birth weight in infants from birth to attainment of age 1 100.05 Failure to thrive in children from birth to attainment of age 3 100.00 Low  Birth Weight and Failure to Thrive A. What conditions do we evaluate under these listings? We evaluate low birth weight (LBW) in infants from birth to attainment of age 1 and failure to thrive (FTT) in infants and toddlers from birth to attainment of age 3. B. How do we evaluate disability based on LBW under  100.04? In 100.04A and 100.04B ,\n    we use an infant’s birth weight as documented by an original or certified copy of the infant’s birth certificate or by a medical record signed by a physician. Birth weight means the first weight  recorded after birth.\n    In 100.04B , gestational age is the infant’s age based on the date of conception as recorded in the medical record.\n    If the infant’s impairment meets the requirements for listing 100.04A or 100.04B , \n      we will follow the rules in § 416.990(b)(11) of this chapter. C. How do we evaluate disability under 100.05 ? 1. General. We establish FTT with or without a known cause when we have documentation of an infant’s or toddler’s growth failure and developmental delay from an acceptable medical source(s) \n        as defined in § 416.913(a) of this chapter.\n    We require documentation of growth measurements in 100.05A and developmental delay in 100.05B or 100.05C within the same consecutive 12-month period.\n    The dates of developmental testing and reports may be different from  the dates of the growth measurements. After the attainment of age 3, we evaluate growth failure under the affected body system(s). 2. Growth failure. Under 100.05A ,\n    we use the appropriate table(s) under 105.08B in the digestive system to determine whether a child’s growth is less than the third percentile.\n    The child does not need to have a digestive disorder for the purposes of 100.05 . a.  For children from birth to attainment of age 2, we use the weight-for-length table corresponding to the child’s gender (Table I or Table II). b.  For children age 2 to the attainment of age 3, we use the body mass index (BMI)-for-age table corresponding to the child’s gender (Table III or Table IV). c.  BMI is the ratio of a child’s weight to the square of his or her height.\n          We calculate BMI using the formulas in the digestive disorders body system ( 105.00 ). d. Growth measurements. The weight-for-length measurements for children from birth to attainment of age 2 and BMI-for-age measurements in children age 2 to attainment of age 3 that are required for this listing must be obtained  within a 12-month period and at least 60 days apart. If a child attains 2  during the evaluation period, additional measurements are not needed. Any  measurements taken before the child attains age 2 can be used to evaluate the  impairment under the appropriate listing for the child’s age. If the child  attains age 3 during the evaluation period, the measurements can be used to  evaluate the impairment in the affected body system. 3. Developmental Delay. a.  Under 100.05B and C , \n      we use reports from acceptable medical sources to  establish delay in a child’s development. b.  Under 100.05B , \n      we document the severity of developmental delay with results from a standardized developmental assessment, \n      which compares a child’s level of development to the level typically expected for his or her chronological age.  \n      If the child was born prematurely, we may use the corrected chronological age (CCA) for comparison. \n      (See § 416.924b(b) of this chapter.)\n    CCA is the chronological age adjusted by a period of gestational prematurity. CCA=  (chronological age) – (number of weeks premature).\n    Acceptable medical sources or early intervention specialists, physical or occupational therapists, and other sources may conduct standardized developmental assessments and developmental screenings.\n    The results of these tests and screening must be accompanied by a statement or records from an acceptable medical source who established the child has a developmental delay. c. Under 100.05C , \n      when there are no results from a standardized developmental assessment in the case record, \n      we need narrative developmental reports from the child’s medical sources in sufficient detail to assess the severity of his or her developmental delay. \n      A narrative developmental report is based on clinical observations, progress notes, and well-baby check-ups. To meet the requirements for 100.05C ,\n    the report must include: the child’s developmental history; examination findings (with abnormal findings noted on repeated examinations); \n      and an overall assessment of the child’s development (that is, more than one or two  isolated skills) by the medical source. \n      Some narrative developmental reports may include results from developmental screening tests, which can identify a child who is not developing or achieving skills within expected timeframes. \n      Although medical sources may refer to screening test results as supporting evidence in the narrative developmental report, \n      screening test results alone cannot establish a diagnosis or the severity of developmental delay. D. How do we evaluate disorders that do not meet one  of our listings? 1.  We may find infants disabled due to other disorders when their birth weights are greater than 1200 grams but less than 2000 grams and their \n      weight and gestational age do not meet listing 100.04 . The most common disorders of prematurity and LBW include retinopathy of prematurity (ROP),\n    chronic lung disease of infancy (CLD, previously known as bronchopulmonary dysplasia, or  BPD), intraventricular hemorrhage (IVH), necrotizing enterocolitis (NEC),\n    and periventricular leukomalacia (PVL). Other disorders include poor nutrition and growth failure, hearing disorders, seizure disorders, cerebral palsy, and developmental disorders.\n    We evaluate these disorders under the affected body systems. 2.  We may evaluate infants and toddlers with growth failure that is associated  with a known medical disorder under the body system of that medical disorder,  for example, the respiratory or digestive body systems. 3. If an infant or toddler has a severe medical  determinable impairment(s) that does not meet the criteria of any listing, \n      we must also consider whether the child has an impairment(s) that medically equals a listing \n      (see § 416.926 of this chapter).\n    If the child’s impairment(s) does not meet or medically equal a listing, we will determine whether the child’s  impairment(s) functionally equals the listings\n    (see § 416.926a of this chapter)\n    considering the factors in § 416.924a of this chapter.\n    We use the rules in § 416.994a of this chapter when we decide whether a child continues to be disabled. 100.01 Category of Impairments, Low Birth Weight and Failure to Thrive 100.04 Low birth weight in infants from birth to attainment of age 1. A. Birth weight (see 100.00B ) of less than 1200 grams. OR B. The following gestational age and birth weight: Gestational Age (in weeks) Birth Weight 37-40 2000 grams or less 36 1875 grams or less 35 1700 grams or less 34 1500 grams or less 33 1325 grams or less 32 1250 grams or less 100.05 Failure to thrive in children from birth to attainment of age 3 (see 100.00C ), documented by A and B, or A and C. A.  Growth failure as required in 1 or 2: 1. For children from birth to attainment of age 2, three weight-for-length measurements that are: a.  Within a consecutive 12-month period; and b.  At least 60 days apart; and c.  Less than the third percentile on the appropriate weight-for-length table under 105.08B1 ; or 2. For children age 2 to attainment of age 3, three BMI-for-age measurements that are: a.  Within a consecutive 12-month period; and b.  At least 60 days apart; and c.  Less than the third percentile on the appropriate BMI-for-age table under 105.08B2 . AND B.  Developmental delay (see 100.00C1 and C3 ), \n      established by an acceptable medical source and documented by findings from one current report of a standardized developmental assessment (see 100.00C3b ) that: 1.  Shows development not more than two-thirds of the level typically expected for the child’s age; or 2.  Results in a valid score that is at least two standard deviations below the mean. OR C.  Developmental delay (see 100.00C3 ), \n      established by an acceptable medical source and documented by findings from two narrative developmental reports (see 100.00C3c ) that: 1.  Are dated at least 120 days apart (see 100.00C1 ); and 2. Indicate current development not more than two-thirds of the level typically expected for the child’s age. Back to Top",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security100.00 Low Birth Weight and Failure to Thrive\n - Childhood"
      }
    ],
    "tables": [
      [
        [
          "Gestational Age (in weeks)",
          "Birth Weight"
        ],
        [
          "37-40",
          "2000 grams or less"
        ],
        [
          "36",
          "1875 grams or less"
        ],
        [
          "35",
          "1700 grams or less"
        ],
        [
          "34",
          "1500 grams or less"
        ],
        [
          "33",
          "1325 grams or less"
        ],
        [
          "32",
          "1250 grams or less"
        ]
      ]
    ],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_01",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04A",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04B",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04B",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04A",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04B",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0990.htm#b11",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0913.htm#a",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05A",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05B",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05C",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05A",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05B",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05C",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05B",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0924b.htm#b",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05C",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_05C",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_04",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0924a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0994a.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00B",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B1",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B2",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C1",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C3b",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C3c",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00C1",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm"
    ],
    "html_file": "ssa_bluebook_data/html/8c901de9df8ae4044b11f56ae48f00f2.html",
    "fetched_at": 1762482822.0598474
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm",
    "url_hash": "fbf7c5b1b3a9701ebd007bd916b11b7f",
    "title": "101.00 Musculoskeletal Disorders - Childhood | Disability | SSA",
    "text_content": "101.00 Musculoskeletal Disorders - Childhood | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Listing of Impairments - Child Listings (Part B) 101.00 Musculoskeletal Disorders - Childhood Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security 101.00 Musculoskeletal Disorders - Childhood Section 101.01 Category of Impairments, Musculoskeletal 101.15 Disorders of the skeletal spine resulting in compromise of a nerve root(s) 101.16 Lumbar spinal stenosis resulting in compromise of the cauda equina 101.17 Reconstructive surgery or surgical arthrodesis of a major weight-bearing joint 101.18 Abnormality of a major joint(s) in any extremity 101.19 Pathologic fractures due to any cause 101.20 Amputation due to any cause 101.21 Soft tissue injury or abnormality under continuing surgical management 101.22 Non-healing or complex fracture of the femur, tibia, pelvis, or one or more of the talocrural bones 101.23 Non-healing or complex fracture of an upper extremity 101.24 Musculoskeletal disorders of infants and toddlers, from birth to attainment of age 3, with developmental motor delay 101.00 Musculoskeletal Disorders A. Which musculoskeletal disorders do we evaluate under these listings? 1. We evaluate disorders of the skeletal spine (vertebral column) or of the upper or lower extremities that affect musculoskeletal \n                            functioning under these listings. We use the term “skeletal” when we are referring to the structure of the bony skeleton. \n                            The skeletal spine refers to the bony structures, ligaments, and discs making up the spine. \n                            We refer to the skeletal spine in some musculoskeletal listings to differentiate it from the neurological spine (see 101.00B1 ).\n                            Musculoskeletal disorders may be congenital or acquired, and may include deformities, amputations, or other abnormalities.\n                            These disorders may involve the bones or major joints; or the tendons, ligaments, muscles, or other soft tissues. 2. We evaluate soft tissue injuries (including burns) or abnormalities that are under continuing surgical management \n                            (see 101.00P1 ). \n                            The injuries or abnormalities may affect any part of the body, including the face and skull. 3. We evaluate curvatures of the skeletal spine that affect musculoskeletal functioning under 101.15 .\n                            If a curvature of the skeletal spine is under continuing surgical management (see 101.00P1 ),\n                            we will evaluate it under 101.21 using our rules for determining medical equivalence.\n                            See § 416.926 of this chapter. B. Which related disorders do we evaluate under other listings? 1. We evaluate a disorder or injury of the skeletal spine that results in damage to, and neurological dysfunction of, \n                            the spinal cord and its associated nerves (for example, paraplegia or quadriplegia) under the listings in 111.00 . 2. We evaluate inflammatory arthritis (for example, rheumatoid arthritis) under the listings in 114.00 . 3. We evaluate curvatures of the skeletal spine that interfere with your ability to breathe under the listings in 103.00 , impair myocardial function under the listings in 104.00 , or result in social withdrawal or depression under the listings in 112.00 . 4. We evaluate non-healing or pathological fractures due to cancer, whether it is a primary site or metastases, under the listings in 113.00 . 5. We evaluate the leg pain associated with peripheral vascular claudication under the listings in 104.00 . 6. We evaluate burns that do not require continuing surgical management under the listings in 108.00 . Back to Top C. What evidence do we need to evaluate your musculoskeletal disorder? 1. General. We need objective medical evidence from an acceptable medical source to establish that you have a\n                            medically determinable musculoskeletal disorder.\n                            We also need evidence from both medical and nonmedical sources,\n                            who can describe how you function, to assess the severity and duration of your musculoskeletal disorder.\n                            We will determine the extent and kinds of evidence we need from medical and nonmedical sources based on the individual facts about your disorder.\n                            For our basic rules on evidence, see §§ 416.912 , 416.913 , and 416.920b of this chapter.\n                            For our rules on evidence about your symptoms,\n                            see § 416.929 of this chapter. 2. Physical examination report(s). In the report(s) of your physical examination, \n                            we require a medical source's detailed description of the orthopedic, neurologic, \n                            or other objective clinical findings appropriate to your specific musculoskeletal disorder from his or her direct observations during your physical examination. \n                            We will not accept a report of your statements about your symptoms and limitations in place of the medical source’s report of objective clinical findings. \n                            We will not use findings on imaging or other diagnostic tests (see 101.00C3 ) as a substitute for findings on physical examination. a. When the medical source reports that a clinical test sign(s) is positive, unless we have evidence to the contrary, we will assume that he or she performed the test properly and accept the medical source’s interpretation of the test. For example, we will assume a straight-leg raising test was conducted properly (that is, in sitting and supine positions), even if the medical source does not specify the positions in which the test was performed. b. If you use an assistive device (see 101.00C6 ), \n                            the report must support the medical need for the device. c. If your musculoskeletal disorder causes a reduction in muscle strength, the report must document measurement of the strength of the muscle(s) in question. The measurement should be based on a muscle strength grading system that is considered medically acceptable based on your age and impairments. For example, a grading system of 0 to 5, with 0 indicating complete loss of strength and 5 indicating maximum strength or equivalent medically acceptable scale (see Table 1). Reduction in muscle strength is demonstrated by evidence that your muscle strength is less than active range of motion (ROM) against gravity with maximum resistance. If the reduction in muscle strength involves one or both of your hands, the report must also document measurements of grip and pinch strength. Table 1 - Grading System of Muscle Function Grade Function of the Muscle 0 None No visible or palpable contraction. 1 Trace Visible or palpable contraction with no motion. 2 Poor Active ROM with gravity eliminated. 3 Fair Active ROM against gravity only, without resistance. 4 Good Active ROM against gravity, moderate resistance. 5 Normal Active ROM against gravity, maximum resistance. 3. Imaging and other diagnostic tests. a. Imaging refers to medical imaging techniques, such as x-ray, computed tomography (CT), magnetic resonance imaging (MRI), and radionuclide scanning. For the purpose of these listings, the imaging must be consistent with the prevailing state of medical knowledge and clinical practice as the proper technique to support the evaluation of the disorder. b. Findings on imaging must have lasted, or be expected to last, for a continuous period of at least 12 months. c. Imaging and other diagnostic tests can provide evidence of physical abnormalities; however, these abnormalities may correlate poorly with your symptoms, including pain, or with your musculoskeletal functioning. Accordingly, we will not use findings on imaging or other diagnostic tests as a substitute for findings on physical examination about your ability to function, nor can we infer severity or functional limitations based solely on such tests. d. For our rules on purchasing imaging and other diagnostic tests,\n                            see §§ 416.919k and 416.919m of this chapter. 4. Operative reports. If you have had a surgical procedure, we need a copy of the operative report, including details of the findings at surgery and information about any medical complications that may have occurred. If we do not have the operative report, we need confirmatory evidence of the surgical procedure from a medical source (for example, detailed follow-up reports or notations in the medical records concerning the surgical procedure in your medical history). 5. Effects of treatment. a. General. Treatments for musculoskeletal disorders may have beneficial or adverse effects, and responses to treatment vary from person to person. We will evaluate all of the effects of treatment (including surgical treatment, medications, and therapy) on the symptoms, signs, and laboratory findings of your musculoskeletal disorder, and on your musculoskeletal functioning. b. Response to treatment. To evaluate your musculoskeletal functioning in response to treatment, we need the following: A description, including the frequency of the administration, of your medications; the type and frequency of therapy you receive; and a description of your response to treatment and any complications you experience related to your musculoskeletal disorder. The effects of treatment may be temporary or long-term. We need information over a sufficient period to determine the effects of treatment on your current musculoskeletal functioning and permit reasonable projections about your future functioning. We will determine the amount of time that constitutes a sufficient period in consultation with a medical consultant on a case by case basis. In some cases, we will need additional evidence to make an assessment about your response to treatment. Your musculoskeletal disorder may meet or medically equal one of these listings regardless of whether you were prescribed opioid medication, or whether you were prescribed opioid medication and did not follow this prescribed treatment. 6. Assistive devices. a. General. An assistive device, for the purposes of these listings, is any device that you use to improve your stability, dexterity,\n                            or mobility. An assistive device can be worn (see 101.00C6b and 101.00C6c ),\n                            hand-held (see 101.00C6d ),\n                            or used in a seated position (see 101.00C6e ).\n                            When we use the phrase “documented medical need,” we mean that there is evidence from a medical source that supports your medical need for an assistive device\n                            (see 101.00C2b ) for a continuous period of at least 12 months\n                            (see 101.00c2a ). This evidence must describe any limitation(s) in your upper or lower extremity functioning and the circumstances for which you need to use the assistive device.\n                            We do not require that you have a specific prescription for the assistive device. b. Prosthesis(es). A prosthesis is a wearable device, such as an artificial limb, that takes the place of an absent body part.\n                            If you have a prosthesis(es), we need evidence from a medical source documenting your ability to walk,\n                            or perform fine and gross movements (see 101.00E4 ),\n                            with the prosthesis(es) in place. When amputation(s) involves one or both lower extremities,\n                            it is not necessary for the medical source to evaluate your ability to walk without the prosthesis(es) in place.\n                            If you cannot use your prosthesis(es) due to complications affecting your residual limb(s),\n                            we need evidence from a medical source documenting the condition of your residual limb(s) and the medical basis for your inability to use the device(s). c. Orthosis(es). An orthosis is a wearable device, such as a brace,\n                            that prevents or corrects a dysfunction or deformity by aligning or supporting the affected body part.\n                            If you have an orthosis(es), we need evidence from a medical source documenting your ability to walk,\n                            or perform fine and gross movements (see 101.00E4 ),\n                            with the orthosis(es) in place. If you cannot use your orthosis(es),\n                            we need evidence from a medical source documenting the medical basis for your inability to use the device(s). d. Hand-held assistive devices. Hand-held assistive devices include walkers, canes, or crutches,\n                            which you hold onto with your hand(s) to support or aid you in walking. When you use a one-handed, hand-held assistive device\n                            (such as a cane) with one upper extremity to walk and you cannot use your other upper extremity for fine or gross movements\n                            (see 101.00E4 ), the need for the assistive device limits the use of both upper extremities. If you use a hand-held assistive device,\n                            we need evidence from a medical source describing how you walk with the device. e. Wheeled and seated mobility devices. Wheeled and seated mobility devices are assistive devices that you use in a seated position,\n                            such as manual wheelchairs, motorized wheelchairs, rollators, and power operated vehicles.\n                            If you use a wheeled and seated mobility device,\n                            we need evidence from a medical source describing the type of wheeled and seated mobility device that you use and how you use the assistive device,\n                            including any customizations or modifications to the assistive device itself or for your use of the assistive device.\n                            For example, if you use a wheelchair that typically requires the use of both hands but has been customized for your use with one hand,\n                            then we will evaluate your use of the assistive device using the criteria in 101.00E3b and not 101.00E3a . (i) Wheeled and seated mobility devices involving the use of both hands. Some wheeled and seated mobility devices involve the use of both hands to use the assistive device (for example, most manual wheelchairs). \n                            If you use a wheeled and seated mobility device that involves the use of both hands, then the need for the assistive device limits the use of both upper extremities. (ii) Wheeled and seated devices involving the use of one hand. Some wheeled and seated mobility devices involve the use of one hand to use the assistive device (for example, most motorized wheelchairs).\n                            If you use a wheeled and seated mobility device that involves the use of one upper extremity and you cannot use your other upper extremity for fine or gross movements\n                            (see 101.00E4 ), then the need for the assistive device limits the use of both upper extremities. 7. Longitudinal evidence. a. The term pandemic period as used in 101.00C7c means the period beginning on April 2, 2021, and ending on May 11, 2025. The term post-pandemic evaluation period as used in 101.00C7c means the period beginning on May 12, 2025, and ending on May 11, 2029. b. We generally need a longitudinal medical record to assess the severity and duration of your musculoskeletal disorder because the severity of symptoms, signs, and laboratory findings related to most musculoskeletal disorders may improve over time or respond to treatment. Evidence over an extended period will show whether your musculoskeletal functioning is improving, worsening, or unchanging. c. For 101.15 , 101.16 , 101.17 , 101.18 , 101.20C , 101.20D , 101.22 ,\n                            and 101.23 ,\n                            all of the required criteria must be present simultaneously, or within a close proximity of time, to satisfy the level of severity needed to meet the listing. The phrase \"within a close proximity of time\" means that all of the relevant criteria must appear in the medical record within a consecutive 4-month period, except for claims determined or decided during the pandemic period or post-pandemic evaluation period. For claims determined or decided during the pandemic period or post-pandemic evaluation period, all of the relevant criteria must appear in the medical record within a consecutive 12-month period. When the criterion is imaging, we mean that we could reasonably expect the findings on imaging to have been present at the date of impairment or date of onset. For listings that use the word \"and\" to link the elements of the required criteria, the medical record must establish the simultaneous presence, or presence within a close proximity of time, of all the required medical criteria. Once this level of severity is established, the medical record must also show that this level of severity has continued, or is expected to continue, for a continuous period of at least 12 months. 8. Surgical treatment or physical therapy. For some musculoskeletal disorders, a medical source may recommend surgery,\n                            or physical therapy (PT). If you have not yet had the recommended surgery or PT,\n                            we will not assume that these interventions will resolve your disorder or improve your functioning. We will assess each case on an individual basis.\n                            Depending on your response to treatment, or your medical sources’ treatment plans, we may defer our findings regarding the effect of surgery or PT,\n                            until a sufficient period has passed to permit proper consideration or judgment about your future functioning. When necessary,\n                            we will follow the rules on following prescribed treatment in § 416.930 of this chapter,\n                                including consideration of your reasons for failure to follow prescribed treatment. D. How do we consider symptoms, including pain, under these listings? 1. Musculoskeletal disorders may cause pain or other symptoms;\n                            however, your statements about your pain or other symptoms will not alone establish that you are disabled.\n                            We will not substitute an alleged or a reported increase in the intensity of a symptom, such as pain, no matter how severe,\n                            for a medical sign or diagnostic finding present in the listing criteria.\n                            Pain is included as just one consideration in 101.15A , 101.16A ,\n                            and 101.18A , but it is not required to satisfy the criteria\n                            in 101.15 , 101.16 ,\n                            and 101.18 . 2. To consider your symptom(s),\n                            we require objective medical evidence from an acceptable medical source showing the existence of a medically determinable musculoskeletal impairment that\n                            we could reasonably expect to produce the symptom(s).\n                            See § 416.929 of this chapter for how we evaluate symptoms, including pain, related to your musculoskeletal disorder. E. How do we use the functional criteria to evaluate your musculoskeletal disorder under these listings? 1. General. The functional criteria for children age 3 and older are based on\n                            impairment-related physical limitations in your ability to use both upper extremities, one or both lower extremities,\n                            or a combination of one upper and one lower extremity.\n                            We will use the relevant evidence that we have to compare your musculoskeletal functioning to the functioning of children your age who do not have impairments.\n                            The required impairment-related physical limitation of musculoskeletal functioning must have lasted, or be expected to last,\n                            for a continuous period of at least 12 months.\n                            We do not use the functional criteria in 101.20A , 101.20B , 101.21 ,\n                            or 101.24 . 2. Medical and functional criteria, birth to attainment of age 3. The medical and functional criteria for children in this age group are in 101.24 . 3. Functional criteria, age 3 to attainment of age 18. The functional criteria are based on impairment-related physical limitations in your ability to use both upper extremities, one or both lower extremities, or a combination of one upper and one lower extremity. A musculoskeletal disorder satisfies the functional criteria of a listing when the medical documentation shows the presence of at least one of the impairment-related limitations cited in the listing. The functional criteria require impairment-related physical limitation of musculoskeletal functioning that has lasted, or can be expected to last, for a continuous period of at least 12 months, medically documented by one of the following: a. A documented medical need (see 101.00C6a ) for a walker,\n                            bilateral canes, or bilateral crutches (see 101.00C6d )\n                            or a wheeled and seated mobility device involving the use of both hands (see 101.00C6e(i) ); b. An inability to use one upper extremity to independently initiate, sustain,\n                            and complete age-appropriate activities involving fine and gross movements (see 101.00E4 ),\n                            and a documented medical need (see 101.00C6a ) for a one-handed,\n                            hand-held assistive device (see 101.00C6d )\n                            that requires the use of your other upper extremity or a wheeled and seated mobility device involving the use of one hand\n                            (see 101.00C6e(ii) ); c. An inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain,\n                            and complete age-appropriate activities involving fine and gross movements (see 101.00E4 ). 4. Fine and gross movements. Fine movements,\n                            for the purposes of these listings, involve use of your wrists, hands, and fingers; such movements include picking, pinching, manipulating, and fingering. Gross movements involve use of your shoulders, upper arms, forearms, and hands; \n                            such movements include handling, gripping, grasping, holding, turning, and reaching. \n                            Gross movements also include exertional abilities such as lifting, carrying, pushing, and pulling. F. What do we consider when we evaluate disorders of the skeletal spine resulting in compromise of a nerve root(s)\n                                ( 101.15 )? 1. General. We consider musculoskeletal disorders such as skeletal dysplasias, caudal regression syndrome, tethered spinal cord syndrome,\n                            vertebral slippage (spondylolisthesis), scoliosis, and vertebral fracture or dislocation.\n                            Spinal disorders may cause cervical or lumbar spine dysfunction when abnormalities of the skeletal spine compromise nerve roots of the cervical spine,\n                            a nerve root of the lumbar spine, or a nerve root of both cervical and lumbar spines. We consider spinal nerve disorders that originate in the nervous system\n                            (for example, spinal arachnoiditis), under the neurological disorders body system, 111.00 . 2. Compromise of a nerve root(s). Compromise of a nerve root, sometimes referred to as “nerve root impingement,” is a phrase used when a physical object, such as a tumor, herniated disc, foreign body, or arthritic spur, is pushing on the nerve root as seen on imaging or during surgery. It can occur when a musculoskeletal disorder produces irritation, inflammation, or compression of the nerve root(s) as it exits the skeletal spine between the vertebrae. Related symptoms must be associated with, or follow the path of, the affected nerve root(s). a. Compromise of unilateral nerve root of the cervical spine. Compromise of a nerve root as it exits the cervical spine between the vertebrae may affect the functioning of the associated upper extremity. The physical examination reproduces the related symptoms based on radicular signs and clinical tests appropriate to the specific cervical nerve root (for example, a positive Spurling test). b. Compromise of bilateral nerve roots of the cervical spine. Although uncommon, if compromise of a nerve root occurs on both sides of the cervical spinal column, functioning of both upper extremities may be limited. c. Compromise of a nerve root(s) of the lumbar spine. Compromise of a nerve root as it exits the lumbar spine between the vertebrae may limit the functioning of the associated lower extremity. The physical examination reproduces the related symptoms based on radicular signs and clinical tests. When a nerve root of the lumbar spine is compromised, we require a positive straight-leg raising test (also known as a Lasègue test) in both supine and sitting positions appropriate to the specific lumbar nerve root that is compromised. G. What do we consider when we evaluate lumbar spinal stenosis resulting in compromise of the cauda equina\n                                ( 101.16 )? 1. General. We consider how pain, sensory changes, and muscle weakness caused by compromise of the cauda equina due to lumbar spinal stenosis affect your functioning. The cauda equina is a bundle of nerve roots that descends from the lower part of the spinal cord. Lumbar spinal stenosis can compress the nerves of the cauda equina, causing sensory changes and muscle weakness that may affect your ability to stand or walk. Pain related to compromise of the cauda equina is nonradicular because it is not typically associated with a specific nerve root (as is radicular pain in the cervical or lumbar spine). 2. Compromise of the cauda equina due to lumbar spinal stenosis can affect your ability to walk or stand because of neurogenic claudication (also known as pseudoclaudication), a condition usually causing nonradicular pain that starts in the low back and radiates bilaterally (or less commonly, unilaterally) into the buttocks and lower extremities (or extremity). Extension of the lumbar spine, which occurs when you walk or stand, may provoke the pain of neurogenic claudication. The pain may be relieved by forward flexion of the lumbar spine or by sitting. In contrast, the leg pain associated with peripheral vascular claudication results from inadequate arterial blood flow to a lower extremity. It occurs repeatedly and consistently when a person walks a certain distance and is relieved when the person rests. H. What do we consider when we evaluate reconstructive surgery or surgical arthrodesis of a major weight-bearing joint\n                                ( 101.17 )? 1. General. We consider reconstructive surgery or surgical arthrodesis when an acceptable medical source(s) documents the surgical procedure(s) and associated medical treatments to restore function of, or eliminate motion in, the affected major weight-bearing joint(s). Reconstructive surgery may be done in a single procedure or a series of procedures directed toward the salvage or restoration of functional use of the affected joint. 2. Major weight-bearing joints are the hip, knee, and ankle-foot. The ankle and foot are considered together as one major joint. 3. Surgical arthrodesis is the artificial fusion of the bones that form a joint, essentially eliminating the joint. I. What do we consider when we evaluate abnormality of a major joint(s) in any extremity\n                                ( 101.18 )? 1. General. We consider musculoskeletal disorders that produce anatomical abnormalities of major joints of the extremities, which result in functional abnormalities in the upper or lower extremities (for example, chronic infections of bones and joints, and surgical arthrodesis of a joint). Abnormalities of the joints include ligamentous laxity or rupture, soft tissue contracture, or tendon rupture, and can cause muscle weakness of the affected joint(s). a. An anatomical abnormality is one that is readily observable by a medical source during a physical examination (for example, subluxation or contracture), or is present on imaging (for example, joint space narrowing, bony destruction, ankylosis, or deformity). b. A functional abnormality is abnormal motion or instability of the affected joint(s), including limitation of motion, excessive motion (hypermobility), movement outside the normal plane of motion for the joint (for example, lateral deviation), or fixation of the affected joint(s). 2. Major joint of an upper extremity refers to the shoulder, elbow, and wrist-hand. We consider the wrist and hand together as one major joint. 3. Major joint of a lower extremity refers to the hip, knee, and ankle-foot. We consider the ankle and hindfoot together as one major joint. Back to Top J. What do we consider when we evaluate pathologic fractures due to any cause\n                                ( 101.19 )? We consider pathologic fractures of the bones in the skeletal spine, extremities, or other parts of the skeletal system.\n                            Pathologic fractures result from disorders that weaken the bones, making them vulnerable to breakage.\n                            Pathologic fractures may occur with osteoporosis, osteogenesis imperfecta or any other skeletal dysplasias,\n                            side effects of medications, and disorders of the endocrine or other body systems.\n                            Under 101.19 , the fractures must have occurred on separate, distinct occasions,\n                            rather than multiple fractures occurring at the same time, but the fractures may affect the same bone(s) multiple times.\n                            There is no required time that must elapse between the fractures, but all three must occur within a 12-month period;\n                            for example, separate incidents may occur within hours or days of each other.\n                            We evaluate non-healing or complex traumatic fractures without accompanying pathology under 101.22 or 101.23 . K. What do we consider when we evaluate amputation due to any cause\n                                ( 101.20 )? 1. General. We consider amputation (the full or partial loss or absence of any extremity) due to any cause including trauma, congenital abnormality or absence, surgery for treatment of conditions such as cancer or infection, or complications of peripheral vascular disease or diabetes mellitus. 2. Amputation of both upper extremities\n                                ( 101.20A ). Under 101.20A ,\n                            we consider upper extremity amputations that occur at any level at or above the wrists (carpal joints),\n                            up to and including disarticulation of the shoulder (glenohumeral) joint.\n                            If you have had both upper extremities amputated at any level at or above the wrists up to and including the shoulder,\n                            your impairment satisfies the duration requirement in § 416.909 of this chapter.\n                            For amputations below the wrist, we will follow the rules described in 101.00R .\n                            We do not evaluate amputations below the wrists under 101.20A because the resulting limitation of function of the thumb(s),\n                            finger(s), or hand(s) will vary, depending on the extent of loss and corresponding effect on fine and gross movements. 3. Hemipelvectomy or hip disarticulation ( 101.20B ). Under 101.20B , we consider hemipelvectomy,\n                            which involves amputation of an entire lower extremity through the sacroiliac joint, and hip disarticulation,\n                            which involves amputation of an entire lower extremity through the hip joint capsule and closure of the remaining musculature over the exposed acetabular bone.\n                            If you have had a hemipelvectomy or hip disarticulation,\n                            your impairment satisfies the duration requirement in § 416.909 of this chapter. 4. Amputation of one upper extremity and one lower extremity ( 101.20C ). Under 101.20C ,\n                            we consider the amputation of one upper extremity at any level at or above the wrist and one lower extremity at or above the ankle.\n                            If you have a documented medical need for a one-handed, hand-held assistive device (such as a cane) or a wheeled and seated mobility device involving the use of one hand\n                            (such as a motorized wheelchair), then you must use your remaining upper extremity to hold the device,\n                            making the extremity unavailable to perform other fine and gross movements (see 101.00E4 ). 5. Amputation of one lower extremity or both lower extremities with complications of the residual limb(s)\n                                ( 101.20D ). Under 101.20D ,\n                            we consider the amputation of one lower extremity or both lower extremities at or above the ankle.\n                            We also consider the condition of your residual limb(s), whether you can wear a prosthesis(es)\n                            (see 101.00C6b ), and whether you have a documented medical need\n                            (see 101.00C6a ) for a hand-held assistive device(s)\n                            (see 101.00C6d ) or a wheeled and seated mobility device\n                            (see 101.00C6e ). If you have a non-healing residual limb(s) and are receiving ongoing surgical treatment expected to re-establish or improve function,\n                            and that ongoing surgical treatment has not ended, or is not expected to end,\n                            within at least 12 months of the initiation of the surgical management (see 101.00L ),\n                            we evaluate your musculoskeletal disorder under 101.21 . L. What do we consider when we evaluate soft tissue injury or abnormality under continuing surgical management\n                                ( 101.21 )? 1. General. a. We consider any soft tissue injury or abnormality involving the soft tissues of the body, whether congenital or acquired, \n                            when an acceptable medical source(s) documents the need for ongoing surgical procedures and associated medical treatments to restore function of the affected body part(s) \n                            (see 101.00P1 ). \n                            Surgical management includes the surgery(ies) itself, as well as various post-surgical procedures, surgical complications, \n                            infections or other medical complications, related illnesses, or related treatments that delay your attainment of maximum benefit from therapy \n                            (see 101.00P2 ). b. Surgical procedures and associated treatments typically take place over extended periods, which may render you unable to perform age-appropriate activity on a sustained basis. To document such inability, we must have evidence from an acceptable medical source(s) confirming that the surgical management has continued, or is expected to continue, for at least 12 months from the date of the first surgical intervention. These procedures and treatments must be directed toward saving, reconstructing, or replacing the affected part of the body to re-establish or improve its function, and not for cosmetic appearances alone. c. Examples include malformations, third- and fourth-degree burns, crush injuries, craniofacial injuries, avulsive injuries, and amputations with complications of the residual limb(s). d. We evaluate skeletal spine abnormalities or injuries\n                            under 101.15 or 101.16 , as appropriate.\n                            We evaluate abnormalities or injuries of bones in the lower extremities\n                            under 101.17 , 101.18 , or 101.22 .\n                            We evaluate abnormalities or injuries of bones in the upper extremities\n                            under 101.18 or 101.23 . 2. Documentation. In addition to the objective medical evidence we need to establish your soft tissue injury or abnormality, we also need all of the following medically documented evidence about your continuing surgical management: a. Operative reports and related laboratory findings; b. Records of post-surgical procedures; c. Records of any surgical or medical complications (for example, related infections or systemic illnesses); d. Records of any prolonged post-operative recovery periods and related treatments (for example, surgeries and treatments for burns); e. An acceptable medical source’s plans for additional surgeries; and f. Records detailing any other factors that have delayed, or that an acceptable medical source expects to delay, the saving, restoring, or replacing of the involved part for a continuous period of at least 12 months following the initiation of the surgical management. 3. Burns. Third- and fourth-degree burns damage or destroy nerve tissue,\n                            reducing or preventing transmission of signals through those nerves.\n                            Such burns frequently require multiple surgical procedures and related therapies to re-establish or improve function,\n                            which we evaluate under 101.21 .\n                            When burns are no longer under continuing surgical management (see 101.00P1 ), we evaluate the residual impairment(s).\n                            When the residual impairment(s) affects the musculoskeletal system, as often occurs in third- and fourth-degree burns,\n                            it can result in permanent musculoskeletal tissue loss, joint contractures, or loss of extremities.\n                            We will evaluate such impairments under the relevant musculoskeletal disorders listing,\n                            for example, 101.18 or 101.20 .\n                            When the residual impairment(s) involves another body system, we will evaluate the impairment(s) under the listings in the relevant body system(s). 4. Craniofacial injuries or congenital abnormalities. Surgeons may treat craniofacial injuries or congenital abnormalities with multiple surgical procedures. These injuries or abnormalities may affect vision, hearing, speech, and the initiation of the digestive process, including mastication. When the craniofacial injury-related or congenital abnormality-related residual impairment(s) involves another body system(s), we will evaluate the impairment(s) under the listings in the relevant body system(s). M. What do we consider when we evaluate non-healing or complex fractures of the femur, tibia, pelvis,\n                                or one or more of the talocrural bones ( 101.22 )? 1. Non-healing fracture. A non-healing (nonunion) fracture is a fracture that has failed to unite completely. Nonunion is usually established when a minimum of 9 months has elapsed since the injury and the fracture site has shown no, or minimal, progressive signs of healing for a minimum of 3 months. 2. Complex fracture. A complex fracture is a fracture with one or more of the following: a. Comminuted (broken into many pieces) bone fragments; b. Multiple fractures in a single bone; c. Bone loss due to severe trauma; d. Damage to the surrounding soft tissue; e. Severe cartilage damage to the associated joint; or f. Dislocation of the associated joint. 3. When a complex fracture involves soft tissue damage, \n                            the treatment may involve continuing surgical management to restore or improve functioning. \n                            In such cases, we may evaluate the fracture(s) under 101.21 . N. What do we consider when we evaluate non-healing or complex fractures of an upper extremity\n                                ( 101.23 )? 1. Non-healing fracture. A non-healing (nonunion) fracture is a fracture that has failed to unite completely. Nonunion is usually established when a minimum of 9 months has elapsed since the injury and the fracture site has shown no, or minimal, progressive signs of healing for a minimum of 3 months. 2. Complex fracture. A complex fracture is a fracture with one or more of the following: a. Comminuted (broken into many pieces) bone fragments; b. Multiple fractures in a single bone; c. Bone loss due to severe trauma; d. Damage to the surrounding soft tissue; e. Severe cartilage damage to the associated joint; or f. Dislocation of the associated joint. 3. When a complex fracture involves soft tissue damage, \n                            the treatment may involve continuing surgical management to restore or improve functioning. \n                            In such cases, we may evaluate the fracture(s) under 101.21 . O. What do we consider when we evaluate musculoskeletal disorders of infants and toddlers from birth to attainment of\n                                age 3 with developmental motor delay ( 101.24 )? 1. General. Under 101.24 ,\n                            we require reports from an acceptable medical source(s) to establish a delay in your motor development as a medically determinable impairment.\n                            Examples of disorders we evaluate under this listing include arthrogryposis, clubfoot, osteogenesis imperfecta, caudal regression syndrome,\n                            fracture complications, disorders affecting the hip and pelvis, and complications associated with your musculoskeletal disorder or its treatment.\n                            Some medical records may simply document your condition as “developmental motor delay.” 2. Severity of developmental motor delay. To evaluate the severity of your developmental motor delay, we need developmental test reports from an acceptable medical source, or from early intervention specialists, physical and occupational therapists, and other sources. a. If there is a standardized developmental assessment in your medical record,\n                            we will use the results to evaluate your developmental motor delay under 101.24A .\n                            Such an assessment compares your level of development to the level typically expected for children of your chronological age.\n                            If you were born prematurely, we use your corrected chronological age for comparison.\n                            See § 416.924b(b) of this chapter. b. If there is no standardized developmental assessment in your medical record, \n                            we will use narrative developmental reports from a medical source(s) to evaluate your developmental motor delay under 101.24B . \n                            These reports must provide detailed information sufficient for us to assess the severity of your motor delay. \n                            If we cannot obtain sufficient detail from narrative reports, we may purchase standardized developmental assessments. (i) A narrative developmental report is based on clinical observations, progress notes, and well-baby check-ups, and must include your developmental history, examination findings (with abnormal findings noted on repeated examinations), and an overall assessment of your development (that is, more than one or two isolated skills) by the medical source. (ii) Some narrative developmental reports may include results from developmental screening tests, which can show that you are not developing or achieving skills within expected timeframes. Although medical sources may refer to screening test results as supporting evidence in the narrative developmental report, screening test results alone cannot establish a medically determinable impairment or the severity of developmental motor delay. P. How will we determine whether your soft tissue injury or abnormality or your upper extremity fracture is no longer under continuing surgical management\n                                or you have received maximum benefit from therapy? 1. We will determine that your soft tissue injury or abnormality, or your upper extremity fracture, \n                            is no longer under continuing surgical management , \n                            as used in 101.21 and 101.23 , \n                            when the last surgical procedure or medical treatment directed toward the re-establishment or improvement of function of the involved part has occurred. 2. We will determine that you have received maximum benefit from therapy , \n                            as used in 101.21 , if there are no significant changes in physical findings \n                            or on appropriate imaging for any 6-month period after the last surgical procedure or medical treatment. \n                            We may also determine that you have received maximum benefit from therapy if your medical source(s) indicates \n                            that further improvement is not expected after the last surgical procedure or medical treatment. 3. When you have received maximum benefit from therapy, we will evaluate any impairment-related residual symptoms, signs, \n                            and laboratory findings (including those on imaging), any complications associated with your surgical procedures or medical treatments, \n                            and any residual limitations in your functioning (see 101.00R ). Q. How do we evaluate your musculoskeletal disorder if there is no record of ongoing treatment? 1. Despite having a musculoskeletal disorder, you may not have received ongoing treatment, may have just begun treatment,\n                            may not have access to prescribed medical treatment, or may not have an ongoing relationship with the medical community.\n                            In any of these situations, you will not have a longitudinal medical record for us to review when we evaluate your disorder\n                            and we may ask you to attend a consultative examination to determine the severity and potential duration of your disorder.\n                            See § 416.919a(b) of this chapter. 2. In some instances, we may be able to assess the severity \n                            and duration of your musculoskeletal disorder based on your medical record and current evidence alone. \n                            If the information in your case record is not sufficient to show that you have a musculoskeletal disorder \n                            that meets the criteria of one of the musculoskeletal disorders listings, \n                            we will follow the rules described in 101.00R . R. How do we evaluate musculoskeletal disorders that do not meet one of these listings? 1. These listings are only examples of musculoskeletal disorders that we consider severe enough to result in marked and severe functional limitations. If your impairment(s) does not meet the criteria of any of these listings, we must also consider whether you have an impairment(s) that meets the criteria of a listing in another body system. 2. If you have a severe medically determinable impairment(s) that does not meet a listing,\n                            we will determine whether your impairment(s) medically equals a listing.\n                            See § 416.926 of this chapter.\n                            If your impairment(s) does not meet or medically equal a listing, we will determine whether it functionally equals the listings.\n                            See § 416.926a of this chapter. 3. We use the rules in § 416.994a of this chapter when we decide whether you continue to be disabled. 101.01\n                                Category of Impairments, Musculoskeletal 101.15 Disorders of the skeletal spine resulting in compromise of a nerve root(s) (see 101.00F ), documented by A, B, C, and D: A. Neuro-anatomic (radicular) distribution of one or more of the \n                            following symptoms consistent with compromise of the affected nerve root(s): 1. Pain; or 2. Paresthesia; or 3. Muscle fatigue. AND B. Radicular distribution of neurological signs present during physical examination\n                            (see 101.00C2 ) or on a diagnostic test\n                            (see 101.00C3 ) and evidenced by 1, 2, and either 3 or 4: 1. Muscle weakness; and 2. Sign(s) of nerve root irritation, tension, or compression, consistent with compromise of the affected nerve root \n                            (see 101.00F2 ) 3. Sensory changes evidenced by: a. Decreased sensation; or b. Sensory nerve deficit (abnormal sensory nerve latency) on electrodiagnostic testing; or 4. Decreased deep tendon reflexes. AND C. Findings on imaging\n                            (see 101.00C3 ) consistent with compromise of a nerve root(s) in the cervical or lumbosacral spine. AND D. Impairment-related physical limitation of musculoskeletal functioning that has lasted, \n                            or is expected to last, for a continuous period of at least 12 months, \n                            and medical documentation of at least one of the following: 1. A documented medical need\n                            (see 101.00C6a ) for a walker, bilateral canes, or bilateral crutches\n                            (see 101.00C6d ) or a wheeled and seated mobility device involving the use of both hands\n                            (see 101.00C6e(i) ); or 2. An inability to use one upper extremity to independently initiate, sustain,\n                            and complete age-appropriate activities involving fine and gross movements\n                            (see 101.00E4 ), and a documented medical need\n                            (see 101.00C6a ) for a one-handed,\n                            hand-held assistive device (see 101.00C6d )\n                            that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand\n                            (see 101.00C6e(ii) ); or 3. An inability to use both upper extremities to the extent that neither can be used to independently initiate, \n                            sustain, and complete age-appropriate activities involving fine and gross movements (see 101.00E4 ). 101.16 Lumbar spinal stenosis resulting in compromise of the cauda equina (see 101.00G ), documented by A, B, C, and D: A. Symptom(s) of neurological compromise manifested as: 1. Nonradicular distribution of pain in one or both lower extremities; or 2. Nonradicular distribution of sensory loss in one or both lower extremities; or 3. Neurogenic claudication. AND B. Nonradicular neurological signs present during physical examination\n                            (see 101.00C2 ) or on a diagnostic test\n                            (see 101.00C3 ) and evidenced by 1 and either 2 or 3: 1. Muscle weakness. 2. Sensory changes evidenced by: a. Decreased sensation; or b. Sensory nerve deficit (abnormal sensory nerve latency) on electrodiagnostic testing; or c. Areflexia, trophic ulceration, or bladder or bowel incontinence. 3. Decreased deep tendon reflexes in one or both lower extremities. AND C. Findings on imaging (see 101.00C3 ) or in an operative report\n                            (see 101.00C4 ) consistent with compromise of the cauda equina with lumbar spinal stenosis. AND D. Impairment-related physical limitation of musculoskeletal functioning that has lasted, \n                            or is expected to last, for a continuous period of at least 12 months, \n                            and medical documentation of at least one of the following: 1. A documented medical need (see 101.00C6a ) for a walker, \n                            bilateral canes, or bilateral crutches \n                            (see 101.00C6d ) or a wheeled and seated mobility device involving the use of both hands \n                            (see 101.00C6e(i) ); or 2. An inability to use one upper extremity to independently initiate, sustain,\n                            and complete age-appropriate activities involving fine and gross movements\n                            (see 101.00E4 ), and a documented medical need\n                            (see 101.00C6a ) for a one-handed, hand-held assistive device\n                            (see 101.00C6d ) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand\n                            (see 101.00C6e(ii) ). 101.17 Reconstructive surgery or surgical arthrodesis of a major weight-bearing joint (see 101.00H ), documented by A, B, and C: A. History of reconstructive surgery or surgical arthrodesis of a major weight-bearing joint. AND B. Impairment-related physical limitation of musculoskeletal functioning that has lasted, or is expected to last, for a continuous period of at least 12 months. AND C. A documented medical need (see 101.00C6a ) for a walker, \n                            bilateral canes, or bilateral crutches \n                            (see 101.00C6d ) or a wheeled and seated mobility device involving the use of both hands \n                            (see 101.00C6e(i) ). 101.18 Abnormality of a major joint(s) in any extremity (see 101.00I ), documented by A, B, C, and D: A. Chronic joint pain or stiffness. AND B. Abnormal motion, instability, or immobility of the affected joint(s). AND C. Anatomical abnormality of the affected joint(s) noted on: 1. Physical examination (for example, subluxation, contracture, or bony or fibrous ankylosis); or 2. Imaging (for example, joint space narrowing, bony destruction, or ankylosis or arthrodesis of the affected joint). AND D. Impairment-related physical limitation of musculoskeletal functioning that has lasted, \n                            or is expected to last, for a continuous period of at least 12 months, \n                            and medical documentation of at least one of the following: 1. A documented medical need \n                            (see 101.00C6a ) for a walker, bilateral canes, or bilateral crutches \n                            (see 101.00C6d ) or a wheeled and seated mobility device involving the use of both hands \n                            (see 101.00C6e(i) ); or 2. An inability to use one upper extremity to independently initiate, sustain,\n                            and complete age-appropriate activities involving fine and gross movements\n                            (see 101.00E4 ), and a documented medical need (see 101.00C6a ) for a one-handed,\n                            hand-held assistive device\n                            (see 101.00C6d ) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand\n                            (see 101.00C6e(ii) ); or 3. An inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, \n                            and complete age-appropriate activities involving fine and gross movements (see 101.00E4 ). 101.19 Pathologic fractures due to any cause (see 101.00J ), documented by A and B: A. Pathologic fractures occurring on three separate occasions within a 12-month period. AND B. Impairment-related physical limitation of musculoskeletal functioning that has lasted, \n                            or is expected to last, for a continuous period of at least 12 months, \n                            and medical documentation of at least one of the following: 1. A documented medical need (see 101.00C6a ) for a walker,\n                            bilateral canes, or bilateral crutches (see 101.00C6d )\n                            or a wheeled and seated mobility device involving the use of both hands (see 101.00C6e(i) ); or 2. An inability to use one upper extremity to independently initiate, sustain,\n                            and complete age-appropriate activities involving fine and gross movements (see 101.00E4 ), and a documented medical need (see 101.00C6a ) for a one-handed,\n                            hand-held assistive device (see 101.00C6d )\n                            that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand\n                            (see 101.00C6e(ii) ); or 3. An inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, \n                            and complete age-appropriate activities involving fine and gross movements (see 101.00E4 ). 101.20 Amputation due to any cause (see 101.00K ), documented by A, B, C, or D: A. Amputation of both upper extremities, occurring at any level at or above the wrists (carpal joints), up to and including the shoulder (glenohumeral) joint. OR B. Hemipelvectomy or hip disarticulation. OR C. Amputation of one upper extremity, occurring at any level at or above the wrist (carpal joints), \n                            and amputation of one lower extremity, occurring at or above the ankle (talocrural joint), \n                            and medical documentation of at least one of the following: 1. A documented medical need (see 101.00C6a ) for a walker, \n                            bilateral canes, or bilateral crutches (see 101.00C6d ) \n                            or a wheeled and seated mobility device involving the use of both hands \n                            (see 101.00C6e(i) ); or 2. A documented medical need (see 101.00C6a ) for a one-handed, \n                            hand-held assistive device (see 101.00C6d ) requiring the use of the other upper extremity \n                            or a wheeled and seated mobility device involving the use of one hand \n                            (see 101.00C6e(ii) ); or 3. The inability to use the remaining upper extremity to independently initiate, sustain, \n                            and complete age-appropriate activities involving fine and gross movements \n                            ( 101.00E4 ). OR D. Amputation of one or both lower extremities, occurring at or above the ankle (talocrural joint), \n                            with complications of the residual limb(s) that have lasted, or are expected to last, \n                            for a continuous period of at least 12 months, and medical documentation of 1 and 2: 1. The inability to use a prosthesis(es); and 2. A documented medical need (see 101.00C6a ) for a walker, \n                            bilateral canes, or bilateral crutches (see 101.00C6d ) \n                            or a wheeled and seated mobility device involving the use of both hands (see 101.00C6e(i) ). 101.21 Soft tissue injury or abnormality under continuing surgical management (see 101.00L ), documented by A, B, and C: A. Evidence confirms continuing surgical management\n                            (see 101.00P1 ) directed toward saving, reconstructing, or replacing the affected part of the body. AND B. The surgical management has been, or is expected to be, ongoing for a continuous period of at least 12 months. AND C. Maximum benefit from therapy (see 101.00P2 ) has not yet been achieved. 101.22 Non-healing or complex fracture of the femur, tibia, pelvis, or one or more of the talocrural bones (see 101.00M ), documented by A, B, and C: A. Solid union not evident on imaging (see 101.00C3 ) and not clinically solid. AND B. Impairment-related physical limitation of musculoskeletal functioning that has lasted, or is expected to last, for a continuous period of at least 12 months. AND C.  A documented medical need (see 101.00C6a ) for a walker,\n                            bilateral canes, or bilateral crutches (see 101.00C6d )\n                            or a wheeled and seated mobility device involving the use of both hands (see 101.00C6e(i) ). 101.23 Non-healing or complex fracture of an upper extremity (see 101.00N ), documented by A and B: A. Nonunion or complex fracture, of the shaft of the humerus, radius, or ulna, under continuing surgical management \n                            see 101.00P1 ) directed toward restoration of functional use of the extremity. AND B. Medical documentation of an inability to independently initiate, sustain, \n                            and complete age-appropriate activities involving fine and gross movements \n                            (see 101.00E4 ) that has lasted, or is expected to last, for a continuous period of at least 12 months. 101.24 Musculoskeletal disorders of infants and toddlers, from birth to attainment of age 3, with developmental motor delay (see 101.00O ), documented by A or B: A. A standardized developmental motor assessment that: 1. Shows motor development not more than one-half of the level typically expected for the child’s age; or 2. Results in a valid score that is at least three standard deviations below the mean. OR B. Two narrative developmental reports that: 1. Are dated at least 120 days apart; and 2. Indicate current motor development not more than one-half of the level typically expected for the child’s age.",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security101.00 Musculoskeletal Disorders - Childhood"
      }
    ],
    "tables": [
      [
        [
          "Grade",
          "Function of the Muscle"
        ],
        [
          "0",
          "None",
          "No visible or palpable contraction."
        ],
        [
          "1",
          "Trace",
          "Visible or palpable contraction with no motion."
        ],
        [
          "2",
          "Poor",
          "Active ROM with gravity eliminated."
        ],
        [
          "3",
          "Fair",
          "Active ROM against gravity only, without resistance."
        ],
        [
          "4",
          "Good",
          "Active ROM against gravity, moderate resistance."
        ],
        [
          "5",
          "Normal",
          "Active ROM against gravity, maximum resistance."
        ]
      ]
    ],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_01",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_15",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_16",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_17",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_18",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_19",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_22",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_23",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_24",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00B1",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00P1",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_15",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00P1",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#Top",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0912.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0913.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0920b.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0929.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0919k.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0919m.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6b",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6c",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6e",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C2b",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C2a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E3b",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E3a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C7c",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C7c",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_15",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_16",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_17",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_18",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20C",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20C",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_22",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_23",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0930.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_15A",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_16A",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_18A",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_15",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_16",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_18",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0929.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20A",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20B",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_24",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_24",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6eii",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_15",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_16",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_17",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_18",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_19",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_19",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_22",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_23",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20A",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20A",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0909.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00R",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20A",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20B",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20B",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0909.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20C",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20C",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20D",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20D",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6b",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6e",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00L",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00P1",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00P2",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_15",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_16",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_17",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_18",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_22",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_18",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_23",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00P1",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_18",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_22",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_23",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_24",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_24",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_24A",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0924b.htm#b",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_24B",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_23",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00R",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0919a.htm#b",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00R",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0994a.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C2",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00F2",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6eii",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00G",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C2",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6eii",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00H",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00I",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6eii",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00J",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6eii",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00K",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6eii",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00L",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00P1",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00P2",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00M",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00N",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00P1",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00O",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm"
    ],
    "html_file": "ssa_bluebook_data/html/fbf7c5b1b3a9701ebd007bd916b11b7f.html",
    "fetched_at": 1762482832.4266577
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00",
    "url_hash": "8a61055998953d0002698cd0bf8626c1",
    "title": "111.00 Neurological - Childhood | Disability | SSA",
    "text_content": "111.00 Neurological - Childhood | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Listing of Impairments - Child Listings (Part B) 111.00 Neurological - Childhood Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security 111.00 Neurological - Childhood Section 111.01 Category of Impairments, Neurological Disorders 111.02 Epilepsy 111.03 [Reserved] 111.04 Vascular insult to the brain 111.05 Benign brain tumors 111.06 [Reserved] 111.07 Cerebral Palsy 111.08 Spinal cord disorders 111.09 Communication impairment 111.10 [Reserved] 111.11 [Reserved] 111.12 Myasthenia gravis 111.13 Muscular dystrophy 111.14 Peripheral neuropathy 111.15 [Reserved] 111.16 [Reserved] 111.17 Neurodegenerative disorders of the central nervous system, such as Juvenile-onset Huntington's disease and Friedreich's ataxia 111.18 Traumatic brain injury, characterized by disorganization of motor function in two extremities (see 111.00D1) 111.19 [Reserved] 111.20 Coma or persistent vegetative state, persisting for at least 1 month 111.21 Multiple sclerosis 111.22 Motor neuron disorders 111.00 Neurological A. Which neurological disorders do  we evaluate under these listings ? We evaluate epilepsy, coma or persistent vegetative state (PVS), and neurological disorders that cause disorganization of motor function, bulbar and neuromuscular dysfunction, \n        or communication impairment. Under this body system, we evaluate the limitations resulting from the impact of the neurological disease process itself. \n        If you have a neurological disorder(s) that affects your physical and mental functioning, we will evaluate your impairments under the rules we use to determine functional equivalence. \n        If your neurological disorder results in only mental impairment or  if you have a co-occurring mental condition that is not caused by your neurological disorder \n        (for example, Autism spectrum disorder), we will evaluate  your mental impairment under the mental disorders body system, 112.00 . B. What evidence do we need to document your neurological disorder ? We need both medical and non-medical evidence (signs, symptoms,  and laboratory findings) to assess the effects of your neurological disorder.  Medical evidence should include your medical history, examination findings,  relevant laboratory tests, and the results of imaging. Imaging refers to  medical imaging techniques, such as x-ray, computerized tomography (CT),  magnetic resonance imaging (MRI), and electroencephalography (EEG). The imaging  must be consistent with the prevailing state of medical knowledge and clinical  practice as the proper technique to support the evaluation of the disorder. In  addition, the medical evidence may include descriptions of any prescribed  treatment and your response to it. We consider non-medical evidence such as  statements you or others make about your impairments, your restrictions, your  daily activities, or, if you are an adolescent, your efforts to work. We will make every  reasonable effort to obtain the results of your laboratory and imaging  evidence. When the results of any of these tests are part of the existing  evidence in your case record, we will evaluate the test results and all other  relevant evidence. We will not purchase imaging, or other diagnostic tests or  laboratory tests that are complex, may involve  significant risk, or that are invasive. We will not routinely purchase  tests that are expensive or not readily available. C. How do we consider adherence to prescribed treatment in neurological disorders ? \n            In 111.02 (Epilepsy) and 111.12 (Myasthenia gravis),\n    we require that limitations from these neurological disorders exist despite adherence to prescribed treatment.\n    “Despite adherence to prescribed treatment” means that you have taken medication(s) or followed other treatment procedures for your neurological disorder(s)\n    as prescribed by a physician for three consecutive months but your impairment continues to meet the other listing requirements despite this treatment.\n    You may receive your treatment at a health care facility that you visit regularly, even if you do not see the same physician on each visit. D. What do we mean by disorganization of motor function ? Disorganization of motor function means interference, due to your neurological disorder, with movement of two extremities; \n                  i.e., the lower extremities, or upper extremities (including fingers, wrists, hands, arms, and shoulders). By two extremities we mean both lower extremities, \n                  or both upper extremities, or one upper extremity and one lower extremity. \n                  All listings in this body system, except for 111.02 (Epilepsy) \n                  and 111.20 (Coma and persistent vegetative state), \n                  include criteria for disorganization of motor function that results in an extreme limitation in your ability to: Stand up from a seated position; or Balance while standing or walking; or Use the upper extremities (e.g., fingers, wrists, hands, arms, and shoulders). Extreme limitation means the inability to stand up from a seated position, maintain balance in a standing  position and while walking, or use your upper extremities to independently  initiate, sustain, and complete age-appropriate activities. The assessment of  motor function depends on the degree of interference with standing up;  balancing while standing or walking; or using the upper extremities (including  fingers, hands, arms, and shoulders). Inability to stand up from a seated position means that once seated you are unable to stand and maintain an upright  position without the assistance of another person or the use of an assistive  device, such as a walker, two crutches, or two canes. Inability to maintain balance in a standing position means that you are unable to maintain an upright position  while standing or walking without the assistance of another person or an  assistive device, such as a walker, two crutches, or two canes. Inability to use your upper extremities means that you have a loss of function of both upper extremities  (e.g., fingers, wrists, hands, arms, and shoulders) that very seriously limits  your ability to independently initiate, sustain, and complete age- appropriate  activities involving fine and gross motor movements. Inability to perform fine  and gross motor movements could include not being able to pinch, manipulate,  and use your fingers; or not being able to use your hands, arms, and shoulders  to perform gross motor movements, such as handling, gripping, grasping,  holding, turning, and reaching; or not being able to engage in exertional  movements such a lifting, carrying, pushing, and pulling. For children who are not yet able to balance, stand up, or walk independently, we consider their function based  on assessments of limitations in the ability to perform comparable  age-appropriate activities with the lower and upper extremities, given normal  developmental milestones. For such children, an extreme level of limitation  means developmental milestones at less than one-half of the child's  chronological age. E. What do we mean by bulbar and neuromuscular dysfunction ? \n    The bulbar region of the brain is responsible for controlling the bulbar muscles in  the throat, tongue, jaw, and face. \n    Bulbar and neuromuscular dysfunction refers to weakness in these muscles, resulting in breathing, swallowing, and speaking impairments. \n    Listings 111.12 (Myasthenia gravis) and 111.22 (Motor neuron  disorders) \n    include criteria for evaluating bulbar and neuromuscular dysfunction.  If your neurological disorder has resulted in a breathing disorder, we may evaluate that condition under the respiratory system, 103.00 . F. What is epilepsy, and how do we evaluate it under 111.02 ? Epilepsy is a pattern of recurrent and unprovoked seizures that are manifestations of abnormal electrical activity in the brain. \n                  There are various types of generalized and “focal” or partial seizures. In children, the most common potentially disabling seizure types are generalized tonic-clonic seizures, \n                  dyscognitive seizures (formerly complex partial  seizures), and absence seizures. \n                  However, psychogenic nonepileptic seizures and  pseudoseizures are not epileptic seizures for the purpose of 111.02 .\n    We evaluate psychogenic seizures and pseudoseizures under the mental disorders body system, 112.00 . Generalized tonic-clonic seizures are characterized by loss of consciousness accompanied by a tonic phase (sudden muscle tensing causing the child to lose postural control) followed by a clonic phase (rapid  cycles of muscle contraction and relaxation, also called convulsions). Tongue  biting and incontinence may occur during generalized tonic-clonic seizures, and  injuries may result from falling. Dyscognitive seizures are characterized by alteration of consciousness without convulsions or loss of muscle control. \n                      During the seizure, blank staring, change of facial expression, and automatisms (such as  lip smacking, chewing or swallowing, or repetitive simple actions, \n                      such as gestures or verbal utterances) may occur. During its course, a dyscognitive seizure may progress into a generalized tonic-clonic seizure \n                      (see 111.00F1a ). Absence seizures (petit mal) are also characterized by an alteration in consciousness, but are shorter than other generalized seizures (e.g., tonic-clonic and dyscognitive) seizures, generally lasting for only a  few seconds rather than minutes. They may present with blank staring, change of  facial expression, lack of awareness and responsiveness, and a sense of lost  time after the seizure. An aura never precedes absence seizures. Although  absence seizures are brief, frequent occurrence may limit functioning. This  type of seizure usually does not occur after adolescence. Febrile seizures may occur in young children in association with febrile illnesses. We will consider seizures occurring during febrile illnesses. \n                      To meet 111.02 ,\n    we require documentation of seizures during nonfebrile periods and epilepsy must be established. Description of seizure. We require at least one detailed description of your seizures from someone, preferably a medical  professional, who has observed at least one of your typical seizures. If you  experience more than one type of seizure, we require a description of each  type. Serum drug levels. We do not require serum drug levels; therefore, we will not purchase them. However, if serum drug levels are  available in your medical records, we will evaluate them in the context of the  other evidence in your case record. Counting seizures. \n              The period specified in 111.02A or B cannot begin earlier than one month after you began prescribed treatment.\n    The required number of seizures must occur within the period we are considering in connection with your application or continuing disability review.\n    When we evaluate the frequency of your seizures,\n    we also consider your adherence to prescribed treatment (see 111.00C ).\n    When we determine the number of seizures you have had in the specified period, we will: Count multiple seizures occurring in a 24-hour period  as one seizure. Count status epilepticus (a continuous series of  seizures without return to consciousness between seizures) as one seizure. Count a dyscognitive seizure that progresses into a generalized tonic-clonic seizure as one generalized tonic-clonic seizure. We do not count seizures that occur during a period when you are not adhering to prescribed treatment without good reason. \n                  When we determine that you had a good reason for not adhering to prescribed treatment, we will consider your physical, mental, educational, and communicative limitations \n                  (including any language barriers). We will consider you to have  good reason for not following prescribed treatment if, for example, \n                  the treatment is very risky for you due to its consequences or unusual nature, or if you are unable to afford prescribed treatment that you are willing to accept, \n                  but for which no free community resources are available. We will follow guidelines found in our policy, \n                  such as § 416.930(c) of this chapter,\n    when we determine whether you have a good reason for not adhering to prescribed treatment. We do not count psychogenic nonepileptic seizures or pseudoseizures under 111.02 .\n    We evaluate these seizures under the mental disorders body system, 112.00 . Electroencephalography (EEG) testing. We do not  require EEG test results; therefore, we will not purchase them. However, if EEG  test results are available in your medical records, we will evaluate them in  the context of the other evidence in your case record. G . What is vascular insult to the brain, and how do we evaluate it under 111.04 ? Vascular insult to the brain (cerebrum, cerebellum, or  brainstem), commonly referred to as stroke or cerebrovascular accident (CVA), \n              is brain cell death caused by an interruption of blood flow within or leading to the brain, or by a hemorrhage from a ruptured blood vessel or aneurysm in the brain. \n              If you have a vision impairment resulting from your vascular insult, we may evaluate that impairment under the special senses body system, 102.00 . We generally need evidence from at least 3 months after the vascular insult to determine whether you have disorganization of motor function under 111.04 . In some cases, evidence of your vascular insult is sufficient to allow your claim within 3 months post-vascular insult. If we are unable to allow your claim within 3 months after your vascular insult, we will  defer adjudication of the claim until we obtain evidence of your neurological  disorder at least 3 months post-vascular insult. H. What are benign brain tumors, and how do we evaluate them under 111.05 ? Benign brain tumors are noncancerous (nonmalignant) abnormal growths of tissue in or on the brain that invade healthy brain tissue or apply pressure on the brain or cranial nerves. \n    We evaluate their effects on your functioning as discussed in 111.00D .\n    We evaluate malignant brain tumors under the cancer body system in 113.00 .\n    If you have a vision impairment resulting from your benign brain tumor,\n    we may evaluate that impairment under the special senses body system, 102.00 . I. What is cerebral palsy, and how do we evaluate it under 111.07 ? Cerebral palsy (CP) is a term that describes a group of static, nonprogressive disorders caused by abnormalities within the brain  that disrupt the brain's ability to control movement, muscle coordination, and  posture. The resulting motor deficits manifest very early in a child's  development, with delayed or abnormal progress in attaining developmental  milestones; deficits may become more obvious as the child grows and matures  over time. We evaluate your signs and symptoms, such as ataxia, spasticity, flaccidity, athetosis, chorea, and difficulty with precise  movements when we determine your ability to stand up, balance, walk, or perform  fine and gross motor movements. We will also evaluate your signs, such as  dysarthria and apraxia of speech, and receptive and expressive language  problems when we determine your ability to communicate. We will consider your other impairments or signs and symptoms that develop secondary to the disorder, such as post-impairment  syndrome (a combination of pain, fatigue, and weakness due to muscle  abnormalities); overuse syndromes (repetitive motion injuries); arthritis;  abnormalities of proprioception (perception of the movements and position of  the body); abnormalities of stereognosis (perception and identification of  objects by touch); learning problems; anxiety; and depression. J. What are spinal cord disorders, and how do we evaluate them under 111.08 ? Spinal cord disorders may be congenital or caused by injury to the spinal cord. Motor signs and symptoms of spinal cord disorders  include paralysis, flaccidity, spasticity, and weakness. Spinal cord disorders with complete loss of function \n              ( 111.08A ) addresses spinal cord disorders that result in complete lack of  motor, sensory, \n              and autonomic function of the affected part(s) of the body. Spinal cord disorders with disorganization of motor function\n              ( 111.08B ) addresses spinal cord disorders that result in less than complete loss of function of the affected part(s) of the body, \n              reducing,  but not eliminating, motor, sensory, and autonomic function. When we evaluate your spinal cord disorder, we generally need evidence from at least 3 months after your symptoms began in  order to evaluate your disorganization of motor function. In some cases,  evidence of your spinal cord disorder may be  sufficient to allow your claim within 3 months after the spinal cord disorder.  If the medical evidence demonstrates total cord transection causing a loss of  motor and sensory functions below the level of injury, we will not wait 3  months but will make the allowance decision immediately. K. What are communication impairments associated with neurological disorders, \n              and how do we evaluate them under 111.09 ? Communication impairments result from medically determinable neurological disorders that cause dysfunction in the parts of the \n              brain responsible for speech and language. Under 111.09 ,\n    we must have recent  comprehensive evaluation including all areas of affective and effective  communication, performed by a qualified professional, to document a  communication impairment associated with a neurological disorder. Under 111.09A ,\n    we need documentation from a qualified  professional that your neurological disorder has resulted in a speech deficit that  significantly affects your ability to communicate. Significantly affects means  that you demonstrate a serious limitation in communicating, and a person who is  unfamiliar with you cannot easily understand or interpret your speech. Under 111.09B ,\n    we need documentation from a qualified professional that shows that your neurological disorder has resulted in a  comprehension deficit that results in ineffective verbal communication for your age. \n              For the purposes of 111.09B , comprehension deficit means a deficit in  receptive language. Ineffective verbal communication means that you demonstrate  serious limitation in your ability to communicate orally on the same level as  other children of the same age and level of development. Under 111.09C ,\n    we need documentation of a neurological disorder that has resulted in hearing loss. Your hearing loss will be evaluated under listing 102.10 or 102.11 . We evaluate speech deficits due to non-neurological disorders under 2.09 . L. What are neurodegenerative disorders of the central nervous system, \n              such as Juvenile -onset Huntington's disease and Friedreich's ataxia, \n              and how do we evaluate them under 111.17 ? Neurodegenerative disorders of the central nervous system are disorders characterized by progressive and irreversible degeneration of neurons or their supporting cells. \n                Over time, these disorders impair many of the body's motor or cognitive and other mental functions. \n                We consider neurodegenerative disorders of the central nervous system under 111.17 that we do not evaluate elsewhere in section 111.00 , \n                such as juvenile-onset Huntington's disease (HD) and Friedreich's ataxia.  \n                When these disorders result in solely cognitive and other mental functional limitations, we will evaluate the disorder under the  mental disorder listings, 112.00 . M. What is traumatic brain injury, and how do we evaluate it under 111.18 ? Traumatic brain injury (TBI) is damage to the brain resulting from skull fracture, collision with an external force leading to a closed head injury, \n              or penetration by an object that enters the skull and makes contact with brain tissue. \n              We evaluate a TBI that results in coma or persistent vegetative state (PVS) under 111.20 . We generally need evidence from at least 3 months after the TBI to evaluate whether you have disorganization of motor function under 111.18 .\n    In some cases, evidence of your TBI is sufficient to determine disability. If we are unable to allow your claim within 3 months post-TBI,\n    we will defer adjudication of the claim until we obtain evidence of your neurological disorder at least 3 months post-TBI.\n    If a finding of disability still is not possible at that time, we will again defer adjudication of the claim until we obtain evidence at least 6 months after your TBI. N. What are coma and persistent vegetative state, and how do we evaluate them under 111.20 ? Coma is a state of unconsciousness in which a child does not exhibit a sleep/wake cycle, and is unable to perceive or respond to external stimuli. Children  who do not fully emerge from coma may progress into persistent vegetative state  (PVS). PVS is a condition of partial arousal in which a child may have a low  level of consciousness but is still unable to react to external stimuli. In  contrast to coma, a child in a PVS retains sleep/wake cycles and may exhibit  some key lower brain functions, such as spontaneous movement, opening and  moving eyes, and grimacing. Coma or PVS may result from a TBI, a nontraumatic  insult to the brain (such as a vascular insult, infection, or brain tumor), or  a neurodegenerative or metabolic disorder. Medically induced comas should be  considered under the section pertaining to the underlying reason the coma was  medically induced and not under this section. O. What is multiple sclerosis, and how do we evaluate it under 111.21 ? Multiple sclerosis (MS) is a chronic, inflammatory, degenerative disorder that damages the myelin sheath surrounding the nerve fibers in the brain and spinal cord. The damage disrupts the normal transmission  of nerve impulses within the brain and between the brain and other parts of the  body causing impairment in muscle coordination, strength, balance, sensation,  and vision. There are several forms of MS, ranging from slightly to highly  aggressive. Milder forms generally involve acute attacks (exacerbations) with  partial or complete recovery from signs and symptoms (remissions). Aggressive  forms generally exhibit a steady progression of signs and symptoms with few or  no remissions. The effects of all forms vary from child to child. We evaluate your signs and symptoms, such as flaccidity, spasticity, spasms, incoordination, imbalance, tremor, physical fatigue, muscle weakness, \n              dizziness, tingling, and numbness when we determine  your ability to stand up, balance, walk, or perform fine and gross motor  movements, such as using your arms, hands, and fingers. \n              If you have a vision  impairment resulting from your MS, we may evaluate that impairment under the special senses body system, 102.00 . P. What are motor neuron disorders, and how do we evaluate them under 111.22 ? Motor neuron disorders are progressive neurological disorders that destroy the cells  that control voluntary muscle activity, such as walking, breathing, swallowing, and speaking. \n    The most common motor neuron disorders in children are progressive bulbar palsy and spinal muscular dystrophy syndromes. \n    We evaluate the effects of these disorders on motor functioning or bulbar and neuromuscular functioning. Q. How do we consider symptom s of fatigue in these listings? Fatigue is one of  the most common and limiting symptoms of some neurological disorders, such as  multiple sclerosis and myasthenia gravis. \n    These disorders may result in physical fatigue (lack of muscle strength) or mental fatigue (decreased awareness or  attention). When we evaluate your fatigue, we will consider the intensity, \n    persistence, and effects of fatigue on your functioning. This may include  information such as the clinical and laboratory data and other objective  evidence concerning your neurological deficit, \n    a description of fatigue  considered characteristic of your disorder, and information about your functioning. We consider the effects of physical fatigue on your ability to stand up, \n    balance, walk, or perform fine and gross motor movements using the criteria described in 111.00D . R. How do we evaluate your neurological disorder when it does not meet one of these listings? If your neurological disorder does not meet the criteria of any of these listings, \n              we must also consider whether your impairment(s) meets the criteria of a listing in another body system. If  you have a severe medically determinable impairment(s) that does not meet a listing, \n              we will determine whether your impairment(s) medically equals a listing. \n              See § 416.926 of this chapter. If your impairment(s) does not meet or medically equal a listing, we will consider whether your impairment(s) functionally equals the  listings. \n              See § 416.926a of this chapter. We use the rules in § 416.994a of this chapter when we decide whether you continue to be disabled. 111.01 Category of Impairments, Neurological Disorders 111.02 Epilepsy ,  documented by a detailed description of a typical seizure and characterized by  A or B: A. Generalized tonic-clonic seizures (see 111.00F1a ),\n    occurring at least once a month for at least 3 consecutive months\n    (see 111.00F4 ) despite adherence to prescribed treatment\n    (see 111.00C ). OR B.  Dyscognitive seizures (see 111.00F1b )\n    or absence seizures (see 111.00F1c ),\n    occurring at least once a week for at least 3 consecutive months (see 111.00F4 )\n    despite adherence to prescribed treatment (see 111.00C ). 111.03 [Reserved] 111.04 Vascular insult to the brain , \n    characterized by disorganization of motor function in two extremities (see 111.00D1 ),\n    resulting in an extreme limitation (see 111.00D2 ) in the ability to stand up from a seated position,\n    balance while standing or walking, or use the upper extremities, persisting for at least 3 consecutive months after the insult. 111.05 Benign brain tumors , \n    characterized by disorganization of motor function in two extremities (see 111.00D1 ),\n    resulting in an extreme limitation (see 111.00D2 ) in the ability to stand up from a seated position,\n    balance while standing or walking, or use the upper extremities. 111.06 [Reserved] 111.07 Cerebral palsy , characterized by disorganization of motor function in two extremities (see 111.00D1 ),\n    resulting in an extreme limitation (see 111.00D2 )\n    in the ability to stand up from a seated position, balance while  standing or walking, or use the upper extremities. 111.08 Spinal cord disorders , characterized by A or B: A. Complete loss of function, \n    as described in 111.00J2 ,\n    persisting for 3 consecutive months after the disorder (see 111.00J4 ). OR B. Disorganization of motor function in two extremities (see 111.00D1 ),\n    resulting in an extreme limitation (see 111.00D2 ) in the ability to stand up from a seated position,\n    balance while standing or walking,\n    or use the upper extremities persisting for 3 consecutive months after the disorder (see 111.00J4 ). 111.09 Communication  impairment , associated with documented neurological disorder and  one of the following: A. Documented speech deficit that significantly affects \n    (see 111.00K1 ) the clarity and content of the speech. OR B. Documented comprehension deficit resulting in ineffective verbal communication \n    (see 111.00K2 ) for age. OR C. Impairment of hearing as described under the criteria in 102.10 or 102.11 . 111.10 [Reserved] 111.11 [Reserved] 111.12 Myasthenia  gravis , characterized by A or B despite adherence to prescribed treatment for at least 3 months \n            (see 111.00C ): A. Disorganization of motor function in two extremities (see 111.00D1 ),\n                resulting in an extreme limitation (see 111.00D2 ) in the ability to stand up from a seated position,\n                balance while standing or walking, or use the upper extremities. OR B. Bulbar and neuromuscular dysfunction (see 111.00E ), resulting in: One myasthenic crisis requiring mechanical ventilation; or Need for supplemental enteral nutrition via a gastrostomy or parenteral nutrition via a central venous catheter. 111.13 Muscular dystrophy , \n    characterized by disorganization of motor function in two extremities (see 111.00D1 ),\n    resulting in an extreme limitation (see  111.00D2) in the ability to stand up from a seated position, balance while  standing or walking, or use the upper extremities. 111.14 Peripheral neuropathy , \n    characterized by disorganization of motor function in two extremities (see 111.00D1 ),\n    resulting in an extreme limitation (see 111.00D2 )\n    in the ability to stand up from a seated position, balance while standing or  walking, or use the upper extremities. 111.15 [Reserved] 111.16 [Reserved] 111.17 Neurodegenerative disorders of the central nervous system, \n              such as Juvenile-onset Huntington's disease and Friedreich's ataxia , characterized by disorganization of motor function in two extremities (see 111.00D1 ),\n    resulting in an extreme limitation (see 111.00D2 )\n    in the ability to stand up from a seated position, balance while standing or walking, or use the  upper extremities. 111.18 Traumatic brain injury , \n    characterized by disorganization of motor function in two extremities (see 111.00D1 ),\n    resulting in an extreme limitation (see 111.00D2 ) in the ability to stand up from a seated position,\n    balance while standing or walking, or use the upper extremities, persisting for at least 3 consecutive months after the injury. 111.19 [Reserved] 111.20 Coma or persistent vegetative state , persisting for at least 1 month. 111.21 Multiple sclerosis , \n    characterized by disorganization of motor function in two extremities (see 111.00D1 ),\n    resulting in an extreme limitation (see 111.00D2 )\n    in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities. 111.22 Motor neuron disorders , characterized by A or B: A. Disorganization of motor function in two extremities (see 111.00D1 ),\n    resulting in an extreme limitation (see 111.00D2 )\n    in the ability to stand up from a seated position, balance while standing or walking, or use the upper extremities. OR B. Bulbar and neuromuscular dysfunction (see 111.00E ), resulting in: Acute respiratory failure requiring invasive mechanical ventilation; or Need for supplemental enteral nutrition via a gastrostomy or parenteral nutrition via a central venous catheter.",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security111.00 Neurological - Childhood"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_01",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_02",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_03",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_04",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_05",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_06",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_07",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_08",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_09",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_10",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_11",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_12",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_13",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_14",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_15",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_16",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_17",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_18",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_19",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_20",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_21",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_22",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_02",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_12",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_02",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_20",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_12",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_22",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_02",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_02",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00F1a",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_02",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_02A",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_02B",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00C",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0930.htm#c",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_02",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_04",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_04",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_05",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_07",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_08",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_08A",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_08B",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_09",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_09A",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_09A",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_09B",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_09B",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_09C",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_10",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_11",
      "https://www.ssa.gov/disability/professionals/bluebook/2.00-SpecialSensesandSpeech-Adult.htm#2_09",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_17",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_17",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_18",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_20",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_18",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_20",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_21",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_22",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm#a",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0994.htm#a",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00F1a",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00F4",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00C",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00F1b",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00F1c",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00F4",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00C",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D1",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D1",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D1",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00J2",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00J4",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D1",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00J4",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00K1",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00K2",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_10",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_11",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00C",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D1",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00E",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D1",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D1",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D1",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D1",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D1",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D1",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00E",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm"
    ],
    "html_file": "ssa_bluebook_data/html/8a61055998953d0002698cd0bf8626c1.html",
    "fetched_at": 1762482862.8986294
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00",
    "url_hash": "df34ec3ef2bc3c8d001c0c12cfc27930",
    "title": "114.00 Immune System Disorders | Disability | SSA",
    "text_content": "114.00 Immune System Disorders | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Listing of Impairments - Child Listings (Part B) 114.00 Immune System Disorders - Childhood Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security 114.00 Immune System Disorders - Childhood Section 114.01 Category \n              of Impairments, Immune System Disorders 114.02 Systemic lupus erythematosus 114.03 Systemic vasculitis 114.04 Systemic sclerosis (scleroderma) 114.05 Polymyositis or dermatomyositis 114.06 Undifferentiated and mixed connective tissue disease 114.07 Immune deficiency disorders, excluding HIV infection 114.08 [Reserved] 114.09 Inflammatory arthritis 114.10 Sjögren’s syndrome 114.11 Human immunodeficiency virus (HIV) infection 114.00 Immune System Disorders A. What disorders do we evaluate under the immune system disorders listings? 1. We evaluate  immune system disorders that cause dysfunction in one or more components of  your immune system. a. The dysfunction may be due to problems in antibody  production, impaired cell-mediated immunity, a combined type of  antibody/cellular deficiency, impaired phagocytosis, or complement deficiency. b. Immune system disorders may result in recurrent and  unusual infections, or inflammation and dysfunction of the body’s own tissues.  Immune system disorders can cause a deficit in a single organ or body system  that results in extreme (that is, very serious) loss of function. They can also  cause lesser degrees of limitations  in two or more organs or body systems, and when associated with symptoms or signs, such as severe  fatigue, fever, malaise, diffuse  musculoskeletal pain, or involuntary weight loss, can also result in extreme limitation. In children, immune system disorders or their  treatment may also affect growth, development, and the performance of age‑appropriate  activities. c. We organize the discussions of immune system  disorders in three categories: Autoimmune disorders; Immune deficiency  disorders, excluding human immunodeficiency virus (HIV) infection; and HIV  infection. Back to Top 2. Autoimmune disorders ( 114.00D ). Autoimmune disorders are caused by dysfunctional immune responses directed against the body’s own tissues, resulting in chronic,\n                multisystem impairments that differ in clinical manifestations, course, and outcome.\n                They are sometimes referred to as rheumatic diseases, connective tissue disorders, or collagen vascular disorders.\n                Some of the features of autoimmune disorders in children differ from the features of the same disorders in adults.\n                The impact of the disorders or their treatment on physical, psychological, and developmental growth of  pre-pubertal children may be considerable,\n                and often differs from that of post-pubertal adolescents or adults. 3. Immune deficiency disorders, excluding HIV infection ( 114.00E ). Immune deficiency disorders are characterized by recurrent or unusual infections that respond poorly to treatment, and are often  associated with complications affecting other parts of the body.\n                Immune deficiency disorders are classified as either primary (congenital) or acquired .\n                Children with immune deficiency disorders also have an increased risk of malignancies and of having autoimmune disorders. 4. Human immunodeficiency virus (HIV) infection ( 114.00F ). HIV infection may be characterized by increased susceptibility to common infections as well as opportunistic infections, cancers,\n                or other conditions listed in 114.11 . Back to Top B. What information do we need to show that you have an immune system  disorder? Generally, we need your medical  history, a report(s) of a physical examination, a report(s) of laboratory  findings, and in some instances, appropriate medically acceptable imaging or  tissue biopsy reports to show that you have an immune system disorder.  Therefore, we will make every reasonable effort to obtain your medical history, medical findings, and results of laboratory tests. We explain the information we need  in more detail in the sections below. C. Definitions 1. Appropriate medically acceptable imaging includes, but is not limited to, angiography, x-ray imaging, computerized axial tomography (CAT scan) or magnetic resonance imaging (MRI), with or without contrast material,  myelography, and radionuclear bone scans. “Appropriate” means that the  technique used is the proper one to support the evaluation and diagnosis of the  impairment. 2. Constitutional symptoms or signs , as used in these listings, means  severe fatigue, fever, malaise, or involuntary weight loss. Severe fatigue means a frequent sense of exhaustion that results in significantly reduced  physical activity or mental function. Malaise means frequent feelings of  illness, bodily discomfort, or lack of well-being that result in significantly  reduced physical activity or mental function. 3. Disseminated means that a condition  is spread over a considerable area. The type and extent of the spread will  depend on your specific disease. 4. Dysfunction means that one or more of the body regulatory mechanisms are impaired, causing  either an excess or deficiency of immunocompetent cells or their products. Back to Top 5. Extra-articular means “other than the joints”; for example, an organ(s) such as the heart,  lungs, kidneys, or skin. 6. Documented medical need has the same meaning as in 101.00C6a . 7. Fine and gross movements has the same meaning as in 101.00E4 . 8. Major joint of an upper or a lower extremity has the same meaning as in 101.00I2 and 101.00I3 . 9. Persistent means that a sign(s) or symptom(s) has continued over  time. The precise meaning will depend on the specific immune system disorder,  the usual course of the disorder, and the other circumstances of your clinical  course. 10. Recurrent means that a condition that previously responded  adequately to an appropriate course of treatment returns after a period of  remission or regression. The precise meaning, such as the extent of response or  remission and the time periods involved, will depend on the specific disease or  condition you have, the body system affected, the usual course of the disorder  and its treatment, and the other facts of your particular case. 11. Resistant to treatment means that a  condition did not respond adequately to an appropriate course of treatment.  Whether a response is adequate or a course of treatment is appropriate will  depend on the specific disease or condition you have, the body system affected,  the usual course of the disorder and its treatment, and the other facts of your  particular case. Back to Top 12. Severe means medical severity as used by the medical community.\n                The term does not have the same meaning as it does when we use it in connection with a finding at the second step of the sequential evaluation process\n                in § 416.920 of this chapter. D. How do we document and evaluate the listed autoimmune disorders? 1. Systemic lupus erythematosus ( 114.02 ). a. General. Systemic lupus erythematosus (SLE) is a chronic inflammatory disease that can affect any organ or body  system. It is frequently, but not always, accompanied by constitutional  symptoms or signs (severe fatigue, fever, malaise, involuntary weight loss).  Major organ or body system involvement can include: Respiratory (pleuritis,  pneumonitis), cardiovascular (endocarditis, myocarditis, pericarditis,  vasculitis), renal (glomerulonephritis), hematologic (anemia, leukopenia,  thrombocytopenia), skin (photosensitivity), neurologic (seizures), mental  (anxiety, fluctuating cognition (“lupus fog”), mood disorders, organic brain  syndrome, psychosis), or immune system disorders (inflammatory arthritis).  Immunologically, there is an array of circulating serum auto-antibodies and  pro- and anti-coagulant proteins that may occur in a highly variable pattern. b. Documentation of SLE. Generally, but not always, the medical evidence will show that your SLE satisfies the criteria in the current “Criteria for the Classification of Systemic Lupus  Erythematosus” by the American College of Rheumatology found in the most recent  edition of the Primer on the Rheumatic Diseases published by the  Arthritis Foundation. Back to Top 2. Systemic vasculitis ( 114.03 ). a. General. (i) Vasculitis is an inflammation of blood vessels. It may occur acutely in  association with adverse drug reactions, certain chronic infections, and  occasionally, malignancies. More often, it is chronic and the cause is unknown.  Symptoms vary depending on which blood vessels are involved. Systemic  vasculitis may also be associated with other autoimmune disorders; for example,  SLE or dermatomyositis. (ii) Children can develop the vasculitis of Kawasaki disease,\n                of which the most serious manifestation is formation of coronary artery aneurysms and related complications.\n                We evaluate heart problems related to Kawasaki disease under the criteria in the cardiovascular listings \n                ( 104.00 ).\n                Children can also develop the vasculitis of anaphylactoid purpura (Henoch-Schoenlein purpura), which may cause intestinal and renal disorders.\n                We evaluate intestinal and  renal disorders related to vasculitis of anaphylactoid purpura under the criteria in the digestive\n                ( 105.00 ) or\n                genitourinary ( 106.00 ) listings.\n                Other clinical patterns include, but are not limited to, polyarteritis nodosa,\n                Takayasu’s arteritis (aortic arch arteritis), and Wegener’s granulomatosis. b. Documentation of systemic vasculitis. Angiography or tissue biopsy confirms a diagnosis of systemic vasculitis when the disease is suspected clinically. When you have had angiography or tissue biopsy for  systemic vasculitis, we will make every reasonable effort to obtain reports of  the results of that procedure. However, we will not purchase angiography or  tissue biopsy. Back to Top 3. Systemic sclerosis (scleroderma) ( 114.04 ). a. General. Systemic sclerosis  (scleroderma) constitutes a spectrum of disease in which thickening of the skin  is the clinical hallmark. Raynaud’s phenomenon, often medically severe and  progressive, is present frequently and may be the peripheral manifestation of a  vasospastic abnormality in the heart, lungs, and kidneys. The CREST syndrome  (calcinosis, Raynaud’s phenomenon, esophageal dysmotility, sclerodactyly, and  telangiectasia) is a variant that may slowly progress over years to the  generalized process, systemic sclerosis. b. Diffuse cutaneous systemic sclerosis. In  diffuse cutaneous systemic sclerosis (also known as diffuse scleroderma), major  organ or systemic involvement can include the gastrointestinal tract, lungs,  heart, kidneys, and muscle in addition to skin or blood vessels. Although  arthritis can occur, joint dysfunction results primarily from soft  tissue/cutaneous thickening, fibrosis, and contractures. c. Localized scleroderma (linear scleroderma  and morphea). (i) Localized scleroderma (linear scleroderma and  morphea) is more common in children than systemic scleroderma.\n                To assess the severity of the impairment, we need a description of the extent of involvement of linear scleroderma and the location of the lesions.\n                For example, linear scleroderma involving the arm but not crossing any joints is not as functionally limiting as sclerodactyly (scleroderma localized to the fingers).\n                Linear scleroderma of a lower extremity involving skin thickening and atrophy of underlying muscle or bone can result in contractures and leg length discrepancy.\n                In such cases, we may evaluate your impairment under the musculoskeletal listings \n                ( 101.00 ). Back to Top (ii) When there is isolated morphea of the face causing facial disfigurement from unilateral hypoplasia of the mandible,\n                maxilla, zygoma, or orbit, adjudication  may be more appropriate under the criteria in the affected body system,\n                such as special senses and speech ( 102.00 )\n                or mental disorders ( 112.00 ). (iii) Chronic variants of these syndromes include disseminated morphea, Shulman’s  disease (diffuse fasciitis with eosinophilia),\n                and eosinophilia-myalgia syndrome (often associated with toxins such as toxic oil or contaminated tryptophan),\n                all of which can impose medically severe musculoskeletal dysfunction and may also lead to restrictive pulmonary disease.\n                We evaluate these variants of the disease under the criteria in the musculoskeletal listings\n                ( 101.00 ) or\n                respiratory system listings ( 103.00 ). d. Documentation of systemic sclerosis (scleroderma). Documentation involves differentiating the clinical features  of systemic sclerosis (scleroderma) from other autoimmune disorders. However,  there may be an overlap . 4. Polymyositis and dermatomyositis ( 114.05 ). a. General. (i) Polymyositis and dermatomyositis are related  disorders that are characterized by an inflammatory process in striated muscle,  occurring alone or in association with other autoimmune disorders. The most  common manifestations are symmetric weakness, and less frequently, pain and  tenderness of the proximal limb-girdle (shoulder or pelvic) musculature. There  may also be involvement of the cervical, cricopharyngeal, esophageal,  intercostal, and diaphragmatic muscles. Back to Top (ii) Polymyositis occurs rarely in children; the more  common presentation in children is dermatomyositis with symmetric proximal muscle weakness and characteristic skin findings. The clinical course of  dermatomyositis can be more severe when it is accompanied by systemic  vasculitis rather than just localized to striated muscle. Late in the disease,  some children with dermatomyositis develop calcinosis of the skin and  subcutaneous tissues, muscles, and joints. We evaluate the involvement of other  organs/body systems under the criteria for the listings in the affected body  system. b. Documentation  of polymyositis and dermatomyositis. Generally, but not always,  polymyositis is associated with elevated serum muscle enzymes (creatine  phosphokinase (CPK), aminotransferases, and aldolase), and characteristic  abnormalities on electromyography and muscle biopsy. In children, the diagnosis  of dermatomyositis is supported largely by medical history, findings on  physical examination that include the characteristic skin findings, and  elevated serum muscle enzymes. Muscle inflammation or vasculitis depicted on  MRI is additional evidence supporting the diagnosis of childhood  dermatomyositis. When you have had electromyography, muscle biopsy, or MRI for  polymyositis or dermatomyositis, we will make every reasonable effort to obtain  reports of the results of that procedure. However, we will not purchase  electromyography, muscle biopsy, or MRI. c. Additional information about how we  evaluate polymyositis and dermatomyositis under the listings. Back to Top (i) In newborn and younger infants (birth  to attainment of age 1), we consider muscle weakness that affects motor skills, such as head control,\n                reaching, grasping, taking solids, or self-feeding, under 114.05A .\n                In older infants and toddlers (age 1 to attainment of age 3), we also consider muscle weakness affecting your ability to roll over, sit, crawl,\n                or walk under 114.05A . (ii) If you are of preschool age through  adolescence (age 3 to attainment of age 18),\n                weakness of your pelvic girdle muscles that results in your inability to rise independently from a squatting\n                or sitting position or to climb stairs may be an indication that you are unable to walk without assistance.\n                Weakness of your shoulder girdle muscles may result in  your inability to perform lifting, carrying, and reaching overhead,\n                and also may seriously affect your ability to perform activities requiring fine movements.\n                We evaluate these limitations under 114.05A . 5. Undifferentiated and mixed connective tissue disease ( 114.06 ). a. General. This listing includes syndromes with clinical and immunologic features of several autoimmune  disorders, but which do not satisfy the criteria for any of the specific  disorders described. For example, you may have clinical features of SLE and  systemic vasculitis, and the serologic (blood test) findings of rheumatoid  arthritis. The most common pattern of undifferentiated autoimmune disorders in  children is mixed connective tissue disease (MCTD). b. Documentation of undifferentiated and  mixed connective tissue disease. Undifferentiated connective tissue disease  is diagnosed when clinical features and serologic (blood test) findings, such  as rheumatoid factor or antinuclear antibody (consistent with an autoimmune  disorder) are present but do not satisfy the criteria for a specific disease.  Children with MCTD have laboratory findings of extremely high antibody titers  to extractable nuclear antigen (ENA) or ribonucleoprotein (RNP) without high  titers of anti-dsDNA or anti-SM antibodies. There are often clinical findings  suggestive of SLE or childhood dermatomyositis. Many children later develop  features of scleroderma. Back to Top 6. Inflammatory arthritis ( 114.09 ). a. General. The spectrum of inflammatory arthritis includes a vast array of disorders that differ in cause, course, and outcome.\n                Clinically, inflammation of major joints in an upper or a lower extremity may be the dominant manifestation causing difficulties with walking or fine and gross movements;\n                there may be joint pain, swelling, and tenderness. The arthritis may affect other joints, or cause less limitation in walking or fine and gross movements.\n                However, in combination with extra-articular features, including constitutional symptoms or signs\n                (severe fatigue, fever, malaise and involuntary weight loss),\n                inflammatory arthritis may result in an extreme limitation. b. Inflammatory arthritis involving the axial spine (spondyloarthropathy). In children, inflammatory arthritis involving the axial spine may be associated with disorders such as: (i)  Reactive arthropathies; (ii)  Juvenile ankylosing spondylitis; (iii)  Psoriatic arthritis; (iv)  SEA syndrome (seronegative enthesopathy arthropathy syndrome); Back to Top (v)  Behçet’s disease; and (vi)  Inflammatory bowel disease. c. Inflammatory  arthritis involving the peripheral joints. In children, inflammatory arthritis involving peripheral joints may be associated with disorders such as: (i)  Juvenile rheumatoid arthritis; (ii)  Sjögren’s syndrome; (iii)  Psoriatic arthritis; (iv)  Crystal deposition disorders (gout and pseudogout); (v)  Lyme disease; and (vi)  Inflammatory bowel disease. d. Documentation of inflammatory arthritis. Generally, but not always, the diagnosis of inflammatory arthritis is based on the clinical features and serologic findings described in the most recent edition  of the Primer on the Rheumatic Diseases published by the Arthritis  Foundation. Back to Top e. How we evaluate inflammatory arthritis under the listings. (i) Listing-level severity in 114.09A and 114.09C1 is shown by the presence of an impairment-related physical limitation of functioning.\n                In 114.09C1 ,\n                if you have the required ankylosis (fixation) of your cervical or dorsolumbar spine,\n                we will find that you have a listing-level impairment-related physical limitation in your ability to see in front of you, above you, and to the side , even though you might not require bilateral upper limb assistance. (ii) Listing-level severity in 114.09B and 114.09C2 is shown\n                by inflammatory arthritis that involves various combinations of complications (such as inflammation or deformity, extra-articular features, repeated manifestations, and constitutional symptoms and signs) of one or more major of one or more major joints in an upper or a lower extremity (see 114.00C8 ) or other joints.\n                Extra-articular impairments may also meet listings in other body systems. (iii) Extra-articular features of inflammatory arthritis may involve any body system; for example: Musculoskeletal (heel enthesopathy), ophthalmologic (iridocyclitis,  keratoconjunctivitis sicca, uveitis), pulmonary (pleuritis, pulmonary fibrosis  or nodules, restrictive lung disease), cardiovascular (aortic valve  insufficiency, arrhythmias, coronary arteritis, myocarditis, pericarditis,  Raynaud’s phenomenon, systemic vasculitis), renal (amyloidosis of the kidney),  hematologic (chronic anemia, thrombocytopenia), neurologic (peripheral  neuropathy, radiculopathy, spinal cord or cauda equina compression with sensory  and motor loss), mental (cognitive dysfunction, poor memory), and immune system  (Felty’s syndrome (hypersplenism with compromised immune competence)). Back to Top (iv) If both inflammation and chronic deformities are present, we evaluate your  impairment under the criteria of any appropriate listing. 7. Sjögren’s syndrome ( 114.10 ). a. General. (i) Sjögren’s syndrome is an immune-mediated disorder of the exocrine glands.  Involvement of the lacrimal and salivary glands is the hallmark feature,  resulting in symptoms of dry eyes and dry mouth, and possible complications,  such as corneal damage, blepharitis (eyelid inflammation), dysphagia  (difficulty in swallowing), dental caries, and the inability to speak for  extended periods of time. Involvement of the exocrine glands of the upper  airways may result in persistent dry cough. (ii) Many other organ systems may be involved, including musculoskeletal (arthritis, myositis), respiratory (interstitial fibrosis), gastrointestinal (dysmotility,  dysphagia, involuntary weight loss), genitourinary (interstitial cystitis,  renal tubular acidosis), skin (purpura, vasculitis,), neurologic (central  nervous system disorders, cranial and peripheral neuropathies), mental  (cognitive dysfunction, poor memory), and neoplastic (lymphoma). Severe fatigue  and malaise are frequently reported. Sjögren’s syndrome may be associated with  other autoimmune disorders (for example, rheumatoid arthritis or SLE); usually  the clinical features of the associated disorder predominate. b. Documentation of Sjögren’s syndrome. If you have Sjögren’s syndrome, the medical evidence will generally, but not  always, show that your disease satisfies the criteria in the current “Criteria  for the Classification of Sjögren’s Syndrome” by the American College  of Rheumatology found in the most recent edition of the Primer on the  Rheumatic Diseases published by the Arthritis Foundation. Back to Top E. How do we document and evaluate immune deficiency disorders, excluding HIV infection ? 1. General. a. Immune deficiency disorders can be classified as: (i) Primary (congenital); for example, X-linked agammaglobulinemia, thymic hypoplasia (DiGeorge syndrome), severe combined immunodeficiency (SCID), chronic  granulomatous disease (CGD), C1 esterase inhibitor deficiency. (ii) Acquired; for example, medication-related. b. Primary immune deficiency disorders are seen mainly  in children. However, recent advances in the treatment of these disorders have  allowed many affected children to survive well into adulthood. Occasionally,  these disorders are first diagnosed in adolescence or adulthood. 2. Documentation of immune deficiency disorders. The medical evidence must include documentation of the specific  type of immune deficiency. Documentation may be by laboratory evidence or by  other generally acceptable methods consistent with the prevailing state of  medical knowledge and clinical practice. Back to Top 3. Immune deficiency disorders treated by stem cell transplantation. a. Evaluation in the first 12 months. If you undergo stem cell transplantation for your immune deficiency disorder, we  will consider you disabled until at least 12 months from the date of the  transplant. b. Evaluation after the 12-month period has elapsed. After the 12-month period has elapsed, we will consider any  residuals of your immune deficiency disorder as well as any residual  impairment(s) resulting from the treatment, such as complications arising from: (i) Graft-versus-host (GVH) disease. (ii) Immunosuppressant therapy, such as frequent infections. (iii) Significant deterioration of other organ systems. 4. Medication-induced immune suppression. Medication effects can result in varying degrees of immune  suppression, but most resolve when the medication is ceased. However, if you  are prescribed medication for long-term immune suppression, such as after an  organ transplant, we will evaluate: a. The frequency and severity of infections. b. Residuals from the organ transplant itself, after the 12-month period has elapsed. c. Significant deterioration of other organ systems. Back to Top F. How do we document and evaluate HIV infection? Any child with HIV infection, including one with a diagnosis of acquired immune deficiency syndrome (AIDS),\n                may be found disabled under 114.11 if his\n                or her impairment meets the criteria in that listing or is medically equivalent to the criteria in that listing. 1. Documentation of HIV infection. a. Definitive documentation of HIV infection. We may document a diagnosis of HIV infection by positive findings on one or more of the following definitive laboratory tests: (i) HIV antibody screening test (for  example, enzyme immunoassay, or EIA), confirmed by a supplemental HIV antibody test such as the Western blot (immunoblot) or immunofluorescence assay, for any  child age 18 months or older. (ii) HIV nucleic acid (DNA or RNA) detection test (for example, polymerase chain reaction, or PCR). (iii) HIV p24 antigen (p24Ag) test, for any child age 1 month or older. (iv) Isolation of HIV in viral culture. (v) Other tests that are highly specific for detection of HIV and that are consistent with the prevailing state  of medical knowledge. b. We will make every reasonable effort to obtain the results of your laboratory testing.\n                Pursuant to § 416.919f ,\n                we will purchase examinations or tests necessary to make a determination in your claim if no other acceptable documentation exists. c. Other acceptable documentation of HIV infection. We may also  document HIV infection without definitive laboratory evidence. (i) We will accept a persuasive report from a physician that a positive diagnosis of your HIV infection was confirmed by an appropriate laboratory test(s),\n                such as those described in 114.00F1a .\n                To be persuasive, this report must state that you had the appropriate definitive laboratory test(s) for diagnosing your HIV infection and provide the results.\n                The report must also be consistent with the remaining evidence of record. (ii) We may also document HIV infection by the medical history, clinical and laboratory findings, and  diagnosis(es) indicated in the medical evidence, provided that such  documentation is consistent with the prevailing state of medical knowledge and  clinical practice and is consistent with the other evidence in your case  record. For example, we will accept a diagnosis of HIV infection without  definitive laboratory evidence of the HIV infection if you have an  opportunistic disease that is predictive of a defect in cell-mediated immunity  (for example, toxoplasmosis of the brain or Pneumocystis pneumonia (PCP)), and  there is no other known cause of diminished resistance to that disease (for  example, long-term steroid treatment or lymphoma). In such cases, we will make  every reasonable effort to obtain full details of the history, medical findings,  and results of testing. 2. Documentation of the manifestations of HIV infection. a. Definitive documentation of manifestations of HIV infection. We may document manifestations of HIV infection by positive findings on definitive  laboratory tests, such as culture, microscopic examination of biopsied tissue  or other material (for example, bronchial washings), serologic tests, or on  other generally acceptable definitive tests consistent with the prevailing  state of medical knowledge and clinical practice. b. We will make every reasonable effort to obtain the results of your laboratory testing. \n                Pursuant to § 416.919f ,\n                we will purchase examinations or tests necessary to make a determination of your claim if no other acceptable documentation exists. c. Other acceptable documentation of manifestations of HIV infection. We may also document manifestations of HIV infection without definitive  laboratory evidence. (i) We will accept a persuasive report from a physician that a positive diagnosis of your manifestation of HIV  infection was confirmed by an appropriate laboratory test(s). To be persuasive,  this report must state that you had the appropriate definitive laboratory  test(s) for diagnosing your manifestation of HIV infection and provide the  results. The report must also be consistent with the remaining evidence of  record. (ii) We may also document manifestations of HIV infection without the definitive laboratory evidence described\n                in 114.00F2a,\n                provided that such documentation is consistent with the  prevailing state of medical knowledge and clinical practice and is consistent with the other evidence in your case record.\n                For example, many conditions are now commonly diagnosed based on some or all of the following:\n                Medical history, clinical manifestations, laboratory findings (including appropriate medically acceptable imaging), and treatment responses.\n                In such cases, we will make every reasonable effort to obtain full details of the history, medical findings, and results of testing. 3. Disorders associated with HIV infection \n                ( 114.11A - E ). a. Multicentric Castleman disease (MCD, 114.11A )\n                affects multiple groups of lymph nodes and organs containing lymphoid tissue.\n                This widespread involvement distinguishes MCD from localized (or unicentric) Castleman disease, which affects only a single set of lymph nodes.\n                While not a cancer, MCD is  known as a lymphoproliferative disorder. \n                Its clinical presentation and progression is similar to that of lymphoma, and its treatment may include radiation or chemotherapy.\n                We require characteristic findings on microscopic examination of the biopsied lymph nodes or other generally acceptable methods consistent\n                with the prevailing state of medical knowledge and clinical practice to establish the diagnosis.\n                Localized (or unicentric) Castleman disease does not meet or medically equal the criterion\n                in 114.11A , \n                but we may evaluate it under the criteria in 114.11G or 14.11I in part A. b. Primary central nervous system lymphoma (PCNSL, 114.11B ) originates in the brain, spinal cord, meninges, or eye.\n                Imaging tests (for example, MRI) of the brain, while not diagnostic, may show a single lesion or multiple lesions in the white matter of the brain.\n                We require characteristic findings on  microscopic examination of the cerebral spinal fluid or of the biopsied brain tissue,\n                or other generally acceptable methods consistent with the prevailing state of medical knowledge and clinical practice to establish the diagnosis. c. Primary effusion lymphoma (PEL, 114.11C ) is also known as body cavity lymphoma.\n                We require characteristic findings on microscopic examination of the effusion fluid or of the biopsied tissue from the affected internal organ,\n                or other generally acceptable methods consistent with the prevailing  state of medical knowledge and clinical practice to establish the diagnosis. d. Progressive multifocal leukoencephalopathy (PML, 114.11D ) is a progressive neurological degenerative syndrome caused by the John Cunningham (JC) virus in immunosuppressed children.\n                Clinical findings of PML include clumsiness, progressive weakness, and visual and speech changes.\n                Personality and cognitive changes may also occur. We require appropriate clinical findings, characteristic white matter lesions on MRI,\n                and a positive PCR test for the JC virus in the cerebrospinal fluid to establish the diagnosis.\n                We also accept a positive brain biopsy for JC virus or other generally acceptable methods consistent with the prevailing state of medical knowledge and clinical practice to establish the diagnosis. e. Pulmonary Kaposi sarcoma (Kaposi sarcoma in the lung, 114.11E )\n                is the most serious form of Kaposi sarcoma (KS). Other internal KS tumors (for example, tumors of the gastrointestinal tract) have a more variable prognosis.\n                We require characteristic findings on microscopic examination of the induced sputum, bronchoalveolar lavage washings,\n                or of the biopsied transbronchial tissue,\n                or other generally acceptable methods consistent with the prevailing state of medical knowledge and clinical practice to establish the diagnosis. 4. CD4 measurement ( 114.11F ). To evaluate your HIV infection under 114.11F , we require one measurement of your absolute CD4 count\n                (also known as CD4 count or CD4+ T-helper lymphocyte count) or CD4 percentage for children from birth to attainment of age 5,\n                or one measurement of your absolute CD4 count for children from age 5 to attainment of age 18.\n                These measurements (absolute CD4 count or CD4 percentage)\n                must occur within the period we are considering in connection with your application or continuing disability review.\n                If you have more than one CD4 measurement within this period, we will use your lowest absolute CD4 count or your lowest CD4 percentage. 5. Complications of HIV infection requiring hospitalization ( 114.11G ). a. Complications of HIV infection may include infections (common or opportunistic), cancers, and other conditions. Examples of complications that may result in hospitalization include:  Depression; diarrhea; immune reconstitution inflammatory syndrome; malnutrition;  and PCP and other severe infections. b. Under 114.11G ,\n                we require three hospitalizations within a 12-month period that are at least 30 days apart and that result from a complication(s) of HIV infection.\n                The hospitalizations may be for the same complication or different complications of HIV infection and are not limited to the examples of complications that may result in hospitalization\n                listed in 114.00F5a .\n                All three hospitalizations must occur  within the period we are considering in connection with your application or continuing disability review.\n                Each hospitalization must last at least 48 hours, including hours in a hospital emergency department immediately before the hospitalization. c. We will use the rules on medical equivalence\n                in § 416.926 to evaluate your HIV infection if you have fewer, but longer, hospitalizations, or more frequent, but shorter, hospitalizations,\n                or if you receive nursing, rehabilitation, or other care in alternative settings. 6. Neurological manifestations specific to children ( 114.11H ). The methods of identifying and evaluating neurological manifestations may vary depending on a child's age. For example, in an infant,\n                impaired brain growth can be documented by a decrease in the growth rate of the head. In an older child,\n                impaired brain growth may be documented by brain atrophy on a CT scan or MRI.\n                Neurological manifestations may present in the loss of acquired developmental milestones\n                (developmental regression) in infants and young children or, in the loss of acquired intellectual abilities in school-age children and adolescents.\n                A child may demonstrate loss of intellectual abilities by a decrease in IQ scores, by forgetting information previously learned,\n                by inability to learn new information, or by a sudden onset of a new learning disability.\n                When infants and young children present with serious developmental delays (without regression),\n                we evaluate the child's impairment(s) under 112.00 . 7. Growth failure due to HIV immune suppression ( 114.11I ). a. To evaluate growth failure due to  HIV immune suppression,\n                we require documentation of the laboratory values described in 114.11I1 and the growth measurements in 114.11I2 or 114.11I3 within the same consecutive 12-month period.\n                The dates of laboratory findings may be different from the dates of growth measurements. b. Under 114.11I2 and 114.11I3 ,\n                we use the appropriate table under 105.08B in the digestive system to determine whether a child’s growth is less than the third percentile. (i) For children from birth to  attainment of age 2, we use the weight-for-length table corresponding to the  child’s gender (Table I or Table II). (ii) For children from age 2 to  attainment of age 18, we use the body mass index (BMI)-for-age corresponding to  the child’s gender (Table III or Table IV). (iii) BMI is the ratio of a child’s  weight to the square of his or her height.\n                We calculate BMI using the formulas in the digestive disorders body system ( 105.00 ). Back to Top G. How do we consider the  effects of treatment in evaluating your autoimmune disorder, immune deficiency  disorder, or HIV infection? 1. General. If your impairment does not  otherwise meet the requirements of a listing, we will consider your medical  treatment in terms of its effectiveness in improving the signs, symptoms, and  laboratory abnormalities of your specific immune system disorder or its  manifestations, and in terms of any side effects that limit your functioning.  We will make every reasonable effort to obtain a specific description of the  treatment you receive (including surgery) for your immune system disorder. We  consider: a. The effects of medications you take. b. Adverse side effects (acute and chronic). Back to Top c. The intrusiveness and complexity of your treatment (for example, the dosing  schedule, need for injections). d. The effect of treatment on your mental functioning (for example, cognitive  changes, mood disturbance). e. Variability of your response to treatment (see 114.00G2 ). f. The interactive and cumulative effects of your treatments. For example, many  children with immune system disorders receive treatment both for their immune  system disorders and for the manifestations of the disorders or co-occurring  impairments, such as treatment for HIV infection and hepatitis C. The  interactive and cumulative effects of these treatments may be greater than the  effects of each treatment considered separately. g. The duration of your treatment. h. Any other aspects of treatment that may interfere with your ability to function. 2. Variability of your response to treatment. Your response to treatment and the adverse or beneficial consequences of your treatment may vary widely. The effects of your treatment  may be temporary or long term. For example, some children may show an initial  positive response to a drug or combination of drugs followed by a decrease in  effectiveness. When we evaluate your response to treatment and how your  treatment may affect you, we consider such factors as disease activity before  treatment, requirements for changes in therapeutic regimens, the time required  for therapeutic effectiveness of a particular drug or drugs, the limited number  of drug combinations that may be available for your impairment(s), and the  time-limited efficacy of some drugs. For example, a child with HIV infection or  another immune deficiency disorder who develops otitis media may not respond to  the same antibiotic regimen used in treating children without HIV infection or  another immune deficiency disorder, or may not respond to an antibiotic that he  or she responded to before. Therefore, we must consider the effects of your  treatment on an individual basis, including the effects of your treatment on  your ability to function. Back to Top 3. How we evaluate the effects of treatment for autoimmune disorders on your ability to function. Some medications may have acute or long-term side effects. When we consider the effects of corticosteroids or other treatments for autoimmune disorders on your ability to  function,\n                we consider the factors in 114.00G1 and 114.00G2 .\n                Long-term corticosteroid treatment can cause ischemic necrosis of bone, posterior subcapsular cataract, impaired growth, weight gain, glucose intolerance,\n                increased susceptibility to infection, and osteopenia that may result in a loss of function. In addition,\n                medications used in the treatment of autoimmune disorders may also have effects on mental functioning, including cognition\n                (for example, memory), concentration, and mood. 4. How we evaluate the effects of treatment for immune deficiency disorders, excluding HIV infection, on your ability to  function. When we consider the effects of your treatment for your immune deficiency disorder on your ability to function,\n                we consider the factors in 114.00G1 and 114.00G2 .\n                A frequent need for treatment such as intravenous immunoglobulin and gamma interferon therapy can be intrusive and interfere with  your ability to function.\n                We will also consider whether you have chronic side effects from these or other medications, including severe fatigue, fever,\n                headaches, high blood pressure, joint swelling, muscle aches, nausea, shortness of breath,\n                or limitations in mental function including cognition (for example, memory) concentration, and mood. 5. How we evaluate the effects of treatment for HIV infection on your ability to function. Back to Top a. General. When we consider the effects of antiretroviral drugs (including the effects of highly active antiretroviral  therapy (HAART))\n                and the effects of treatments for the manifestations of HIV infection on your ability to function,\n                we consider the factors in 114.00G1 and 114.00G2 .\n                Side effects of antiretroviral drugs include, but are not limited to: Bone marrow suppression, pancreatitis,\n                gastrointestinal intolerance (nausea,  vomiting, diarrhea), neuropathy, rash, hepatotoxicity, lipodystrophy\n                (fat redistribution, such as “buffalo hump”), glucose intolerance, and lactic acidosis. In addition,\n                medications used in the treatment of HIV infection may also have effects on mental functioning, including cognition (for example,  memory),\n                concentration, and mood, and may result in malaise, severe fatigue, joint and muscle pain, and insomnia.\n                The symptoms of HIV infection and the side effects of medication may be indistinguishable from each other.\n                We will consider all of your functional limitations, whether they result from your symptoms or signs of HIV infection or the side effects of your treatment. b. Structured treatment interruptions. A  structured treatment interruption (STI, also called a “drug holiday”) is a  treatment practice during which your treating source advises you to stop taking  your medications temporarily. An STI in itself does not imply that your medical  condition has improved; nor does it imply that you are noncompliant with your  treatment because you are following your treating source’s advice. Therefore,  if you have stopped taking medication because your treating source prescribed  or recommended an STI, we will not find that you are failing to follow  treatment or draw inferences about the severity of your impairment on this fact  alone. We will consider why your treating source has prescribed or recommended  an STI and all the other information in your case record when we determine the  severity of your impairment. Back to Top 6. When there is  no record of ongoing treatment. If you have not received ongoing treatment  or have not had an ongoing relationship with the medical community despite the  existence of a severe impairment(s), we will evaluate the medical severity and  duration of your immune system disorder on the basis of the current objective  medical evidence and other evidence in your case record, taking into  consideration your medical history, symptoms, clinical and laboratory findings,  and medical source opinions. If you have just begun treatment and we cannot  determine whether you are disabled based on the evidence we have, we may need  to wait to determine the effect of the treatment on your ability to develop and  function in an age‑appropriate manner. The amount of time we need to wait will  depend on the facts of your case. If you have not received treatment, you may  not be able to show an impairment that meets the criteria of one of the immune  system disorders listings, but your immune system disorder may medically equal  a listing or functionally equal the listings. H. How do we consider your symptoms, including your pain, severe fatigue, and malaise? Your symptoms, including pain, severe fatigue, and malaise,\n                may be important factors in our determination whether your immune system disorder(s) meets or medically equals a listing or in our determination whether you otherwise have marked\n                and severe functional limitations. In order for us to consider your symptoms,\n                you must have medical signs or laboratory findings showing the existence of a medically determinable impairment(s) that could reasonably be expected to produce the symptoms.\n                If you have such an impairment(s), we will evaluate the intensity, persistence,\n                and functional effects of your symptoms using the rules throughout 114.00 and in our other regulations.\n                See §§ 416.921 and 416.929 .\n                Additionally, when we assess the credibility of your complaints about your symptoms and their functional effects,\n                we will not draw any inferences from the fact that you do not receive treatment or that you are not following treatment without considering all of the relevant evidence in your case record,\n                including any explanations you provide that may explain why you are not receiving or following treatment. Back to Top I. How do we consider the impact of your immune system disorder on your  functioning? 1. We will consider all relevant information in your case record to determine the full impact of your immune system disorder,\n                including HIV infection, on your ability to function. Functional limitation may result from the impact of the disease process itself on your mental functioning,\n                physical functioning, or both your mental and physical functioning. This could result from persistent or intermittent symptoms, such as depression, diarrhea,\n                severe fatigue, or pain, resulting in a limitation of your ability to acquire information, to concentrate, to persevere at a task, to interact with others,\n                to move about, or to cope with stress. You may also have limitations because of your treatment and its side effects\n                (see 114.00G ). 2. Important factors we will consider when we evaluate your functioning include, but are not limited to:\n                Your symptoms (see 114.00H ),\n                the frequency and duration of manifestations of your immune system disorder, periods of exacerbation and remission, and the functional impact of your treatment,\n                including the side effects of your medication (see 114.00G ).\n                See §§ 416.924a and 416.926a for additional guidance on the factors we consider when we evaluate your functioning. 3. We will use the rules in\n                §§ 416.924a and 416.926a to evaluate your functional limitations and determine  whether your impairment functionally equals the listings. Back to Top J. How do we  evaluate your immune system disorder when it does not meet one of the  listings? 1. These listings are only examples of immune system  disorders that we consider severe enough to result in marked and severe  functional limitations. If your impairment(s) does not meet the criteria of any  of these listings, we must also consider whether you have an impairment(s) that  satisfies the criteria of a listing in another body system. 2. Individuals with immune system disorders, including HIV infection, may  manifest signs or symptoms of a mental impairment or of another physical impairment. For example, HIV infection may accelerate the  onset of conditions such as diabetes or affect the course of or treatment  options for diseases such as cardiovascular disease or hepatitis. We may evaluate these impairments under the affected body system. For example,  we will evaluate: a. Growth impairment under 100.00 . b. Musculoskeletal involvement, such as surgical reconstruction of a joint,\n                under 101.00 . c. Ocular involvement, such as dry eye,\n                under 102.00 . d. Respiratory impairments, such as pleuritis,\n                under 103.00 . e. Cardiovascular impairments, such as cardiomyopathy,\n                under 104.00 . Back to Top f. Digestive impairments, such as hepatitis (including  hepatitis C) or weight loss as a result of HIV infection that affects the digestive system,\n                under 105.00 . g. Genitourinary impairments, such as nephropathy,\n                under 106.00 . h. Hematologic abnormalities, such as anemia, granulocytopenia, and thrombocytopenia,\n                under 107.00 . i. Skin impairments, such as persistent fungal and  other infectious skin eruptions, and photosensitivity,\n                under 108.00 . j. Neurologic impairments, such as neuropathy or  seizures,\n                under 111.00 . k. Mental disorders, such as depression, anxiety, or cognitive deficits,\n                under 112.00 . l. Allergic disorders, such as asthma or atopic dermatitis,\n                under 103.00 or 108.00 or under the criteria in another affected body system. m. Syphilis or neurosyphilis under the criteria for  the affected body system,\n                for example, 102.00 Special senses and speech, 104.00 Cardiovascular system,\n                or 111.00 Neurological. 3. If you have a severe medically determinable impairment(s) that does not meet a listing,\n                we will determine whether your impairment(s) medically equals a listing.\n                (See § 416.926 .)\n                If it does not, we  will also consider whether you have an impairment(s) that functionally equals the listings.\n                (See § 416.926a .)\n                We use the rules in § 416.994a when we decide whether you continue to be disabled. Back to Top 114.01 Category  of Impairments, Immune System Disorders 114.02 Systemic lupus erythematosus ,\n                as described in 114.00D1 .\n                With involvement of two or more organs/body systems, and with: A. One of the  organs/body systems involved to at least a moderate level of severity; AND B. At least two of the  constitutional symptoms and signs (severe fatigue, fever, malaise, or  involuntary weight loss). Back to Top 114.03 Systemic vasculitis ,\n                as described in 114.00D2 .\n                With involvement of two or more organs/body systems, and with: A. One of the organs/body systems involved to at  least a moderate level of severity; AND B. At least two of the constitutional symptoms  and signs (severe fatigue, fever, malaise, or involuntary weight loss). Back to Top 114.04 Systemic sclerosis (scleroderma). As described in 114.00D3 . With: A. Involvement of two or more organs/body systems, with: 1. One of the organs/body systems  involved to at least a moderate level of severity; and 2. At least two of the constitutional  symptoms and signs (severe fatigue, fever, malaise, or involuntary weight  loss). OR B. One of the following: 1. Toe contractures or fixed deformity of one or both feet, and medical documentation of at least one of the following: A documented medical need (see 114.00C6 ) for a walker, bilateral canes, or bilateral crutches (see 101.00C6d ) or a wheeled and seated mobility device involving the use of both hands (see 101.00C6e(i) ); or An inability to use one upper extremity to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements (see 114.00C7 ), and a documented medical need (see 114.00C6 ) for a one-handed, \n\t\t\t\t\t\thand-held assistive device (see 101.00C6d ) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand (see 101.00C6e(ii) ); or 2. Finger contractures or fixed  deformity in both hands and medical documentation of an inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements (see 114.00C7 ); or 3. Atrophy with irreversible damage in one or both lower extremities and medical documentation of at least one of the following: A documented medical need (see 114.00C6 ) for a walker, bilateral canes, or bilateral crutches (see 101.00C6d ) or a wheeled and seated mobility device involving the use of both hands (see 101.00C6e(i) ); or An inability to use one upper extremity to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements (see 114.00C7 ), and a documented medical need (see 114.00C6 ) for a one-handed, hand-held assistive device (see 101.00C6d ) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand (see 1.00C6e(ii) ); or 4. Atrophy with irreversible damage in both upper extremities and medical documentation of an inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements (see 114.00C7 ); or Back to Top C. Raynaud’s  phenomenon, characterized by: 1. Gangrene involving at least two extremities; or 2. Ischemia with ulcerations of toes or fingers and medical documentation of at least one of the following: A documented medical need (see 114.00C6 ) for a walker, bilateral canes, or bilateral crutches (see 101.00C6d ) or a wheeled and seated mobility device involving the use of both hands (see 101.00C6e(i) ); or An inability to use one upper extremity to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements (see 114.00C7 ), and a documented medical need (see 114.00C6 ) for a one-handed, hand-held assistive device (see 101.00C6d ) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand (see 1.00C6e(ii) ); or An inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements (see 114.00C7 ). Back to Top 114.05 Polymyositis and dermatomyositis. As described in 114.00D4 . With: A. Proximal limb-girdle (pelvic or shoulder) muscle weakness and medical documentation of at least one of the following: A documented medical need (see 114.00C6 ) for a walker, bilateral canes, or bilateral crutches (see 101.00C6d ) or a wheeled and seated mobility device involving the use of both hands (see 101.00C6e(i) ); or An inability to use one upper extremity to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements (see 114.00C7 ), and a documented medical need (see 114.00C6 ) for a one-handed, hand-held assistive device (see 101.00C6d ) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand (see 101.00C6e(ii) ); or An inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements (see 114.00C7 ); or OR B. Impaired  swallowing (dysphagia) with aspiration due to muscle weakness. OR C. Impaired  respiration due to intercostal and diaphragmatic muscle weakness. OR D. Diffuse  calcinosis with limitation of joint mobility or intestinal motility. Back to Top 114.06 Undifferentiated and mixed connective tissue disease ,\n                as described in 114.00D5 .\n                With involvement of two or more organs/body systems, and with: A. One of the organs/body systems involved to at  least a moderate level of severity; AND B. At least two of the constitutional symptoms  and signs (severe fatigue, fever, malaise, or involuntary weight loss). Back to Top 114.07 Immune deficiency disorders, excluding HIV  infection. As described in 114.00E . With: A. One or more of the following infections. The infection(s) must either be resistant to treatment or require hospitalization or intravenous treatment three or more times in a 12-month period. 1. Sepsis; or 2. Meningitis; or 3. Pneumonia; or 4. Septic arthritis; or 5. Endocarditis; or 6. Sinusitis documented by appropriate medically acceptable imaging. OR B. Stem cell transplantation as described under 114.00E3 .\n                Consider under a disability until at least 12 months from the date of transplantation. Thereafter, evaluate any residual impairment(s) under the criteria for the affected body system. Back to Top 114.08 [Reserved] 114.09 Inflammatory arthritis . As described in 114.00D6 . With: A. Persistent inflammation or persistent  deformity of: 1. One or more major joints in a lower extremity (see 114.00C8 ) and medical documentation of at least one of the following: A documented medical need (see 114.00C6 ) for a walker, bilateral canes, or bilateral crutches (see 101.00C6d ) or a wheeled and seated mobility device involving the use of both hands (see 101.00C6e(i) ); or An inability to use one upper extremity to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements (see 114.00C7 ), and a documented medical need (see 114.00C6 ) for a one-handed, hand-held assistive device (see 101.00C6d ) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand (see 101.00C6e(ii) ); or 2. One or more major joints in each upper extremity (see 114.00C8 ) and medical documentation of an inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements (see 114.00C7 ); or B. Inflammation or deformity in one or more major joints of an upper or lower extremity (see 114.00C8 ) with: 1. Involvement of two or more  organs/body systems with one of the organs/body systems involved to at least a moderate level of severity; and 2. At least two of the constitutional symptoms or signs (severe fatigue, fever, malaise, or  involuntary weight loss). Back to Top OR C. Ankylosing spondylitis or other spondyloarthropathies, with: 1. Ankylosis (fixation) of the dorsolumbar or cervical spine as shown by appropriate medically acceptable imaging and measured on physical examination at 45° or more of flexion from the  vertical position (zero degrees); or 2. Ankylosis (fixation) of the dorsolumbar or cervical spine as shown by appropriate medically acceptable imaging and measured on physical examination at 30° or more of flexion (but  less than 45°) measured from the vertical  position (zero degrees), and involvement of two or more organs/body systems  with one of the organs/body systems involved to at least a moderate level of  severity. Back to Top 114.10   Sjögren’s syndrome ,\n                as described in 114.00D7 . With involvement of two or more organs/body systems, and with: A. One of the organs/body systems involved to at least a moderate level of severity; AND B. At least two of the constitutional symptoms and signs (severe fatigue, fever, malaise, or involuntary weight loss). Back to Top 114.11 Human immunodeficiency virus (HIV) infection. With documentation as described in 114.00F1 and one of the following: A. Multicentric (not localized or unicentric) Castleman disease affecting multiple groups of lymph nodes or  organs containing lymphoid tissue (see 114.00F3a). OR B. Primary central nervous system lymphoma\n                (see 114.00F3b ). OR C. Primary effusion lymphoma\n                (see 114.00F3c ). OR D. Progressive multifocal leukoencephalopathy\n                (see 114.00F3d ). OR E. Pulmonary Kaposi sarcoma\n                (see 114.00F3e ). OR F. Absolute CD4 count or CD4 percentage\n                (see 114.00F4 ): 1. For children from birth to attainment of age 1, absolute CD4 count of 500 cells/mm3 or less, or  CD4 percentage of less than 15 percent; or 2. For children from age 1 to attainment of age 5, absolute CD4 count of 200 cells/mm3 or less, or  CD4 percentage of less than 15 percent; or 3. For children from age 5 to attainment of age 18, absolute CD4 count of 50 cells/mm3 or less. OR G. Complication(s) of HIV infection requiring at least three hospitalizations within a 12-month period and at least 30 days apart\n                (see 114.00F5 ). Each hospitalization must last at least 48 hours, including hours in a hospital emergency department immediately before the hospitalization. OR H. A neurological manifestation of HIV  infection (for example, HIV encephalopathy or peripheral neuropathy)\n                (see 114.00F6 ) resulting in one of the following: 1. Loss of previously acquired  developmental milestones or intellectual ability (including the sudden onset of  a new learning disability), documented on two examinations at least 60 days  apart; or 2. Progressive motor dysfunction  affecting gait and station or fine and gross motor skills, documented on two  examinations at least 60 days apart; or 3. Microcephaly with head circumference  that is less than the third percentile for age, documented on two examinations  at least 60 days apart; or 4. Brain atrophy, documented by appropriate medically acceptable imaging. OR I. Immune suppression and growth failure\n                (see 114.00F7 ) documented by 1 and 2, or by 1 and 3: 1. CD4 measurement: a. For children from birth to attainment of age 5, CD4 percentage of less than 20 percent; or b. For children from age 5 to attainment of age 18, absolute CD4 count of less than 200 cells/mm3  or CD4 percentage of less than 14 percent; and 2. For children from birth to attainment of age 2, three weight-for-length measurements that are: a. Within a consecutive 12-month  period; and b. At least 60 days apart; and c. Less than the third percentile on the appropriate weight-for-length table\n                under 105.08B1 ; or 3. For children from age 2 to attainment of age 18, three BMI-for-age measurements that are: a. Within a consecutive 12-month  period; and b. At least 60 days apart; and c. Less than the third percentile on  the appropriate BMI-for-age table\n                under 105.08B2 . Back to Top",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security114.00 Immune System Disorders - Childhood"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_01",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_02",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_03",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_04",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_05",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_06",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_07",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_08",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_09",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_10",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00D",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00E",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00I2",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00I3",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0920.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_02",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_03",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00",
      "https://www.ssa.gov/disability/professionals/bluebook/106.00-Genitourinary-Childhood.htm#106_00",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_04",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_05",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_05A",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_05A",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_05A",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_06",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_09",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_09A",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_09C1",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_09C1",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_09B",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_09C2",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C8",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_10",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0919f.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00F1a",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0919f.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11A",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11E",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11A",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11A",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11G",
      "https://www.ssa.gov/disability/professionals/bluebook/14.00-Immune-Adult.htm#14_11I",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11B",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11C",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11D",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11E",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11F",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11F",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11G",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11G",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00F5a",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11H",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11I",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11I1",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11I2",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11I3",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11I2",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11I3",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00G2",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00G1",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00G2",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00G1",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00G2",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00G1",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00G2",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0921.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0929.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00G",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00H",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00G",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0924a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0924a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00",
      "https://www.ssa.gov/disability/professionals/bluebook/106.00-Genitourinary-Childhood.htm#106_00",
      "https://www.ssa.gov/disability/professionals/bluebook/107.00-HematologicalDisorders-Childhood.htm#107_00",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0994a.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00D1",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00D3",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C6",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C7",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C6",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6eii",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C7",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C6",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C7",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C6",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/1.00-Musculoskeletal-Adult.htm#1_00C6eii",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C7",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C6",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C7",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C6",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/1.00-Musculoskeletal-Adult.htm#1_00C6eii",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C7",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00D4",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C6",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C7",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C6",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6eii",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C7",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00D5",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00E",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00E3",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00D6",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C8",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C6",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C7",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C6",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6eii",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C8",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C7",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00C8",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00D7",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00F1",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00F3b",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00F3c",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00F3d",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00F3e",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00F4",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00F5",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00F6",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00F7",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B1",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B2",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm"
    ],
    "html_file": "ssa_bluebook_data/html/df34ec3ef2bc3c8d001c0c12cfc27930.html",
    "fetched_at": 1762482865.167167
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00",
    "url_hash": "2375525e6ef38fd1e33930edb1ebc553",
    "title": "103.00 Respiratory Disorders - Childhood | Disability | SSA",
    "text_content": "103.00 Respiratory Disorders - Childhood | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Listing of Impairments - Child Listings (Part B) 103.00 Respiratory Disorders - Childhood Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security 103.00 Respiratory Disorders - Childhood Section 103.01 Category of Impairments, Respiratory System 103.02 Chronic Respiratory Disorders 103.03 Asthma 103.04 Cystic Fibrosis 103.05 [Reserved] 103.06 Growth failure due to any chronic respiratory disorder 103.07 [Reserved] 103.08 [Reserved] 103.09 [Reserved] 103.10 [Reserved] 103.10 [Reserved] 103.11 Lung Transplantation 103.12 [Reserved] 103.13 [Reserved] 103.14 Respiratory failure 103.00 Respiratory Disorders A. Which disorders do we evaluate in  this body system? We evaluate respiratory disorders that result in obstruction (difficulty moving air out of the lungs) or restriction (difficulty moving air into the lungs),\n                  or that interfere with diffusion (gas exchange) across cell membranes in the lungs.\n                  Examples of such disorders and the listings we use to evaluate them  include chronic obstructive pulmonary disease ( 103.02 ),\n                  chronic lung disease of infancy (also known as bronchopulmonary dysplasia, 103.02C or 103.02E ),\n                  pulmonary fibrosis ( 103.02 ),\n                  asthma ( 103.02 or 103.03 ),\n                  and cystic fibrosis ( 103.04 ).  We also use listings in this body system to evaluate respiratory failure resulting from an underlying chronic respiratory disorder\n                  ( 103.04E or 103.14 )\n                  and lung transplantation ( 103.11 ). We evaluate cancers affecting the respiratory system under the listings in 113.00 .\n                  We evaluate the pulmonary effects of neuromuscular and autoimmune disorders under\n                  these listings or under the listings in 111.00 or 114.00 , respectively. B. What are the symptoms and signs of respiratory disorders? Symptoms and signs of respiratory disorders include dyspnea (shortness of breath), chest pain, coughing, wheezing, sputum production, hemoptysis (coughing up blood from the respiratory tract), use of accessory muscles of respiration, and tachypnea  (rapid rate of breathing). C. What abbreviations do we use in this body system? BiPAP means bi-level positive airway  pressure ventilation. BTPS means body temperature and ambient  pressure, saturated with water vapor. CF means cystic fibrosis. CFRD means CF-related diabetes. CFTR means CF transmembrane  conductance regulator. CLD means chronic lung disease of  infancy. FEV 1 means forced  expiratory volume in the first second of a forced expiratory maneuver. FVC means forced vital capacity. L means liter. D. What documentation do we need to evaluate your respiratory disorder? We need medical evidence to document and assess the severity of your respiratory disorder.\n                  Medical evidence should include your medical history, physical examination findings,\n                  the results of imaging (see 103.00D3 ), spirometry (see 103.00E ),\n                  other relevant laboratory tests, and descriptions of any prescribed treatment and your response to it.\n                  We may not need all of this evidence depending on your particular respiratory disorder and its effects on you. If you use supplemental oxygen , we  still need medical evidence to establish the severity of your respiratory disorder. Imaging refers to medical imaging techniques, such as x-ray and computerized tomography. The imaging must be consistent with the prevailing state of medical knowledge and clinical practice  as the proper technique to support the evaluation of the disorder. E. What is spirometry and what are our requirements for an acceptable test and report? Spirometry, which measures how well you move air into and out of your lungs, involves at least three forced expiratory maneuvers during the same test session.\n              A forced expiratory maneuver is a maximum inhalation followed by a forced maximum  exhalation, and measures exhaled volumes of air over time.\n              The volume of air you exhale in the first second of the forced expiratory maneuver is the FEV 1 .\n              The total volume of air that you exhale during the entire forced expiratory maneuver is the FVC.\n              We use your highest FEV 1 value to evaluate your respiratory disorder under 103.02A and 103.04A , and your highest FVC value to evaluate your respiratory disorder under 103.02B ,\n              regardless of whether the values are from the same forced expiratory maneuver or different forced expiratory maneuvers.\n              We will not purchase spirometry for children who have not attained age 6. We have the following requirements for spirometry under these listings: You must be medically stable at the time of the test. Examples of when we would not consider you to be medically stable include when you are: Within 2 weeks of a change in your prescribed respiratory medication. Experiencing, or within 30 days of completion of treatment for, a lower respiratory tract infection. Experiencing, or within 30 days of completion of treatment for, an acute exacerbation (temporary worsening) of a chronic respiratory disorder. Wheezing by itself  does not indicate that you are not medically stable. During testing, if your FEV 1 is less than 70 percent of your predicted  normal value, we require repeat spirometry after inhalation of a bronchodilator to evaluate your respiratory disorder under these listings, unless it is  medically contraindicated. If you used a bronchodilator before the test and  your FEV 1 is less than 70 percent of your predicted normal value, we  still require repeat spirometry after inhalation of a bronchodilator unless the  supervising physician determines that it is not safe for you to take a  bronchodilator again (in which case we may need to reschedule the test). If you  do not have post-bronchodilator spirometry, the test report must explain why.  We can use the results of spirometry administered without bronchodilators when  the use of bronchodilators is medically contraindicated. Your forced expiratory maneuvers must be satisfactory. We consider a forced  expiratory maneuver to be satisfactory when you exhale with maximum effort following a full inspiration, and when the test tracing has a sharp takeoff and  rapid rise to peak flow, has a smooth contour, and either lasts for at least 6  seconds (for children age 10 and older) or for at least 3 seconds (for children  who have not attained age 10), or maintains a plateau for at least 1 second. The spirometry report must include the following information: The date of the test and your name, age or date of birth, gender, and height without  shoes. (We will assume that your recorded height on the date of the test is without shoes, unless we have evidence to the contrary.) If your spine is  abnormally curved (for example, you have kyphoscoliosis), we will substitute  the longest distance between your outstretched fingertips with your arms  abducted 90 degrees in place of your height when this measurement is greater  than your standing height without shoes. Any factors, if applicable, that can affect the interpretation of the test results  (for example, your cooperation or effort in doing the test). Legible tracings of your forced expiratory maneuvers in a volume-time format showing  your name and the date of the test for each maneuver. If you have attained age 6, we may need to purchase spirometry to determine  whether your disorder meets a listing, unless we can make a fully favorable  determination or decision on another basis. Before  we purchase spirometry for a child age 6 or older, a medical consultant\n              (see § 416.1016 of this chapter),\n              preferably one with experience in the care of children with respiratory disorders, must review your case record to determine if we need the test.\n              If we purchase spirometry, the medical source we designate to administer the test is solely responsible for deciding whether it is safe for you to do the test and for how to administer it. F. What is CLD and how do we evaluate it? CLD , also known as bronchopulmonary dysplasia, or BPD, is scarring of the immature lung.\n              CLD may develop as a complication of mechanical ventilation and oxygen therapy for infants with significant neonatal respiratory problems.\n              Within the first 6 months of life, most infants with CLD are successfully weaned from mechanical ventilation, and then weaned from oxygen supplementation.\n              We evaluate CLD under 103.02C , 103.02E ,\n              or if you are age 2 or older, under 103.03 or another appropriate listing. If you have CLD, are not yet 6 months old, and need 24-hour-per-day oxygen supplementation,\n              we will not evaluate your CLD under 103.02C until you are 6 months old.\n              Depending on the evidence in your case record, we may make a fully favorable determination or decision under other rules before you are 6 months old. We evaluate your CLD under 103.02C if you are at least 6 months old and you need\n              24-hour-per-day oxygen supplementation. (If you were born prematurely, we use your corrected chronological age.\n              See § 416.924b(b) of this chapter.)\n              We also  evaluate your CLD under 103.02C if you were weaned off oxygen supplementation but needed it again by the time you were 6 months old or older. We evaluate your CLD under 103.02E if you are any age from birth to the attainment of age 2\n              and have CLD exacerbations or complications (for example, wheezing, lower respiratory tract infections, or acute respiratory distress) that require hospitalization.\n              For the purpose of 103.02E , we count your initial birth hospitalization as one hospitalization.\n              The phrase “consider under a disability for 1 year from the discharge date of the last hospitalization or until the attainment of age 2,\n              whichever is later” in 103.02E does not refer to the date on which your disability began,\n              only to the date on which we must reevaluate whether your impairment(s) continues to meet a listing or is otherwise disabling. G. What is asthma and how do we evaluate it? Asthma is a chronic inflammatory disorder of the lung airways that we evaluate under 103.02 or 103.03 . If you have respiratory failure resulting from chronic asthma (see 103.00J ),\n              we will evaluate it under 103.14 . For the purposes of 103.03 : The phrase “consider under a disability for 1 year” explains how long your asthma  can meet the requirements of the listing. It does not refer to the date on  which your disability began, only to the date on which we must reevaluate  whether your asthma continues to meet a listing or is otherwise disabling. We determine the onset of your disability based on the facts of your case,\n                  but it will be no later than the admission date of your first of three hospitalizations that satisfy the criteria of 103.03 . H. What is CF and how do we evaluate it? General . We evaluate CF , a genetic disorder that results in abnormal salt and water transport across cell membranes in the lungs,\n              pancreas, and other body organs, under 103.04 .\n              We need the evidence described in 103.00H2 to establish that you have CF. Documentation of CF . We need a report signed by a physician\n              (see § 416.913(a) of this chapter) showing both a and b: One of the following: A positive newborn screen for CF; or A history of CF in a sibling; or Documentation of at least one specific CF phenotype  or clinical criterion (for example, chronic sino-pulmonary disease with  persistent colonization or infections with typical CF pathogens, pancreatic insufficiency,  or salt-loss syndromes); and One of the following definitive laboratory tests: An elevated sweat chloride concentration equal to or  greater than 60 millimoles per L; or The identification of two CF gene mutations  affecting the CFTR; or Characteristic abnormalities in ion transport across  the nasal epithelium. When we have the report showing a and b, but it is not signed by a physician, we  also need a report from a physician stating that you have CF. When we do not have the report showing a and b, we need a report from a physician that is persuasive that a  positive diagnosis of CF was confirmed by an appropriate definitive laboratory  test. To be persuasive, this report must include a statement by the physician  that you had the appropriate definitive laboratory test for diagnosing CF. The  report must provide the test results or explain how your diagnosis was  established that is consistent with the prevailing state of medical knowledge  and clinical practice. CF pulmonary exacerbations . Examples of CF pulmonary exacerbations include increased cough and sputum production,  hemoptysis, increased shortness of breath, increased fatigue, and reduction in  pulmonary function. Treatment usually includes intravenous antibiotics and intensified  airway clearance therapy (for example, increased frequencies of chest  percussion or increased use of inhaled nebulized therapies, such as  bronchodilators or mucolytics). For 103.04G ,\n              we require any two exacerbations or complications from the list in 103.04G1 through 103.04G4 within a 12-month period. You may have two of the same exacerbation or complication or two different ones. If you have two of the acute exacerbations or complications we describe in 103.04G1 and 103.04G2 , there must be at least 30 days between the two. If you have one of the acute exacerbations or complications we describe in 103.04G1 and 103.04G2 and one of the chronic complications we describe in 103.04G3 and 103.04G4 , the two can occur during the same time.\n                  For example, your CF meets 103.04G if you have the pulmonary hemorrhage we describe in 103.04G2 and the weight loss we describe in 103.04G3 even if the pulmonary hemorrhage occurs during the 90-day period in 103.04G3. Your CF also meets 103.04G if you have both of the chronic complications in 103.04G3 and 103.04G4 . CF may also affect other body systems such as digestive or endocrine. If your CF, including pulmonary exacerbations and  nonpulmonary complications, does not meet or medically equal a respiratory  disorders listing, we may evaluate your CF-related impairments under the listings in the affected body system. I. How do we evaluate lung transplantation? If you receive a lung transplant (or a lung transplant simultaneously with other organs, such as the heart),\n          we  will consider you to be disabled under 103.11 for 3 years from the date of the transplant.\n          After that, we evaluate your residual impairment(s) by considering  the adequacy of your post-transplant function,\n          the frequency and severity of any rejection episodes you have, complications in other body systems, and adverse treatment effects.\n          Children who receive organ transplants generally have impairments that meet our definition of disability before they undergo transplantation.\n          The phrase “consider under a disability for 3 years” in 103.11 does not refer to the date on which your disability began,\n          only to the date on which we must reevaluate whether your impairment(s) continues to meet a listing or is otherwise disabling.\n          We determine the onset of your disability based on the facts of your case. J. What is respiratory failure and how do we evaluate it? Respiratory failure is the inability of the lungs to perform their basic function of gas exchange.\n          We evaluate respiratory failure under 103.04E if you have CF-related respiratory failure,\n          or under 103.14 if you have respiratory failure due to any other chronic respiratory disorder.\n          Continuous positive airway pressure does not satisfy the criterion in 103.04E or 103.14 , and cannot be substituted as an equivalent finding, for invasive mechanical ventilation or noninvasive ventilation with BiPAP. K. How do we evaluate growth failure due to any chronic respiratory disorder? To evaluate growth failure due to any chronic respiratory disorder,\n              we require documentation of the oxygen supplementation described in 103.06A and the growth measurements in 103.06B within the same consecutive 12-month period.\n              The dates of oxygen supplementation may be different from the dates of growth measurements. Under 103.06B ,\n              we use the appropriate table(s) under 105.08B in the digestive system to determine whether a child’s growth is less than the third percentile. For children from birth to attainment of age 2, we use the weight-for-length table  corresponding to the child’s gender (Table I or Table II). For children age 2 to attainment of age 18, we use the body mass index  (BMI)-for-age table corresponding to the child’s gender (Table III or Table  IV). BMI is the ratio of a child’s weight to the square of his or her height.\n                  We calculate BMI using the formulas in the digestive disorders body system ( 105.00 ). L. How do we evaluate respiratory disorders that do not meet one of these listings? These listings are only examples of common respiratory disorders that we consider  severe enough to result in marked and severe functional limitations.\n              If your impairment(s) does not meet the criteria of any of these listings, we must also consider whether you have an impairment(s) that meets the criteria of a listing in another body system.\n              For example, if your CF has resulted in chronic pancreatic or hepatobiliary disease, we evaluate your impairment under the listings in 105.00 . If you have a severe medically determinable impairment(s) that does not meet a listing,\n              we will determine whether your impairment(s) medically equals a listing.\n              See § 416.926 of this chapter.\n              Respiratory disorders may be associated with disorders in other body systems,\n              and we consider the combined effects of multiple impairments when we determine whether they medically equal a listing.\n              If your impairment(s) does not meet or medically equal a listing, we will also consider whether it functionally equals the listings.\n              See § 416.926a of this chapter.\n              We use the rules in § 416.994a of this chapter when we decide whether you continue to be disabled. 103.01 Category of Impairments, Respiratory Disorders 103.02 Chronic respiratory disorders due to any cause except CF\n          (for CF, see 103.04 ), with A, B, C, D, or E: A. FEV 1 (see 103.00E )\n          less than or equal to the value in Table I-A or I-B for your age, gender,\n          and height without shoes (see 103.00E3a ). Table I: FEV 1 Criteria for 103.02A Table I-A Age 6 to attainment of age 13 (For both females and males) Height without shoes (centimeters) < means less    than Height    without shoes (inches) < means less    than FEV 1 less    than or equal to (L, BTPS) <123.0 <48.50 0.80 123.0 to <129.0 48.50 to <50.75 0.90 129.0 to <134.0 50.75 to <52.75 1.00 134.0 to <139.0 52.75 to <54.75 1.10 139.0 to <144.0 54.75 to <56.75 1.20 144.0 to <149.0 56.75 to <58.75 1.30 149.0 or more 58.75 or more 1.40 Table I-B Age 13 to attainment of age 18 Height without shoes (centimeters) < means less    than Height    without shoes (inches) < means less    than Females FEV 1 less    than or equal    to (L,    BTPS) Males FEV 1 less    than or equal    to (L,    BTPS) <153.0 <60.25 1.35 1.40 153.0 to <159.0 60.25 to <62.50 1.45 1.50 159.0 to <164.0 62.50 to <64.50 1.55 1.60 164.0 to <169.0 64.50 to <66.50 1.65 1.70 169.0 to <174.0 66.50 to <68.50 1.75 1.85 174.0 to <180.0 68.50 to <70.75 1.85 2.00 180.0 or more 70.75 or more 1.95 2.10 OR B.  FVC (see 103.00E ) less than or equal to the value in Table II-A or II-B for your age,\n          gender, and height without shoes (see 103.00E3a ). Table II: FVC Criteria for 103.02B Table II-A Age    6 to attainment of age 13 (For    both females and males) Height without shoes (centimeters) <    means less than Height without shoes (inches) <    means less than FVC less than or equal to (L, BTPS) <123.0 <48.50 0.85 123.0    to <129.0 48.50    to <50.75 1.00 129.0    to <134.0 50.75    to <52.75 1.10 134.0    to <139.0 52.75    to <54.75 1.30 139.0    to <144.0 54.75    to <56.75 1.40 144.0    to <149.0 56.75    to <58.75 1.55 149.0 or    more 58.75 or    more 1.70 Table II-B Age    13 to attainment of age 18 Height without shoes (centimeters) <    means less than Height without shoes (inches) <    means less than Females FVC less than or equal to (L, BTPS) Males FVC less than or equal to (L, BTPS) <153.0 <60.25 1.65 1.65 153.0    to <159.0 60.25    to <62.50 1.70 1.80 159.0    to <164.0 62.50    to <64.50 1.80 1.95 164.0    to <169.0 64.50    to <66.50 1.95 2.10 169.0    to <174.0 66.50    to <68.50 2.05 2.25 174.0    to <180.0 68.50    to <70.75 2.20 2.45 180.0 or    more 70.75 or    more 2.30 2.55 OR C.  Hypoxemia with the need for at least 1.0 L per minute of continuous (24 hours  per day) oxygen supplementation for at least 90 consecutive days. OR D.  The presence of a tracheostomy. Consider under a disability until the attainment of age 3; or Upon the attainment of age 3, documented need for mechanical ventilation via a  tracheostomy for at least 4 hours per day and for at least 90 consecutive days. OR E.  For children who have not attained age 2, CLD (see 103.00F )\n          with exacerbations or complications requiring three hospitalizations within a 12-month period and at least 30 days apart\n          (the 12-month period must occur within the period we are considering in connection with your application or continuing disability review).\n          Each hospitalization must last at least 48 hours, including hours in a hospital emergency department immediately before the hospitalization.\n          (A child’s initial birth hospitalization when CLD is first diagnosed counts as one hospitalization.)\n          Consider under a disability for 1 year from the discharge date of the last hospitalization or until the attainment of age 2, whichever is later.\n          After that, evaluate the impairment(s) under 103.03 or another appropriate listing. 103.03 Asthma . (see 103.00G ) with exacerbations or complications requiring three hospitalizations within a 12-month period\n          and at least 30 days apart (the 12-month period must occur within the period we are considering in connection with your application or continuing disability review).\n          Each hospitalization must last at least 48 hours, including hours in a hospital emergency department immediately before the hospitalization.\n          Consider under a disability for 1 year from the discharge date of the last hospitalization;\n          after that, evaluate the residual impairment(s) under 103.03 or another appropriate listing. 103.04 Cystic fibrosis . (documented as described in 103.00H ), with A, B, C, D, E, F, or G: A. FEV 1 (see 103.00E )\n          less than or equal to the value in Table III-A or Table III-B for your age, gender, and height without shoes (see 103.00E3a ). Table III: FEV 1 Criteria  for 103.04A Table III-A Age    6 to attainment of age 13 (For    both females and males) Height without shoes (centimeters) <    means less than Height without shoes (inches) <    means less than FEV 1 less than or equal to (L, BTPS) <123.0 <48.50 1.00 123.0    to <129.0 48.50    to <50.75 1.15 129.0    to <134.0 50.75    to <52.75 1.25 134.0    to <139.0 52.75    to <54.75 1.40 139.0    to <144.0 54.75    to <56.75 1.50 144.0    to <149.0 56.75    to <58.75 1.70 149.0 or    more 58.75 or    more 1.80 Table III-B Age    13 to attainment of age 18 Height without shoes (centimeters) <    means less than Height without shoes (inches) <    means less than Females FEV 1 less than or equal to (L, BTPS) Males FEV 1 less than or equal to (L, BTPS) <153.0 <60.25 1.75 1.85 153.0    to <159.0 60.25    to <62.50 1.85 2.05 159.0    to <164.0 62.50    to <64.50 1.95 2.15 164.0    to <169.0 64.50    to <66.50 2.10 2.30 169.0    to <174.0 66.50    to <68.50 2.25 2.45 174.0    to <180.0 68.50    to <70.75 2.35 2.60 180.0 or    more 70.75 or    more 2.50 2.70 OR B. For children who have not attained age 6, findings on imaging (see 103.00D3 )\n          of thickening of the proximal bronchial airways, nodular-cystic lesions, segmental or lobular atelectasis, or consolidation, and documentation of one of the following: Shortness of breath with activity; or Accumulation of secretions as manifested by repetitive coughing; or Bilateral rales or rhonchi, or reduction of breath sounds. OR C. Exacerbations or complications (see 103.00H3 )\n          requiring three hospitalizations of any length within a 12-month period and at least 30 days apart\n          (the 12-month period must occur within the period we are considering in connection with your application or continuing disability review). OR D. Spontaneous pneumothorax, secondary to CF, requiring chest tube placement. OR E. Respiratory failure (see 103.00J ) requiring invasive mechanical ventilation,\n          noninvasive ventilation with BiPAP, or a combination of both treatments, for a continuous period of at least 48 hours, or for a continuous period of at least 72 hours if postoperatively. OR F. Pulmonary hemorrhage requiring vascular embolization to control bleeding. OR G. Two of the following exacerbations or complications\n          (either two of the same or two different, see 103.00H3 and 103.00H4 ) within a 12-month period\n          (the 12-month period must occur within the period we are considering in connection with your application or continuing disability review): Pulmonary exacerbation requiring 10 consecutive days of intravenous antibiotic treatment. Pulmonary hemorrhage (hemoptysis with more than blood-streaked sputum but not requiring vascular embolization) requiring hospitalization of any length. Weight loss requiring daily supplemental enteral nutrition via a gastrostomy for at least 90 consecutive days or parenteral nutrition via a central venous  catheter for at least 90 consecutive days. CFRD requiring daily insulin therapy for at least 90 consecutive days. 103.05 [Reserved] 103.06 Growth failure due to any chronic respiratory disorder (see 103.00K ), documented by: A. Hypoxemia with the need for at least 1.0 L per min of oxygen supplementation  for at least 4 hours per day and for at least 90 consecutive days. AND B. Growth failure as required in 1 or 2: For children from birth to attainment of age 2 , three weight-for-length measurements that are: Within a consecutive 12-month period; and At least 60 days apart; and Less than the third percentile on the appropriate weight-for-length table under 105.08B1 ; or For children age 2 to attainment of age 18 ,  three BMI-for-age measurements that are: Within a consecutive 12-month period; and At least 60 days apart; and Less than the third percentile on the appropriate BMI-for-age table under 105.08B2 . 103.07 [Reserved] 103.08 [Reserved] 103.09 [Reserved] 103.10 [Reserved] 103.11 Lung transplantation (see 103.00I ). Consider under a disability for 3 years from the date of the  transplant; after that, evaluate the residual impairment(s). 103.12 [Reserved] 103.13 [Reserved] 103.14 Respiratory failure (see 103.00J )\n          resulting from any underlying chronic respiratory disorder except CF (for CF, see 103.04E ), requiring invasive mechanical ventilation, noninvasive  ventilation with BiPAP, or a combination of both treatments, for a continuous  period of at least 48 hours, or for a continuous period of at least 72 hours if  postoperatively, twice within a 12-month period and at least 30 days  apart (the 12-month period must occur within the period we are considering in  connection with your application or continuing disability review).",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security103.00 Respiratory Disorders - Childhood"
      }
    ],
    "tables": [
      [
        [
          "Table I-A"
        ],
        [
          "Age 6 to attainment of age 13(For both females and males)"
        ],
        [
          "Heightwithoutshoes(centimeters)< meansless    than",
          "Height    withoutshoes(inches)< meansless    than",
          "FEV1less    than or equal to (L, BTPS)"
        ],
        [
          "<123.0",
          "<48.50",
          "0.80"
        ],
        [
          "123.0 to <129.0",
          "48.50 to <50.75",
          "0.90"
        ],
        [
          "129.0 to <134.0",
          "50.75 to <52.75",
          "1.00"
        ],
        [
          "134.0 to <139.0",
          "52.75 to <54.75",
          "1.10"
        ],
        [
          "139.0 to <144.0",
          "54.75 to <56.75",
          "1.20"
        ],
        [
          "144.0 to <149.0",
          "56.75 to <58.75",
          "1.30"
        ],
        [
          "149.0or more",
          "58.75or more",
          "1.40"
        ]
      ],
      [
        [
          "Table I-B"
        ],
        [
          "Age 13 to attainment of age 18"
        ],
        [
          "Heightwithoutshoes(centimeters)< meansless    than",
          "Height    withoutshoes(inches)< meansless    than",
          "FemalesFEV1less    thanor equal    to(L,    BTPS)",
          "MalesFEV1less    thanor equal    to(L,    BTPS)"
        ],
        [
          "<153.0",
          "<60.25",
          "1.35",
          "1.40"
        ],
        [
          "153.0 to <159.0",
          "60.25 to <62.50",
          "1.45",
          "1.50"
        ],
        [
          "159.0 to <164.0",
          "62.50 to <64.50",
          "1.55",
          "1.60"
        ],
        [
          "164.0 to <169.0",
          "64.50 to <66.50",
          "1.65",
          "1.70"
        ],
        [
          "169.0 to <174.0",
          "66.50 to <68.50",
          "1.75",
          "1.85"
        ],
        [
          "174.0 to <180.0",
          "68.50 to <70.75",
          "1.85",
          "2.00"
        ],
        [
          "180.0or more",
          "70.75or more",
          "1.95",
          "2.10"
        ]
      ],
      [
        [
          "Table II-A"
        ],
        [
          "Age    6 to attainment of age 13(For    both females and males)"
        ],
        [
          "Heightwithoutshoes(centimeters)<    meansless than",
          "Height withoutshoes(inches)<    meansless than",
          "FVCless than or equal to(L, BTPS)"
        ],
        [
          "<123.0",
          "<48.50",
          "0.85"
        ],
        [
          "123.0    to <129.0",
          "48.50    to <50.75",
          "1.00"
        ],
        [
          "129.0    to <134.0",
          "50.75    to <52.75",
          "1.10"
        ],
        [
          "134.0    to <139.0",
          "52.75    to <54.75",
          "1.30"
        ],
        [
          "139.0    to <144.0",
          "54.75    to <56.75",
          "1.40"
        ],
        [
          "144.0    to <149.0",
          "56.75    to <58.75",
          "1.55"
        ],
        [
          "149.0or    more",
          "58.75or    more",
          "1.70"
        ]
      ],
      [
        [
          "Table II-B"
        ],
        [
          "Age    13 to attainment of age 18"
        ],
        [
          "Heightwithoutshoes(centimeters)<    meansless than",
          "Height withoutshoes(inches)<    meansless than",
          "FemalesFVCless thanor equal to(L, BTPS)",
          "MalesFVCless thanor equal to(L, BTPS)"
        ],
        [
          "<153.0",
          "<60.25",
          "1.65",
          "1.65"
        ],
        [
          "153.0    to <159.0",
          "60.25    to <62.50",
          "1.70",
          "1.80"
        ],
        [
          "159.0    to <164.0",
          "62.50    to <64.50",
          "1.80",
          "1.95"
        ],
        [
          "164.0    to <169.0",
          "64.50    to <66.50",
          "1.95",
          "2.10"
        ],
        [
          "169.0    to <174.0",
          "66.50    to <68.50",
          "2.05",
          "2.25"
        ],
        [
          "174.0    to <180.0",
          "68.50    to <70.75",
          "2.20",
          "2.45"
        ],
        [
          "180.0or    more",
          "70.75or    more",
          "2.30",
          "2.55"
        ]
      ],
      [
        [
          "Table III-A"
        ],
        [
          "Age    6 to attainment of age 13(For    both females and males)"
        ],
        [
          "Heightwithoutshoes(centimeters)<    meansless than",
          "Height withoutshoes(inches)<    meansless than",
          "FEV1less than or equal to(L, BTPS)"
        ],
        [
          "<123.0",
          "<48.50",
          "1.00"
        ],
        [
          "123.0    to <129.0",
          "48.50    to <50.75",
          "1.15"
        ],
        [
          "129.0    to <134.0",
          "50.75    to <52.75",
          "1.25"
        ],
        [
          "134.0    to <139.0",
          "52.75    to <54.75",
          "1.40"
        ],
        [
          "139.0    to <144.0",
          "54.75    to <56.75",
          "1.50"
        ],
        [
          "144.0    to <149.0",
          "56.75    to <58.75",
          "1.70"
        ],
        [
          "149.0or    more",
          "58.75or    more",
          "1.80"
        ]
      ],
      [
        [
          "Table III-B"
        ],
        [
          "Age    13 to attainment of age 18"
        ],
        [
          "Heightwithoutshoes(centimeters)<    meansless than",
          "Height withoutshoes(inches)<    meansless than",
          "FemalesFEV1less thanor equal to(L, BTPS)",
          "MalesFEV1less thanor equal to(L, BTPS)"
        ],
        [
          "<153.0",
          "<60.25",
          "1.75",
          "1.85"
        ],
        [
          "153.0    to <159.0",
          "60.25    to <62.50",
          "1.85",
          "2.05"
        ],
        [
          "159.0    to <164.0",
          "62.50    to <64.50",
          "1.95",
          "2.15"
        ],
        [
          "164.0    to <169.0",
          "64.50    to <66.50",
          "2.10",
          "2.30"
        ],
        [
          "169.0    to <174.0",
          "66.50    to <68.50",
          "2.25",
          "2.45"
        ],
        [
          "174.0    to <180.0",
          "68.50    to <70.75",
          "2.35",
          "2.60"
        ],
        [
          "180.0or    more",
          "70.75or    more",
          "2.50",
          "2.70"
        ]
      ]
    ],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_01",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_03",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_05",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_06",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_07",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_08",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_09",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_10",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_10",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_11",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_12",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_13",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_14",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02C",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02E",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_03",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04E",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_14",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_11",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00D3",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00E",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02A",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04A",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02B",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-1016.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02C",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02E",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_03",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02C",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02C",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0924b.htm#b",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02C",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02E",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02E",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02E",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_03",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00J",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_14",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_03",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_03",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00H2",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0913.htm#a",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04G",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04G1",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04G4",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04G1",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04G2",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04G1",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04G2",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04G3",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04G4",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04G",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04G2",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04G3",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04G",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04G3",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04G4",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_11",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_11",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04E",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_14",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04E",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_14",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_06A",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_06B",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_06B",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0994.htm#a",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00E",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00E3a",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02A",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00E",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00E3a",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_02B",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_03",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00G",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_03",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00H",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00E",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00E3a",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04A",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00D3",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00H3",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00J",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00H3",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00H4",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00K",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B1",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B2",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00I",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00J",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_04E",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm"
    ],
    "html_file": "ssa_bluebook_data/html/2375525e6ef38fd1e33930edb1ebc553.html",
    "fetched_at": 1762482867.4988606
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm",
    "url_hash": "866d5cc0089a2a21105635d84dbc0107",
    "title": "104.00 Cardiovascular System - Childhood | Disability | SSA",
    "text_content": "104.00 Cardiovascular System - Childhood | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Listing of Impairments - Child Listings (Part B) 104.00 Cardiovascular System - Childhood Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security 104.00 Cardiovascular System - Childhood Section 104.01 Category \n              of Impairments, Cardiovascular System 104.02 Chronic heart failure 104.05 Recurrent arrhythmias 104.06 Congenital heart disease 104.09 Heart transplant 104.13 Rheumatic heart disease 104.00 Cardiovascular \n            System A. General 1. What do we mean by a cardiovascular impairment? a. We mean any disorder that affects the proper functioning of the heart or the circulatory system (that is, arteries, veins, capillaries, and the lymphatic drainage). The disorder can be congenital or  acquired. b. Cardiovascular impairment results from one or more of four consequences of heart disease: Back to Top (i) Chronic heart failure or ventricular dysfunction. (ii) Discomfort or pain due to myocardial ischemia, with or without necrosis of heart muscle. (iii) Syncope, or near syncope, due to inadequate cerebral perfusion from any cardiac cause, such as obstruction of flow or disturbance in rhythm or conduction resulting in inadequate cardiac output. (iv) Central cyanosis due to right-to-left shunt, reduced oxygen concentration in the arterial blood, or pulmonary vascular disease. c. Disorders of the veins or arteries (for example, obstruction, rupture, or aneurysm) may cause impairments of the lower extremities \n    (peripheral vascular disease), the central nervous system, the  eyes, the kidneys, and other organs. \n    We will evaluate peripheral vascular disease under 4.11 or 4.12 in part A, \n    and impairments of another body system(s) under the listings for that body system(s). Back to Top 2. What do we consider in evaluating cardiovascular impairments? The listings in this section describe cardiovascular impairments based on symptoms, signs, laboratory  findings, response to a regimen of prescribed treatment, and functional  limitations. 3. What do the following terms or phrases mean in these listings? a. Medical consultant is an individual defined in §§ 404.1616(a) and 416.1016(a) . \n    This term does not include medical sources who provide consultative examinations for  us. We use the abbreviation “MC” throughout this section to designate a medical consultant. b. Persistent means that the longitudinal clinical record shows that, with few exceptions,  the required finding(s) has been present, or is expected to be present, for a  continuous period of at least 12 months, such that a pattern of continuing  severity is established. c. Recurrent means that the longitudinal clinical record shows that, within a consecutive  12-month period, the finding(s) occurs at least three times, with intervening  periods of improvement of sufficient duration that it is clear that separate  events are involved. Back to Top d. Appropriate medically acceptable imaging means that the technique used is  the proper one to evaluate and diagnose the impairment and is commonly  recognized as accurate for assessing the cited finding. e. A consecutive 12-month period means a period of 12 consecutive  months, all or part of which must occur within the period we are considering in  connection with an application or continuing disability review. f. Currently present means that the finding is present at the time of  adjudication. g. Uncontrolled means the impairment does not respond adequately to standard  prescribed medical treatment. B. Documenting Cardiovascular Impairment 1. What basic documentation do we need? We need sufficiently detailed  reports of history, physical examinations, laboratory studies, and any  prescribed treatment and response to allow us to assess the severity and  duration of your cardiovascular impairment. A longitudinal clinical record covering  a period of not less than 3 months of observations and treatment is usually  necessary, unless we can make a determination or decision based on the current  evidence. Back to Top 2. Why is a longitudinal clinical record important? We will usually need a  longitudinal clinical record to assess the severity and expected duration of  your impairment(s). If you have a listing-level impairment, you probably will  have received medically prescribed treatment. Whenever there is evidence of  such treatment, your longitudinal clinical record should include a description  of the ongoing management and evaluation provided by your treating or other  medical source. It should also include your response to this medical  management, as well as information about the nature and severity of your  impairment. The record will provide us with information on your functional  status over an extended period of time and show whether your ability to  function is improving, worsening, or unchanging. 3. What if you have not received ongoing medical treatment? a. You may not have received ongoing treatment or have  an ongoing relationship with the medical community despite the existence of a  severe impairment(s). In this situation, we will base our evaluation on the  current objective medical evidence and the other evidence we have. If you do  not receive treatment, you cannot show an impairment that meets the criteria of  these listings. However, we may find you disabled because you have another  impairment(s) that in combination with your cardiovascular impairment medically  equals the severity of a listed impairment or that functionally equals the  listings. b. Unless we can decide your claim favorably on the  basis of the current evidence, a longitudinal record is still important. In  rare instances where there is no or insufficient longitudinal evidence, we may  purchase a consultative examination(s) to help us establish the severity and duration  of your impairment. Back to Top 4. When will we wait before we ask for more evidence? a. We will wait when we have information showing that  your impairment is not yet stable and the expected change in your impairment  might affect our determination or decision. In these situations, we need to  wait to properly evaluate the severity and duration of your impairment during a  stable period. Examples of when we might wait are: (i) If you have had a recent acute event; for example,  acute rheumatic fever. (ii) If you have recently had a corrective cardiac  procedure; for example, open-heart surgery. (iii) If you have started new drug therapy and your  response to this treatment has not yet been established; for example,  beta-blocker therapy for dilated congestive cardiomyopathy. b. In these situations, we will obtain more evidence 3  months following the event before we evaluate your impairment. However, we will  not wait if we have enough information to make a determination or decision  based on all of the relevant evidence in your case. Back to Top 5. Will we purchase any studies? In appropriate situations, we will purchase studies necessary to substantiate the diagnosis or to document the severity of your impairment, \n    generally after we have evaluated the medical and other evidence we already have. \n    We will not purchase studies involving exercise testing if there is significant risk involved or if there is another medical reason not to perform the test. \n    We will follow sections 4.00C6 , 4.00C7 , 4.00C8 , \n    and 104.00B7 when we decide whether to purchase exercise testing. \n    We will make a reasonable effort to obtain any additional studies from a qualified medical source in an office or center experienced in pediatric cardiac assessment. \n    (See  § 416.919g .) 6. What studies will we not purchase? We will not purchase any studies involving cardiac catheterization, such as coronary angiography, \n    arteriograms,  or electrophysiological studies. However, if the results of catheterization are  part of the existing evidence we have, we will consider them together with the other relevant evidence. \n    See 4.00C15a in part A. Back to Top 7. Will we use exercise tolerance tests (ETTs) for evaluating  children with cardiovascular impairment? a. ETTs, though increasingly used, are still less  frequently indicated in children than in adults, and can rarely be performed  successfully by children under 6 years of age. An ETT may be of value in the  assessment of some arrhythmias, in the assessment of the severity of chronic  heart failure, and in the assessment of recovery of function following cardiac  surgery or other treatment. b. We will purchase an ETT in a childhood claim only if we cannot make a determination or decision based on the evidence we have and an MC, \n    preferably one with experience in the care of children with cardiovascular impairments, \n    has determined that an ETT is needed to evaluate your impairment. We will not purchase an ETT if you are less than 6 years of age. If we do purchase an ETT for a child age 12 or younger, \n    it must be performed by a qualified medical source in a specialty center for pediatric cardiology or other facility qualified to perform exercise tests of children. c. For full details on ETT requirements and usage, \n    see 4.00C in part A. Back to Top C. Evaluating Chronic Heart Failure 1. What is chronic heart failure (CHF)? a. CHF is the inability of the heart to  pump enough oxygenated blood to body tissues. This syndrome is characterized by  symptoms and signs of pulmonary or systemic congestion (fluid retention) or  limited cardiac output. Certain laboratory findings of cardiac functional and  structural abnormality support the diagnosis of CHF. b. CHF is considered in these listings as a single category whether due to atherosclerosis (narrowing of the arteries),  \n    cardiomyopathy, hypertension, or rheumatic, congenital, or other heart disease.  However, if the CHF is the result of primary pulmonary hypertension secondary to disease of the lung (cor pulmonale), \n    we will evaluate your impairment using 3.09 in the respiratory system listings in part A. Back to Top 2. What evidence of CHF do we need? a. Cardiomegaly or ventricular dysfunction must be present and demonstrated by appropriate medically acceptable imaging, such as chest x-ray, echocardiography (M-Mode, 2-dimensional, and Doppler),  radionuclide studies, or cardiac catheterization. (i) Cardiomegaly is present when: (A) Left  ventricular diastolic dimension or systolic dimension is greater than 2  standard deviations above the mean for the child’s body surface area; (B) Left ventricular mass is greater than 2 standard deviations above the  mean for the child’s body surface area; or (C) Chest  x-ray (6 foot PA film) is indicative of cardiomegaly if the cardiothoracic  ratio is over 60 percent at 1 year of age or less, or 55 percent or greater at  more than 1 year of age. (ii) Ventricular dysfunction is present when indices of  left ventricular function, such as fractional shortening or ejection fraction  (the percentage of the blood in the ventricle actually pumped out with each  contraction), are greater than 2 standard deviations below the mean for the child’s  age. (Fractional shortening, also called shortening fraction, reflects the left  ventricular systolic function in the absence of segmental wall motion  abnormalities and has a linear correlation with ejection fraction. In children,  fractional shortening is more commonly used than ejection fraction.) Back to Top (iii) However, these measurements alone do not reflect  your functional capacity, which we evaluate by considering all of the relevant  evidence. (iv) Other findings on appropriate medically acceptable  imaging may include increased pulmonary vascular markings, pleural effusion,  and pulmonary edema. These findings need not be present on each report, since  CHF may be controlled by prescribed treatment. b. To establish that you have chronic heart failure, we require that your medical history and physical examination  describe characteristic symptoms and signs of pulmonary or systemic congestion  or of limited cardiac output associated with the abnormal findings on  appropriate medically acceptable imaging. When a remediable factor, such as an  arrhythmia, triggers an acute episode of heart failure, you may experience  restored cardiac function and a chronic impairment may not be present. (i) Symptoms of congestion or of limited cardiac output  include easy fatigue, weakness, shortness of breath (dyspnea), cough, or chest  discomfort at rest or with activity. Children with CHF may also experience  shortness of breath on lying flat (orthopnea) or episodes of shortness of  breath that wake them from sleep (paroxysmal nocturnal dyspnea). They may also  experience cardiac arrhythmias resulting in palpitations, lightheadedness, or  fainting. Fatigue or exercise intolerance in an infant may be manifested by  prolonged feeding time, often associated with excessive respiratory effort and  sweating. (ii) During infancy, other  manifestations of chronic heart failure may include repeated lower respiratory  tract infections. (iii)  Signs of congestion may include hepatomegaly, ascites, increased jugular venous  distention or pressure, rales, peripheral edema, rapid shallow breathing  (tachypnea), or rapid weight gain. However, these signs need not be found on  all examinations because fluid retention may be controlled by prescribed  treatment. 3. How do we evaluate growth failure  due to CHF? a. To evaluate growth failure due to CHF, \n    we require documentation of the clinical findings of CHF described in 104.00C2 and the growth measurements in 104.02C within the same consecutive 12-month period.\n    The dates of clinical findings may be different from the dates of growth measurements. b. Under 104.02C , \n    we use the appropriate table(s) under 105.08B in the digestive system to determine whether a child’s growth is less than the third percentile. (i) For Children from birth to attainment of age 2, we use the weight-for-length table corresponding to the child’s gender (Table I or Table II). (ii) For children age 2 to attainment of age 18, we use the body mass index (BMI)-for-age table corresponding to  the child’s gender (Table III or Table IV). (iii) BMI is the ratio of a child’s  weight to the square of his or her height.\n                We calculate BMI using the formulas in the digestive disorders body system ( 105.00 ). D. Evaluating Congenital Heart Disease 1. What is congenital heart disease? Congenital heart disease is any  abnormality of the heart or the major blood vessels that is present at birth. Examples  include: a. Abnormalities of cardiac septation , including ventricular septal defect or atrioventricular canal; b. Abnormalities resulting in cyanotic heart disease , including tetralogy of Fallot or transposition of the great arteries; Back to Top c. Valvular defects or obstructions to ventricular outflow, including pulmonary or aortic  stenosis or coarctation of the aorta; and d. Major abnormalities of ventricular development , including  hypoplastic left heart syndrome or pulmonary tricuspid atresia with hypoplastic  right ventricle. 2. How will we evaluate symptomatic congenital heart disease? a. Because of improved treatment methods, more children with congenital heart disease are living longer. \n    Although some types of congenital heart disease may be corrected by surgery, \n    many children with treated congenital heart disease continue to have problems throughout their lives (symptomatic congenital heart disease). \n    If you have congenital heart disease that results in chronic heart failure with evidence of ventricular dysfunction or in recurrent arrhythmias, \n    we will evaluate your impairment under 104.02 or 104.05 .\n    Otherwise, we will evaluate your impairment under 104.06 . b. For 104.06A2 ,\n    we will accept pulse oximetry measurements instead of arterial O2, but the arterial O2 values are preferred, if available. c. For 104.06D , \n    examples of impairments that in most instances will require life-saving surgery or a combination of surgery and other major interventional procedures \n    (for example, multiple “balloon” catheter  procedures) before age 1 include, but are not limited to, the following: Back to Top (i) Hypoplastic left heart syndrome, (ii) Critical aortic stenosis with neonatal heart failure, (iii) Critical coarctation of the aorta, with or without associated anomalies, (iv) Complete atrioventricular canal defects, (v) Transposition of the great arteries, (vi) Tetralogy of Fallot, (vii) Pulmonary atresia with intact ventricular septum, (viii) Single ventricle, (ix) Tricuspid atresia, and (x) Multiple ventricular septal defects. Back to Top E. Evaluating Arrhythmias 1. What is an arrhythmia? An arrhythmia is a change in the regular beat of the heart. Your heart may seem to skip a beat or beat irregularly, very quickly (tachycardia), or very slowly  (bradycardia). 2. What are the different types of arrhythmias? a. There are many types of arrhythmias. Arrhythmias are  identified by where they occur in the heart (atria or ventricles) and by what  happens to the heart’s rhythm when they occur. b. Arrhythmias arising in the cardiac atria (upper  chambers of the heart) are called atrial or supraventricular arrhythmias. Ventricular  arrhythmias begin in the ventricles (lower chambers). In general, ventricular  arrhythmias caused by heart disease are the most serious. Back to Top 3. How do we evaluate arrhythmias using 104.05 ? a. We will use 104.05 when you have arrhythmias that are not fully controlled by medication, \n    an implanted pacemaker, or an implanted cardiac defibrillator and you have uncontrolled recurrent episodes of syncope or near syncope. \n    If your arrhythmias are controlled, we will evaluate your underlying heart disease using the appropriate listing. \n    For other considerations when we evaluate arrhythmias in the presence of an implanted cardiac defibrillator, see 104.00E4 . b. We consider near syncope to be a period of altered consciousness, since syncope is a  loss of consciousness or a faint. It is not merely a feeling of  light-headedness, momentary weakness, or dizziness. c. For purposes of 104.05 , there must be a documented association between the syncope or near syncope and the recurrent arrhythmia. The  recurrent arrhythmia, not some other cardiac or non-cardiac disorder, must be  established as the cause of the associated symptom. This documentation of the  association between the symptoms and the arrhythmia may come from the usual  diagnostic methods, including Holter monitoring (also called ambulatory  electrocardiography) and tilt-table testing with a concurrent ECG. Although an  arrhythmia may be a coincidental finding on an ETT, we will not purchase an ETT  to document the presence of a cardiac arrhythmia. Back to Top 4. What will we consider when you have an implanted cardiac defibrillator and you do not have arrhythmias that meet the requirements of 104.05 ? a. Implanted cardiac defibrillators are used to prevent sudden cardiac death in children who have had, or are at high risk for, \n    cardiac arrest from life-threatening ventricular arrhythmias. The largest group of children at risk for sudden cardiac death consists of children with cardiomyopathy \n    (ischemic or non-ischemic) and reduced ventricular function. However, life-threatening ventricular arrhythmias can also occur in children with little or no ventricular dysfunction. \n    The shock from the implanted cardiac  defibrillator is a unique form of treatment; it rescues a child from what may have been cardiac arrest. \n    However, as a consequence of the shock(s), children may experience psychological distress, \n    which we may evaluate under the mental disorders listings in 112.00ff . b. Most implantable cardiac defibrillators have  rhythm-correcting and pacemaker capabilities. In some children, these functions  may result in the termination of ventricular arrhythmias without an otherwise  painful shock. (The shock is like being kicked in the chest.) Implanted cardiac  defibrillators may deliver inappropriate shocks, often repeatedly, in response  to benign arrhythmias or electrical malfunction. Also, exposure to strong electrical  or magnetic fields, such as from MRI (magnetic resonance imaging), can trigger  or reprogram an implanted cardiac defibrillator, resulting in inappropriate  shocks. We must consider the frequency of, and the reason(s) for, the shocks  when evaluating the severity and duration of your impairment. c. In general, the exercise limitations imposed on  children with an implanted cardiac defibrillator are those dictated by the  underlying heart impairment. However, the exercise limitations may be greater  when the implanted cardiac defibrillator delivers an inappropriate shock in  response to the increase in heart rate with exercise, or when there is  exercise-induced ventricular arrhythmia. Back to Top F. Evaluating Other Cardiovascular Impairments 1. What is ischemic heart disease (IHD) and how will we evaluate it in children? IHD results when one or more of your coronary arteries is narrowed or obstructed or, in rare situations, constricted due to vasospasm, \n    interfering with the normal flow of blood to your heart muscle (ischemia). \n    The obstruction may be the result of an embolus, a thrombus, or plaque. When heart muscle tissue dies as a result of the reduced blood supply, \n    it is called a myocardial infarction (heart attack). Ischemia is rare in children, but when it occurs, its effects on children are the same as on adults. \n    If you have IHD, we will evaluate it under 4.00E and 4.04 in part A. 2. How will we evaluate hypertension? Because hypertension (high blood pressure) generally  causes disability through its effects on other body systems, we will evaluate  it by reference to the specific body system(s) affected (heart, brain, kidneys,  or eyes) when we consider its effects under the listings. We will also consider  any limitations imposed by your hypertension when we consider whether you have  an impairment that functionally equals the listings. Back to Top 3. What is cardiomyopathy and how will we evaluate it? Cardiomyopathy is a disease of the heart muscle. \n    The heart loses its ability to pump blood (heart failure), and in some instances, heart rhythm is disturbed, leading to irregular heartbeats (arrhythmias). \n    Usually, the exact cause of the muscle damage is never found (idiopathic cardiomyopathy). \n    There are various types of cardiomyopathy, which fall into two major categories: Ischemic and nonischemic cardiomyopathy. \n    Ischemic cardiomyopathy typically refers to heart muscle damage that results from  coronary artery disease, including heart attacks. \n    Nonischemic cardiomyopathy includes several types: Dilated, hypertrophic, and restrictive. \n    We will evaluate cardiomyopathy under 4.04 in part A, 104.02 , 104.05 , \n    or 111.06 , depending on its effects on you. 4. How will we evaluate valvular heart disease? We will evaluate valvular heart disease under the listing appropriate for its effect on you.\n    Thus, we may use 4.04 in part A, 104.02 , 104.05 , 104.06 ,\n    or an appropriate neurological listing in 111.00ff . 5. What do we consider when we evaluate heart transplant recipients? a. After your heart transplant, we will consider you disabled for 1 year following the surgery because there is a greater likelihood of rejection of the organ and infection during the first year. Back to Top b. However, heart transplant patients generally meet our definition of disability before they undergo transplantation. We will determine the onset of your disability based on the facts in your case. c. We will not assume that you became disabled when your name was placed on a transplant waiting list. This is because you may be  placed on a waiting list soon after diagnosis of the cardiac disorder that may  eventually require a transplant. Physicians recognize that candidates for  transplantation often have to wait months or even years before a suitable donor  heart is found, so they place their patients on the list as soon as permitted. d. When we do a continuing disability review to determine whether you are still disabled, \n    we will evaluate your residual impairment(s), as shown by symptoms, signs, and laboratory findings, including any side effects of medication. \n    We will consider any remaining symptoms, signs, and laboratory findings indicative of cardiac dysfunction in deciding whether medical improvement \n    (as defined in § 416.994a ) has occurred. Back to Top 6. How will we evaluate chronic rheumatic fever or rheumatic heart disease? The diagnosis should be made in accordance with the current revised Jones criteria for guidance in the diagnosis of rheumatic fever. \n    We will evaluate persistence of rheumatic fever activity under 104.13 .\n    If you have evidence of chronic heart failure or recurrent arrhythmias associated with rheumatic heart disease,\n    we will use 104.02 or 104.05 . 7. What is hyperlipidemia and how will we evaluate it? Hyperlipidemia is the general term for an  elevation of any or all of the lipids (fats or cholesterol) in the blood; for  example, hypertriglyceridemia, hypercholesterolemia, and hyperlipoproteinemia. These  disorders of lipoprotein metabolism and transport can cause defects throughout  the body. The effects most likely to interfere with function are those produced by atherosclerosis (narrowing of the arteries) and coronary  artery disease. We will evaluate your lipoprotein disorder by considering its  effects on you. 8. How will we evaluate Kawasaki disease? We will evaluate Kawasaki disease under the listing appropriate to its effects on you, which may include major coronary artery aneurysm or heart failure. \n    A major coronary artery aneurysm may cause ischemia or arrhythmia, \n    which we will evaluate under 4.04 in part A or 104.05 .\n    We will evaluate chronic heart failure under 104.02 . Back to Top 9. What is lymphedema and how  will we evaluate it? a. Lymphedema is edema of the extremities due to a disorder of the lymphatic circulation; at its worst, it is called elephantiasis. Primary lymphedema is caused by abnormal development of lymph  vessels and may be present at birth (congenital lymphedema), but more often  develops during the teens (lymphedema praecox). Secondary lymphedema is due to obstruction  or destruction of normal lymphatic channels due to tumor, surgery, repeated  infections, or parasitic infection such as filariasis. Lymphedema most commonly  affects one extremity. b. Lymphedema does not meet the requirements of 4.11 in part A, \n    although it may medically  equal the severity of that listing. \n    We will evaluate lymphedema by considering  whether the underlying cause meets or medically equals any listing or whether the lymphedema medically equals a cardiovascular listing, \n    such as 4.11 , or a  musculoskeletal disorders listing,\n    such as 101.18 .\n    If no listing is met or medically equaled, we will evaluate any functional limitations imposed by your lymphedema when we consider whether you have an impairment that functionally equals the listings. Back to Top 10. What is Marfan syndrome and how will we evaluate it? a. Marfan syndrome is a genetic connective tissue disorder that affects multiple body systems, including the skeleton, eyes, heart, blood vessels, nervous system,  skin, and lungs. There is no specific laboratory test to diagnose Marfan  syndrome. The diagnosis is generally made by medical history, including family  history, physical examination, including an evaluation of the ratio of arm/leg  size to trunk size, a slit lamp eye examination, and a heart test(s), such as  an echocardiogram. In some cases, a genetic analysis may be useful, but such  analyses may not provide any additional helpful information. b. The effects of Marfan syndrome can range from mild to severe. \n    In most cases, the disorder progresses as you age. Most individuals with Marfan syndrome have  abnormalities associated with the heart and blood vessels. \n    Your heart’s mitral  valve may leak, causing a heart murmur. Small leaks may not cause symptoms, but larger ones may cause shortness of breath, fatigue, and palpitations. \n    Another effect is that the wall of the aorta may be weakened and stretch (aortic  dilation). \n    This aortic dilation may tear, dissect, or rupture, causing serious heart problems or sometimes sudden death. \n    We will evaluate the manifestations of your Marfan syndrome under the appropriate body system criteria, \n    such as 4.10 in part A, \n    or if necessary consider the functional limitations imposed by  your impairment. Back to Top G. Other Evaluation Issues 1. What effect does obesity have on the cardiovascular system and how will we evaluate it? Obesity is a medically determinable impairment that is often associated with disorders of the  cardiovascular system. Disturbance of this system can be a major cause of  disability in children with obesity. Obesity may affect the cardiovascular  system because of the increased workload the additional body mass places on the  heart. Obesity may make it harder for the chest and lungs to expand. This can  mean that the respiratory system must work harder to provide needed oxygen. This  in turn would make the heart work harder to pump blood to carry oxygen to the  body. Because the body would be working harder at rest, its ability to perform  additional work would be less than would otherwise be expected. Thus, the  combined effects of obesity with cardiovascular impairments can be greater than  the effects of each of the impairments considered separately. We must consider  any additional and cumulative effects of obesity when we determine whether you  have a severe cardiovascular impairment or a listing-level cardiovascular  impairment (or a combination of impairments that medically equals a listing),  and when we determine whether your impairment(s) functionally equals the  listings. Back to Top 2. How do we relate treatment to  functional status? In  general, conclusions about the severity of a cardiovascular impairment cannot  be made on the basis of type of treatment rendered or anticipated. \n    The amount of function restored and the time required for improvement after treatment  (medical, surgical, or a prescribed program of progressive physical activity) \n    vary with the nature and extent of the disorder, the type of treatment, and other factors. Depending upon the timing of this treatment in relation to the alleged onset date of disability, \n    we may need to defer evaluation of the impairment for a period of up to 3 months from the date treatment began to permit consideration of treatment effects, \n    unless we can make a determination or decision using the evidence we have. \n    See 104.00B4 . 3. How do we evaluate impairments that do not meet one of the cardiovascular listings? a. These listings are only examples of common cardiovascular disorders that we consider  severe enough to result in marked and severe functional limitations. If your  severe impairment(s) does not meet the criteria of any of these listings, we  must also consider whether you have an impairment(s) that satisfies the  criteria of a listing in another body system. b. If you have a severe medically determinable impairment(s) that does not meet a listing, \n    we will determine whether your impairment(s) medically equals a listing. \n    (See § 416.926 .)\n    If you have a severe impairment(s) that does not meet or medically equal the criteria of a listing, we will consider whether it functionally equals the listings.\n    (See § 416.926a .)\n    When we decide whether you continue to be disabled, we use the rules in § 416.994a . Back to Top 104.01 Category of Impairments, Cardiovascular System 104.02 Chronic heart failure while on a regimen of prescribed treatment with symptoms and signs described in 104.00C2 and with one of the following: A. Persistent tachycardia at rest (see Table I); OR B. Persistent tachypnea at rest (see Table II) or  markedly decreased exercise tolerance \n    (see 104.00C2b ); OR C. Growth failure as required in 1 or 2: 1. For children from birth to  attainment of age 2, three weight-for-length measurements that are: a. Within a consecutive 12-month  period; and b. At least 60 days apart; and c. Less than the third percentile on the appropriate weight-for-length Table I or II under 105.08B1 ; or 2. For children age 2 to attainment of age 18, three BMI-for-age measurements that are: a. Within a consecutive 12-month  period; and b. At least 60 days apart; and c. Less than the third percentile on the appropriate BMI-for-age Table III or IV under 105.08B2 . Back to Top Table I ‑  Tachycardia at Rest Age Apical    heart rate (beats per    minute) Under 1 year 150 1 through 3 years 130 4 through 9 years 120 10 through 15 years 110 Over 15 years 100 Table II ‑ Tachypnea  at Rest Age Respiratory    rate over  (per minute) Under 1 year 40 1 through 5 years 35 6 through 9 years 30 Over 9 years 25 Back to Top 104.05 Recurrent arrhythmias, not related to reversible causes such as electrolyte abnormalities or digitalis glycoside or antiarrhythmic drug toxicity, \n    resulting in uncontrolled (see 104.00A3g ), \n                recurrent (see 104.00A3c )\n    episodes of cardiac syncope or near syncope (see 104.00E3b ),\n    despite prescribed treatment (see 104.00B3 if there is no prescribed treatment),\n    and documented by resting or ambulatory (Holter) electrocardiography, or by other appropriate medically acceptable testing,\n    coincident with the occurrence of syncope or near syncope (see 104.00E3c ). Back to Top 104.06 Congenital heart disease, documented by appropriate medically acceptable imaging (see 104.00A3d ) or cardiac catheterization, with one of the following: A. Cyanotic heart disease, with  persistent, chronic hypoxemia as manifested by: 1. Hematocrit of 55 percent or  greater on two evaluations 3 months or more apart within a consecutive 12-month  period \n    (see 104.00A3e ); or 2. Arterial O2 saturation of less than 90 percent in room air, or resting arterial PO2 of 60 Torr or less; or 3. Hypercyanotic spells, syncope, characteristic squatting, or other incapacitating symptoms directly related to  documented cyanotic heart disease; or 4. Exercise intolerance with increased hypoxemia on exertion. OR B. Secondary pulmonary vascular obstructive disease with pulmonary arterial systolic pressure elevated to at least 70 percent of the systemic arterial systolic pressure. OR C. Symptomatic acyanotic heart disease, with ventricular dysfunction interfering very seriously with the ability to independently initiate, sustain, or complete activities. OR D. For infants under 12 months of age at the time of filing, with life-threatening congenital heart impairment that will require or already has required surgical treatment in the first year  of life, and the impairment is expected to be disabling (because of residual  impairment following surgery, or the recovery time required, or both) until the  attainment of at least 1 year of age, consider the infant to be under  disability until the attainment of at least age 1; thereafter, evaluate  impairment severity with reference to the appropriate listing. Back to Top 104.09 Heart transplant . Consider under a disability for 1  year following surgery; thereafter, evaluate residual impairment under the  appropriate listing. 104.13 Rheumatic heart disease, with persistence of rheumatic fever activity manifested by significant murmurs(s), cardiac enlargement or ventricular dysfunction \n    (see 104.00C2a ), and other associated abnormal laboratory findings;\n    for example, an elevated sedimentation rate or ECG findings, for 6 months or  more in a consecutive 12-month period\n    (see 104.00A3e ). Consider under a disability for 18 months from the established onset of impairment, then evaluate any residual impairment(s). Back to Top",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security104.00 Cardiovascular System - Childhood"
      }
    ],
    "tables": [
      [
        [
          "Age",
          "Apical    heart rate(beats per    minute)"
        ],
        [
          "Under 1 year",
          "150"
        ],
        [
          "1 through 3 years",
          "130"
        ],
        [
          "4 through 9 years",
          "120"
        ],
        [
          "10 through 15 years",
          "110"
        ],
        [
          "Over 15 years",
          "100"
        ]
      ],
      [
        [
          "Age",
          "Respiratory    rate over  (per minute)"
        ],
        [
          "Under 1 year",
          "40"
        ],
        [
          "1 through 5 years",
          "35"
        ],
        [
          "6 through 9 years",
          "30"
        ],
        [
          "Over 9 years",
          "25"
        ]
      ]
    ],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_01",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_02",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_06",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_09",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_13",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_11",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_12",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/OP_Home/cfr20/404/404-1616.htm#a",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-1016.htm#a",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_00C6",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_00C7",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_00C8",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00B7",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0919g.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_00C15a",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_00C",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm#3_09",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00C2",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_02C",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_02C",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_02",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_06",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_06A2",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_06D",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_00E",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_04",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_04",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_02",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_06",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_04",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_02",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_06",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0994a.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_13",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_02",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_04",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_02",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_11",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_11",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_18",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_10",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00B4",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0994a.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00C2",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00C2b",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B1",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B2",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00A3g",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00A3c",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00E3b",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00E3c",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00A3d",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00A3e",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00C2a",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00A3e",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm"
    ],
    "html_file": "ssa_bluebook_data/html/866d5cc0089a2a21105635d84dbc0107.html",
    "fetched_at": 1762482869.813269
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00",
    "url_hash": "00b7d1b0dd12393f77932cb07be082b7",
    "title": "112.00 Mental Disorders - Childhood | Disability | SSA",
    "text_content": "112.00 Mental Disorders - Childhood | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Listing of Impairments - Child Listings (Part B) 112.00 Mental Disorders - Childhood Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security 112.00 Mental Disorders - Childhood Section 112.01 Category of Impairments, Mental Disorders 112.02 Neurocognitive disorders 112.03 Schizophrenia spectrum and other psychotic disorders 112.04 Depressive, bipolar and related disorders 112.05 Intellectual disorder 112.06 Anxiety and obsessive-compulsive disorders 112.07 Somatic symptom and related disorders 112.08 Personality and impulse-control disorders 112.09 [Reserved] 112.10 Autism spectrum disorder 112.11 Neurodevelopmental disorders 112.12 [Reserved] 112.13 Eating disorders 112.14 Developmental disorders in infants and toddlers 112.15 Trauma- and stressor-related disorders 112.00 Mental Disorders A. How are the listings for mental disorders for children arranged, and what do they require? The listings for mental disorders for children are arranged in 12 categories:\n                neurocognitive disorders ( 112.02 );\n                schizophrenia spectrum and other psychotic disorders ( 112.03 );\n                depressive, bipolar and related disorders ( 112.04 );\n                intellectual disorder ( 112.05 );\n                anxiety and obsessive-compulsive disorders ( 112.06 );\n                somatic symptom and related disorders ( 112.07 );\n                personality and impulse-control disorders ( 112.08 );\n                autism spectrum disorder ( 112.10 );\n                neurodevelopmental disorders ( 112.11 );\n                eating disorders ( 112.13 );\n                developmental disorders in infants and toddlers ( 112.14 );\n                and trauma- and stressor-related disorders ( 112.15 ). \n                All of these listings, with the exception of 112.14 ,\n                apply to children from age three to attainment of age 18. \n                Listing 112.14 is for children from birth to attainment of age 3. Listings 112.07 , 112.08 , 112.10 , 112.11 , 112.13 ,\n                and 112.14 have two paragraphs,\n                designated A and B; your mental disorder must satisfy the requirements of both paragraphs A and B.\n                Listings 112.02 , 112.03 , 112.04 , 112.06 , and 112.15 have three paragraphs,\n                designated A, B, and C; your mental disorder must satisfy the requirements of both paragraphs A and B, or the requirements of both paragraphs A and C. \n                Listing 112.05 has two paragraphs that are unique to that listing\n                (see 112.00A3 );\n                your mental disorder must satisfy the requirements of either paragraph A or paragraph B. Paragraph A of each listing (except 112.05 )\n                        includes the  medical criteria that must be present in your medical evidence. Paragraph B of each listing (except 112.05 )\n                        provides the  functional criteria we assess to evaluate how your mental disorder limits your functioning. \n                        For children ages 3 to 18, these criteria represent the areas of mental functioning a child uses to  perform age-appropriate activities.  \n                        They are: understand, remember, or apply information; interact with others; concentrate, persist, or maintain pace; and adapt  or manage oneself.  \n                        (See 112.00I for a discussion of the criteria for children from birth to attainment of age 3 under 112.14 .)  We will determine the degree to which your medically determinable mental impairment affects the four areas of mental functioning\n                        and your ability to function age-appropriately in a manner comparable to that of other children your age who do not have impairments. \n                        (Hereinafter, the words \"age-appropriately\" incorporate the qualifying statement,\n                        \"in a manner comparable to that of other children your age who do not have impairments.\") \n                        To satisfy the paragraph B criteria, your  mental disorder must result in \"extreme\" limitation of one, or \"marked\" limitation of two,\n                        of the four areas of mental functioning. \n                        (When we refer to \"paragraph B criteria\" or \"area[s] of mental functioning\" in the introductory text of this body system,\n                        we mean the criteria in paragraph B of every listing except 112.05 and 112.14 .) Paragraph C of listings 112.02 , 112.03 , 112.04 , 112.06 , and 112.15 provides the criteria we use to evaluate \"serious and persistent mental disorders.\" \n                        To satisfy the paragraph C criteria, your mental disorder must be \"serious and persistent\";\n                        that is, there must be a medically documented history of the existence of the disorder over a period of at least 2 years,\n                        and evidence that satisfies the criteria in both C1 and C2 (see 112.00G ).\n                        (When we refer to \"paragraph C\" or \"the paragraph C criteria\" in the introductory text of this body system,\n                        we mean the criteria in paragraph C of listings 112.02 , 112.03 , 112.04 , 112.06 , and 112.15 .) Listing 112.05 has two paragraphs,\n                designated A and B, that apply to only intellectual disorder. \n                Each paragraph requires that you have significantly subaverage general intellectual functioning and significant deficits in current adaptive functioning. B. Which mental disorders do we evaluate under each listing category for children? Neurocognitive disorders ( 112.02 ). These disorders are characterized in children by a clinically significant deviation in normal cognitive development or by a decline in cognitive functioning.  Symptoms and signs may include, but are not  limited to, disturbances in memory, executive functioning (that is,  higher-level cognitive processes; for example, regulating attention, planning,  inhibiting responses, decision-making), visual-spatial functioning, language  and speech, perception, insight, and judgment. Examples of disorders that we evaluate in this category include major neurocognitive disorder;\n                    mental impairments resulting from medical conditions such as a metabolic disease (for example, juvenile Tay-Sachs disease), human immunodeficiency virus infection,\n                    vascular malformation, progressive brain tumor, or traumatic brain injury; or substance-induced cognitive disorder associated with drugs of abuse, medications, or toxins. \n                    (We evaluate neurological disorders under that body system (see 111.00 ). \n                    We evaluate cognitive impairments that result from neurological disorders under 112.02 if they do not satisfy the requirements in 111.00 .  \n                    We evaluate catastrophic genetic disorders under listings in 110.00 , 111.00 , or 112.00 ,\n                    as appropriate. We evaluate genetic disorders that are not catastrophic under the affected body system(s).) This category does not include the mental disorders that we evaluate under intellectual disorder\n                    ( 112.05 ), autism spectrum disorder ( 112.10 ),\n                    and neurodevelopmental disorders ( 112.11 ). Schizophrenia spectrum and other psychotic disorders ( 112.03 ). These disorders are characterized by delusions, hallucinations, disorganized speech, or grossly disorganized or catatonic behavior, causing a clinically significant decline in  functioning.  Symptoms and signs may include,  but are not limited to, inability to initiate and persist in goal-directed  activities, social withdrawal, flat or inappropriate affect, poverty of thought  and speech, loss of interest or pleasure, disturbances of mood, odd beliefs and  mannerisms, and paranoia. Examples of disorders that we evaluate in this category include schizophrenia, schizoaffective disorder, delusional disorder, and psychotic disorder due to  another medical condition. Depressive, bipolar and related disorders ( 112.04 ). These disorders are characterized by an irritable, depressed, elevated, or expansive mood, or by a  loss of interest or pleasure in all or almost all activities, causing a  clinically significant decline in functioning.   Symptoms and signs may include, but are not limited to, feelings of hopelessness  or guilt, suicidal ideation, a clinically significant change in body weight or  appetite, sleep disturbances, an increase or decrease in energy, psychomotor  abnormalities, disturbed concentration, pressured speech, grandiosity, reduced  impulse control, sadness, euphoria, and social withdrawal.  Depending on a child’s age and developmental  stage, certain features, such as somatic complaints, irritability, anger,  aggression, and social withdrawal may be more commonly present than other  features. Examples of disorders that we evaluate in this category include bipolar disorders (I or  II), cyclothymic disorder, disruptive mood dysregulation disorder, major  depressive disorder, persistent depressive disorder (dysthymia), and bipolar or  depressive disorder due to another medical condition. Intellectual disorder ( 112.05 ). This disorder is  characterized by significantly subaverage general intellectual functioning and significant deficits in current adaptive functioning.  Signs may include, but are not limited to,  poor conceptual, social, or practical skills evident in your adaptive  functioning. The disorder that we evaluate in this category may be described in the evidence as intellectual disability, intellectual developmental disorder, or historically used terms  such as “mental retardation.” This category does not include the mental disorders that we evaluate under neurocognitive disorders \n                ( 112.02 ), autism spectrum disorder ( 112.10 ),\n                    or neurodevelopmental  disorders ( 112.11 ). Anxiety and obsessive-compulsive disorders ( 112.06 ). These disorders are  characterized by excessive anxiety, worry, apprehension, and fear, or by avoidance  of feelings, thoughts, activities, objects, places, or people.  Symptoms and signs may include, but are not  limited to, restlessness, difficulty concentrating, hyper-vigilance, muscle  tension, sleep disturbance, fatigue, panic attacks, obsessions and compulsions,  constant thoughts and fears about safety, and frequent physical  complaints.  Depending on a child’s age and developmental stage, other features may  also include refusal to go to school, academic failure, frequent stomachaches  and other physical complaints, extreme worries about sleeping away from home,  being overly clinging, and exhibiting tantrums at times of separation from  caregivers. Examples of  disorders that we evaluate in this category include separation anxiety  disorder, social anxiety disorder, panic disorder, generalized anxiety  disorder, agoraphobia, and obsessive-compulsive disorder. This category does not include the mental disorders that we evaluate under trauma- \n                and stressor-related disorders ( 112.15 ). Somatic symptom and related disorders ( 112.07 ). These disorders are  characterized by physical symptoms or deficits that are not intentionally  produced or feigned, and that, following clinical investigation, cannot be  fully explained by a general medical condition, another mental disorder, the  direct effects of a substance, or a culturally sanctioned behavior or  experience.  Symptoms and signs may  include, but are not limited to, pain and other abnormalities of sensation,  gastrointestinal symptoms, fatigue, abnormal motor movement, pseudoseizures,  and pseudoneurological symptoms, such as blindness or deafness. Examples of  disorders that we evaluate in this category include somatic symptom disorder and conversion disorder. Personality and impulse-control disorders ( 112.08 ). These disorders are  characterized by enduring, inflexible, maladaptive, and pervasive patterns of  behavior.  Onset may occur in childhood  but more typically occurs in adolescence or young adulthood.  Symptoms and signs may include, but are not  limited to, patterns of distrust, suspiciousness, and odd beliefs; social  detachment, discomfort, or avoidance; hypersensitivity to negative evaluation;  an excessive need to be taken care of; difficulty making independent decisions;  a preoccupation with orderliness, perfectionism, and control; and  inappropriate, intense, impulsive anger and behavioral expression grossly out  of proportion to any external provocation or psychosocial stressors. Examples of  disorders that we evaluate in this category include paranoid, schizoid,  schizotypal, borderline, avoidant, dependent, obsessive-compulsive personality  disorders, and intermittent explosive disorder. Autism spectrum disorder ( 112.10 ). These disorders are characterized by qualitative deficits in the development of reciprocal social interaction, verbal and nonverbal communication skills, and symbolic or  imaginative play; restricted repetitive and stereotyped patterns of behavior,  interests, and activities; and stagnation of development or loss of acquired  skills.  Symptoms and signs may include,  but are not limited to, abnormalities and unevenness in the development of  cognitive skills; unusual responses to sensory stimuli; and behavioral  difficulties, including hyperactivity, short attention span, impulsivity,  aggressiveness, or self-injurious actions. Examples of disorders that we evaluate in this category include autism spectrum disorder with or without accompanying intellectual impairment, and autism spectrum disorder with or without accompanying language impairment. This category does not include the mental disorders that we evaluate under neurocognitive\n                    disorders ( 112.02 ), intellectual disorder ( 112.05 ),\n                    and neurodevelopmental disorders ( 112.11 ). Neurodevelopmental disorders ( 112.11 ). These disorders are characterized by onset during the developmental period, that is, during childhood  or adolescence, although sometimes they are not diagnosed until adulthood.  Symptoms and signs may include, but are not  limited to, underlying abnormalities in cognitive processing (for example,  deficits in learning and applying verbal or nonverbal information, visual  perception, memory, or a combination of these); deficits in attention or  impulse control; low frustration tolerance; excessive or poorly planned motor  activity; difficulty with organizing (time, space, materials, or tasks);  repeated accidental injury; and deficits in social skills.  Symptoms and signs specific to tic disorders  include sudden, rapid, recurrent, non-rhythmic, motor movement or  vocalization. Examples of disorders that we evaluate in this category include specific learning disorder,  borderline intellectual functioning, and tic disorders (such as Tourette  syndrome). This category does not include the mental disorders that we evaluate under neurocognitive\n                    disorders ( 112.02 ), autism spectrum disorder ( 112.10 ),\n                    or personality andimpulse-control disorders ( 112.08 ). Eating disorders ( 112.13 ). These disorders are characterized in young children by persistent eating of nonnutritive substances  or repeated episodes of regurgitation and re-chewing of food, or by persistent  failure to consume adequate nutrition by mouth.   In adolescence, these disorders are characterized by disturbances in  eating behavior and preoccupation with, and excessive self-evaluation of, body  weight and shape.  Symptoms and signs may  include, but are not limited to, failure to make expected weight gains; restriction of energy consumption  when compared with individual requirements; recurrent  episodes of binge eating or behavior intended to prevent weight gain, such as self-induced vomiting, excessive exercise, or misuse of laxatives;  mood disturbances, social withdrawal, or irritability; amenorrhea; dental  problems; abnormal laboratory findings; and cardiac abnormalities. Examples of disorders that we evaluate in this category include anorexia nervosa, bulimia nervosa, binge-eating disorder, and avoidant/restrictive food disorder. Developmental disorders in infants and toddlers ( 112.14 ). Developmental disorders are characterized by a delay or deficit in the development of age-appropriate  skills, or a loss of previously acquired skills, involving motor planning and  control, learning, relating and communicating, and self-regulating. Examples of disorders that we evaluate in this category include developmental coordination  disorder, separation anxiety disorder, autism spectrum disorder, and regulation  disorders of sensory processing (difficulties in regulating emotions, behaviors,  and motor abilities in response to sensory stimulation).  Some infants and toddlers may have only a  general diagnosis of “developmental delay.” This category does not include eating disorders related to low birth weight and failure to thrive,\n                    which we evaluate under that body system ( 100.00 ). Trauma- and stressor-related disorders ( 112.15 ). These disorders are characterized by experiencing or witnessing a traumatic or stressful event, or  learning of a traumatic event occurring to a close family member or close  friend, and the psychological aftermath of clinically significant effects on  functioning.  Symptoms and signs may include,  but are not limited to, distressing memories, dreams, and flashbacks related to  the trauma or stressor; avoidant or withdrawn behavior; constriction of play  and significant activities; increased frequency of negative emotional states (for  example, fear, sadness) or reduced expression of positive emotions (for example,  satisfaction, affection); anxiety; irritability; aggression; exaggerated  startle response; difficulty concentrating; sleep disturbance; and a loss of  previously acquired developmental skills. Examples of disorders that we evaluate in this category include posttraumatic stress disorder, reactive  attachment disorder, and other specified trauma- and stressor-related disorders  (such as adjustment-like disorders with prolonged duration without prolonged  duration of stressor). This category does not include the mental disorders that we evaluate under anxiety\n                    and obsessive-compulsive disorders ( 112.06 ), and cognitive impairments that result from neurological disorders,\n                    such as a traumatic brain injury, which we evaluate under neurocognitive disorders ( 112.02 ). C. What evidence do we need to evaluate your mental disorder? General. We need objective medical evidence from an acceptable medical source to establish that you have a medically determinable mental disorder.\n            We also need evidence to assess the severity of your mental disorder and its effects on your ability to function age-appropriately.\n            We will determine the extent and kinds of evidence we need from medical and nonmedical sources based on the individual facts about your disorder.\n            For additional evidence requirements for intellectual disorder ( 112.05 ), see 112.00H .\n            For our basic rules on evidence, see §§ 416.912 , 416.913 ,\n            and 416.920b of this chapter.\n            For our rules on evaluating medical opinions,\n            see §§ 416.1520c and 416.927 of this chapter.\n            For our rules on evidence about your symptoms,\n            see § 416.929 of this chapter. Evidence from medical sources. We will consider all relevant medical evidence about your disorder from your physician, psychologist, and other medical sources, which  include health care providers such as physician assistants, psychiatric nurse  practitioners, licensed clinical social workers, and clinical mental health  counselors.  Evidence from your medical  sources may include: Your reported symptoms. Your developmental, medical, psychiatric, and psychological history. The results of physical or mental status examinations, structured clinical interviews, psychiatric or psychological rating scales, measures of adaptive functioning, or other clinical findings. Developmental assessments, psychological testing, imaging results, or other laboratory findings. Your diagnosis. The type, dosage, and beneficial effects of medications you take. The type, frequency, duration, and beneficial effects of therapy you receive. Side effects of medication or other treatment that limit your ability to function. Your clinical course, including changes in your medication, therapy, or other treatment, and the time required for therapeutic  effectiveness. Observations and descriptions of how you function during examinations or therapy. Information about sensory, motor, or speech  abnormalities, or about your cultural background (for example, language or  customs) that may affect an evaluation of your mental disorder. The expected duration of your symptoms and signs and their effects on your ability to  function age-appropriately, both currently and in the future. Evidence from you and people who know you. We will consider all relevant evidence  about your mental disorder and your daily functioning that we receive from you  and from people who know you.  If you are  too young or unable to describe your symptoms and your functioning, we will ask  for a description from the person who is most familiar with you.  We will ask about your symptoms, your daily  functioning, and your medical treatment.  We will ask for information from third parties  who can tell us about your mental disorder, but we must have permission to do  so.  This evidence may include  information from your family, caregivers, teachers, other educators, neighbors,  clergy, case managers, social workers, shelter staff, or other community  support and outreach workers.  We will  consider whether your statements and the statements from third parties are  consistent with the medical and other evidence we have. Evidence from early intervention programs, school, vocational training, work, and work-related programs. Early intervention programs. You may receive services in an Early Intervention Program (EIP) to help you with your developmental needs.  If so, we will  consider information from your Individualized Family Service Plan (IFSP) and  the early intervention specialists who help you. School. You may receive special education or related services at your preschool or school.  If so, we  will try to obtain information from your school sources when we need it to  assess how your mental disorder affects your ability to function.  Examples of this information include your Individualized Education Programs (IEPs), your  Section 504 plans, comprehensive evaluation reports, school-related therapy progress  notes, information from your teachers about how you function in a classroom  setting, and information from special educators, nurses, school psychologists,  and occupational, physical, and speech/language therapists about any special  education services or accommodations you receive at school. Vocational training, work, and work-related programs. You may have recently participated in or may still be participating in vocational training, work-related programs, or work activity.  \n                If so, we will try to obtain information from  your training program or your employer when we need it to assess how your mental disorder affects your ability to function.  \n                Examples of this information include training  or work evaluations, modifications to your work duties or work schedule, \n                and any special supports or accommodations you have required or now require in  order to work.  If you have worked or are working through a community mental health program, \n                sheltered or supported work program, rehabilitation program, or transitional employment program, \n                we will consider the type and degree of support you have received or are receiving in order to work \n                (see 112.00D ). Need for longitudinal evidence. General. Longitudinal medical evidence can help us learn how you function over time, \n                and help us evaluate any variations in the level of your functioning.  \n                We will request longitudinal evidence of your mental disorder when your medical providers have records concerning you and your mental disorder over a period of  months or perhaps years \n                (see § 416.912(d) of this chapter). Non-medical sources of longitudinal evidence. Certain situations, such as chronic homelessness, may make it difficult for you to provide longitudinal medical evidence.  If you have a severe mental disorder, you will probably have evidence of its  effects on your functioning over time, even if you have not had an ongoing  relationship with the medical community or are not currently receiving  treatment.  For example, family members,  caregivers, teachers, neighbors, former employers, social workers, case  managers, community support staff, outreach workers, or government agencies may  be familiar with your mental health history.   We will ask for information from third parties who can tell us about  your mental disorder, but you must give us permission to do so. Absence of longitudinal evidence. In the absence of longitudinal evidence, we will use current objective medical evidence and all other relevant evidence available to us in your case record to evaluate your  mental disorder.  \n                If we purchase a  consultative examination to document your disorder, the record will include the results of that examination \n                (see § 416.914 of this chapter).  \n                We will take into consideration your medical history, symptoms, clinical and laboratory findings, and medical source  opinions.  If you do not have longitudinal evidence,\n                the current evidence alone may not be sufficient or appropriate to show that you have a disorder that meets the criteria of one of the mental disorders listings.  \n                In that case, we will follow the rules in 112.00K . Evidence of functioning in unfamiliar situations or supportive situations. Unfamiliar situations. We recognize that evidence about your functioning in unfamiliar situations does not necessarily show how you would function on a sustained basis in a school or other  age-appropriate setting.  In one-time,  time-limited, or other unfamiliar situations, you may function differently than  you do in familiar situations.  In  unfamiliar situations, you may appear more, or less, limited than you do on a  daily basis and over time. Supportive  situations. Your ability to function  in settings that are highly structured, or that are less demanding or more supportive than settings in which children your age without impairments  typically function, does not necessarily demonstrate your ability to function  age-appropriately. Our assessment. We must assess your ability to function  age-appropriately by evaluating all the evidence, such as reports about your functioning from third parties who are familiar with you, with an emphasis on  how well you can initiate, sustain, and complete age-appropriate activities  despite your impairment(s), compared to other children your age who do not have  impairments. D. How do we consider psychosocial supports, structured settings, living arrangements, and treatment when we evaluate the functioning of children? General. Psychosocial supports, structured settings, and living arrangements, including assistance from your family or others, may help you by reducing the demands made on you. \n            In addition, treatment you receive  may reduce your symptoms and signs and possibly improve your functioning, or may have side effects that limit your functioning. \n            Therefore, when we evaluate the effects of your mental disorder and rate the limitation of your areas of mental functioning, we will consider the kind and extent of supports you receive,\n            the characteristics of any structured setting in which you spend your time (compared to children your age without impairments), and the effects of any treatment. \n            This evidence may come from reports about your functioning from third parties who are familiar with you, and other third-party statements or information. \n            Following are some examples of the supports you may receive: You receive help from family members or other people in ways that children your age without impairments typically do not need in order to function age-appropriately.  For example, an aide may accompany you on the  school bus to help you control your actions or to monitor you to ensure you do  not injure yourself or others. You receive one-on-one assistance in your classes every day; or you have a full-time personal aide who helps you to function in your classroom; or you are a student in a self-contained classroom; or you attend a separate or alternative school  where you receive special education services. You participate in a special education or vocational training program, or a psychosocial rehabilitation day treatment or community support program, where you receive training in daily living and entry-level work skills. You participate in a sheltered, supported, or transitional work program, or in a competitive employment setting with the help of a job coach or supervisor. You receive comprehensive “24/7 wrap-around” mental health services while living in a group home or transitional housing, while participating in a semi-independent living program, or while living at home. You live in a residential school, hospital, or other institution with 24-hour care. You receive assistance from a crisis response team, social workers, or community mental health workers who help you meet your physical needs, and who may also represent you in dealings with government or community social services. How we consider different levels of support and structure in  psychosocial rehabilitation programs. Psychosocial  rehabilitation programs are based on your specific needs.  Therefore, we cannot make any assumptions  about your mental disorder based solely on the fact that you are associated  with such a program.  We must know the  details of the program(s) in which you are involved and the pattern(s) of your  involvement over time. The kinds and levels  of supports and structures in psychosocial rehabilitation programs typically  occur on a scale of “most restrictive” to “least restrictive.”  Participation in a psychosocial  rehabilitation program at the most restrictive level would suggest greater  limitation of your areas of mental functioning than would participation at a  less restrictive level.  The length of  time you spend at different levels in a program also provides information about  your functioning.  For example, you could  begin participation at the most restrictive crisis intervention level but  gradually improve to the point of readiness for a lesser level of support and  structure and, if you are an older adolescent, possibly some form of  employment. How we consider the help or support you receive. We will consider the  complete picture of your daily functioning, including the kinds, extent, and  frequency of help and support you receive, when we evaluate your mental  disorder and determine whether you are able to use the four areas of mental functioning  age-appropriately.  The fact that you  have done, or currently do, some routine activities without help or support  does not necessarily mean that you do not have a mental disorder or that you  are not disabled.  For example, you may  be able to take age-appropriate care of your personal needs, or you may be old  enough and able to cook, shop, and take public transportation.  You may demonstrate both strengths and  deficits in your daily functioning. You may receive various kinds of help and support from others that enable you to do many things that, because of your mental disorder, \n                you might not be able to do independently.  Your daily functioning may depend on the special contexts in which you function.  For example, \n                you may spend your time among only familiar people or surroundings, in a simple and steady routine or an  unchanging environment, or in a highly structured classroom or alternative school.  \n                However, this does not  necessarily show whether you would function age-appropriately without those supports or contexts.  \n                (See 112.00H for further discussion of these issues regarding significant deficits in adaptive functioning for the purpose \n                of 112.05 .) How we consider treatment. We will consider the effect of any treatment on your functioning when we evaluate your mental disorder.  Treatment  may include medication(s), psychotherapy, or other forms of intervention, which  you receive in a doctor’s office, during a hospitalization, or in a day program  at a hospital or outpatient treatment program.   With treatment, you may not only have your symptoms and signs reduced,  but may also be able to function age-appropriately.  However, treatment may not resolve all of the  limitations that result from your mental disorder, and the medications you take  or other treatment you receive for your disorder may cause side effects that  limit your mental or physical functioning.   For example, you may experience drowsiness, blunted affect, memory loss,  or abnormal involuntary movements. E. What are the paragraph B criteria for children age 3 to the  attainment of age 18? Understand, remember, or apply information (paragraph B1). This area of mental functioning refers to the  abilities to learn, recall, and use information to perform age-appropriate  activities.  Examples include:  understanding and learning terms,  instructions, procedures; following one- or two-step oral instructions to carry  out a task; describing an activity to someone else; asking and answering  questions and providing explanations; recognizing a mistake and correcting it;  identifying and solving problems; sequencing multi-step activities; and using  reason and judgment to make decisions.   These examples illustrate the nature of the area of mental functioning.  We do not require documentation of all of the  examples.  How you manifest this area of mental  functioning and your limitations in using it depends, in part, on your age. Interact with others (paragraph B2). This area of mental functioning refers to the  abilities to relate to others age-appropriately at home, at school, and in the  community.  Examples include:  engaging in interactive play; cooperating with  others; asking for help when needed; initiating and maintaining friendships;  handling conflicts with others; stating own point of view; initiating or  sustaining conversation; understanding and responding to social cues (physical,  verbal, emotional); responding to requests, suggestions, criticism, correction,  and challenges; and keeping social interactions free of excessive irritability,  sensitivity, argumentativeness, or suspiciousness.  These examples illustrate the nature of this  area of mental functioning.  We do not  require documentation of all of the examples.  How you manifest this area of mental functioning  and your limitations in using it depends, in part, on your age. Concentrate, persist, or maintain pace (paragraph B3). This area of mental functioning refers to the  abilities to focus attention on activities and stay on task  age-appropriately.  Examples include:  initiating and performing an activity that you  understand and know how to do; engaging in an activity at home or in school at  an appropriate and consistent pace; completing tasks in a timely manner;  ignoring or avoiding distractions while engaged in an activity or task;  changing activities without being disruptive; engaging in an activity or task  close to or with others without interrupting or distracting them; sustaining an  ordinary routine and regular attendance at school; and engaging in activities  at home, school, or in the community without needing an unusual amount of  rest.  These examples illustrate the  nature of this area of mental functioning.   We do not require documentation of all of the examples.  How you manifest this area of mental functioning  and your limitations in using it depends, in part, on your age. Adapt or manage oneself (paragraph B4). This area  of mental functioning refers to  the abilities to regulate emotions, control behavior, and maintain well-being  in age-appropriate activities and settings.   Examples include:  responding  to demands; adapting to changes; managing your psychologically based symptoms;  distinguishing between acceptable and unacceptable performance in community- or  school-related activities; setting goals; making plans independently of others;  maintaining personal hygiene; and protecting yourself from harm and  exploitation by others.  These examples  illustrate the nature of this area of mental functioning.  We do not require documentation of all of the  examples.  How you manifest this area of mental  functioning and your limitations in using it depends, in part, on your age. F. How do we use the paragraph B criteria to evaluate mental  disorders in children? General. We use the  paragraph B criteria to rate the degree of your limitations.  \n        We consider only the limitations that result from your mental disorder(s).  \n        We will determine whether you are able to use each of the paragraph B areas of mental functioning in age-appropriate activities in a manner comparable to that of other children your age who \n        do not have impairments.  We will consider, for example, the range of  your activities and whether they are age-appropriate; how well you can initiate, sustain, and complete your activities; \n        the kinds and frequency of  help or supervision you receive; and the kinds of structured or supportive  settings you need in order to function age-appropriately \n        (see 112.00D ). Degrees of limitation. We evaluate the effects of your mental disorder on each of the four areas of mental functioning.  \n        To satisfy the paragraph B criteria, your mental disorder must result in extreme limitation of one, or marked limitation of two, paragraph B areas of mental functioning.  \n        See §§ 416.925(b)(2)(ii) and 416.926a(e) of this chapter for the definitions of the terms marked and extreme as they apply to children. Rating the limitations of your areas of mental functioning. General. We use all of the relevant medical and  non-medical evidence in your case record to evaluate your mental disorder:  the symptoms and signs of your disorder, the  reported limitations in your activities, and any help and support you receive  that is necessary for you to function.  The  medical evidence may include descriptors regarding the diagnostic stage or  level of your disorder, such as “mild” or “moderate.”  Clinicians may use these terms to characterize  your medical condition.  However, these  terms will not always be the same as the degree of your limitation in a  paragraph B area of mental functioning. Areas of mental functioning  in daily activities. You use the  same four areas of mental functioning in daily activities at home, at school,  and in the community.  With respect to a  particular task or activity, you may have trouble using one or more of the  areas.  For example, you may have  difficulty understanding and remembering what to do; or concentrating and  staying on task long enough to do it; or engaging in the task or activity with  other people; or trying to do the task without becoming frustrated and losing  self-control.  Information about your  daily functioning in your activities at home, at school, or in your community  can help us understand whether your mental disorder limits one or more of these  areas; and, if so, whether it also affects your ability to function  age-appropriately. Overall effect of limitations. Limitation of an area of mental functioning reflects the overall degree  to which your mental disorder interferes with that area.  The degree of limitation does not necessarily  reflect a specific type or number of activities, including activities of daily  living, that you have difficulty doing.   In addition, no single piece of information (including test results) can  establish whether you have extreme or marked limitation of an area of mental functioning. Effects of support, supervision, structure on functioning. The degree of limitation of an area of mental functioning also reflects the kind and extent of supports or supervision you receive \n                (beyond what other children your age without impairments typically receive) and the characteristics of any structured setting where you spend your time, which enable you to function.  \n                The more extensive the support you need from others (beyond what is age-appropriate) or the more structured the setting you need in order to function, \n                the more limited we will find you to be (see 112.00D ). Specific instructions for  paragraphs B1, B3, and B4. For  paragraphs B1, B3, and B4, the greatest degree of limitation of any part of the  area of mental functioning directs the rating of limitation of that whole area  of mental functioning. To do an age-appropriate activity, you must be able to understand and remember and apply information required by the  activity.  Similarly, you must be able to concentrate and persist and maintain pace in order to complete the activity, and adapt and manage  yourself age-appropriately.  Limitation in any one of these parts (understand or remember or apply; concentrate or persist or maintain pace; adapt or manage oneself) may prevent you from completing  age-appropriate activities. We will document the rating of limitation of the whole area  of mental functioning, not each individual part.  We will not add ratings  of the parts together.  For example, with respect to paragraph B3, if you  have marked limitation in concentrating, but your limitations in persisting and  maintaining pace do not rise to a marked level, we will find that you have  marked limitation in the whole paragraph B3 area of mental functioning. Marked limitation in more than one part of the same paragraph B area of mental functioning does not satisfy the requirement to have  marked limitation in two paragraph B areas of mental functioning. How we evaluate mental disorders involving exacerbations and remissions. When we evaluate the effects of your mental disorder, we will consider how often you have exacerbations and remissions, how long they last, \n                what causes your mental disorder to worsen or improve, and any other relevant information.  \n                We will assess whether your mental impairment(s) causes marked or extreme limitation of the affected paragraph B area(s) of mental functioning \n                (see 112.00F2 ).  We will consider whether you can use the area of mental functioning age-appropriately on a sustained basis.  \n                We will not find that you function age-appropriately solely because you have a period(s) of improvement (remission), \n                or that you are disabled solely because you have a period of worsening (exacerbation), of your mental disorder. If you have a mental disorder involving exacerbations and remissions, you may be able to use the  four areas of mental functioning at home, at school, or in the community for a  few weeks or months.  Recurrence or  worsening of symptoms and signs, however, can interfere enough to render you  unable to function age-appropriately. G. What are the paragraph C criteria, and how do we use them to evaluate mental disorders in children age 3 to the attainment of age 18? General. The paragraph C criteria are an alternative to the paragraph B criteria under listings 112.02 , 112.03 , 112.04 , 112.06 , and 112.15 . \n            We use the paragraph C criteria to evaluate mental disorders that are “serious and persistent.”  In the paragraph C criteria,\n            we recognize that mental health interventions may control the more obvious symptoms and signs of your mental disorder. Paragraph C criteria. We find a mental  disorder to be “serious and persistent” when there is a medically documented  history of the existence of the mental disorder in the listing category over a  period of at least 2 years, and evidence shows that your disorder satisfies both  C1 and C2. The criterion in C1  is satisfied when the evidence shows that you rely, on an ongoing basis, upon  medical treatment, mental health therapy, \n                psychosocial support(s), or a highly structured setting(s), to diminish the symptoms and signs of your mental disorder \n                (see 112.00D ).  We consider that you receive ongoing medical treatment when the medical evidence \n                establishes that you obtain medical treatment with a frequency consistent with accepted medical practice for the type of treatment or evaluation required for your  medical condition.  \n                We will consider  periods of inconsistent treatment or lack of compliance with treatment that may  result from your mental disorder.  \n                If the evidence indicates that the inconsistent treatment or lack of compliance is a feature of your mental disorder, and it has led to an exacerbation of your symptoms and signs, \n                we will not use it as evidence to support a finding that you have not received ongoing medical treatment as required by this paragraph. The criterion in C2 is satisfied when the evidence shows that, despite your diminished symptoms and signs, you have achieved only marginal adjustment.  \n                “Marginal adjustment” means that your adaptation to the requirements of daily life is fragile; that is, \n                you have minimal capacity to adapt to changes in your environment or to demands that are not already part of your daily  life.  \n                We will consider that you have achieved only marginal adjustment when the evidence shows that changes or increased demands have led to exacerbation of your symptoms \n                and signs and to deterioration in your functioning; for example, you have become unable to function outside of your home or a more restrictive setting, \n                without substantial psychosocial supports (see 112.00D ).  \n                Such deterioration may have necessitated a significant change in medication or other treatment.  \n                Similarly, because of the nature of your  mental disorder, evidence may document episodes of deterioration that have required you to be hospitalized or absent from school, \n                making it difficult for  you to sustain age-appropriate activity over time. H.  How do we document and evaluate intellectual disorder under 112.05 ? General. Listing 112.05 is based on the two elements that characterize intellectual disorder for children up to age 18: \n        significantly subaverage general intellectual functioning and significant deficits in current adaptive functioning. Establishing significantly subaverage general intellectual functioning. Definition. Intellectual functioning refers to the general mental capacity to learn, reason, plan, solve problems,\n                    and perform other cognitive functions.  Under 112.05A ,\n                    we identify significantly  subaverage general intellectual functioning by the cognitive inability to  function at a level required to participate in standardized intelligence testing.  \n                    Our findings under 112.05A are based on evidence from an acceptable medical source. \n                    Under 112.05B , we identify significantly subaverage general intellectual functioning by an IQ score(s)\n                    on an individually administered standardized test of general intelligence that meets program requirements and has a mean of 100 and a standard deviation of 15. \n                    A qualified specialist (see 112.00H2c ) must administer the standardized intelligence testing. Psychometric standards. We will find standardized intelligence test results usable for the purposes of 112.05B1 when the measure employed meets contemporary psychometric standards for validity,\n                    reliability, normative data, and scope of measurement; and a qualified specialist has ndividually administered the test according to all pre-requisite testing conditions. Qualified specialist. A “qualified specialist” is currently licensed or certified at the independent level of practice in the State where the test was performed, and has the  training and experience to administer, score, and interpret intelligence  tests.  If a  psychological assistant or paraprofessional administered the test, a  supervisory qualified specialist must interpret the test findings and co-sign  the examination report. Responsibility for conclusions based on testing. We generally  presume that your obtained IQ score(s) is an accurate reflection of your general intellectual functioning,\n                    unless evidence in the record suggests otherwise.  Examples of this evidence include:\n                    a statement from the test administrator indicating that your obtained score is not an accurate reflection of your general intellectual functioning, prior or internally inconsistent IQ scores,\n                    or information about your daily  functioning.  Only qualified specialists, Federal and State agency medical and psychological consultants,\n                    and other contracted medical and psychological experts may conclude that your obtained IQ score(s) is not an accurate reflection of your general intellectual functioning. \n                    This conclusion must be  well supported by appropriate clinical and laboratory diagnostic techniques and must be based on relevant evidence in the case record, such as: The data obtained in testing; Your developmental history, including when your signs and symptoms began; Information about  how you function on a daily basis in a variety of settings; and Clinical  observations made during the testing period, such as your ability to sustain  attention, concentration, and effort; to relate appropriately to the examiner;  and to perform tasks independently without prompts or reminders. Establishing significant deficits in adaptive functioning. Definition. Adaptive functioning refers to how you learn and use conceptual, social, and practical skills in dealing with common life demands.\n                    It is your typical functioning at home, at school, and in the community, alone or among others.\n                    Under 112.05A ,\n                    we identify significant deficits in adaptive functioning based on your dependence on others to care for your personal needs,\n                    such as eating and bathing (grossly in excess of age-appropriate dependence).\n                    We will base our conclusions about your adaptive functioning on evidence from a variety of sources\n                    (see 112.00H3b ) and not on your statements alone.\n                    Under 112.05B2 ,\n                    we identify significant deficits in adaptive functioning based on whether there is extreme limitation of one, or marked limitation of two, of the paragraph B criteria\n                    (see 112.00E ; 112.00F ). Evidence.  Evidence about your adaptive functioning may come from: Medical sources, including their clinical observations; Standardized tests of adaptive functioning (see 112.00H3c ); Third party information, such as a report of your functioning from a family member or your caregiver; School records; A teacher questionnaire; Reports from employers or supervisors; and Your own statements about how you handle all of your daily activities. Standardized tests of adaptive functioning.  We do not require the results of an individually administered standardized test of adaptive functioning.\n                    If your case record includes these test results, we will consider the results along with all other relevant evidence; however,\n                    we will use the guidelines in 112.00E and F to evaluate and determine the degree of your deficits in adaptive functioning,\n                    as required under 112.05B2 . Standardized developmental assessments.  We do not require the results of standardized developmental assessments,\n                    which compare your level of development to the level typically expected for your chronological age.  If your case record includes test results,\n                    we will consider the results along with all other relevant evidence.  However,\n                    we will use the guidelines in 112.00E and F to evaluate and determine the degree of your deficits in adaptive functioning,\n                    as required under 112.05B2 . How we consider common everyday activities. The fact that you engage in common everyday activities, such as caring for your personal needs, preparing simple meals, or driving a car,\n                            will not always mean that you do not have deficits in adaptive functioning as required by 112.05B2 . \n                            You may demonstrate both strengths and  deficits in your adaptive functioning.  However, a lack of deficits in one area does not negate the presence of deficits in another area. \n                            When we assess your adaptive functioning, we will consider all of your activities and your performance of them. Our conclusions about your adaptive functioning rest on the quality of your daily activities and whether you do them age-appropriately.\n                            If you receive help in performing your activities, we need to know the kind, extent, and frequency of help you receive in order to perform them.\n                            We will not assume that your ability to do some common everyday activities, or to do some things without help or support,\n                            demonstrates that your mental disorder does not meet the requirements of 112.05B2 . \n                            (See 112.00D regarding the factors we consider when we evaluate your functioning,\n                            including how we consider any help or support you receive.) How we consider work activity. The fact that you have engaged in work activity, or that you work intermittently or steadily in a job commensurate with your abilities, \n                will not always mean that you do not have deficits in adaptive functioning as required by 112.05B2 .  \n                When you have engaged in work activity, we need complete information about the work, and about your functioning in the work activity and work setting, \n                before we reach any conclusions about your adaptive functioning.  \n                We will consider all factors involved in your work history before concluding whether your impairment satisfies the criteria for intellectual disorder \n                under 112.05B .  We will consider your prior and current work history, if any, \n                and various other factors influencing how you function.  For example, we consider whether the work was in a supported setting, whether you required more supervision than other employees, \n                how your job duties compared to others in the same job, how much time it took you to learn the job duties, and  the reason the work ended, if applicable. I. What additional considerations do we use to evaluate developmental disorders of infants and toddlers? General. We evaluate developmental disorders from birth to attainment of age 3 under 112.14 .  \n        We evaluate your ability to acquire and  maintain the motor, cognitive, social/communicative, and emotional skills that  you need to function age-appropriately.  \n        When we rate your impairment-related limitations for this listing \n        (see §§ 416.925(b)(2)(ii) and 416.926a(e) of this chapter), \n        we consider only limitations you have because of your developmental disorder.  \n        If you have a chronic illness or physical abnormality(ies), we will evaluate it under the affected body system, for example, the cardiovascular or musculoskeletal system. Age and typical development in early childhood. Prematurity and age. If you were born prematurely, we  will use your corrected chronological age (CCA) for comparison.  CCA is your chronological age adjusted by a period of gestational prematurity.  \n                CCA =  (chronological age) – (number of weeks premature).  If you have not attained age 1, we will correct your chronological age, using the same formula.  \n                If you are over age 1, we will decide whether to correct your chronological age, based on our judgment and all the facts of  your case \n                (see § 416.924b(b) of this chapter). Developmental assessment. We will use the results  from a standardized developmental assessment to compare your level of  development with that typically expected for your chronological age.  When there are no results from a  comprehensive standardized developmental assessment in the case record, we need  narrative developmental reports from your medical sources in sufficient  detail to assess the limitations resulting from your developmental disorder. Variation. When we evaluate your developmental disorder, we will consider the wide variation in the range of normal or typical development in early childhood.  At the  end of a recognized milestone period, new skills typically begin to  emerge.  If your new skills begin to  emerge later than is typically expected, the timing of their emergence may or  may not indicate that you have a developmental delay or deficit that can be  expected to last for 1 year. Evidence. Standardized developmental assessments. We use standardized test reports from acceptable medical sources or from early intervention specialists, physical or occupational therapists, and other qualified professionals.  \n                Only the qualified professional who administers the test, Federal and State agency medical and psychological consultants, \n                and other contracted medical and psychological experts may conclude that the assessment results are not an accurate reflection of your development.  \n                This conclusion must be well supported by appropriate clinical and laboratory diagnostic techniques and must be based on relevant evidence in the case record.  \n                If the assessment results are not an accurate reflection of your development, we may purchase a new developmental assessment  \n                If the developmental assessment is inconsistent with other information in your case record, \n                we will follow the guidelines in § 416.920b of this chapter. Narrative developmental reports. A narrative developmental report is based on clinical observations, progress notes, and well-baby check-ups, and includes your developmental  history, examination findings (with abnormal findings noted on repeated  examinations), and an overall assessment of your development (that is, more  than one or two isolated skills) by the medical source.  Although medical  sources may refer to screening test results as supporting evidence in the  narrative developmental report, screening test results alone cannot establish a  diagnosis or the severity of developmental disorder. What are the paragraph B criteria for 112.14 ? General. The paragraph B criteria for 112.14 are slightly different from the paragraph B criteria for the other listings.\n                    They are the developmental abilities that infants and toddlers use to acquire and maintain the skills needed to function age-appropriately. \n                    An infant or toddler is expected to use his or her developmental abilities to achieve a recognized pattern of milestones, over a typical range of time,\n                    in order to acquire and maintain the skills needed to function age-appropriately.  \n                    We will find that your developmental disorder satisfies the requirements of 112.14 if it results in extreme limitation of one,\n                    or marked limitation of two, of the 112.14 paragraph B criteria. \n                    (See §§ 416.925(b)(2)(ii) and 416.926a(e) of this chapter for the definitions of the terms marked and extreme as they apply to children.) Definitions of the 112.14 paragraph B developmental abilities. Ability to plan and control motor movement. This criterion refers to the developmental  ability to plan, remember, and execute controlled motor movements by  integrating and coordinating perceptual and sensory input with motor output.  Using this ability develops gross and fine  motor skills, and makes it possible for you to engage in age-appropriate  symmetrical or alternating motor activities.   You use this ability when, for example, you grasp and hold objects with  one or both hands, pull yourself up to stand, walk without holding on, and go  up and down stairs with alternating feet.   These examples illustrate the nature of the developmental ability.  We do not require documentation of all of the  examples.  How you manifest this  developmental ability and your limitations in using it depends, in part, on  your age. Ability to learn and remember. This criterion refers to the developmental  ability to learn by exploring the environment, engaging in trial-and-error  experimentation, putting things in groups, understanding that words represent  things, and participating in pretend play.   Using this ability develops the skills that help you understand what  things mean, how things work, and how you can make things happen.  You use this ability when, for example, you  show interest in objects that are new to you, imitate simple actions, name body  parts, understand simple cause-and-effect relationships, remember simple  directions, or figure out how to take something apart.  These examples illustrate the nature of the  developmental ability.  We do not require  documentation of all of the examples.  How  you manifest this developmental ability and your limitations in using it  depends, in part, on your age. Ability to interact with others. This criterion refers to the developmental  ability to participate in reciprocal social interactions and relationships by  communicating your feelings and intents through vocal and visual signals and  exchanges; physical gestures and contact; shared attention and affection;  verbal turn taking; and understanding and sending increasingly complex  messages.  Using this ability develops  the social skills that make it possible for you to influence others (for  example, by gesturing for a toy or saying “no” to stop an action); invite  someone to interact with you (for example, by smiling or reaching); and draw  someone’s attention to what interests you (for example, by pointing or taking  your caregiver’s hand and leading that person).   You use this ability when, for example, you use vocalizations to  initiate and sustain a “conversation” with your caregiver; respond to limits  set by an adult with words, gestures, or facial expressions; play alongside  another child; or participate in simple group activities with adult help.  These examples illustrate the nature of the  developmental ability.  We do not require  documentation of all of the examples.  How  you manifest this developmental ability and your limitations in using it  depends, in part, on your age. Ability to regulate physiological functions,  attention, emotion, and behavior. This criterion refers to the developmental ability to stabilize  biological rhythms (for example, by developing an age-appropriate sleep/wake  cycle); control physiological functions (for example, by achieving regular  patterns of feeding); and attend, react, and adapt to environmental stimuli,  persons, objects, and events (for example, by becoming alert to things  happening around you and in relation to you, and responding without overreacting  or underreacting).  Using this ability  develops the skills you need to regulate yourself and makes it possible for you  to achieve and maintain a calm, alert, and organized physical and emotional  state.  You use this ability when, for  example, you recognize your body’s needs for food or sleep, focus quickly and  pay attention to things that interest you, cry when you are hurt but become  quiet when your caregiver holds you, comfort yourself with your favorite toy  when you are upset, ask for help when something frustrates you, or refuse help  from your caregiver when trying to do something for yourself.  These examples illustrate the nature of the  developmental ability.  We do not require  documentation of all of the examples.  How  you manifest this developmental ability and your limitations in using it  depends, in part, on your age. Deferral of determination. Full-term infants. In the first few months of life, full-term infants typically display some irregularities in observable behaviors\n                    (for example, sleep cycles, feeding, responding to stimuli, attending to faces, self‑calming), making it difficult to assess the presence, extent, and duration of a developmental disorder. \n                    When the evidence indicates that you may have a significant developmental delay, but there is insufficient evidence to make a determination,\n                    we will defer making a disability determination under 112.14 until you are at least 6 months old. \n                    This deferral will allow us to obtain a longitudinal medical history so that we can more accurately evaluate your developmental patterns and functioning over time. \n                    In most cases, when you are at least 6 months old, any developmental delay you may have can be better assessed, and you can undergo standardized developmental testing, if indicated. Premature infants. When the evidence indicates that you may have a significant developmental delay, but there is insufficient evidence to make a determination,\n                    we will defer your case until you attain a CCA\n                    (see 112.00I2a ) of at least 6 months in order to better evaluate your developmental delay. When we will not defer a determination. We will not defer our determination if we have sufficient evidence to determine that you are disabled under 112.14 or any other listing, \n                or that you have an impairment or combination of impairments that functionally equalsthe listings.  In addition, \n                we will not defer our determination if the evidence demonstrates that you are not disabled. J. How do we evaluate substance use disorders? If we find that you are disabled and there is medical evidence in your case record establishing that you have a substance use disorder, \n    we will determine whether your substance use disorder is a contributing factor material to the determination of disability \n    (see § 416.935 of this chapter). K. How do we evaluate mental disorders that do not meet one of the mental disorders listings? These listings  include only examples of mental disorders that we consider serious enough to  result in marked and severe functional limitations.  If your severe mental disorder does not meet  the criteria of any of these listings, we will consider whether you have an  impairment(s) that meets the criteria of a listing in another body system.  You may have another impairment(s) that is  secondary to your mental disorder.  For  example, if you have an eating disorder and develop a cardiovascular impairment  because of it, we will evaluate your cardiovascular impairment under the  listings for the cardiovascular body system. If you have a severe  medically determinable impairment(s) that does not meet a listing, we will determine whether your impairment(s) medically equals a listing \n        (see § 416.926 of this chapter). If your impairment(s) does not meet or medically equal a listing, we will consider whether you have an impairment(s) that functionally equals the listings \n        (see § 416.926a of this chapter). Although we present these alternatives in a specific sequence above, each represents listing-level severity, and we can evaluate your claim in any order.  \n        For example, if the factors of your case indicate that the combination of your impairments may functionally equal the listings, we may start with that analysis.  \n        We use the rules in § 416.994a of this chapter, \n        as appropriate, when we decide whether you continue to be disabled. 112.01 Category of Impairments, Mental Disorders 112.02 Neurocognitive disorders (see 112.00B1 ),\n    for children age 3 to attainment of age 18, satisfied by A and B, or A and C: Medical  documentation of a clinically significant deviation in normal cognitive  development or by significant cognitive decline from a prior level of  functioning in one or more of the cognitive areas: Complex attention; Executive function; Learning and memory; Language; Perceptual-motor; or Social cognition. AND Extreme limitation  of one, or marked limitation of two, of the following areas of mental  functioning (see 112.00F ): Understand,  remember, or apply information (see 112.00E1 ). Interact with others (see 112.00E2 ). Concentrate, persist, or maintain pace (see 112.00E3 ). Adapt or manage oneself (see 112.00E4 ). OR Your mental disorder in this listing category is “serious and persistent;” that is, you have a  medically documented history of the existence of the disorder over a period of  at least 2 years, and there is evidence of both: Medical treatment, mental health therapy, psychosocial support(s),\n                    or a highly structured  setting(s) that is ongoing and that diminishes the symptoms and signs of your mental disorder\n                    (see 112.00G2b ); and Marginal adjustment, that is,\n                    you have minimal capacity to adapt to changes in your environment or to demands that are not already part of your daily life\n                    (see 112.00G2c ). 112.03 Schizophrenia spectrum and other psychotic disorders (see 112.00B2 ),\n    for children age 3 to attainment of age 18, satisfied by A and B, or A and C: Medical  documentation of one or more of the following: Delusions or hallucinations; Disorganized thinking (speech); or Grossly disorganized  behavior or catatonia. AND Extreme limitation  of one, or marked limitation of two, of the following areas of mental functioning (see 112.00F ): Understand, remember, or apply information (see 112.00E1 ). Interact with others (see 112.00E2 ). Concentrate, persist, or maintain pace (see 112.00E3 ). Adapt or manage oneself (see 112.00E4 ). OR Your mental disorder  in this listing category is “serious and persistent;” that is,\n            you have a medically documented history of the existence of the disorder over a period of at least 2 years, and there is evidence of both: Medical treatment, mental health therapy, psychosocial support(s),\n                    or a highly structured setting(s) that is ongoing and that diminishes the symptoms and signs of your mental disorder\n                    (see 112.00G2b ); and Marginal adjustment, that is,\n                    you have minimal capacity to adapt to changes in your environment or to demands that are not already part of your daily life\n                    (see 112.00G2c ). 112.04 Depressive, bipolar and related disorders (see 112.00B3 ),\n    for children age 3 to attainment of age 18, satisfied by A and B, or A and C: Medical documentation of the requirements of paragraph 1, 2, or 3: Depressive disorder,  characterized by five or more of the following: Depressed or irritable mood; Diminished interest  in almost all activities; Appetite disturbance  with change in weight (or a failure to achieve an expected weight gain); Sleep disturbance; Observable psychomotor agitation or retardation; Decreased energy; Feelings of guilt or  worthlessness; Difficulty concentrating or thinking; or Thoughts of death or  suicide. Bipolar disorder,  characterized by three or more of the following: Pressured speech; Flight of ideas; Inflated  self-esteem; Decreased need for  sleep; Distractibility; Involvement in  activities that have a high probability of painful consequences that are not  recognized; or Increase in goal-directed activity or psychomotor agitation. Disruptive mood dysregulation disorder, beginning prior to age 10, and all of the following: Persistent, significant irritability or anger; Frequent, developmentally inconsistent temper outbursts; and Frequent aggressive or destructive behavior. AND Extreme limitation  of one, or marked limitation of two,\n            of the following areas of mental functioning (see 112.00F ): Understand, remember, or apply information (see 112.00E1 ). Interact with others (see 112.00E2 ). Concentrate, persist, or maintain pace (see 112.00E3 ). Adapt or manage oneself (see 112.00E4 ). OR Your mental disorder in this listing category is “serious and persistent;” that is,\n            you have a medically documented history of the existence of the disorder over a period of at least 2 years, and there is evidence of both: Medical treatment, mental health therapy, psychosocial support(s),\n                    or a highly structured setting(s) that is ongoing and that diminishes the symptoms and signs of your mental disorder\n                    (see 112.00G2b ); and Marginal adjustment, that is,\n                    you have minimal capacity to adapt to changes in your environment or to demands that are not already part of your daily life\n                    (see 112.00G2c ). 112.05 Intellectual disorder (see 112.00B4 ),\n    for children age 3 to attainment of age 18, satisfied by A or B: Satisfied by 1 and 2 (see 112.00H ): Significantly subaverage general intellectual functioning evident in your cognitive inability  to function at a level required to participate in standardized testing of  intellectual functioning; and Significant deficits in adaptive functioning currently manifested by your dependence upon others for  personal needs (for example, toileting, eating, dressing, or bathing) in excess  of age-appropriate dependence. OR Satisfied by 1 and 2 (see 112.00H ): Significantly subaverage general intellectual functioning evidenced by a or b: A full scale (or comparable) IQ score of 70 or below on an individually administered standardized test of general intelligence; or A full scale (or comparable) IQ score of 71-75 accompanied by a verbal or performance IQ score (or comparable part score) of 70 or below on an individually administered  standardized test of general intelligence; and Significant deficits in adaptive functioning currently manifested by extreme limitation of one, or marked limitation of two, of the following areas of mental functioning: Understand, remember, or apply information (see 112.00E1 ); or Interact with others (see 112.00E2 ); or Concentrate, persist, or maintain pace (see 112.00E3 ); or Adapt or manage oneself (see 112.00E4 ). 112.06 Anxiety and obsessive-compulsive disorders (see 112.00B5 ),\n    for children age 3 to attainment of age 18, satisfied by A and B, or A and C: Medical documentation of the requirements of paragraph 1, 2, 3, or 4: Anxiety disorder, characterized by one or more of the following: Restlessness; Easily fatigued; Difficulty  concentrating; Irritability; Muscle tension; or Sleep disturbance. Panic disorder or  agoraphobia, characterized by one or both: Panic attacks followed by a persistent concern or worry about additional panic attacks or their consequences; or Disproportionate fear or anxiety about at least two different situations (for example, using public transportation, being in a crowd, being in a line, being outside of your  home, being in open spaces). Obsessive-compulsive disorder, characterized by one or both: Involuntary,  time-consuming preoccupation with intrusive, unwanted thoughts; or; Repetitive behaviors  that appear aimed at reducing anxiety. Excessive fear or anxiety concerning separation from those to whom you are attached. AND Extreme limitation of one, or marked limitation of two, of the following areas of mental functioning (see 112.00F ): Understand, remember, or apply information (see 112.00E1 ). Interact with others (see 112.00E2 ). Concentrate, persist, or maintain pace (see 112.00E3 ). Adapt or manage oneself (see 112.00E4 ). OR Your mental disorder in this listing category is “serious and persistent;” that is,\n            you have a medically documented history of the existence of the disorder over a period of at least 2 years, and there is evidence of both: Medical treatment, mental health therapy, psychosocial support(s),\n                    or a highly structured setting(s) that is ongoing and that diminishes the symptoms and signs of your mental disorder\n                    (see 112.00G2b ); and Marginal adjustment, that is,\n                    you have minimal capacity to adapt to changes in your environment or to demands that are not already part of your daily life\n                    (see 112.00G2c ). 112.07 Somatic symptom and related disorders (see 112.00B6 ),\n    for children age 3 to attainment of age 18, satisfied by A and B: Medical  documentation of one or both of the following: Symptoms of altered voluntary motor or sensory function that are not better explained by  another medical or mental disorder; or One or more somatic symptoms that are distressing, with excessive thoughts, feelings,  or behaviors related to the symptoms. AND Extreme limitation  of one, or marked limitation of two, of the following areas of mental functioning (see 112.00F ): Understand, remember, or apply information (see 112.00E1 ). Interact with others (see 112.00E2 ). Concentrate, persist, or maintain pace (see 112.00E3 ). Adapt or manage oneself (see 112.00E4 ). 112.08 Personality and impulse-control disorders (see 112.00B7 ),\n        for children age 3 to attainment of age 18, satisfied by A and B: Medical documentation of a pervasive pattern of one or more of the following: Distrust and suspiciousness of others; Detachment from social relationships; Disregard for and  violation of the rights of others; Instability of interpersonal relationships; Excessive emotionality and attention seeking; Feelings of inadequacy; Excessive need to be taken care of; Preoccupation with perfectionism and orderliness; or Recurrent, impulsive, aggressive behavioral outbursts. AND Extreme limitation of one, or marked limitation of two, of the following areas of mental functioning (see 112.00F ): Understand, remember, or apply information (see 112.00E1 ). Interact with others (see 112.00E2 ). Concentrate, persist, or maintain pace (see 112.00E3 ). Adapt or manage oneself (see 112.00E4 ). 112.09 [Reserved] 112.10 Autism spectrum disorder (see 112.00B8 ), \n        for children age 3 to attainment of age 18), satisfied by A and B: Medical documentation of both of the following: Qualitative deficits  in verbal communication, nonverbal communication, and social interaction; and Significantly  restricted, repetitive patterns of behavior, interests, or activities. AND Extreme limitation  of one, or marked limitation of two, of the following areas of mental functioning (see 112.00F ): Understand, remember, or apply information (see 112.00E1 ). Interact with others (see 112.00E2 ). Concentrate, persist, or maintain pace (see 112.00E3 ). Adapt or manage oneself (see 112.00E4 ). 112.11 Neurodevelopmental disorders (see 112.00B9 ), \n        for children age 3 to attainment of age 18, satisfied by A and B: Medical documentation of the requirements of paragraph 1, 2, or 3: One or both of the following: Frequent distractibility, difficulty sustaining attention, and difficulty organizing  tasks; or Hyperactive and  impulsive behavior (for example, difficulty remaining seated, talking  excessively, difficulty waiting, appearing restless, or behaving as if being  “driven by a motor”). Significant difficulties  learning and using academic skills; or Recurrent motor  movement or vocalization. AND Extreme limitation  of one, or marked limitation of two, of the following areas of mental functioning (see 112.00F ): Understand, remember, or apply information (see 112.00E1 ). Interact with others (see 112.00E2 ). Concentrate, persist, or maintain pace (see 112.00E3 ). Adapt or manage  oneself (see 112.00E4 ). 112.12 [Reserved] 112.13 Eating disorders (see 112.00B10 ),\n    for children age 3 to  attainment of age 18, satisfied by A and B: Medical documentation of a persistent alteration in eating or eating-related  behavior that results in a change in consumption or absorption of food and that significantly impairs physical or psychological health. AND Extreme limitation  of one, or marked limitation of two, of the following areas of mental  functioning (see 112.00F ): Understand, remember, or apply information (see 112.00E1 ). Interact with others (see 112.00E2 ). Concentrate, persist, or maintain pace (see 112.00E3 ). Adapt or manage oneself (see 112.00E4 ). 112.14 Developmental disorders in infants and toddlers\n    (see 112.00B11 , 112.00I ),\n    satisfied by A and B: Medical documentation of one or both of the following: A delay or deficit in the development of age-appropriate skills; or A loss of previously acquired skills. AND Extreme limitation  of one, or marked limitation of two, of the following developmental abilities  (see 112.00F ): Plan and control  motor movement (see 112.00I4b(i) ). Learn and remember  (see 112.00I4b(ii) ). Interact with others  (see 112.00I4b(iii) ). Regulate  physiological functions, attention, emotion, and behavior (see 112.00I4b(iv) ). 112.15 Trauma- and stressor-related disorders (see 112.00B11 ), \n        for children age 3 to attainment of age 18, satisfied by A and B, or A and C: Medical documentation of the requirements of paragraph 1 or 2: Posttraumatic stress disorder, characterized by all of the following: Exposure to actual or threatened death, serious injury, or violence; Subsequent involuntary re-experiencing of the traumatic event (for example, intrusive memories, dreams, or flashbacks); Avoidance of external reminders of the event; Disturbance in mood and behavior (for example, developmental regression, socially withdrawn behavior); and Increases in arousal and reactivity (for example, exaggerated startle response, sleep disturbance). Reactive attachment disorder, characterized by two or all of the following: Rarely seeks comfort when distressed; Rarely responds to comfort when distressed; or Episodes of unexplained emotional distress. AND Extreme limitation  of one, or marked limitation of two, of the following areas of mental  functioning (see 112.00F ): Understand, remember, or apply information (see 112.00E1 ). Interact with others (see 112.00E2 ). Concentrate, persist, or maintain pace (see 112.00E3 ). Adapt or manage oneself (see 112.00E4 ). OR Your mental disorder  in this listing category is “serious and persistent;” that is,\n            you have a medically documented history of the existence of the disorder over a period of at least 2 years, and there is evidence of both: Medical treatment, mental health therapy, psychosocial support(s), \n                or a highly structured setting(s) that is ongoing and that diminishes the symptoms and signs of your mental disorder \n                (see 112.00G2b ); and Marginal adjustment, that is, you have minimal capacity to adapt to changes in your environment or to demands that are not already part of your daily life \n                (see 112.00G2c ).",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security112.00 Mental Disorders - Childhood"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_01",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_02",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_03",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_04",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_06",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_07",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_08",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_09",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_10",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_11",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_12",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_13",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_14",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_15",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_02",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_03",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_04",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_06",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_07",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_08",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_10",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_11",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_13",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_14",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_15",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_14",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_14",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_07",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_08",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_10",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_11",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_13",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_14",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_02",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_03",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_04",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_06",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_15",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00A3",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00I",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_14",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_14",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_02",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_03",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_04",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_06",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_15",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00G",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_02",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_03",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_04",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_06",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_15",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_02",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_02",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00",
      "https://www.ssa.gov/disability/professionals/bluebook/110.00-MultipleBody-Childhood.htm#110_00",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_10",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_11",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_03",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_04",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_02",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_10",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_11",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_06",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_15",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_07",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_08",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_10",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_02",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_11",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_11",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_02",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_10",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_08",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_13",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_14",
      "https://www.ssa.gov/disability/professionals/bluebook/100.00-GrowthImpairment-Childhood.htm#100_00",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_15",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_06",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_02",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00H",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0912.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0913.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0920b.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-1520.htm#c",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0927.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0929.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00D",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0912.htm#d",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0914.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00K",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00H",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00D",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0925.htm#b2ii",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm#e",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00D",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00F2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_02",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_03",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_04",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_06",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_15",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00D",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00D",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05A",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05A",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05B",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00H2c",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05B1",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05A",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00H3b",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05B2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00H3c",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05B2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05B2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05B2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05B2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00D",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05B2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_05B",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_14",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0925.htm#b2ii",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm#e",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0924b.htm#b",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0920.htm#b",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_14",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_14",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_14",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_14",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0925.htm#b2ii",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm#e",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_14",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_14",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00I2a",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_14",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0935.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0994a.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00B1",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E1",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E3",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00G2b",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00G2c",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E1",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E3",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00G2b",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00G2c",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E1",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E3",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00G2b",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00G2c",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00B4",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00H",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00H",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E1",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E3",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00B5",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E1",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E3",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00G2b",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00G2c",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00B6",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E1",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E3",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00B7",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E1",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E3",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00B8",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E1",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E3",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00B9",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E1",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E3",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00B10",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E1",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E3",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00B11",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00I",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00I4bi",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00I4bii",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00I4biii",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00I4biv",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00B11",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E1",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E2",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E3",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00G2b",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00G2c",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm"
    ],
    "html_file": "ssa_bluebook_data/html/00b7d1b0dd12393f77932cb07be082b7.html",
    "fetched_at": 1762482872.332407
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00",
    "url_hash": "b74206562fea7f21ac9566347c5878a5",
    "title": "113.00 Cancer - Childhood | Disability | SSA",
    "text_content": "113.00 Cancer - Childhood | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Listing of Impairments - Child Listings (Part B) 113.00 Cancer - Childhood Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security 113.00 \n\n\nCancer-Childhood Section 113.00 Cancer 113.01 Category \n                of\n              Impairments,\n  Cancer(malignant, neoplastic, diseases) 113.03 Malignant\n              solid\n              tumors 113.05 Lymphoma 113.06 Leukemia 113.09 Thyroid gland 113.12 Retinoblastoma 113.13 Nervous system 113.21 Neuroblastoma 113.29 Malignant melanoma 113.00 Cancer A. What impairments do  these listings cover? We  use these listings to evaluate all\n          cancers (malignant neoplastic diseases) except certain cancers associated with human immunodeficiency virus (HIV) infection.\n          We use the criteria in 114.11B to evaluate primary central nervous system lymphoma, 114.11C to evaluate primary effusion lymphoma,\n          and 114.11E to evaluate pulmonary Kaposi sarcoma if you also have HIV infection.\n          We evaluate all other cancers associated with HIV infection, for example, Hodgkin lymphoma or non-pulmonary Kaposi sarcoma,\n          under this body system or under 114.11F - I in the immune system disorders body system. B. What do we consider when we evaluate cancer\n              under these listings? We consider factors including: 1. Origin of the cancer. 2. Extent of involvement. 3. Duration, frequency, and response to therapy. 4. Effects of any post-therapeutic residuals. C. How do we apply these listings? We apply the criteria\n          in a specific listing to a cancer originating from that specific\n          site. D. What evidence do we need? 1.  We need medical evidence that specifies the type, extent, and site of the primary,\n          recurrent, or metastatic lesion. In the rare situation in which the primary site\n          cannot be identified, we will use evidence documenting the site(s) of metastasis\n          to evaluate the impairment under 13.27 in part A. 2. For operative procedures,\n          including a biopsy or a needle aspiration, we generally need a\n          copy of both the: a. Operative note, and b. Pathology report. 3. When we cannot get these documents, we will accept the summary\n          of hospitalization(s) or other medical reports. This evidence should\n          include details of the findings at surgery and, whenever appropriate,\n          the pathological findings. 4.\n          In some situations we may also need evidence about recurrence,\n          persistence, or progression of the cancer, the response to\n          therapy, and any significant residuals. (See 113.00G .) E. When do we need longitudinal\n              evidence? 1. Cancer with distant metastases. Most cancer of childhood consist of a local lesion with metastases to regional lymph nodes and, less often, distant metastases. We generally do not need longitudinal evidence for cancer that has metastasized beyond the regional lymph nodes because  this cancer usually meets the requirements of a listing. Exceptions are for  cancer with distant metastases that we expect to respond to anticancer therapy. For these exceptions, we usually need a longitudinal record of 3 months after therapy starts to determine whether the therapy achieved its intended effect, and whether this effect is likely to persist. 2. Other cancers . When there are no distant metastases,\n          many of the listings require that we consider your response to\n          initial anticancer therapy; that is, the initial planned\n          treatment regimen. This therapy may consist of a single modality\n          or a combination of modalities; that is, multimodal therapy (see 113.00I3 ). 3. Types of treatment . Whenever the initial planned\n                  therapy is a single modality, enough time must pass to allow\n                  a determination about whether the therapy will achieve its intended\n                  effect. If the treatment fails, the failure will often happen\n                  within 6 months after treatment starts, and there will often\n                  be a change in the treatment regimen. Whenever the initial planned therapy is multimodal,\n                  we usually cannot make a determination about the effectiveness of the therapy until we can determine the effects of all the planned modalities.\n                  In some cases, we may need to defer adjudication until we can assess the effectiveness of therapy.\n                  However, we do not need to defer adjudication to determine whether the therapy will achieve its intended effect if we can make a fully favorable determination\n                  or decision based on the length and effects of therapy,\n                  or the residuals of the cancer or therapy (see 113.00G ). F. How do we evaluate\n              impairments that do not meet one of the cancer listings? 1. These listings are only examples of cancer that we consider severe enough to result in marked and\n          severe functional limitations. If your impairment(s) does not\n          meet the criteria of any of these listings, we must also consider\n          whether you have an impairment(s) that meets the criteria of\n          a listing in another body system. 2. If you have a severe medically determinable impairment(s) that does not meet a listing,\n          we will determine whether your impairment(s) medically equals a listing.\n          (See §§ 404.1526 and 416.926 of this chapter.)\n          If your impairment(s) does not meet or medically equal a listing, we will also consider whether you have an impairment(s) that functionally equals the listings.\n          (See § 416.926a of this chapter.)\n          We use the rules in §§ 416.994a of this chapter when we decide whether you continue to be disabled. G. How do we consider the effects of anticancer therapy? 1. How we consider the effects of therapy under the listings .\n          In many cases, cancers meet listing criteria only if the therapy is not effective and the cancer persists, progresses, or recurs. However, as explained in the following paragraphs, we will not delay adjudication if we can make a fully favorable determination or decision based on the evidence in the case record. 2. Effects can vary widely. a. We consider each case on an individual basis because the therapy and its toxicity may vary widely. We will request a specific description of the therapy, including these items: i. Drugs given. ii. Dosage. iii. Frequency of drug administration. iv. Plans for continued drug administration. v. Extent of surgery. vi. Schedule and fields of radiation therapy. b. We will also request a description of the complications or adverse effects of\n          therapy, such as the following: i. Continuing gastrointestinal symptoms. ii. Persistent weakness. iii. Neurological complications. iv. Cardiovascular complications. v. Reactive mental disorders. 3. Effects of therapy may change . The severity of the adverse effects of anticancer therapy may change during treatment; therefore, enough time must pass to allow us to evaluate the therapy's effect. The residual effects of treatment are temporary in most instances; however, on occasion, the effects may be disabling for a consecutive period of at least 12 months. In some situations, very serious adverse effects may interrupt and prolong multimodal anticancer therapy for a continuous period of almost 12 months. In these situations, we may determine there is an expectation that your impairment will preclude you from engaging in any age-appropriate activities for at least 12  months. 4. When the initial anticancer therapy is effective .\n          We evaluate any post-therapeutic residual impairment(s) not included\n          in these listings under the criteria for the affected body system.\n          We must consider any complications of therapy. When the residual\n          impairment(s) does not meet a listing, we must consider\n          whether it medically equals a listing, or, as appropriate, functionally\n          equals the listings. H. How long do we consider your impairment to be disabling? 1. In some listings, we specify that we will consider your impairment to be disabling\n          until a particular point in time (for example, until at least 12 months from the date of transplantation). We may consider your impairment to be disabling beyond this point when the medical and other evidence justifies it. 2. When a listing does not contain such a specification, we will consider  an impairment(s) that meets or medically equals a listing in this body system  to be disabling until at least 3 years after onset of complete remission. When  the impairment(s) has been in complete remission for at least 3 years, that is,  the original tumor or a recurrence (or relapse) and any metastases have not  been evident for at least 3 years, the impairment(s) will no longer meet or medically  equal the criteria of a listing in this body system. 3. Following the appropriate period, we will consider any residuals,\n          including residuals of the cancer or therapy (see 113.00G ),\n          in determining  whether you are disabled. If you have a recurrence or relapse of your cancer,\n          your impairment may meet or medically equal one of the listings in  this body system again. I. What do  we mean by the following terms? 1. Anticancer therapy means surgery, radiation, chemotherapy, hormones, immunotherapy, or bone marrow or stem cell transplantation. When we refer to surgery as an anticancer treatment, we mean surgical excision for treatment, not for diagnostic purposes. 2. Metastases means the spread of  cancer cells by blood, lymph, or other body fluid.  This term does not include the spread of  cancer cells by direct extension of the cancer to other tissues or organs. 3. Multimodal therapy means anticancer therapy that is a combination of at least two types of treatment given in close proximity as a unified whole and usually planned before any treatment has begun. There are three types of treatment modalities: surgery, radiation, and systemic drug therapy (chemotherapy, hormone therapy, and immunotherapy or biological modifier therapy). Examples  of multimodal therapy include: a. Surgery followed by chemotherapy or radiation. b. Chemotherapy followed by surgery. c. Chemotherapy and concurrent radiation. 4. Persistent means the planned initial anticancer therapy failed to achieve a complete remission of your cancer; that is, your cancer is evident, even if smaller, after the therapy has ended. 5. Progressive means the cancer becomes more extensive after treatment; that is, there is evidence that your cancer is growing after you have completed at least half of your planned initial anticancer therapy. 6. Recurrent, relapse means the cancer that was in complete remission or entirely removed by surgery has returned. J. Can we establish the existence of a disabling impairment\n              prior to the date of the evidence that shows the cancer satisfies\n              the criteria of a listing? Yes. We will consider factors\n          such as: 1. The type of cancer and its location. 2. The extent of involvement\n          when the cancer was first demonstrated. 3. Your symptoms. K. How do we evaluate specific cancers? 1. Lymphoma . a. We provide criteria for evaluating aggressive lymphomas that are\n          disseminated or have not responded to anticancer therapy in 113.05 . b. Lymphoblastic lymphoma is treated with leukemia-based protocols,\n          so we will evaluate this type of cancer under 113.06 . 2. Leukemia. a. Acute leukemia . The initial diagnosis of acute leukemia, including  the accelerated or blast phase of chronic myelogenous (granulocytic) leukemia,  is based upon definitive bone marrow examination. Additional diagnostic  information is based on chromosomal analysis, cytochemical and surface marker  studies on the abnormal cells, or other methods consistent with the prevailing  state of medical knowledge and clinical practice. Recurrent disease must be  documented by peripheral blood, bone marrow, or cerebrospinal fluid  examination, or by testicular biopsy. The initial and follow-up pathology  reports should be included. b. Chronic myelogenous leukemia (CML) .\n          We need a diagnosis of CML based upon documented granulocytosis, including immature forms such as differentiated or undifferentiated myelocytes and myeloblasts,\n          and a chromosomal analysis that demonstrates the Philadelphia chromosome. In the absence of a chromosomal analysis,\n          or if the Philadelphia chromosome is not present, the diagnosis may be made by other methods consistent with the prevailing state of medical knowledge and clinical practice.\n          The requirement of CML in the accelerated or blast phase is met in 113.06B if laboratory findings show the proportion of blast (immature) cells in the peripheral blood or bone marrow is 10 percent or greater. c. Juvenile chronic myelogenous leukemia (JCML) . JCML\n          is a rare, Philadelphia-chromosome-negative childhood leukemia\n          that is aggressive and clinically similar to acute myelogenous\n          leukemia. We evaluate JCML under 113.06A . d. Elevated white cell count . In cases of chronic leukemia (either myelogenous or lymphocytic), an elevated white cell count, in itself, is not a factor in determining the severity of the impairment. 3. Malignant solid tumors .\n          The tumors we consider under 113.03 include the histiocytosis syndromes except for solitary eosinophilic granuloma.\n          We do not evaluate thyroid cancer (see 113.09 ), retinoblastomas (see 113.12 ),\n          primary central nervous system (CNS) cancers (see 113.13 ),\n          neuroblastomas (see 113.21 ),\n          or malignant melanoma (see 113.29 ) under this listing. 4. Primary central nervous system (CNS) cancers .\n          We use the criteria in 113.13 to evaluate cancers that originate within the CNS\n          (that is, brain and spinal cord cancers). The CNS cancers listed in 113.13A are highly malignant and respond poorly to treatment,\n                  and therefore we do not require additional criteria to evaluate them.\n                  We do not list pituitary gland cancer (for example, pituitary gland carcinoma) in 113.13A ,\n                  although this CNS cancer is highly malignant and responds poorly to treatment.\n                  We evaluate pituitary gland cancer under 113.13A and do not require additional criteria to evaluate it. We consider a CNS tumor to be malignant if it is classified as Grade II, Grade III,\n                  or Grade IV under the World Health Organization (WHO) classification of tumors of the CNS ( WHO Classification of Tumours of the Central Nervous System, 2007 ). We evaluate benign (for example, WHO Grade I)\n                  CNS tumors under 111.05 .\n                  We evaluate metastasized CNS cancers from non-CNS sites under the primary cancers (see 113.00C ).\n                  We evaluate any complications of CNS cancers, such as resultant neurological or psychological impairments,\n                  under the criteria for the affected body system. 5. Retinoblastoma . The treatment for bilateral retinoblastoma\n          usually results in a visual impairment. We will evaluate any\n          resulting visual impairment under 102.02 . 6. Melanoma We evaluate malignant melanoma that affects the skin (cutaneous melanoma), eye (ocular melanoma),\n          or mucosal membranes (mucosal melanoma) under 113.29 .\n          We evaluate melanoma that is not malignant that affects the skin (benign melanocytic tumor)\n          under the listings in 108.00 or other affected body systems. L. How do we evaluate cancer treated by bone marrow or stem cell transplantation,\n              including transplantation using stem cells from umbilical cord blood? Bone marrow or stem cell transplantation is performed for a variety of cancers. We require the transplantation to occur before we evaluate it under these listings.\n          We do not need to restrict our determination of the onset of disability to the date of the transplantation\n          ( 113.05 or 113.06 ).\n          We may be able to establish an earlier onset date of disability due to your transplantation if the evidence in your case record supports such a finding. 1. Acute leukemia (including all types of lymphoblastic lymphoma\n              and JCML) or accelerated or blast phase of CML . If you\n          undergo bone marrow or stem cell transplantation for any of these\n          disorders, we will consider you to be disabled until at least\n          24 months from the date of diagnosis or relapse, or at least\n          12 months from the date of transplantation, whichever is later. 2. Lymphoma or chronic phase of CML . If you undergo bone\n          marrow or stem cell transplantation for any of these disorders,\n          we will consider you to be disabled until at least 12 months\n          from the date of transplantation. 3. Evaluating disability after the appropriate time period\n              has elapsed . We consider any residual impairment(s), such\n          as complications arising from: a. Graft-versus-host (GVH) disease. b. Immunosuppressant therapy, such as frequent infections. c. Significant deterioration of other organ systems. 113.01 Category of Impairments, Cancer (Malignant Neoplastic Diseases) 113.03 Malignant solid tumors Consider under a disability: A. For 24 months from the date of initial diagnosis. Thereafter, evaluate any residual\n          impairment(s) under the criteria for the affected body system. OR B. For 24 months from the date of recurrence of active disease. Thereafter, evaluate\n          any residual impairment(s) under the criteria for the affected body system.. 113.05 Lymphoma (excluding all types of lymphoblastic\n                  lymphoma-- 113.06 ) (See 113.00K1 ) A. Non-Hodgkin lymphoma (including Burkitt's and anaplastic large cell), with either 1 or 2: 1. Bone marrow, brain, spinal cord, liver, or lung involvement at initial diagnosis.\n          Consider under a disability for 24 months from the date of diagnosis. Thereafter,\n          evaluate under 113.05A2 , or any residual impairment(s) under the criteria for the affected body system. 2. Persistent or recurrent following initial anticancer therapy. OR B. Hodgkin lymphoma, with either 1 or 2: 1.  Bone marrow, brain, spinal cord, liver, or lung involvement at initial diagnosis. Consider under a disability for 24 months from the date of diagnosis.\n          Thereafter, evaluate under 113.05B2 ,\n          or any residual impairment(s) under the criteria for the affected body system. 2. Persistent or recurrent following initial anticancer therapy. OR C. With bone marrow or stem cell transplantation. Consider under a disability until\n          at least 12 months from the date of transplantation. Thereafter, evaluate any\n          residual impairment(s) under the criteria of the affected body system. OR D. Mantle cell lymphoma. 113.06 Leukemia (See 113.00K2 ) A. Acute leukemia (including all types of lymphoblastic lymphoma and juvenile chronic\n          myelogenous leukemia (JCML). Consider under a disability until at least 24 months\n          from the date of diagnosis or relapse, or at least 12 months from the date of\n          bone marrow or stem cell transplantation, whichever is later. Thereafter, evaluate\n          any residual impairment(s) under the criteria for the affected body system. OR B. Chronic myelogenous leukemia (except JCML), as described in 1 or 2: 1. Accelerated or blast phase (see 113.00K2b ). \n          Consider under a disability until at least 24 months\n          from the date of diagnosis or relapse, or at least 12 months from the date of\n          bone marrow or stem cell transplantation, whichever is later. Thereafter, evaluate\n          any residual impairment(s) under the criteria for the affected body system. 2. Chronic phase, as described in a or b: a. Consider under a disability until at least 12 months from the date of bone marrow\n          or stem cell transplantation. Thereafter, evaluate any residual impairment(s)\n          under the criteria for the affected body system. b. Progressive disease following initial anticancer therapy. 113.09 Thyroid gland A. Anaplastic (undifferentiated) carcinoma. OR B. Carcinoma with metastases beyond the regional lymph nodes progressive despite\n          radioactive iodine therapy. OR C.   Medullary carcinoma with metastases beyond the regional lymph nodes. 113.12 Retinoblastoma A. With extension beyond the orbit. OR B. Persistent or recurrent following initial anticancer therapy. OR C. With regional or distant metastases. 113.13 Nervous system (See 113.00K4 .) Primary central nervous system (CNS; that is, brain and spinal cord) cancers, as described in A, B, or C: A. Glioblastoma multiforme, ependymoblastoma, and diffuse intrinsic brain stem gliomas (see 113.00K4a ). B. Any Grade III or Grade IV CNS cancer (see 113.00K4b ), including astrocytomas, sarcomas, and medulloblastoma and other primitive neuroectodermal tumors (PNETs). C. Any primary CNS cancer, as described in 1 or 2: 1. Metastatic. 2. Progressive or recurrent following initial anticancer therapy. 113.21 Neuroblastoma A. With extension across the midline. OR B. With distant metastases. OR C. Recurrent. OR D. With onset at age 1 year or older. 113.29 Malignant melanoma (including skin, ocular, or mucosal melanomas), as described in either A, B, or C: A. Recurrent (except an additional primary melanoma at a different site, which is not considered to be recurrent disease) following either 1 or 2: 1. Wide excision (skin melanoma). 2. Enucleation of the eye (ocular melanoma). OR B. With metastases as described in 1, 2, or 3: 1. Metastases to one or more clinically apparent nodes; that is, nodes that are detected by imaging studies (excluding lymphoscintigraphy) or by clinical evaluation (palpable). 2. If the nodes are not clinically apparent, with metastases to four or more nodes. 3. Metastases to adjacent skin (satellite lesions) or distant sites (for example, liver, lung, or brain). OR C. Mucosal melanoma. Back to Top",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security113.00 \n\n\nCancer-Childhood"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_01",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_03",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_05",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_06",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_09",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_12",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_13",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_21",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_21",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11B",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11C",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11E",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11F",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_11I",
      "https://www.ssa.gov/disability/professionals/bluebook/13.00-NeoplasticDiseases-Malignant-Adult.htm#13_27",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00G",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00I3",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00G",
      "https://www.ssa.gov/OP_Home/cfr20/404/404-1526.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0994a.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00G",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_05",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_06",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_06B",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_06A",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_03",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_09",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_12",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_13",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_21",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_29",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_13",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_13A",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_13A",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_13A",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_05",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00C",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_02",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_29",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_05",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_06",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_06",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00K1",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_05A2",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_05B2",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00K2",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00K2b",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00K4",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00K4a",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00K4b",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm"
    ],
    "html_file": "ssa_bluebook_data/html/b74206562fea7f21ac9566347c5878a5.html",
    "fetched_at": 1762482874.597295
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00",
    "url_hash": "03914b1aa335ab849ffc5725cac50ad6",
    "title": "104.00 Cardiovascular System - Childhood | Disability | SSA",
    "text_content": "104.00 Cardiovascular System - Childhood | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Listing of Impairments - Child Listings (Part B) 104.00 Cardiovascular System - Childhood Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security 104.00 Cardiovascular System - Childhood Section 104.01 Category \n              of Impairments, Cardiovascular System 104.02 Chronic heart failure 104.05 Recurrent arrhythmias 104.06 Congenital heart disease 104.09 Heart transplant 104.13 Rheumatic heart disease 104.00 Cardiovascular \n            System A. General 1. What do we mean by a cardiovascular impairment? a. We mean any disorder that affects the proper functioning of the heart or the circulatory system (that is, arteries, veins, capillaries, and the lymphatic drainage). The disorder can be congenital or  acquired. b. Cardiovascular impairment results from one or more of four consequences of heart disease: Back to Top (i) Chronic heart failure or ventricular dysfunction. (ii) Discomfort or pain due to myocardial ischemia, with or without necrosis of heart muscle. (iii) Syncope, or near syncope, due to inadequate cerebral perfusion from any cardiac cause, such as obstruction of flow or disturbance in rhythm or conduction resulting in inadequate cardiac output. (iv) Central cyanosis due to right-to-left shunt, reduced oxygen concentration in the arterial blood, or pulmonary vascular disease. c. Disorders of the veins or arteries (for example, obstruction, rupture, or aneurysm) may cause impairments of the lower extremities \n    (peripheral vascular disease), the central nervous system, the  eyes, the kidneys, and other organs. \n    We will evaluate peripheral vascular disease under 4.11 or 4.12 in part A, \n    and impairments of another body system(s) under the listings for that body system(s). Back to Top 2. What do we consider in evaluating cardiovascular impairments? The listings in this section describe cardiovascular impairments based on symptoms, signs, laboratory  findings, response to a regimen of prescribed treatment, and functional  limitations. 3. What do the following terms or phrases mean in these listings? a. Medical consultant is an individual defined in §§ 404.1616(a) and 416.1016(a) . \n    This term does not include medical sources who provide consultative examinations for  us. We use the abbreviation “MC” throughout this section to designate a medical consultant. b. Persistent means that the longitudinal clinical record shows that, with few exceptions,  the required finding(s) has been present, or is expected to be present, for a  continuous period of at least 12 months, such that a pattern of continuing  severity is established. c. Recurrent means that the longitudinal clinical record shows that, within a consecutive  12-month period, the finding(s) occurs at least three times, with intervening  periods of improvement of sufficient duration that it is clear that separate  events are involved. Back to Top d. Appropriate medically acceptable imaging means that the technique used is  the proper one to evaluate and diagnose the impairment and is commonly  recognized as accurate for assessing the cited finding. e. A consecutive 12-month period means a period of 12 consecutive  months, all or part of which must occur within the period we are considering in  connection with an application or continuing disability review. f. Currently present means that the finding is present at the time of  adjudication. g. Uncontrolled means the impairment does not respond adequately to standard  prescribed medical treatment. B. Documenting Cardiovascular Impairment 1. What basic documentation do we need? We need sufficiently detailed  reports of history, physical examinations, laboratory studies, and any  prescribed treatment and response to allow us to assess the severity and  duration of your cardiovascular impairment. A longitudinal clinical record covering  a period of not less than 3 months of observations and treatment is usually  necessary, unless we can make a determination or decision based on the current  evidence. Back to Top 2. Why is a longitudinal clinical record important? We will usually need a  longitudinal clinical record to assess the severity and expected duration of  your impairment(s). If you have a listing-level impairment, you probably will  have received medically prescribed treatment. Whenever there is evidence of  such treatment, your longitudinal clinical record should include a description  of the ongoing management and evaluation provided by your treating or other  medical source. It should also include your response to this medical  management, as well as information about the nature and severity of your  impairment. The record will provide us with information on your functional  status over an extended period of time and show whether your ability to  function is improving, worsening, or unchanging. 3. What if you have not received ongoing medical treatment? a. You may not have received ongoing treatment or have  an ongoing relationship with the medical community despite the existence of a  severe impairment(s). In this situation, we will base our evaluation on the  current objective medical evidence and the other evidence we have. If you do  not receive treatment, you cannot show an impairment that meets the criteria of  these listings. However, we may find you disabled because you have another  impairment(s) that in combination with your cardiovascular impairment medically  equals the severity of a listed impairment or that functionally equals the  listings. b. Unless we can decide your claim favorably on the  basis of the current evidence, a longitudinal record is still important. In  rare instances where there is no or insufficient longitudinal evidence, we may  purchase a consultative examination(s) to help us establish the severity and duration  of your impairment. Back to Top 4. When will we wait before we ask for more evidence? a. We will wait when we have information showing that  your impairment is not yet stable and the expected change in your impairment  might affect our determination or decision. In these situations, we need to  wait to properly evaluate the severity and duration of your impairment during a  stable period. Examples of when we might wait are: (i) If you have had a recent acute event; for example,  acute rheumatic fever. (ii) If you have recently had a corrective cardiac  procedure; for example, open-heart surgery. (iii) If you have started new drug therapy and your  response to this treatment has not yet been established; for example,  beta-blocker therapy for dilated congestive cardiomyopathy. b. In these situations, we will obtain more evidence 3  months following the event before we evaluate your impairment. However, we will  not wait if we have enough information to make a determination or decision  based on all of the relevant evidence in your case. Back to Top 5. Will we purchase any studies? In appropriate situations, we will purchase studies necessary to substantiate the diagnosis or to document the severity of your impairment, \n    generally after we have evaluated the medical and other evidence we already have. \n    We will not purchase studies involving exercise testing if there is significant risk involved or if there is another medical reason not to perform the test. \n    We will follow sections 4.00C6 , 4.00C7 , 4.00C8 , \n    and 104.00B7 when we decide whether to purchase exercise testing. \n    We will make a reasonable effort to obtain any additional studies from a qualified medical source in an office or center experienced in pediatric cardiac assessment. \n    (See  § 416.919g .) 6. What studies will we not purchase? We will not purchase any studies involving cardiac catheterization, such as coronary angiography, \n    arteriograms,  or electrophysiological studies. However, if the results of catheterization are  part of the existing evidence we have, we will consider them together with the other relevant evidence. \n    See 4.00C15a in part A. Back to Top 7. Will we use exercise tolerance tests (ETTs) for evaluating  children with cardiovascular impairment? a. ETTs, though increasingly used, are still less  frequently indicated in children than in adults, and can rarely be performed  successfully by children under 6 years of age. An ETT may be of value in the  assessment of some arrhythmias, in the assessment of the severity of chronic  heart failure, and in the assessment of recovery of function following cardiac  surgery or other treatment. b. We will purchase an ETT in a childhood claim only if we cannot make a determination or decision based on the evidence we have and an MC, \n    preferably one with experience in the care of children with cardiovascular impairments, \n    has determined that an ETT is needed to evaluate your impairment. We will not purchase an ETT if you are less than 6 years of age. If we do purchase an ETT for a child age 12 or younger, \n    it must be performed by a qualified medical source in a specialty center for pediatric cardiology or other facility qualified to perform exercise tests of children. c. For full details on ETT requirements and usage, \n    see 4.00C in part A. Back to Top C. Evaluating Chronic Heart Failure 1. What is chronic heart failure (CHF)? a. CHF is the inability of the heart to  pump enough oxygenated blood to body tissues. This syndrome is characterized by  symptoms and signs of pulmonary or systemic congestion (fluid retention) or  limited cardiac output. Certain laboratory findings of cardiac functional and  structural abnormality support the diagnosis of CHF. b. CHF is considered in these listings as a single category whether due to atherosclerosis (narrowing of the arteries),  \n    cardiomyopathy, hypertension, or rheumatic, congenital, or other heart disease.  However, if the CHF is the result of primary pulmonary hypertension secondary to disease of the lung (cor pulmonale), \n    we will evaluate your impairment using 3.09 in the respiratory system listings in part A. Back to Top 2. What evidence of CHF do we need? a. Cardiomegaly or ventricular dysfunction must be present and demonstrated by appropriate medically acceptable imaging, such as chest x-ray, echocardiography (M-Mode, 2-dimensional, and Doppler),  radionuclide studies, or cardiac catheterization. (i) Cardiomegaly is present when: (A) Left  ventricular diastolic dimension or systolic dimension is greater than 2  standard deviations above the mean for the child’s body surface area; (B) Left ventricular mass is greater than 2 standard deviations above the  mean for the child’s body surface area; or (C) Chest  x-ray (6 foot PA film) is indicative of cardiomegaly if the cardiothoracic  ratio is over 60 percent at 1 year of age or less, or 55 percent or greater at  more than 1 year of age. (ii) Ventricular dysfunction is present when indices of  left ventricular function, such as fractional shortening or ejection fraction  (the percentage of the blood in the ventricle actually pumped out with each  contraction), are greater than 2 standard deviations below the mean for the child’s  age. (Fractional shortening, also called shortening fraction, reflects the left  ventricular systolic function in the absence of segmental wall motion  abnormalities and has a linear correlation with ejection fraction. In children,  fractional shortening is more commonly used than ejection fraction.) Back to Top (iii) However, these measurements alone do not reflect  your functional capacity, which we evaluate by considering all of the relevant  evidence. (iv) Other findings on appropriate medically acceptable  imaging may include increased pulmonary vascular markings, pleural effusion,  and pulmonary edema. These findings need not be present on each report, since  CHF may be controlled by prescribed treatment. b. To establish that you have chronic heart failure, we require that your medical history and physical examination  describe characteristic symptoms and signs of pulmonary or systemic congestion  or of limited cardiac output associated with the abnormal findings on  appropriate medically acceptable imaging. When a remediable factor, such as an  arrhythmia, triggers an acute episode of heart failure, you may experience  restored cardiac function and a chronic impairment may not be present. (i) Symptoms of congestion or of limited cardiac output  include easy fatigue, weakness, shortness of breath (dyspnea), cough, or chest  discomfort at rest or with activity. Children with CHF may also experience  shortness of breath on lying flat (orthopnea) or episodes of shortness of  breath that wake them from sleep (paroxysmal nocturnal dyspnea). They may also  experience cardiac arrhythmias resulting in palpitations, lightheadedness, or  fainting. Fatigue or exercise intolerance in an infant may be manifested by  prolonged feeding time, often associated with excessive respiratory effort and  sweating. (ii) During infancy, other  manifestations of chronic heart failure may include repeated lower respiratory  tract infections. (iii)  Signs of congestion may include hepatomegaly, ascites, increased jugular venous  distention or pressure, rales, peripheral edema, rapid shallow breathing  (tachypnea), or rapid weight gain. However, these signs need not be found on  all examinations because fluid retention may be controlled by prescribed  treatment. 3. How do we evaluate growth failure  due to CHF? a. To evaluate growth failure due to CHF, \n    we require documentation of the clinical findings of CHF described in 104.00C2 and the growth measurements in 104.02C within the same consecutive 12-month period.\n    The dates of clinical findings may be different from the dates of growth measurements. b. Under 104.02C , \n    we use the appropriate table(s) under 105.08B in the digestive system to determine whether a child’s growth is less than the third percentile. (i) For Children from birth to attainment of age 2, we use the weight-for-length table corresponding to the child’s gender (Table I or Table II). (ii) For children age 2 to attainment of age 18, we use the body mass index (BMI)-for-age table corresponding to  the child’s gender (Table III or Table IV). (iii) BMI is the ratio of a child’s  weight to the square of his or her height.\n                We calculate BMI using the formulas in the digestive disorders body system ( 105.00 ). D. Evaluating Congenital Heart Disease 1. What is congenital heart disease? Congenital heart disease is any  abnormality of the heart or the major blood vessels that is present at birth. Examples  include: a. Abnormalities of cardiac septation , including ventricular septal defect or atrioventricular canal; b. Abnormalities resulting in cyanotic heart disease , including tetralogy of Fallot or transposition of the great arteries; Back to Top c. Valvular defects or obstructions to ventricular outflow, including pulmonary or aortic  stenosis or coarctation of the aorta; and d. Major abnormalities of ventricular development , including  hypoplastic left heart syndrome or pulmonary tricuspid atresia with hypoplastic  right ventricle. 2. How will we evaluate symptomatic congenital heart disease? a. Because of improved treatment methods, more children with congenital heart disease are living longer. \n    Although some types of congenital heart disease may be corrected by surgery, \n    many children with treated congenital heart disease continue to have problems throughout their lives (symptomatic congenital heart disease). \n    If you have congenital heart disease that results in chronic heart failure with evidence of ventricular dysfunction or in recurrent arrhythmias, \n    we will evaluate your impairment under 104.02 or 104.05 .\n    Otherwise, we will evaluate your impairment under 104.06 . b. For 104.06A2 ,\n    we will accept pulse oximetry measurements instead of arterial O2, but the arterial O2 values are preferred, if available. c. For 104.06D , \n    examples of impairments that in most instances will require life-saving surgery or a combination of surgery and other major interventional procedures \n    (for example, multiple “balloon” catheter  procedures) before age 1 include, but are not limited to, the following: Back to Top (i) Hypoplastic left heart syndrome, (ii) Critical aortic stenosis with neonatal heart failure, (iii) Critical coarctation of the aorta, with or without associated anomalies, (iv) Complete atrioventricular canal defects, (v) Transposition of the great arteries, (vi) Tetralogy of Fallot, (vii) Pulmonary atresia with intact ventricular septum, (viii) Single ventricle, (ix) Tricuspid atresia, and (x) Multiple ventricular septal defects. Back to Top E. Evaluating Arrhythmias 1. What is an arrhythmia? An arrhythmia is a change in the regular beat of the heart. Your heart may seem to skip a beat or beat irregularly, very quickly (tachycardia), or very slowly  (bradycardia). 2. What are the different types of arrhythmias? a. There are many types of arrhythmias. Arrhythmias are  identified by where they occur in the heart (atria or ventricles) and by what  happens to the heart’s rhythm when they occur. b. Arrhythmias arising in the cardiac atria (upper  chambers of the heart) are called atrial or supraventricular arrhythmias. Ventricular  arrhythmias begin in the ventricles (lower chambers). In general, ventricular  arrhythmias caused by heart disease are the most serious. Back to Top 3. How do we evaluate arrhythmias using 104.05 ? a. We will use 104.05 when you have arrhythmias that are not fully controlled by medication, \n    an implanted pacemaker, or an implanted cardiac defibrillator and you have uncontrolled recurrent episodes of syncope or near syncope. \n    If your arrhythmias are controlled, we will evaluate your underlying heart disease using the appropriate listing. \n    For other considerations when we evaluate arrhythmias in the presence of an implanted cardiac defibrillator, see 104.00E4 . b. We consider near syncope to be a period of altered consciousness, since syncope is a  loss of consciousness or a faint. It is not merely a feeling of  light-headedness, momentary weakness, or dizziness. c. For purposes of 104.05 , there must be a documented association between the syncope or near syncope and the recurrent arrhythmia. The  recurrent arrhythmia, not some other cardiac or non-cardiac disorder, must be  established as the cause of the associated symptom. This documentation of the  association between the symptoms and the arrhythmia may come from the usual  diagnostic methods, including Holter monitoring (also called ambulatory  electrocardiography) and tilt-table testing with a concurrent ECG. Although an  arrhythmia may be a coincidental finding on an ETT, we will not purchase an ETT  to document the presence of a cardiac arrhythmia. Back to Top 4. What will we consider when you have an implanted cardiac defibrillator and you do not have arrhythmias that meet the requirements of 104.05 ? a. Implanted cardiac defibrillators are used to prevent sudden cardiac death in children who have had, or are at high risk for, \n    cardiac arrest from life-threatening ventricular arrhythmias. The largest group of children at risk for sudden cardiac death consists of children with cardiomyopathy \n    (ischemic or non-ischemic) and reduced ventricular function. However, life-threatening ventricular arrhythmias can also occur in children with little or no ventricular dysfunction. \n    The shock from the implanted cardiac  defibrillator is a unique form of treatment; it rescues a child from what may have been cardiac arrest. \n    However, as a consequence of the shock(s), children may experience psychological distress, \n    which we may evaluate under the mental disorders listings in 112.00ff . b. Most implantable cardiac defibrillators have  rhythm-correcting and pacemaker capabilities. In some children, these functions  may result in the termination of ventricular arrhythmias without an otherwise  painful shock. (The shock is like being kicked in the chest.) Implanted cardiac  defibrillators may deliver inappropriate shocks, often repeatedly, in response  to benign arrhythmias or electrical malfunction. Also, exposure to strong electrical  or magnetic fields, such as from MRI (magnetic resonance imaging), can trigger  or reprogram an implanted cardiac defibrillator, resulting in inappropriate  shocks. We must consider the frequency of, and the reason(s) for, the shocks  when evaluating the severity and duration of your impairment. c. In general, the exercise limitations imposed on  children with an implanted cardiac defibrillator are those dictated by the  underlying heart impairment. However, the exercise limitations may be greater  when the implanted cardiac defibrillator delivers an inappropriate shock in  response to the increase in heart rate with exercise, or when there is  exercise-induced ventricular arrhythmia. Back to Top F. Evaluating Other Cardiovascular Impairments 1. What is ischemic heart disease (IHD) and how will we evaluate it in children? IHD results when one or more of your coronary arteries is narrowed or obstructed or, in rare situations, constricted due to vasospasm, \n    interfering with the normal flow of blood to your heart muscle (ischemia). \n    The obstruction may be the result of an embolus, a thrombus, or plaque. When heart muscle tissue dies as a result of the reduced blood supply, \n    it is called a myocardial infarction (heart attack). Ischemia is rare in children, but when it occurs, its effects on children are the same as on adults. \n    If you have IHD, we will evaluate it under 4.00E and 4.04 in part A. 2. How will we evaluate hypertension? Because hypertension (high blood pressure) generally  causes disability through its effects on other body systems, we will evaluate  it by reference to the specific body system(s) affected (heart, brain, kidneys,  or eyes) when we consider its effects under the listings. We will also consider  any limitations imposed by your hypertension when we consider whether you have  an impairment that functionally equals the listings. Back to Top 3. What is cardiomyopathy and how will we evaluate it? Cardiomyopathy is a disease of the heart muscle. \n    The heart loses its ability to pump blood (heart failure), and in some instances, heart rhythm is disturbed, leading to irregular heartbeats (arrhythmias). \n    Usually, the exact cause of the muscle damage is never found (idiopathic cardiomyopathy). \n    There are various types of cardiomyopathy, which fall into two major categories: Ischemic and nonischemic cardiomyopathy. \n    Ischemic cardiomyopathy typically refers to heart muscle damage that results from  coronary artery disease, including heart attacks. \n    Nonischemic cardiomyopathy includes several types: Dilated, hypertrophic, and restrictive. \n    We will evaluate cardiomyopathy under 4.04 in part A, 104.02 , 104.05 , \n    or 111.06 , depending on its effects on you. 4. How will we evaluate valvular heart disease? We will evaluate valvular heart disease under the listing appropriate for its effect on you.\n    Thus, we may use 4.04 in part A, 104.02 , 104.05 , 104.06 ,\n    or an appropriate neurological listing in 111.00ff . 5. What do we consider when we evaluate heart transplant recipients? a. After your heart transplant, we will consider you disabled for 1 year following the surgery because there is a greater likelihood of rejection of the organ and infection during the first year. Back to Top b. However, heart transplant patients generally meet our definition of disability before they undergo transplantation. We will determine the onset of your disability based on the facts in your case. c. We will not assume that you became disabled when your name was placed on a transplant waiting list. This is because you may be  placed on a waiting list soon after diagnosis of the cardiac disorder that may  eventually require a transplant. Physicians recognize that candidates for  transplantation often have to wait months or even years before a suitable donor  heart is found, so they place their patients on the list as soon as permitted. d. When we do a continuing disability review to determine whether you are still disabled, \n    we will evaluate your residual impairment(s), as shown by symptoms, signs, and laboratory findings, including any side effects of medication. \n    We will consider any remaining symptoms, signs, and laboratory findings indicative of cardiac dysfunction in deciding whether medical improvement \n    (as defined in § 416.994a ) has occurred. Back to Top 6. How will we evaluate chronic rheumatic fever or rheumatic heart disease? The diagnosis should be made in accordance with the current revised Jones criteria for guidance in the diagnosis of rheumatic fever. \n    We will evaluate persistence of rheumatic fever activity under 104.13 .\n    If you have evidence of chronic heart failure or recurrent arrhythmias associated with rheumatic heart disease,\n    we will use 104.02 or 104.05 . 7. What is hyperlipidemia and how will we evaluate it? Hyperlipidemia is the general term for an  elevation of any or all of the lipids (fats or cholesterol) in the blood; for  example, hypertriglyceridemia, hypercholesterolemia, and hyperlipoproteinemia. These  disorders of lipoprotein metabolism and transport can cause defects throughout  the body. The effects most likely to interfere with function are those produced by atherosclerosis (narrowing of the arteries) and coronary  artery disease. We will evaluate your lipoprotein disorder by considering its  effects on you. 8. How will we evaluate Kawasaki disease? We will evaluate Kawasaki disease under the listing appropriate to its effects on you, which may include major coronary artery aneurysm or heart failure. \n    A major coronary artery aneurysm may cause ischemia or arrhythmia, \n    which we will evaluate under 4.04 in part A or 104.05 .\n    We will evaluate chronic heart failure under 104.02 . Back to Top 9. What is lymphedema and how  will we evaluate it? a. Lymphedema is edema of the extremities due to a disorder of the lymphatic circulation; at its worst, it is called elephantiasis. Primary lymphedema is caused by abnormal development of lymph  vessels and may be present at birth (congenital lymphedema), but more often  develops during the teens (lymphedema praecox). Secondary lymphedema is due to obstruction  or destruction of normal lymphatic channels due to tumor, surgery, repeated  infections, or parasitic infection such as filariasis. Lymphedema most commonly  affects one extremity. b. Lymphedema does not meet the requirements of 4.11 in part A, \n    although it may medically  equal the severity of that listing. \n    We will evaluate lymphedema by considering  whether the underlying cause meets or medically equals any listing or whether the lymphedema medically equals a cardiovascular listing, \n    such as 4.11 , or a  musculoskeletal disorders listing,\n    such as 101.18 .\n    If no listing is met or medically equaled, we will evaluate any functional limitations imposed by your lymphedema when we consider whether you have an impairment that functionally equals the listings. Back to Top 10. What is Marfan syndrome and how will we evaluate it? a. Marfan syndrome is a genetic connective tissue disorder that affects multiple body systems, including the skeleton, eyes, heart, blood vessels, nervous system,  skin, and lungs. There is no specific laboratory test to diagnose Marfan  syndrome. The diagnosis is generally made by medical history, including family  history, physical examination, including an evaluation of the ratio of arm/leg  size to trunk size, a slit lamp eye examination, and a heart test(s), such as  an echocardiogram. In some cases, a genetic analysis may be useful, but such  analyses may not provide any additional helpful information. b. The effects of Marfan syndrome can range from mild to severe. \n    In most cases, the disorder progresses as you age. Most individuals with Marfan syndrome have  abnormalities associated with the heart and blood vessels. \n    Your heart’s mitral  valve may leak, causing a heart murmur. Small leaks may not cause symptoms, but larger ones may cause shortness of breath, fatigue, and palpitations. \n    Another effect is that the wall of the aorta may be weakened and stretch (aortic  dilation). \n    This aortic dilation may tear, dissect, or rupture, causing serious heart problems or sometimes sudden death. \n    We will evaluate the manifestations of your Marfan syndrome under the appropriate body system criteria, \n    such as 4.10 in part A, \n    or if necessary consider the functional limitations imposed by  your impairment. Back to Top G. Other Evaluation Issues 1. What effect does obesity have on the cardiovascular system and how will we evaluate it? Obesity is a medically determinable impairment that is often associated with disorders of the  cardiovascular system. Disturbance of this system can be a major cause of  disability in children with obesity. Obesity may affect the cardiovascular  system because of the increased workload the additional body mass places on the  heart. Obesity may make it harder for the chest and lungs to expand. This can  mean that the respiratory system must work harder to provide needed oxygen. This  in turn would make the heart work harder to pump blood to carry oxygen to the  body. Because the body would be working harder at rest, its ability to perform  additional work would be less than would otherwise be expected. Thus, the  combined effects of obesity with cardiovascular impairments can be greater than  the effects of each of the impairments considered separately. We must consider  any additional and cumulative effects of obesity when we determine whether you  have a severe cardiovascular impairment or a listing-level cardiovascular  impairment (or a combination of impairments that medically equals a listing),  and when we determine whether your impairment(s) functionally equals the  listings. Back to Top 2. How do we relate treatment to  functional status? In  general, conclusions about the severity of a cardiovascular impairment cannot  be made on the basis of type of treatment rendered or anticipated. \n    The amount of function restored and the time required for improvement after treatment  (medical, surgical, or a prescribed program of progressive physical activity) \n    vary with the nature and extent of the disorder, the type of treatment, and other factors. Depending upon the timing of this treatment in relation to the alleged onset date of disability, \n    we may need to defer evaluation of the impairment for a period of up to 3 months from the date treatment began to permit consideration of treatment effects, \n    unless we can make a determination or decision using the evidence we have. \n    See 104.00B4 . 3. How do we evaluate impairments that do not meet one of the cardiovascular listings? a. These listings are only examples of common cardiovascular disorders that we consider  severe enough to result in marked and severe functional limitations. If your  severe impairment(s) does not meet the criteria of any of these listings, we  must also consider whether you have an impairment(s) that satisfies the  criteria of a listing in another body system. b. If you have a severe medically determinable impairment(s) that does not meet a listing, \n    we will determine whether your impairment(s) medically equals a listing. \n    (See § 416.926 .)\n    If you have a severe impairment(s) that does not meet or medically equal the criteria of a listing, we will consider whether it functionally equals the listings.\n    (See § 416.926a .)\n    When we decide whether you continue to be disabled, we use the rules in § 416.994a . Back to Top 104.01 Category of Impairments, Cardiovascular System 104.02 Chronic heart failure while on a regimen of prescribed treatment with symptoms and signs described in 104.00C2 and with one of the following: A. Persistent tachycardia at rest (see Table I); OR B. Persistent tachypnea at rest (see Table II) or  markedly decreased exercise tolerance \n    (see 104.00C2b ); OR C. Growth failure as required in 1 or 2: 1. For children from birth to  attainment of age 2, three weight-for-length measurements that are: a. Within a consecutive 12-month  period; and b. At least 60 days apart; and c. Less than the third percentile on the appropriate weight-for-length Table I or II under 105.08B1 ; or 2. For children age 2 to attainment of age 18, three BMI-for-age measurements that are: a. Within a consecutive 12-month  period; and b. At least 60 days apart; and c. Less than the third percentile on the appropriate BMI-for-age Table III or IV under 105.08B2 . Back to Top Table I ‑  Tachycardia at Rest Age Apical    heart rate (beats per    minute) Under 1 year 150 1 through 3 years 130 4 through 9 years 120 10 through 15 years 110 Over 15 years 100 Table II ‑ Tachypnea  at Rest Age Respiratory    rate over  (per minute) Under 1 year 40 1 through 5 years 35 6 through 9 years 30 Over 9 years 25 Back to Top 104.05 Recurrent arrhythmias, not related to reversible causes such as electrolyte abnormalities or digitalis glycoside or antiarrhythmic drug toxicity, \n    resulting in uncontrolled (see 104.00A3g ), \n                recurrent (see 104.00A3c )\n    episodes of cardiac syncope or near syncope (see 104.00E3b ),\n    despite prescribed treatment (see 104.00B3 if there is no prescribed treatment),\n    and documented by resting or ambulatory (Holter) electrocardiography, or by other appropriate medically acceptable testing,\n    coincident with the occurrence of syncope or near syncope (see 104.00E3c ). Back to Top 104.06 Congenital heart disease, documented by appropriate medically acceptable imaging (see 104.00A3d ) or cardiac catheterization, with one of the following: A. Cyanotic heart disease, with  persistent, chronic hypoxemia as manifested by: 1. Hematocrit of 55 percent or  greater on two evaluations 3 months or more apart within a consecutive 12-month  period \n    (see 104.00A3e ); or 2. Arterial O2 saturation of less than 90 percent in room air, or resting arterial PO2 of 60 Torr or less; or 3. Hypercyanotic spells, syncope, characteristic squatting, or other incapacitating symptoms directly related to  documented cyanotic heart disease; or 4. Exercise intolerance with increased hypoxemia on exertion. OR B. Secondary pulmonary vascular obstructive disease with pulmonary arterial systolic pressure elevated to at least 70 percent of the systemic arterial systolic pressure. OR C. Symptomatic acyanotic heart disease, with ventricular dysfunction interfering very seriously with the ability to independently initiate, sustain, or complete activities. OR D. For infants under 12 months of age at the time of filing, with life-threatening congenital heart impairment that will require or already has required surgical treatment in the first year  of life, and the impairment is expected to be disabling (because of residual  impairment following surgery, or the recovery time required, or both) until the  attainment of at least 1 year of age, consider the infant to be under  disability until the attainment of at least age 1; thereafter, evaluate  impairment severity with reference to the appropriate listing. Back to Top 104.09 Heart transplant . Consider under a disability for 1  year following surgery; thereafter, evaluate residual impairment under the  appropriate listing. 104.13 Rheumatic heart disease, with persistence of rheumatic fever activity manifested by significant murmurs(s), cardiac enlargement or ventricular dysfunction \n    (see 104.00C2a ), and other associated abnormal laboratory findings;\n    for example, an elevated sedimentation rate or ECG findings, for 6 months or  more in a consecutive 12-month period\n    (see 104.00A3e ). Consider under a disability for 18 months from the established onset of impairment, then evaluate any residual impairment(s). Back to Top",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security104.00 Cardiovascular System - Childhood"
      }
    ],
    "tables": [
      [
        [
          "Age",
          "Apical    heart rate(beats per    minute)"
        ],
        [
          "Under 1 year",
          "150"
        ],
        [
          "1 through 3 years",
          "130"
        ],
        [
          "4 through 9 years",
          "120"
        ],
        [
          "10 through 15 years",
          "110"
        ],
        [
          "Over 15 years",
          "100"
        ]
      ],
      [
        [
          "Age",
          "Respiratory    rate over  (per minute)"
        ],
        [
          "Under 1 year",
          "40"
        ],
        [
          "1 through 5 years",
          "35"
        ],
        [
          "6 through 9 years",
          "30"
        ],
        [
          "Over 9 years",
          "25"
        ]
      ]
    ],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_01",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_02",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_06",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_09",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_13",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_11",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_12",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/OP_Home/cfr20/404/404-1616.htm#a",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-1016.htm#a",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_00C6",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_00C7",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_00C8",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00B7",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0919g.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_00C15a",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_00C",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/3.00-Respiratory-Adult.htm#3_09",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00C2",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_02C",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_02C",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_02",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_06",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_06A2",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_06D",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_00E",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_04",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_04",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_02",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_06",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_04",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_02",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_06",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0994a.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_13",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_02",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_04",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_05",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_02",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_11",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_11",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_18",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm#4_10",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00B4",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0994a.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00C2",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00C2b",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B1",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_08B2",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00A3g",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00A3c",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00E3b",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00E3c",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00A3d",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00A3e",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00C2a",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00A3e",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm"
    ],
    "html_file": "ssa_bluebook_data/html/03914b1aa335ab849ffc5725cac50ad6.html",
    "fetched_at": 1762482876.9038973
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00",
    "url_hash": "17f320916a8191600ce06d401bff66cc",
    "title": "108.00 Skin Disorders - Childhood | Disability | SSA",
    "text_content": "108.00 Skin Disorders - Childhood | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Listing of Impairments - Child Listings (Part B) 108.00 Skin Disorders - Childhood Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security 108.00 Skin Disorders - Childhood Section 108.01 Category of Impairments, Skin Disorders 108.07 Genetic photosensitivity disorders 108.08 Burns 108.09 Chronic conditions of the skin or mucous membranes 108.00 Skin Disorders A. Which skin disorders do we evaluate under these listings? We use these listings to evaluate skin disorders that result from hereditary, congenital, or acquired pathological processes. \n                            We evaluate genetic photosensitivity disorders ( 108.07 ), burns ( 108.08 ), \n                            and chronic conditions of the skin or mucous membranes such as ichthyosis, bullous disease, dermatitis, psoriasis, \n                            and hidradenitis suppurativa ( 108.09 ) under these listings. B. What are our definitions for the following terms used in this body system? 1. Assistive device(s): An assistive device, for the purposes of these listings, is any device used to improve stability, dexterity, or mobility. An assistive device can be hand-held, such as a cane(s), a crutch(es), or a walker; used in a seated position, such as a wheelchair, rollator, or power operated vehicle; or worn, such as a prosthesis or an orthosis. 2. Chronic skin lesions: Chronic skin lesions can have recurrent exacerbations (see 108.00B7 ).\n                            They can occur despite prescribed medical treatment. These chronic skin lesions can develop on any part of your body, including upper extremities, lower extremities, palms of your hands,\n                            soles of your feet, the perineum, inguinal (groin) region, and axillae (underarms).\n                            Chronic skin lesions may result in functional limitations as described in 108.00D2 . 3. Contractures: Contractures are permanent fibrous scar tissue resulting in tightening and thickening of skin that prevents normal movement of the damaged area. \n                            They can develop on any part of your musculoskeletal system, including upper extremities, lower extremities, palms of your hands, soles of your feet, the perineum, inguinal (groin) region, \n                            and axillae (underarms). Contractures may result in functional limitations as described in 108.00D2 . 4. Documented medical need: When we use the term \"documented medical need,\" we mean that there is evidence\n                            (see § 416.913 of this chapter)\n                            from your medical source(s) in the medical record that supports your need for an assistive device (see 108.00B1 ) for a continuous period of at least 12 months.\n                            The evidence must include documentation from your medical source(s) describing any limitation(s) in your upper or lower extremity functioning that supports your need for the assistive device\n                            and describing the circumstances for which you need it. The evidence does not have to include a specific prescription for the device. 5. Fine and gross movements: Fine movements, for the purposes of these listings, involve use of your wrists, hands, and fingers; such movements include picking, pinching, manipulating, and fingering. Gross movements involve use of your shoulders, upper arms, forearms, and hands; such movements include handling, gripping, grasping, holding, turning, and reaching. Gross movements also include exertional activities such as lifting, carrying, pushing, and pulling. Evaluation of fine and gross movements is dependent on your age. 6. Surgical management: For the purposes of these listings, surgical management includes the surgery(ies) itself, as well as various post-surgical procedures, surgical complications, infections or other medical complications, related illnesses, or related treatments that delay a person's attainment of maximum benefit from surgery. 7. Exacerbation: For the purposes of these listings, exacerbation means an increase in the signs or symptoms of the skin disorder. Exacerbation may also be referred to as flare, flare-up, or worsening of the skin disorder. Back to Top C. What evidence do we need to evaluate your skin disorder? 1. To establish the presence of a skin disorder as a medically determinable impairment, we need objective medical evidence from an acceptable medical source (AMS) who has examined you for the disorder. 2. We will make every reasonable effort to obtain your medical history, treatment records, and relevant laboratory findings, but we will not purchase genetic testing. 3. When we evaluate the presence and severity of your skin disorder(s), we generally need information regarding: a. The onset, duration, and frequency of exacerbations (see 108.00B7 ); b. The prognosis of your skin disorder; c. The location, size, and appearance of lesions and contractures; d. Any available history of familial incidence; e. Your exposure to toxins, allergens or irritants; seasonal variations; and stress factors; f. Your ability to function outside of a highly protective environment (see 108.00E4 ); g. Laboratory findings (for example, a biopsy obtained independently of Social Security disability evaluation or results of blood tests); h. Evidence from other medically acceptable methods consistent with the prevailing state of medical knowledge and clinical practice; and i. Statements you or others make about your disorder(s), your restrictions, and your daily activities. D. How do we evaluate the severity of skin disorders? 1. General. We evaluate the severity of skin disorders based on the site(s) of your chronic skin lesions (see 108.00B2 )\n                            or contractures (see 108.00B3 ), functional limitations caused by your signs and symptoms\n                            (including pain) (see 108.00D2 ), and how your prescribed treatment affects you.\n                            We consider the frequency and severity of your exacerbations (see 108.00B7 ), how quickly they resolve,\n                            and how you function between exacerbations (see 108.00B7 ),\n                            to determine whether your skin disorder meets or medically equals a listing (see 108.00D3 ).\n                            If there is no record of ongoing medical treatment for your disorder, we will follow the guidelines in 108.00D6 .\n                            We will determine the extent and kinds of evidence we need from medical and non-medical sources based on the individual facts about your disorder.\n                            For our basic rules on evidence, see §§ 416.912 , 416.913 ,\n                            and 416.920b of this chapter.\n                            For our rules on evaluating your symptoms, see § 416.929 of this chapter. 2. Limitation(s) of physical functioning due to skin disorders. a. Skin disorders may be due to chronic skin lesions (see 108.00B2 ) \n                            or contractures (see 108.00B3 ),\n                            and may cause pain or restrict movement, which can limit your ability to initiate, sustain, and complete age-appropriate activities.\n                            For example, skin lesions in the axilla may limit your ability to raise or reach with the affected arm, or lesions in the inguinal region may limit your ability to ambulate, sit, or lift and carry.\n                            To evaluate your skin disorder(s) under 108.07B , 108.08 ,\n                            and 108.09 , we require medically documented evidence of physical limitation(s) of functioning related to your disorder.\n                            The decrease in physical function must have lasted, or can be expected to last, for a continuous period of at least 12 months\n                            (see § 416.909 of this chapter).\n                            Xeroderma pigmentosum is the only skin disorder that does not include functional criteria because the characteristics\n                            and severity of the disorder itself are sufficient to meet the criteria in 108.07A . b. The functional criteria require impairment-related physical limitations in using upper or lower extremities that have lasted, or can be expected to last, for a continuous period of at least 12 months, medically documented by one of the following: (i) Inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, \n                            and complete age-appropriate activities involving fine and gross movements (see 108.00B5 ) due to chronic skin lesions (see 108.00B2 ) \n                            or contractures (see 108.00B3 ); or (ii) Inability to use one upper extremity to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements \n                            (see 108.00B5 ) due to chronic skin lesions (see 108.00B2 ) \n                            or contractures (see 108.00B3 ), and a documented medical need \n                            (see 108.00B4 ) for an assistive device (see 108.00B1 ) that requires the use of the other upper extremity; or (iii) Inability to stand up from a seated position and maintain an upright position to the extent needed to independently initiate, sustain, \n                            and complete age-appropriate activities due to chronic skin lesions (see 108.00B2 ) \n                            or contractures (see 108.00B3 ) affecting at least two extremities \n                            (including when the limitations are due to involvement of the perineum or the inguinal region); or (iv) Inability to maintain an upright position while standing or walking to the extent needed to independently initiate, sustain, and complete age-appropriate activities due to chronic skin lesions \n                            (see 108.00B2 ) or contractures (see 108.00B3 ) affecting both lower extremities \n                            (including when the limitations are due to involvement of the perineum or the inguinal region). 3. Frequency of exacerbations due to chronic skin lesions. A skin disorder resulting in chronic skin lesions (see 108.00B2 ) may have frequent exacerbations \n                            (see 108.00B7 ) severe enough to meet a listing even if each individual skin lesion exacerbation \n                            (see 108.00B7 ) did not last for an extended amount of time. We will consider the frequency, severity, \n                            and duration of skin lesion exacerbations (see 108.00B7 ), \n                            how quickly they resolve, and how you function in the time between skin lesion exacerbations (see 108.00B7 ), \n                            to determine whether your skin disorder meets or medically equals a listing. 4. Symptoms (including pain). Your symptoms may be an important factor in our determination of whether your skin disorder(s) meets or medically equals a listing.\n                            We consider your symptoms only when you have a medically determinable impairment(s) that could reasonably be expected to produce the symptoms.\n                            See § 416.929 of this chapter. 5. Treatment. a. General. Treatments for skin disorders may have beneficial or adverse effects, and responses to treatment vary from person to person. Your skin disorder's response to treatment may vary due to treatment resistance or side effects that can result in functional limitations. We will evaluate all of the effects of treatment (including surgical treatment, medications, and therapy) on the symptoms, signs, and laboratory findings of your skin disorder, and on your ability to function. b. Despite adherence to prescribed medical treatment for 3 months. Under 108.09 , we require that your symptoms persist \"despite adherence to prescribed medical treatment for 3 months.\" \n                            This requirement means that you must have taken prescribed medication(s) or followed other medical treatment prescribed by a medical source for 3 consecutive months. \n                            Treatment or effects of treatment may be temporary. In most cases, sufficient time must elapse to allow us to evaluate your response to treatment, including any side effects. \n                            For our purposes, “sufficient time” means a period of at least 3 months. \n                            If your treatment has not lasted for at least 3 months, we will follow the rules in 108.00D6a . \n                            The 3 months adherence to prescribed medical treatment must be within the period of at least 12 months that we use to evaluate severity. c. Treatment with PUVA (psoralen and ultraviolet A (UVA) light) or biologics. If you receive additional treatment with PUVA or biologics to treat your skin disorder(s), we will defer adjudication of your claim for 6 months from the start of treatment with PUVA or biologics to evaluate the effectiveness of these treatments unless we can make a fully favorable determination or decision on another basis. 6. No record of ongoing treatment. a. Despite having a skin disorder, you may not have received ongoing treatment, may have just begun treatment, may not have access to prescribed medical treatment,\n                            or may not have an ongoing relationship with the medical community. In any of these situations, you will not have a longitudinal medical record for us to review when we evaluate your disorder.\n                            In some instances, we may be able to assess the severity and duration of your skin disorder based on your medical record and current evidence alone.\n                            We may ask you to attend a consultative examination to determine the severity and potential duration of your skin disorder\n                            (see § 416.919a of this chapter). b. If, for any reason, you have not received treatment, your skin disorder cannot meet the criteria for 108.09 . \n                            If the information in your case record is not sufficient to show that you have a skin disorder that meets the criteria of one of the skin disorders listings, \n                            we will follow the rules in 108.00I . E. How do we evaluate genetic photosensitivity disorders under 108.07 ? Genetic photosensitivity disorders are disorders of the skin caused by an increase in the sensitivity of the skin to sources of ultraviolet light, including sunlight. 1. Xeroderma pigmentosum (XP)( 108.07A ). XP is a genetic photosensitivity disorder with lifelong hypersensitivity to all forms of ultraviolet light. \n                            Laboratory testing confirms the diagnosis by documenting abnormalities in the body's ability to repair DNA (deoxyribonucleic acid) mutations after ultraviolet light exposure. \n                            Your skin disorder meets the requirements of 108.07A if you have clinical and laboratory findings supporting a diagnosis of XP \n                            (see 108.00E3 ). 2. Other genetic photosensitivity disorders ( 108.07B ). The effects of other genetic photosensitivity disorders may vary and may not persist over time. To meet the requirements of 108.07B , \n                            a genetic photosensitivity disorder other than XP must be established by clinical and laboratory findings \n                            (see 108.00C ) and must result either in chronic skin lesions ( 108.00B2 ) \n                            or contractures (see 108.00B3 ) that result in functional limitations ( 108.00D2 ), \n                            or must result in the inability to function outside of a highly protective environment (see 108.00E4 ). \n                            Some genetic photosensitivity disorders can have very serious effects on other body systems, especially special senses and speech, neurological, mental, and cancer. \n                            We will evaluate your disorder(s) under the listings in 102.00 , 111.00 , 112.00 , \n                            or 113.00 , as appropriate. 3. What evidence do we need to document that you have XP or another genetic photosensitivity disorder? We will make a reasonable effort to obtain evidence of your disorder(s), but we will not purchase genetic testing. When the results of genetic tests are part of the existing evidence in your case record, \n                            we will evaluate the test results with all other relevant evidence. We need the following clinical and laboratory findings to document that you have XP or another genetic photosensitivity disorder: a. A laboratory report of a definitive genetic test documenting appropriate chromosomal changes, including abnormal DNA repair or another DNA abnormality specific to your type of photosensitivity disorder, signed by an AMS; or b. A laboratory report of a definitive test that is not signed by an AMS, and a report from an AMS stating that you have undergone definitive genetic laboratory studies documenting appropriate chromosomal changes, including abnormal DNA repair or another DNA abnormality specific to your type of photosensitivity disorder; or c. If we do not have a laboratory report of a definitive test, we need documentation from an AMS that an appropriate laboratory analysis or other diagnostic method(s) confirms a positive diagnosis of your skin disorder. This documentation must state that you had the appropriate definitive laboratory test(s) for diagnosing your disorder and provide the results, or explain how another diagnostic method(s), consistent with the prevailing state of medical knowledge and clinical practice, established your diagnosis. 4. Inability to function outside of a highly protective environment means that you must avoid exposure to ultraviolet light (including sunlight passing through windows and light from similar unshielded light sources), wear protective clothing and eyeglasses, and use opaque broad-spectrum sunscreens in order to avoid skin cancer or other serious effects. F. How do we evaluate burns under 108.08 ? 1. Electrical, chemical, or thermal burns frequently affect other body systems; for example, musculoskeletal, special senses and speech, respiratory, cardiovascular, genitourinary, neurological, or mental. \n                            We evaluate burns in the same way we evaluate other disorders that can affect the skin and other body systems, using the listing for the predominant feature of your disorder. \n                            For example, if your soft tissue injuries resulting from burns are under surgical management (as defined in 108.00B6 ), \n                            we will evaluate your disorder under the listings in 101.00 . 2. We evaluate burns resulting in chronic skin lesions (see 108.00B2 ) \n                            or contractures (see 108.00B3 ) that have been documented by an AMS to have reached maximum therapeutic benefit \n                            and therefore are no longer receiving surgical management, under 108.08 . \n                            To be disabling, these burns must result in functional limitation(s) \n                            (see 108.00D2 ) that has lasted or can be expected to last for a continuous period of at least 12 months. G. How do we evaluate chronic conditions of the skin or mucous membranes under 108.09 ? We evaluate skin disorders that result in chronic skin lesions (see 108.00B2 ) \n                            or contractures (see 108.00B3 ) under 108.09 . \n                            These disorders must result in chronic skin lesions (see 108.00B2 ) \n                            or contractures (see 108.00B3 ) that continue to persist despite adherence to prescribed medical treatment for 3 months \n                            (see 108.00D5b ) and cause functional limitations (see 108.00D2 ). \n                            Examples of skin disorders evaluated under this listing are ichthyosis, bullous diseases (such as pemphigus, epidermolysis bullosa, and dermatitis herpetiformis), \n                            chronic skin infections, dermatitis, psoriasis, and hidradenitis suppurativa. H. How do we evaluate disorders in other body systems that affect the skin? When your disorder(s) in another body system affects your skin, we first evaluate the predominant feature of your disorder(s) under the appropriate body system. \n                            Examples of disorders in other body systems that affect the skin include the following: 1. Tuberous sclerosis. The predominant functionally limiting features of tuberous sclerosis are seizures and intellectual disorder or other mental disorders. \n                            We evaluate these features under the listings in 111.00 or 112.00 , as appropriate. 2. Malignant tumors of the skin. Malignant tumors of the skin (for example, malignant melanomas) are cancers, or malignant neoplastic diseases, \n                            that we evaluate under the listings in 113.00 . 3. Immune system disorders. We evaluate skin manifestations of immune system disorders such as systemic lupus erythematosus, scleroderma, psoriasis, \n                            and human immunodeficiency virus (HIV) infection under the listings in 114.00 . 4. Head or facial disfigurement or deformity, and other physical deformities caused by skin disorders. A head or facial disfigurement or deformity may result in loss of your sight, hearing, speech, or ability to chew. In addition to head and facial disfigurement and deformity, \n                            other physical deformities may result in associated psychological problems (for example, depression). \n                            We evaluate the effects of head or facial disfigurement or deformity, or other physical deformities caused by skin disorders under the listings in 101.00 , 102.00 , 105.00 , \n                            or 112.00 , as appropriate. 5. Porphyria. We evaluate erythropoietic protoporphyria under the listings in 107.00 . 6. Hemangiomas. We evaluate hemangiomas associated with thrombocytopenia and hemorrhage (for example, Kasabach-Merritt syndrome) \n                            involving coagulation defects under the listings in 107.00 . \n                            When hemangiomas impinge on vital structures or interfere with functioning, we evaluate their primary effects under the listings in the appropriate body system. I. How do we evaluate skin disorders that do not meet one of these listings? 1. These listings are only examples of common skin disorders that we consider severe enough to result in marked and severe limitations. If your impairment(s) does not meet the criteria of any of these listings, we must also consider whether you have an impairment(s) that satisfies the criteria of a listing in another body system. 2. If you have a severe medically determinable impairment(s) that does not meet a listing, we will determine whether your impairment(s) medically equals a listing.\n                            See § 416.926 of this chapter.\n                            If your impairment(s) does not meet or medically equal a listing, we will also consider whether your impairment(s) functionally equals the listings.\n                            See § 416.926a of this chapter.\n                            We use the rules in § 416.994a of this chapter when we decide whether you continue to be disabled. 108.01\n                                Category of Impairments, Skin Disorders 108.02 [Reserved] 108.03 [Reserved] 108.04 [Reserved] 108.05 [Reserved] 108.06 [Reserved] 108.07 Genetic photosensitivity disorders, established as described in 108.00E . The requirements of this listing are met if either paragraph A or paragraph B is satisfied. A. Xeroderma pigmentosum (see 108.00E1 ). OR B. Other genetic photosensitivity disorders (see 108.00E2 ) with either 1 or 2: 1. Chronic skin lesions (see 108.00B2 ) or contractures \n                            (see 108.00B3 ) that cause an inability to function outside of a highly protective environment \n                            (see 108.00E4 ); or 2. Chronic skin lesions (see 108.00B2 ) \n                            or contractures (see 108.00B3 ) causing chronic pain or other physical limitation(s) that result in impairment-related functional limitations \n                            (see 108.00D2 ), as evidenced by: a. Inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements \n                            (see 108.00B5 ) due to chronic skin lesions (see 108.00B2 ) \n                            or contractures (see 108.00B3 ); or b. Inability to use one upper extremity to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements \n                            (see 108.00B5 ) due to chronic skin lesions (see 108.00B2 ) \n                            or contractures (see 108.00B3 ), and a documented medical need \n                            (see 108.00B4 ) for an assistive device \n                            (see 108.00B1 ) that requires the use of the other upper extremity; or c. Inability to stand up from a seated position and maintain an upright position to the extent needed to independently initiate, sustain, \n                            and complete age-appropriate activities due to chronic skin lesions (see 108.00B2 ) \n                            or contractures (see 108.00B3 ) affecting at least two extremities \n                            (including when the limitations are due to involvement of the perineum or the inguinal region); or d. Inability to maintain an upright position while standing or walking to the extent needed to independently initiate, sustain, and complete age-appropriate activities due to chronic skin lesions \n                            (see 108.00B2 ) or contractures (see 108.00B3 ) \n                            affecting both lower extremities (including when the limitations are due to involvement of the perineum or the inguinal region). 108.08 Burns (see 108.00F ). \n                            Burns that do not require continuing surgical management (see 108.00B6 ), \n                            or that have been documented by an acceptable medical source to have reached maximum therapeutic benefit and are no longer receiving surgical management, \n                            resulting in chronic skin lesions (see 108.00B2 ) \n                            or contractures (see 108.00B3 ) causing chronic pain \n                            or other physical limitation(s) that result in impairment-related functional limitations (see 108.00D2 ), as evidenced by: A. Inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements \n                            (see 108.00B5 ) due to chronic skin lesions (see 108.00B2 ) \n                            or contractures (see 108.00B3 ). OR B. Inability to use one upper extremity to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements \n                            (see 108.00B5 ) due to chronic skin lesions (see 108.00B2 ) \n                            or contractures (see 108.00B3 ), and a documented medical need \n                            (see 108.00B4 ) for an assistive device (see 108.00B1 ) \n                            that requires the use of the other upper extremity. OR C. Inability to stand up from a seated position and maintain an upright position to the extent needed to independently initiate, sustain, \n                            and complete age-appropriate activities due to chronic skin lesions (see 108.00B2 ) \n                            or contractures (see 108.00B3 ) affecting at least two extremities \n                            (including when the limitations are due to involvement of the perineum or the inguinal region). OR D. Inability to maintain an upright position while standing or walking to the extent needed to independently initiate, sustain, \n                            and complete age-appropriate activities due to chronic skin lesions (see 108.00B2 ) \n                            or contractures (see 108.00B3 ) affecting both lower extremities \n                            (including when the limitations are due to involvement of the perineum or the inguinal region). 108.09 Chronic conditions of the skin or mucous membranes (see 108.00G ) resulting in: A. Chronic skin lesions (see 108.00B2 ) or contractures (see 108.00B3 ) \n                            causing chronic pain or other physical limitation(s) that persist despite adherence to prescribed medical treatment for 3 months \n                            (see 108.00D5b ). AND B. Impairment-related functional limitations (see 108.00D2 ) demonstrated by 1, 2, 3, or 4: 1. Inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements \n                            (see 108.00B5 ) due to chronic skin lesions (see 108.00B2 ) \n                            or contractures (see 108.00B3 ); or 2. Inability to use one upper extremity to independently initiate, sustain, and complete age-appropriate activities involving fine and gross movements \n                            (see 108.00B5 ) due to chronic skin lesions (see 108.00B2 ) \n                            or contractures (see 108.00B3 ), and a documented medical need \n                            (see 108.00B4 ) for an assistive device (see 108.00B1 ) that requires the use of the other upper extremity; or 3. Inability to stand up from a seated position and maintain an upright position to the extent needed to independently initiate, sustain, and complete age-appropriate activities due to chronic skin lesions \n                            (see 108.00B2 ) or contractures (see 108.00B3 ) affecting at least two extremities \n                            (including when the limitations are due to involvement of the perineum or the inguinal region); or 4. Inability to maintain an upright position while standing or walking to the extent needed to independently initiate, sustain, and complete age-appropriate activities due to chronic skin lesions \n                            (see 108.00B2 ) or contractures (see 108.00B3 ) affecting both lower extremities \n                            (including when the limitations are due to involvement of the perineum or the inguinal region). Back to Top",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security108.00 Skin Disorders - Childhood"
      }
    ],
    "tables": [],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_01",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_07",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_08",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_09",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_07",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_08",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_09",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B7",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00D2",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0913.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B1",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B7",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B7",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B7",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00D3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00D6",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0912.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0913.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0920b.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0929.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_07B",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_08",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_09",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0909.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_07A",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B5",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B5",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B4",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B1",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B7",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B7",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B7",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B7",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0929.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_09",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00D6a",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0919a.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_09",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00I",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_07",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_07A",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_07A",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00E3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_07B",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_07B",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00C",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_08",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B6",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_08",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_09",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_09",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00D5b",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00",
      "https://www.ssa.gov/disability/professionals/bluebook/105.00-Digestive-Childhood.htm#105_00",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00",
      "https://www.ssa.gov/disability/professionals/bluebook/107.00-HematologicalDisorders-Childhood.htm#107_00",
      "https://www.ssa.gov/disability/professionals/bluebook/107.00-HematologicalDisorders-Childhood.htm#107_00",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0994a.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00E",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00E1",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00E2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B5",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B5",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B4",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B1",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B6",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B5",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B5",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B4",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B1",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00G",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00D5b",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00D2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B5",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B5",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B4",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B1",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00B3",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm"
    ],
    "html_file": "ssa_bluebook_data/html/17f320916a8191600ce06d401bff66cc.html",
    "fetched_at": 1762482879.1806598
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#Top",
    "url_hash": "03ae2db3c518a260c6b94460857368f1",
    "title": "101.00 Musculoskeletal Disorders - Childhood | Disability | SSA",
    "text_content": "101.00 Musculoskeletal Disorders - Childhood | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Listing of Impairments - Child Listings (Part B) 101.00 Musculoskeletal Disorders - Childhood Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security 101.00 Musculoskeletal Disorders - Childhood Section 101.01 Category of Impairments, Musculoskeletal 101.15 Disorders of the skeletal spine resulting in compromise of a nerve root(s) 101.16 Lumbar spinal stenosis resulting in compromise of the cauda equina 101.17 Reconstructive surgery or surgical arthrodesis of a major weight-bearing joint 101.18 Abnormality of a major joint(s) in any extremity 101.19 Pathologic fractures due to any cause 101.20 Amputation due to any cause 101.21 Soft tissue injury or abnormality under continuing surgical management 101.22 Non-healing or complex fracture of the femur, tibia, pelvis, or one or more of the talocrural bones 101.23 Non-healing or complex fracture of an upper extremity 101.24 Musculoskeletal disorders of infants and toddlers, from birth to attainment of age 3, with developmental motor delay 101.00 Musculoskeletal Disorders A. Which musculoskeletal disorders do we evaluate under these listings? 1. We evaluate disorders of the skeletal spine (vertebral column) or of the upper or lower extremities that affect musculoskeletal \n                            functioning under these listings. We use the term “skeletal” when we are referring to the structure of the bony skeleton. \n                            The skeletal spine refers to the bony structures, ligaments, and discs making up the spine. \n                            We refer to the skeletal spine in some musculoskeletal listings to differentiate it from the neurological spine (see 101.00B1 ).\n                            Musculoskeletal disorders may be congenital or acquired, and may include deformities, amputations, or other abnormalities.\n                            These disorders may involve the bones or major joints; or the tendons, ligaments, muscles, or other soft tissues. 2. We evaluate soft tissue injuries (including burns) or abnormalities that are under continuing surgical management \n                            (see 101.00P1 ). \n                            The injuries or abnormalities may affect any part of the body, including the face and skull. 3. We evaluate curvatures of the skeletal spine that affect musculoskeletal functioning under 101.15 .\n                            If a curvature of the skeletal spine is under continuing surgical management (see 101.00P1 ),\n                            we will evaluate it under 101.21 using our rules for determining medical equivalence.\n                            See § 416.926 of this chapter. B. Which related disorders do we evaluate under other listings? 1. We evaluate a disorder or injury of the skeletal spine that results in damage to, and neurological dysfunction of, \n                            the spinal cord and its associated nerves (for example, paraplegia or quadriplegia) under the listings in 111.00 . 2. We evaluate inflammatory arthritis (for example, rheumatoid arthritis) under the listings in 114.00 . 3. We evaluate curvatures of the skeletal spine that interfere with your ability to breathe under the listings in 103.00 , impair myocardial function under the listings in 104.00 , or result in social withdrawal or depression under the listings in 112.00 . 4. We evaluate non-healing or pathological fractures due to cancer, whether it is a primary site or metastases, under the listings in 113.00 . 5. We evaluate the leg pain associated with peripheral vascular claudication under the listings in 104.00 . 6. We evaluate burns that do not require continuing surgical management under the listings in 108.00 . Back to Top C. What evidence do we need to evaluate your musculoskeletal disorder? 1. General. We need objective medical evidence from an acceptable medical source to establish that you have a\n                            medically determinable musculoskeletal disorder.\n                            We also need evidence from both medical and nonmedical sources,\n                            who can describe how you function, to assess the severity and duration of your musculoskeletal disorder.\n                            We will determine the extent and kinds of evidence we need from medical and nonmedical sources based on the individual facts about your disorder.\n                            For our basic rules on evidence, see §§ 416.912 , 416.913 , and 416.920b of this chapter.\n                            For our rules on evidence about your symptoms,\n                            see § 416.929 of this chapter. 2. Physical examination report(s). In the report(s) of your physical examination, \n                            we require a medical source's detailed description of the orthopedic, neurologic, \n                            or other objective clinical findings appropriate to your specific musculoskeletal disorder from his or her direct observations during your physical examination. \n                            We will not accept a report of your statements about your symptoms and limitations in place of the medical source’s report of objective clinical findings. \n                            We will not use findings on imaging or other diagnostic tests (see 101.00C3 ) as a substitute for findings on physical examination. a. When the medical source reports that a clinical test sign(s) is positive, unless we have evidence to the contrary, we will assume that he or she performed the test properly and accept the medical source’s interpretation of the test. For example, we will assume a straight-leg raising test was conducted properly (that is, in sitting and supine positions), even if the medical source does not specify the positions in which the test was performed. b. If you use an assistive device (see 101.00C6 ), \n                            the report must support the medical need for the device. c. If your musculoskeletal disorder causes a reduction in muscle strength, the report must document measurement of the strength of the muscle(s) in question. The measurement should be based on a muscle strength grading system that is considered medically acceptable based on your age and impairments. For example, a grading system of 0 to 5, with 0 indicating complete loss of strength and 5 indicating maximum strength or equivalent medically acceptable scale (see Table 1). Reduction in muscle strength is demonstrated by evidence that your muscle strength is less than active range of motion (ROM) against gravity with maximum resistance. If the reduction in muscle strength involves one or both of your hands, the report must also document measurements of grip and pinch strength. Table 1 - Grading System of Muscle Function Grade Function of the Muscle 0 None No visible or palpable contraction. 1 Trace Visible or palpable contraction with no motion. 2 Poor Active ROM with gravity eliminated. 3 Fair Active ROM against gravity only, without resistance. 4 Good Active ROM against gravity, moderate resistance. 5 Normal Active ROM against gravity, maximum resistance. 3. Imaging and other diagnostic tests. a. Imaging refers to medical imaging techniques, such as x-ray, computed tomography (CT), magnetic resonance imaging (MRI), and radionuclide scanning. For the purpose of these listings, the imaging must be consistent with the prevailing state of medical knowledge and clinical practice as the proper technique to support the evaluation of the disorder. b. Findings on imaging must have lasted, or be expected to last, for a continuous period of at least 12 months. c. Imaging and other diagnostic tests can provide evidence of physical abnormalities; however, these abnormalities may correlate poorly with your symptoms, including pain, or with your musculoskeletal functioning. Accordingly, we will not use findings on imaging or other diagnostic tests as a substitute for findings on physical examination about your ability to function, nor can we infer severity or functional limitations based solely on such tests. d. For our rules on purchasing imaging and other diagnostic tests,\n                            see §§ 416.919k and 416.919m of this chapter. 4. Operative reports. If you have had a surgical procedure, we need a copy of the operative report, including details of the findings at surgery and information about any medical complications that may have occurred. If we do not have the operative report, we need confirmatory evidence of the surgical procedure from a medical source (for example, detailed follow-up reports or notations in the medical records concerning the surgical procedure in your medical history). 5. Effects of treatment. a. General. Treatments for musculoskeletal disorders may have beneficial or adverse effects, and responses to treatment vary from person to person. We will evaluate all of the effects of treatment (including surgical treatment, medications, and therapy) on the symptoms, signs, and laboratory findings of your musculoskeletal disorder, and on your musculoskeletal functioning. b. Response to treatment. To evaluate your musculoskeletal functioning in response to treatment, we need the following: A description, including the frequency of the administration, of your medications; the type and frequency of therapy you receive; and a description of your response to treatment and any complications you experience related to your musculoskeletal disorder. The effects of treatment may be temporary or long-term. We need information over a sufficient period to determine the effects of treatment on your current musculoskeletal functioning and permit reasonable projections about your future functioning. We will determine the amount of time that constitutes a sufficient period in consultation with a medical consultant on a case by case basis. In some cases, we will need additional evidence to make an assessment about your response to treatment. Your musculoskeletal disorder may meet or medically equal one of these listings regardless of whether you were prescribed opioid medication, or whether you were prescribed opioid medication and did not follow this prescribed treatment. 6. Assistive devices. a. General. An assistive device, for the purposes of these listings, is any device that you use to improve your stability, dexterity,\n                            or mobility. An assistive device can be worn (see 101.00C6b and 101.00C6c ),\n                            hand-held (see 101.00C6d ),\n                            or used in a seated position (see 101.00C6e ).\n                            When we use the phrase “documented medical need,” we mean that there is evidence from a medical source that supports your medical need for an assistive device\n                            (see 101.00C2b ) for a continuous period of at least 12 months\n                            (see 101.00c2a ). This evidence must describe any limitation(s) in your upper or lower extremity functioning and the circumstances for which you need to use the assistive device.\n                            We do not require that you have a specific prescription for the assistive device. b. Prosthesis(es). A prosthesis is a wearable device, such as an artificial limb, that takes the place of an absent body part.\n                            If you have a prosthesis(es), we need evidence from a medical source documenting your ability to walk,\n                            or perform fine and gross movements (see 101.00E4 ),\n                            with the prosthesis(es) in place. When amputation(s) involves one or both lower extremities,\n                            it is not necessary for the medical source to evaluate your ability to walk without the prosthesis(es) in place.\n                            If you cannot use your prosthesis(es) due to complications affecting your residual limb(s),\n                            we need evidence from a medical source documenting the condition of your residual limb(s) and the medical basis for your inability to use the device(s). c. Orthosis(es). An orthosis is a wearable device, such as a brace,\n                            that prevents or corrects a dysfunction or deformity by aligning or supporting the affected body part.\n                            If you have an orthosis(es), we need evidence from a medical source documenting your ability to walk,\n                            or perform fine and gross movements (see 101.00E4 ),\n                            with the orthosis(es) in place. If you cannot use your orthosis(es),\n                            we need evidence from a medical source documenting the medical basis for your inability to use the device(s). d. Hand-held assistive devices. Hand-held assistive devices include walkers, canes, or crutches,\n                            which you hold onto with your hand(s) to support or aid you in walking. When you use a one-handed, hand-held assistive device\n                            (such as a cane) with one upper extremity to walk and you cannot use your other upper extremity for fine or gross movements\n                            (see 101.00E4 ), the need for the assistive device limits the use of both upper extremities. If you use a hand-held assistive device,\n                            we need evidence from a medical source describing how you walk with the device. e. Wheeled and seated mobility devices. Wheeled and seated mobility devices are assistive devices that you use in a seated position,\n                            such as manual wheelchairs, motorized wheelchairs, rollators, and power operated vehicles.\n                            If you use a wheeled and seated mobility device,\n                            we need evidence from a medical source describing the type of wheeled and seated mobility device that you use and how you use the assistive device,\n                            including any customizations or modifications to the assistive device itself or for your use of the assistive device.\n                            For example, if you use a wheelchair that typically requires the use of both hands but has been customized for your use with one hand,\n                            then we will evaluate your use of the assistive device using the criteria in 101.00E3b and not 101.00E3a . (i) Wheeled and seated mobility devices involving the use of both hands. Some wheeled and seated mobility devices involve the use of both hands to use the assistive device (for example, most manual wheelchairs). \n                            If you use a wheeled and seated mobility device that involves the use of both hands, then the need for the assistive device limits the use of both upper extremities. (ii) Wheeled and seated devices involving the use of one hand. Some wheeled and seated mobility devices involve the use of one hand to use the assistive device (for example, most motorized wheelchairs).\n                            If you use a wheeled and seated mobility device that involves the use of one upper extremity and you cannot use your other upper extremity for fine or gross movements\n                            (see 101.00E4 ), then the need for the assistive device limits the use of both upper extremities. 7. Longitudinal evidence. a. The term pandemic period as used in 101.00C7c means the period beginning on April 2, 2021, and ending on May 11, 2025. The term post-pandemic evaluation period as used in 101.00C7c means the period beginning on May 12, 2025, and ending on May 11, 2029. b. We generally need a longitudinal medical record to assess the severity and duration of your musculoskeletal disorder because the severity of symptoms, signs, and laboratory findings related to most musculoskeletal disorders may improve over time or respond to treatment. Evidence over an extended period will show whether your musculoskeletal functioning is improving, worsening, or unchanging. c. For 101.15 , 101.16 , 101.17 , 101.18 , 101.20C , 101.20D , 101.22 ,\n                            and 101.23 ,\n                            all of the required criteria must be present simultaneously, or within a close proximity of time, to satisfy the level of severity needed to meet the listing. The phrase \"within a close proximity of time\" means that all of the relevant criteria must appear in the medical record within a consecutive 4-month period, except for claims determined or decided during the pandemic period or post-pandemic evaluation period. For claims determined or decided during the pandemic period or post-pandemic evaluation period, all of the relevant criteria must appear in the medical record within a consecutive 12-month period. When the criterion is imaging, we mean that we could reasonably expect the findings on imaging to have been present at the date of impairment or date of onset. For listings that use the word \"and\" to link the elements of the required criteria, the medical record must establish the simultaneous presence, or presence within a close proximity of time, of all the required medical criteria. Once this level of severity is established, the medical record must also show that this level of severity has continued, or is expected to continue, for a continuous period of at least 12 months. 8. Surgical treatment or physical therapy. For some musculoskeletal disorders, a medical source may recommend surgery,\n                            or physical therapy (PT). If you have not yet had the recommended surgery or PT,\n                            we will not assume that these interventions will resolve your disorder or improve your functioning. We will assess each case on an individual basis.\n                            Depending on your response to treatment, or your medical sources’ treatment plans, we may defer our findings regarding the effect of surgery or PT,\n                            until a sufficient period has passed to permit proper consideration or judgment about your future functioning. When necessary,\n                            we will follow the rules on following prescribed treatment in § 416.930 of this chapter,\n                                including consideration of your reasons for failure to follow prescribed treatment. D. How do we consider symptoms, including pain, under these listings? 1. Musculoskeletal disorders may cause pain or other symptoms;\n                            however, your statements about your pain or other symptoms will not alone establish that you are disabled.\n                            We will not substitute an alleged or a reported increase in the intensity of a symptom, such as pain, no matter how severe,\n                            for a medical sign or diagnostic finding present in the listing criteria.\n                            Pain is included as just one consideration in 101.15A , 101.16A ,\n                            and 101.18A , but it is not required to satisfy the criteria\n                            in 101.15 , 101.16 ,\n                            and 101.18 . 2. To consider your symptom(s),\n                            we require objective medical evidence from an acceptable medical source showing the existence of a medically determinable musculoskeletal impairment that\n                            we could reasonably expect to produce the symptom(s).\n                            See § 416.929 of this chapter for how we evaluate symptoms, including pain, related to your musculoskeletal disorder. E. How do we use the functional criteria to evaluate your musculoskeletal disorder under these listings? 1. General. The functional criteria for children age 3 and older are based on\n                            impairment-related physical limitations in your ability to use both upper extremities, one or both lower extremities,\n                            or a combination of one upper and one lower extremity.\n                            We will use the relevant evidence that we have to compare your musculoskeletal functioning to the functioning of children your age who do not have impairments.\n                            The required impairment-related physical limitation of musculoskeletal functioning must have lasted, or be expected to last,\n                            for a continuous period of at least 12 months.\n                            We do not use the functional criteria in 101.20A , 101.20B , 101.21 ,\n                            or 101.24 . 2. Medical and functional criteria, birth to attainment of age 3. The medical and functional criteria for children in this age group are in 101.24 . 3. Functional criteria, age 3 to attainment of age 18. The functional criteria are based on impairment-related physical limitations in your ability to use both upper extremities, one or both lower extremities, or a combination of one upper and one lower extremity. A musculoskeletal disorder satisfies the functional criteria of a listing when the medical documentation shows the presence of at least one of the impairment-related limitations cited in the listing. The functional criteria require impairment-related physical limitation of musculoskeletal functioning that has lasted, or can be expected to last, for a continuous period of at least 12 months, medically documented by one of the following: a. A documented medical need (see 101.00C6a ) for a walker,\n                            bilateral canes, or bilateral crutches (see 101.00C6d )\n                            or a wheeled and seated mobility device involving the use of both hands (see 101.00C6e(i) ); b. An inability to use one upper extremity to independently initiate, sustain,\n                            and complete age-appropriate activities involving fine and gross movements (see 101.00E4 ),\n                            and a documented medical need (see 101.00C6a ) for a one-handed,\n                            hand-held assistive device (see 101.00C6d )\n                            that requires the use of your other upper extremity or a wheeled and seated mobility device involving the use of one hand\n                            (see 101.00C6e(ii) ); c. An inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain,\n                            and complete age-appropriate activities involving fine and gross movements (see 101.00E4 ). 4. Fine and gross movements. Fine movements,\n                            for the purposes of these listings, involve use of your wrists, hands, and fingers; such movements include picking, pinching, manipulating, and fingering. Gross movements involve use of your shoulders, upper arms, forearms, and hands; \n                            such movements include handling, gripping, grasping, holding, turning, and reaching. \n                            Gross movements also include exertional abilities such as lifting, carrying, pushing, and pulling. F. What do we consider when we evaluate disorders of the skeletal spine resulting in compromise of a nerve root(s)\n                                ( 101.15 )? 1. General. We consider musculoskeletal disorders such as skeletal dysplasias, caudal regression syndrome, tethered spinal cord syndrome,\n                            vertebral slippage (spondylolisthesis), scoliosis, and vertebral fracture or dislocation.\n                            Spinal disorders may cause cervical or lumbar spine dysfunction when abnormalities of the skeletal spine compromise nerve roots of the cervical spine,\n                            a nerve root of the lumbar spine, or a nerve root of both cervical and lumbar spines. We consider spinal nerve disorders that originate in the nervous system\n                            (for example, spinal arachnoiditis), under the neurological disorders body system, 111.00 . 2. Compromise of a nerve root(s). Compromise of a nerve root, sometimes referred to as “nerve root impingement,” is a phrase used when a physical object, such as a tumor, herniated disc, foreign body, or arthritic spur, is pushing on the nerve root as seen on imaging or during surgery. It can occur when a musculoskeletal disorder produces irritation, inflammation, or compression of the nerve root(s) as it exits the skeletal spine between the vertebrae. Related symptoms must be associated with, or follow the path of, the affected nerve root(s). a. Compromise of unilateral nerve root of the cervical spine. Compromise of a nerve root as it exits the cervical spine between the vertebrae may affect the functioning of the associated upper extremity. The physical examination reproduces the related symptoms based on radicular signs and clinical tests appropriate to the specific cervical nerve root (for example, a positive Spurling test). b. Compromise of bilateral nerve roots of the cervical spine. Although uncommon, if compromise of a nerve root occurs on both sides of the cervical spinal column, functioning of both upper extremities may be limited. c. Compromise of a nerve root(s) of the lumbar spine. Compromise of a nerve root as it exits the lumbar spine between the vertebrae may limit the functioning of the associated lower extremity. The physical examination reproduces the related symptoms based on radicular signs and clinical tests. When a nerve root of the lumbar spine is compromised, we require a positive straight-leg raising test (also known as a Lasègue test) in both supine and sitting positions appropriate to the specific lumbar nerve root that is compromised. G. What do we consider when we evaluate lumbar spinal stenosis resulting in compromise of the cauda equina\n                                ( 101.16 )? 1. General. We consider how pain, sensory changes, and muscle weakness caused by compromise of the cauda equina due to lumbar spinal stenosis affect your functioning. The cauda equina is a bundle of nerve roots that descends from the lower part of the spinal cord. Lumbar spinal stenosis can compress the nerves of the cauda equina, causing sensory changes and muscle weakness that may affect your ability to stand or walk. Pain related to compromise of the cauda equina is nonradicular because it is not typically associated with a specific nerve root (as is radicular pain in the cervical or lumbar spine). 2. Compromise of the cauda equina due to lumbar spinal stenosis can affect your ability to walk or stand because of neurogenic claudication (also known as pseudoclaudication), a condition usually causing nonradicular pain that starts in the low back and radiates bilaterally (or less commonly, unilaterally) into the buttocks and lower extremities (or extremity). Extension of the lumbar spine, which occurs when you walk or stand, may provoke the pain of neurogenic claudication. The pain may be relieved by forward flexion of the lumbar spine or by sitting. In contrast, the leg pain associated with peripheral vascular claudication results from inadequate arterial blood flow to a lower extremity. It occurs repeatedly and consistently when a person walks a certain distance and is relieved when the person rests. H. What do we consider when we evaluate reconstructive surgery or surgical arthrodesis of a major weight-bearing joint\n                                ( 101.17 )? 1. General. We consider reconstructive surgery or surgical arthrodesis when an acceptable medical source(s) documents the surgical procedure(s) and associated medical treatments to restore function of, or eliminate motion in, the affected major weight-bearing joint(s). Reconstructive surgery may be done in a single procedure or a series of procedures directed toward the salvage or restoration of functional use of the affected joint. 2. Major weight-bearing joints are the hip, knee, and ankle-foot. The ankle and foot are considered together as one major joint. 3. Surgical arthrodesis is the artificial fusion of the bones that form a joint, essentially eliminating the joint. I. What do we consider when we evaluate abnormality of a major joint(s) in any extremity\n                                ( 101.18 )? 1. General. We consider musculoskeletal disorders that produce anatomical abnormalities of major joints of the extremities, which result in functional abnormalities in the upper or lower extremities (for example, chronic infections of bones and joints, and surgical arthrodesis of a joint). Abnormalities of the joints include ligamentous laxity or rupture, soft tissue contracture, or tendon rupture, and can cause muscle weakness of the affected joint(s). a. An anatomical abnormality is one that is readily observable by a medical source during a physical examination (for example, subluxation or contracture), or is present on imaging (for example, joint space narrowing, bony destruction, ankylosis, or deformity). b. A functional abnormality is abnormal motion or instability of the affected joint(s), including limitation of motion, excessive motion (hypermobility), movement outside the normal plane of motion for the joint (for example, lateral deviation), or fixation of the affected joint(s). 2. Major joint of an upper extremity refers to the shoulder, elbow, and wrist-hand. We consider the wrist and hand together as one major joint. 3. Major joint of a lower extremity refers to the hip, knee, and ankle-foot. We consider the ankle and hindfoot together as one major joint. Back to Top J. What do we consider when we evaluate pathologic fractures due to any cause\n                                ( 101.19 )? We consider pathologic fractures of the bones in the skeletal spine, extremities, or other parts of the skeletal system.\n                            Pathologic fractures result from disorders that weaken the bones, making them vulnerable to breakage.\n                            Pathologic fractures may occur with osteoporosis, osteogenesis imperfecta or any other skeletal dysplasias,\n                            side effects of medications, and disorders of the endocrine or other body systems.\n                            Under 101.19 , the fractures must have occurred on separate, distinct occasions,\n                            rather than multiple fractures occurring at the same time, but the fractures may affect the same bone(s) multiple times.\n                            There is no required time that must elapse between the fractures, but all three must occur within a 12-month period;\n                            for example, separate incidents may occur within hours or days of each other.\n                            We evaluate non-healing or complex traumatic fractures without accompanying pathology under 101.22 or 101.23 . K. What do we consider when we evaluate amputation due to any cause\n                                ( 101.20 )? 1. General. We consider amputation (the full or partial loss or absence of any extremity) due to any cause including trauma, congenital abnormality or absence, surgery for treatment of conditions such as cancer or infection, or complications of peripheral vascular disease or diabetes mellitus. 2. Amputation of both upper extremities\n                                ( 101.20A ). Under 101.20A ,\n                            we consider upper extremity amputations that occur at any level at or above the wrists (carpal joints),\n                            up to and including disarticulation of the shoulder (glenohumeral) joint.\n                            If you have had both upper extremities amputated at any level at or above the wrists up to and including the shoulder,\n                            your impairment satisfies the duration requirement in § 416.909 of this chapter.\n                            For amputations below the wrist, we will follow the rules described in 101.00R .\n                            We do not evaluate amputations below the wrists under 101.20A because the resulting limitation of function of the thumb(s),\n                            finger(s), or hand(s) will vary, depending on the extent of loss and corresponding effect on fine and gross movements. 3. Hemipelvectomy or hip disarticulation ( 101.20B ). Under 101.20B , we consider hemipelvectomy,\n                            which involves amputation of an entire lower extremity through the sacroiliac joint, and hip disarticulation,\n                            which involves amputation of an entire lower extremity through the hip joint capsule and closure of the remaining musculature over the exposed acetabular bone.\n                            If you have had a hemipelvectomy or hip disarticulation,\n                            your impairment satisfies the duration requirement in § 416.909 of this chapter. 4. Amputation of one upper extremity and one lower extremity ( 101.20C ). Under 101.20C ,\n                            we consider the amputation of one upper extremity at any level at or above the wrist and one lower extremity at or above the ankle.\n                            If you have a documented medical need for a one-handed, hand-held assistive device (such as a cane) or a wheeled and seated mobility device involving the use of one hand\n                            (such as a motorized wheelchair), then you must use your remaining upper extremity to hold the device,\n                            making the extremity unavailable to perform other fine and gross movements (see 101.00E4 ). 5. Amputation of one lower extremity or both lower extremities with complications of the residual limb(s)\n                                ( 101.20D ). Under 101.20D ,\n                            we consider the amputation of one lower extremity or both lower extremities at or above the ankle.\n                            We also consider the condition of your residual limb(s), whether you can wear a prosthesis(es)\n                            (see 101.00C6b ), and whether you have a documented medical need\n                            (see 101.00C6a ) for a hand-held assistive device(s)\n                            (see 101.00C6d ) or a wheeled and seated mobility device\n                            (see 101.00C6e ). If you have a non-healing residual limb(s) and are receiving ongoing surgical treatment expected to re-establish or improve function,\n                            and that ongoing surgical treatment has not ended, or is not expected to end,\n                            within at least 12 months of the initiation of the surgical management (see 101.00L ),\n                            we evaluate your musculoskeletal disorder under 101.21 . L. What do we consider when we evaluate soft tissue injury or abnormality under continuing surgical management\n                                ( 101.21 )? 1. General. a. We consider any soft tissue injury or abnormality involving the soft tissues of the body, whether congenital or acquired, \n                            when an acceptable medical source(s) documents the need for ongoing surgical procedures and associated medical treatments to restore function of the affected body part(s) \n                            (see 101.00P1 ). \n                            Surgical management includes the surgery(ies) itself, as well as various post-surgical procedures, surgical complications, \n                            infections or other medical complications, related illnesses, or related treatments that delay your attainment of maximum benefit from therapy \n                            (see 101.00P2 ). b. Surgical procedures and associated treatments typically take place over extended periods, which may render you unable to perform age-appropriate activity on a sustained basis. To document such inability, we must have evidence from an acceptable medical source(s) confirming that the surgical management has continued, or is expected to continue, for at least 12 months from the date of the first surgical intervention. These procedures and treatments must be directed toward saving, reconstructing, or replacing the affected part of the body to re-establish or improve its function, and not for cosmetic appearances alone. c. Examples include malformations, third- and fourth-degree burns, crush injuries, craniofacial injuries, avulsive injuries, and amputations with complications of the residual limb(s). d. We evaluate skeletal spine abnormalities or injuries\n                            under 101.15 or 101.16 , as appropriate.\n                            We evaluate abnormalities or injuries of bones in the lower extremities\n                            under 101.17 , 101.18 , or 101.22 .\n                            We evaluate abnormalities or injuries of bones in the upper extremities\n                            under 101.18 or 101.23 . 2. Documentation. In addition to the objective medical evidence we need to establish your soft tissue injury or abnormality, we also need all of the following medically documented evidence about your continuing surgical management: a. Operative reports and related laboratory findings; b. Records of post-surgical procedures; c. Records of any surgical or medical complications (for example, related infections or systemic illnesses); d. Records of any prolonged post-operative recovery periods and related treatments (for example, surgeries and treatments for burns); e. An acceptable medical source’s plans for additional surgeries; and f. Records detailing any other factors that have delayed, or that an acceptable medical source expects to delay, the saving, restoring, or replacing of the involved part for a continuous period of at least 12 months following the initiation of the surgical management. 3. Burns. Third- and fourth-degree burns damage or destroy nerve tissue,\n                            reducing or preventing transmission of signals through those nerves.\n                            Such burns frequently require multiple surgical procedures and related therapies to re-establish or improve function,\n                            which we evaluate under 101.21 .\n                            When burns are no longer under continuing surgical management (see 101.00P1 ), we evaluate the residual impairment(s).\n                            When the residual impairment(s) affects the musculoskeletal system, as often occurs in third- and fourth-degree burns,\n                            it can result in permanent musculoskeletal tissue loss, joint contractures, or loss of extremities.\n                            We will evaluate such impairments under the relevant musculoskeletal disorders listing,\n                            for example, 101.18 or 101.20 .\n                            When the residual impairment(s) involves another body system, we will evaluate the impairment(s) under the listings in the relevant body system(s). 4. Craniofacial injuries or congenital abnormalities. Surgeons may treat craniofacial injuries or congenital abnormalities with multiple surgical procedures. These injuries or abnormalities may affect vision, hearing, speech, and the initiation of the digestive process, including mastication. When the craniofacial injury-related or congenital abnormality-related residual impairment(s) involves another body system(s), we will evaluate the impairment(s) under the listings in the relevant body system(s). M. What do we consider when we evaluate non-healing or complex fractures of the femur, tibia, pelvis,\n                                or one or more of the talocrural bones ( 101.22 )? 1. Non-healing fracture. A non-healing (nonunion) fracture is a fracture that has failed to unite completely. Nonunion is usually established when a minimum of 9 months has elapsed since the injury and the fracture site has shown no, or minimal, progressive signs of healing for a minimum of 3 months. 2. Complex fracture. A complex fracture is a fracture with one or more of the following: a. Comminuted (broken into many pieces) bone fragments; b. Multiple fractures in a single bone; c. Bone loss due to severe trauma; d. Damage to the surrounding soft tissue; e. Severe cartilage damage to the associated joint; or f. Dislocation of the associated joint. 3. When a complex fracture involves soft tissue damage, \n                            the treatment may involve continuing surgical management to restore or improve functioning. \n                            In such cases, we may evaluate the fracture(s) under 101.21 . N. What do we consider when we evaluate non-healing or complex fractures of an upper extremity\n                                ( 101.23 )? 1. Non-healing fracture. A non-healing (nonunion) fracture is a fracture that has failed to unite completely. Nonunion is usually established when a minimum of 9 months has elapsed since the injury and the fracture site has shown no, or minimal, progressive signs of healing for a minimum of 3 months. 2. Complex fracture. A complex fracture is a fracture with one or more of the following: a. Comminuted (broken into many pieces) bone fragments; b. Multiple fractures in a single bone; c. Bone loss due to severe trauma; d. Damage to the surrounding soft tissue; e. Severe cartilage damage to the associated joint; or f. Dislocation of the associated joint. 3. When a complex fracture involves soft tissue damage, \n                            the treatment may involve continuing surgical management to restore or improve functioning. \n                            In such cases, we may evaluate the fracture(s) under 101.21 . O. What do we consider when we evaluate musculoskeletal disorders of infants and toddlers from birth to attainment of\n                                age 3 with developmental motor delay ( 101.24 )? 1. General. Under 101.24 ,\n                            we require reports from an acceptable medical source(s) to establish a delay in your motor development as a medically determinable impairment.\n                            Examples of disorders we evaluate under this listing include arthrogryposis, clubfoot, osteogenesis imperfecta, caudal regression syndrome,\n                            fracture complications, disorders affecting the hip and pelvis, and complications associated with your musculoskeletal disorder or its treatment.\n                            Some medical records may simply document your condition as “developmental motor delay.” 2. Severity of developmental motor delay. To evaluate the severity of your developmental motor delay, we need developmental test reports from an acceptable medical source, or from early intervention specialists, physical and occupational therapists, and other sources. a. If there is a standardized developmental assessment in your medical record,\n                            we will use the results to evaluate your developmental motor delay under 101.24A .\n                            Such an assessment compares your level of development to the level typically expected for children of your chronological age.\n                            If you were born prematurely, we use your corrected chronological age for comparison.\n                            See § 416.924b(b) of this chapter. b. If there is no standardized developmental assessment in your medical record, \n                            we will use narrative developmental reports from a medical source(s) to evaluate your developmental motor delay under 101.24B . \n                            These reports must provide detailed information sufficient for us to assess the severity of your motor delay. \n                            If we cannot obtain sufficient detail from narrative reports, we may purchase standardized developmental assessments. (i) A narrative developmental report is based on clinical observations, progress notes, and well-baby check-ups, and must include your developmental history, examination findings (with abnormal findings noted on repeated examinations), and an overall assessment of your development (that is, more than one or two isolated skills) by the medical source. (ii) Some narrative developmental reports may include results from developmental screening tests, which can show that you are not developing or achieving skills within expected timeframes. Although medical sources may refer to screening test results as supporting evidence in the narrative developmental report, screening test results alone cannot establish a medically determinable impairment or the severity of developmental motor delay. P. How will we determine whether your soft tissue injury or abnormality or your upper extremity fracture is no longer under continuing surgical management\n                                or you have received maximum benefit from therapy? 1. We will determine that your soft tissue injury or abnormality, or your upper extremity fracture, \n                            is no longer under continuing surgical management , \n                            as used in 101.21 and 101.23 , \n                            when the last surgical procedure or medical treatment directed toward the re-establishment or improvement of function of the involved part has occurred. 2. We will determine that you have received maximum benefit from therapy , \n                            as used in 101.21 , if there are no significant changes in physical findings \n                            or on appropriate imaging for any 6-month period after the last surgical procedure or medical treatment. \n                            We may also determine that you have received maximum benefit from therapy if your medical source(s) indicates \n                            that further improvement is not expected after the last surgical procedure or medical treatment. 3. When you have received maximum benefit from therapy, we will evaluate any impairment-related residual symptoms, signs, \n                            and laboratory findings (including those on imaging), any complications associated with your surgical procedures or medical treatments, \n                            and any residual limitations in your functioning (see 101.00R ). Q. How do we evaluate your musculoskeletal disorder if there is no record of ongoing treatment? 1. Despite having a musculoskeletal disorder, you may not have received ongoing treatment, may have just begun treatment,\n                            may not have access to prescribed medical treatment, or may not have an ongoing relationship with the medical community.\n                            In any of these situations, you will not have a longitudinal medical record for us to review when we evaluate your disorder\n                            and we may ask you to attend a consultative examination to determine the severity and potential duration of your disorder.\n                            See § 416.919a(b) of this chapter. 2. In some instances, we may be able to assess the severity \n                            and duration of your musculoskeletal disorder based on your medical record and current evidence alone. \n                            If the information in your case record is not sufficient to show that you have a musculoskeletal disorder \n                            that meets the criteria of one of the musculoskeletal disorders listings, \n                            we will follow the rules described in 101.00R . R. How do we evaluate musculoskeletal disorders that do not meet one of these listings? 1. These listings are only examples of musculoskeletal disorders that we consider severe enough to result in marked and severe functional limitations. If your impairment(s) does not meet the criteria of any of these listings, we must also consider whether you have an impairment(s) that meets the criteria of a listing in another body system. 2. If you have a severe medically determinable impairment(s) that does not meet a listing,\n                            we will determine whether your impairment(s) medically equals a listing.\n                            See § 416.926 of this chapter.\n                            If your impairment(s) does not meet or medically equal a listing, we will determine whether it functionally equals the listings.\n                            See § 416.926a of this chapter. 3. We use the rules in § 416.994a of this chapter when we decide whether you continue to be disabled. 101.01\n                                Category of Impairments, Musculoskeletal 101.15 Disorders of the skeletal spine resulting in compromise of a nerve root(s) (see 101.00F ), documented by A, B, C, and D: A. Neuro-anatomic (radicular) distribution of one or more of the \n                            following symptoms consistent with compromise of the affected nerve root(s): 1. Pain; or 2. Paresthesia; or 3. Muscle fatigue. AND B. Radicular distribution of neurological signs present during physical examination\n                            (see 101.00C2 ) or on a diagnostic test\n                            (see 101.00C3 ) and evidenced by 1, 2, and either 3 or 4: 1. Muscle weakness; and 2. Sign(s) of nerve root irritation, tension, or compression, consistent with compromise of the affected nerve root \n                            (see 101.00F2 ) 3. Sensory changes evidenced by: a. Decreased sensation; or b. Sensory nerve deficit (abnormal sensory nerve latency) on electrodiagnostic testing; or 4. Decreased deep tendon reflexes. AND C. Findings on imaging\n                            (see 101.00C3 ) consistent with compromise of a nerve root(s) in the cervical or lumbosacral spine. AND D. Impairment-related physical limitation of musculoskeletal functioning that has lasted, \n                            or is expected to last, for a continuous period of at least 12 months, \n                            and medical documentation of at least one of the following: 1. A documented medical need\n                            (see 101.00C6a ) for a walker, bilateral canes, or bilateral crutches\n                            (see 101.00C6d ) or a wheeled and seated mobility device involving the use of both hands\n                            (see 101.00C6e(i) ); or 2. An inability to use one upper extremity to independently initiate, sustain,\n                            and complete age-appropriate activities involving fine and gross movements\n                            (see 101.00E4 ), and a documented medical need\n                            (see 101.00C6a ) for a one-handed,\n                            hand-held assistive device (see 101.00C6d )\n                            that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand\n                            (see 101.00C6e(ii) ); or 3. An inability to use both upper extremities to the extent that neither can be used to independently initiate, \n                            sustain, and complete age-appropriate activities involving fine and gross movements (see 101.00E4 ). 101.16 Lumbar spinal stenosis resulting in compromise of the cauda equina (see 101.00G ), documented by A, B, C, and D: A. Symptom(s) of neurological compromise manifested as: 1. Nonradicular distribution of pain in one or both lower extremities; or 2. Nonradicular distribution of sensory loss in one or both lower extremities; or 3. Neurogenic claudication. AND B. Nonradicular neurological signs present during physical examination\n                            (see 101.00C2 ) or on a diagnostic test\n                            (see 101.00C3 ) and evidenced by 1 and either 2 or 3: 1. Muscle weakness. 2. Sensory changes evidenced by: a. Decreased sensation; or b. Sensory nerve deficit (abnormal sensory nerve latency) on electrodiagnostic testing; or c. Areflexia, trophic ulceration, or bladder or bowel incontinence. 3. Decreased deep tendon reflexes in one or both lower extremities. AND C. Findings on imaging (see 101.00C3 ) or in an operative report\n                            (see 101.00C4 ) consistent with compromise of the cauda equina with lumbar spinal stenosis. AND D. Impairment-related physical limitation of musculoskeletal functioning that has lasted, \n                            or is expected to last, for a continuous period of at least 12 months, \n                            and medical documentation of at least one of the following: 1. A documented medical need (see 101.00C6a ) for a walker, \n                            bilateral canes, or bilateral crutches \n                            (see 101.00C6d ) or a wheeled and seated mobility device involving the use of both hands \n                            (see 101.00C6e(i) ); or 2. An inability to use one upper extremity to independently initiate, sustain,\n                            and complete age-appropriate activities involving fine and gross movements\n                            (see 101.00E4 ), and a documented medical need\n                            (see 101.00C6a ) for a one-handed, hand-held assistive device\n                            (see 101.00C6d ) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand\n                            (see 101.00C6e(ii) ). 101.17 Reconstructive surgery or surgical arthrodesis of a major weight-bearing joint (see 101.00H ), documented by A, B, and C: A. History of reconstructive surgery or surgical arthrodesis of a major weight-bearing joint. AND B. Impairment-related physical limitation of musculoskeletal functioning that has lasted, or is expected to last, for a continuous period of at least 12 months. AND C. A documented medical need (see 101.00C6a ) for a walker, \n                            bilateral canes, or bilateral crutches \n                            (see 101.00C6d ) or a wheeled and seated mobility device involving the use of both hands \n                            (see 101.00C6e(i) ). 101.18 Abnormality of a major joint(s) in any extremity (see 101.00I ), documented by A, B, C, and D: A. Chronic joint pain or stiffness. AND B. Abnormal motion, instability, or immobility of the affected joint(s). AND C. Anatomical abnormality of the affected joint(s) noted on: 1. Physical examination (for example, subluxation, contracture, or bony or fibrous ankylosis); or 2. Imaging (for example, joint space narrowing, bony destruction, or ankylosis or arthrodesis of the affected joint). AND D. Impairment-related physical limitation of musculoskeletal functioning that has lasted, \n                            or is expected to last, for a continuous period of at least 12 months, \n                            and medical documentation of at least one of the following: 1. A documented medical need \n                            (see 101.00C6a ) for a walker, bilateral canes, or bilateral crutches \n                            (see 101.00C6d ) or a wheeled and seated mobility device involving the use of both hands \n                            (see 101.00C6e(i) ); or 2. An inability to use one upper extremity to independently initiate, sustain,\n                            and complete age-appropriate activities involving fine and gross movements\n                            (see 101.00E4 ), and a documented medical need (see 101.00C6a ) for a one-handed,\n                            hand-held assistive device\n                            (see 101.00C6d ) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand\n                            (see 101.00C6e(ii) ); or 3. An inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, \n                            and complete age-appropriate activities involving fine and gross movements (see 101.00E4 ). 101.19 Pathologic fractures due to any cause (see 101.00J ), documented by A and B: A. Pathologic fractures occurring on three separate occasions within a 12-month period. AND B. Impairment-related physical limitation of musculoskeletal functioning that has lasted, \n                            or is expected to last, for a continuous period of at least 12 months, \n                            and medical documentation of at least one of the following: 1. A documented medical need (see 101.00C6a ) for a walker,\n                            bilateral canes, or bilateral crutches (see 101.00C6d )\n                            or a wheeled and seated mobility device involving the use of both hands (see 101.00C6e(i) ); or 2. An inability to use one upper extremity to independently initiate, sustain,\n                            and complete age-appropriate activities involving fine and gross movements (see 101.00E4 ), and a documented medical need (see 101.00C6a ) for a one-handed,\n                            hand-held assistive device (see 101.00C6d )\n                            that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand\n                            (see 101.00C6e(ii) ); or 3. An inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, \n                            and complete age-appropriate activities involving fine and gross movements (see 101.00E4 ). 101.20 Amputation due to any cause (see 101.00K ), documented by A, B, C, or D: A. Amputation of both upper extremities, occurring at any level at or above the wrists (carpal joints), up to and including the shoulder (glenohumeral) joint. OR B. Hemipelvectomy or hip disarticulation. OR C. Amputation of one upper extremity, occurring at any level at or above the wrist (carpal joints), \n                            and amputation of one lower extremity, occurring at or above the ankle (talocrural joint), \n                            and medical documentation of at least one of the following: 1. A documented medical need (see 101.00C6a ) for a walker, \n                            bilateral canes, or bilateral crutches (see 101.00C6d ) \n                            or a wheeled and seated mobility device involving the use of both hands \n                            (see 101.00C6e(i) ); or 2. A documented medical need (see 101.00C6a ) for a one-handed, \n                            hand-held assistive device (see 101.00C6d ) requiring the use of the other upper extremity \n                            or a wheeled and seated mobility device involving the use of one hand \n                            (see 101.00C6e(ii) ); or 3. The inability to use the remaining upper extremity to independently initiate, sustain, \n                            and complete age-appropriate activities involving fine and gross movements \n                            ( 101.00E4 ). OR D. Amputation of one or both lower extremities, occurring at or above the ankle (talocrural joint), \n                            with complications of the residual limb(s) that have lasted, or are expected to last, \n                            for a continuous period of at least 12 months, and medical documentation of 1 and 2: 1. The inability to use a prosthesis(es); and 2. A documented medical need (see 101.00C6a ) for a walker, \n                            bilateral canes, or bilateral crutches (see 101.00C6d ) \n                            or a wheeled and seated mobility device involving the use of both hands (see 101.00C6e(i) ). 101.21 Soft tissue injury or abnormality under continuing surgical management (see 101.00L ), documented by A, B, and C: A. Evidence confirms continuing surgical management\n                            (see 101.00P1 ) directed toward saving, reconstructing, or replacing the affected part of the body. AND B. The surgical management has been, or is expected to be, ongoing for a continuous period of at least 12 months. AND C. Maximum benefit from therapy (see 101.00P2 ) has not yet been achieved. 101.22 Non-healing or complex fracture of the femur, tibia, pelvis, or one or more of the talocrural bones (see 101.00M ), documented by A, B, and C: A. Solid union not evident on imaging (see 101.00C3 ) and not clinically solid. AND B. Impairment-related physical limitation of musculoskeletal functioning that has lasted, or is expected to last, for a continuous period of at least 12 months. AND C.  A documented medical need (see 101.00C6a ) for a walker,\n                            bilateral canes, or bilateral crutches (see 101.00C6d )\n                            or a wheeled and seated mobility device involving the use of both hands (see 101.00C6e(i) ). 101.23 Non-healing or complex fracture of an upper extremity (see 101.00N ), documented by A and B: A. Nonunion or complex fracture, of the shaft of the humerus, radius, or ulna, under continuing surgical management \n                            see 101.00P1 ) directed toward restoration of functional use of the extremity. AND B. Medical documentation of an inability to independently initiate, sustain, \n                            and complete age-appropriate activities involving fine and gross movements \n                            (see 101.00E4 ) that has lasted, or is expected to last, for a continuous period of at least 12 months. 101.24 Musculoskeletal disorders of infants and toddlers, from birth to attainment of age 3, with developmental motor delay (see 101.00O ), documented by A or B: A. A standardized developmental motor assessment that: 1. Shows motor development not more than one-half of the level typically expected for the child’s age; or 2. Results in a valid score that is at least three standard deviations below the mean. OR B. Two narrative developmental reports that: 1. Are dated at least 120 days apart; and 2. Indicate current motor development not more than one-half of the level typically expected for the child’s age.",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security101.00 Musculoskeletal Disorders - Childhood"
      }
    ],
    "tables": [
      [
        [
          "Grade",
          "Function of the Muscle"
        ],
        [
          "0",
          "None",
          "No visible or palpable contraction."
        ],
        [
          "1",
          "Trace",
          "Visible or palpable contraction with no motion."
        ],
        [
          "2",
          "Poor",
          "Active ROM with gravity eliminated."
        ],
        [
          "3",
          "Fair",
          "Active ROM against gravity only, without resistance."
        ],
        [
          "4",
          "Good",
          "Active ROM against gravity, moderate resistance."
        ],
        [
          "5",
          "Normal",
          "Active ROM against gravity, maximum resistance."
        ]
      ]
    ],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_01",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_15",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_16",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_17",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_18",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_19",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_22",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_23",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_24",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00B1",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00P1",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_15",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00P1",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00",
      "https://www.ssa.gov/disability/professionals/bluebook/114.00-Immune-Childhood.htm#114_00",
      "https://www.ssa.gov/disability/professionals/bluebook/103.00-Respiratory-Childhood.htm#103_00",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/112.00-MentalDisorders-Childhood.htm#112_00",
      "https://www.ssa.gov/disability/professionals/bluebook/113.00-NeoplasticDiseases-Malignant-Childhood.htm#113_00",
      "https://www.ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm#104_00",
      "https://www.ssa.gov/disability/professionals/bluebook/108.00-Skin-Childhood.htm#108_00",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#Top",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0912.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0913.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0920b.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0929.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0919k.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0919m.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6b",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6c",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6e",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C2b",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C2a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E3b",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E3a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C7c",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C7c",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_15",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_16",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_17",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_18",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20C",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20C",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_22",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_23",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0930.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_15A",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_16A",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_18A",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_15",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_16",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_18",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0929.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20A",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20B",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_24",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_24",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6eii",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_15",
      "https://www.ssa.gov/disability/professionals/bluebook/111.00-Neurological-Childhood.htm#111_00",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_16",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_17",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_18",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_19",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_19",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_22",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_23",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20A",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20A",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0909.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00R",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20A",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20B",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20B",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0909.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20C",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20C",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20D",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20D",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6b",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6e",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00L",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00P1",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00P2",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_15",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_16",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_17",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_18",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_22",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_18",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_23",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00P1",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_18",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_20",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_22",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_23",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_24",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_24",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_24A",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0924b.htm#b",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_24B",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_23",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_21",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00R",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0919a.htm#b",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00R",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0926a.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0994a.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00F",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C2",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00F2",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6eii",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00G",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C2",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6eii",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00H",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00I",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6eii",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00J",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6eii",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00K",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6eii",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00L",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00P1",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00P2",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00M",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C3",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6a",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6d",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00C6ei",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00N",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00P1",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00E4",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm#101_00O",
      "https://www.ssa.gov/disability/professionals/bluebook/101.00-Musculoskeletal-Childhood.htm"
    ],
    "html_file": "ssa_bluebook_data/html/03ae2db3c518a260c6b94460857368f1.html",
    "fetched_at": 1762482881.5017898
  },
  {
    "url": "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm",
    "url_hash": "0161bda829b11dcfc951980e6b3c2768",
    "title": "102.00 Special Senses and Speech - Childhood | Disability | SSA",
    "text_content": "102.00 Special Senses and Speech - Childhood | Disability | SSA Skip to main content Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services. Get a benefit verification letter. Medical/Professional Relations SSA Home Disability Medical/Professional Relations Disability Evaluation Under Social Security Listing of Impairments - Child Listings (Part B) 102.00 Special Senses and Speech - Childhood Adult Listings (Part A) Childhood Listings (Part B) General Information Evidentiary Requirements Listing of Impairments (overview) Revisions to Rules Regarding the Evaluation of Medical Evidence Disability Evaluation Under Social Security 102.00 Special Senses and Speech - Childhood Section 102.01 Category of Impairments, Special Sense Organs 102.02 Loss of Visual Acuity 102.03 Contraction of the visual field in the better eye 102.04 Loss of visual efficiency 102.10 Hearing loss not treated with cochlear implantation 102.11 Hearing loss treated with cochlear implantation 102.00 Special Senses \n            and Speech A. How do we evaluate visual disorders? 1. What are visual disorders? Visual  disorders are abnormalities of the eye, the optic nerve, the optic tracts, or  the brain that may cause a loss of visual acuity or visual fields. A loss of  visual acuity limits your ability to distinguish detail, read, do fine work, or  perform other age-appropriate activities. A loss of visual fields limits your  ability to perceive visual stimuli in the peripheral extent of vision. 2. How  do we define statutory blindness? Statutory blindness is blindness as defined in sections 216(i)(1) and 1614(a)(2) of the Social Security Act (Act). a. The Act defines blindness as central visual acuity of 20/200 or less in the better eye with the use of a correcting lens. \n    We use your best-corrected central visual acuity for  distance in the better eye when we determine if this definition is met. \n    (For visual acuity testing requirements, see 102.00A5 .) b. The Act also provides that an eye that has a visual field limitation such that the widest diameter of the visual field subtends an angle no greater than 20 degrees is considered as having a central visual acuity of 20/200 or less. \n    (For visual field testing  requirements, see 102.00A6 .) c. You have statutory blindness only if your visual disorder meets the criteria of 102.02A , 102.02B , or 102.03A .\n    You do not have statutory blindness if your visual disorder medically equals the criteria of 102.02A , 102.02B , or 102.03A or meets or medically equals the criteria of 102.03B , 102.03C , 102.04A , or 102.04B because your disability is based on criteria other than those in the statutory definition of blindness. Back to Top 3. What evidence do we need to establish statutory blindness under title XVI? To establish that you have statutory blindness under title XVI, \n    we need evidence showing only that your central visual acuity in your better eye or your visual field in your better eye meets the criteria in 102.00A2 , \n    provided that those measurements are  consistent with the other evidence in your case record. We do not need  documentation of the cause of your blindness. \n    Also, there is no duration requirement for statutory blindness under title XVI \n    (see §§ 416.981 and 416.983 of this chapter). 4. What evidence do we need to evaluate visual disorders, including those that result in statutory blindness under title II? To evaluate your visual disorder, we usually need a report of an eye examination that includes measurements of your best-corrected central visual acuity \n    (see 102.00A5 ) or the extent of your visual fields (see 102.00A6 ),\n    as appropriate. If you have visual acuity or visual field loss, we need documentation of the cause of the loss.\n    A standard eye examination will usually indicate the cause of any visual acuity loss. A standard eye examination can also indicate the cause of some types of visual field deficits.\n    Some disorders, such as cortical visual disorders, may result in abnormalities that do not appear on a standard eye examination.\n    If the standard eye examination does not indicate the cause of your vision loss, we will request the information used to establish the presence of your visual disorder.\n    If your visual disorder does not satisfy the criteria in 102.02 , 102.03 , or 102.04 , we will request a description of how your visual disorder affects your ability to function. Back to Top 5. How do we measure best-corrected visual acuity? a. Visual acuity testing. When we need to measure your best-corrected central visual acuity, which is your optimal visual acuity  attainable with the use of a corrective lens, we use visual acuity testing for  distance that was carried out using Snellen methodology or any other testing  methodology that is comparable to Snellen methodology. (i) Your best-corrected central visual acuity for distance is usually measured by determining what you  can see from 20 feet. If your visual acuity is measured for a distance other  than 20 feet, we will convert it to a 20-foot measurement. For example, if your  visual acuity is measured at 10 feet and is reported as 10/40, we will convert  this measurement to 20/80. (ii) A visual acuity recorded as CF (counts fingers), HM (hand motion only), LP or LPO (light perception or light perception only), or NLP (no light perception) indicates  that no optical correction will improve your visual acuity. If your central  visual acuity in an eye is recorded as CF, HM, LP or LPO, or NLP, we will  determine that your best-corrected central visual acuity is 20/200 or less in  that eye. (iii) We will not use the results of pinhole testing or automated refraction acuity to determine your best-corrected central visual acuity. These tests provide an estimate of  potential visual acuity but not an actual measurement of your best-corrected  central visual acuity. (iv) Very young children, such as infants and toddlers, cannot participate in testing using Snellen methodology or other comparable testing. If you are unable to participate in  testing using Snellen methodology or other comparable testing due to your young  age, we will consider clinical findings of your fixation and visual-following  behavior. If both these behaviors are absent, we will consider the anatomical  findings or the results of neuroimaging, electroretinogram, or visual evoked  response (VER) testing when this testing has been performed. Back to Top b. Other test charts. (i) Children between the  ages of 3 and 5 often cannot identify the letters on a Snellen or other letter  test chart. Specialists with expertise in assessment of childhood vision use  alternate methods for measuring visual acuity in young children. We consider  alternate methods, for example, the Landolt C test or the tumbling-E test,  which are used to evaluate young children who are unable to participate in  testing using Snellen methodology, to be comparable to testing using Snellen methodology. (ii) Most test charts that use Snellen methodology do not have lines that measure visual acuity  between 20/100 and 20/200. Some test charts, such as the Bailey-Lovie or the  Early Treatment Diabetic Retinopathy Study (ETDRS), used mostly in research  settings, have such lines. If your visual acuity is measured with one of these  charts, and you cannot read any of the letters on the 20/100 line, we will  determine that you have statutory blindness based on a visual acuity of 20/200  or less. For example, if your best-corrected central visual acuity for distance  in the better eye is 20/160 using an ETDRS chart, we will find that you have  statutory blindness. Regardless of the type of test chart used, you do not have  statutory blindness if you can read at least one letter on the 20/100 line. For  example, if your best-corrected central visual acuity for distance in the  better eye is 20/125+1 using an ETDRS chart, we will find that you do not have  statutory blindness because you are able to read one letter on the 20/100 line. c. Testing using a specialized lens. In some instances, you may perform visual acuity testing using a specialized lens, such  as a contact lens. We will use the visual acuity measurements obtained with a  specialized lens only if you have demonstrated the ability to use the  specialized lens on a sustained basis. We will not use visual acuity  measurements obtained with telescopic lenses. d. Cycloplegic refraction is an examination of the eye performed after  administering cycloplegic eye drops capable of relaxing the ability of the  pupil to become smaller and temporarily paralyzing the focusing muscles. If  your case record contains the results of cycloplegic refraction, we may use the  results to determine your best-corrected central visual acuity. We will not  purchase cycloplegic refraction. e. VER testing measures your response to visual events and can often detect dysfunction that is undetectable through other types of examinations. \n    If  you have an absent response to VER testing in your better eye, \n    we will determine that your best-corrected central visual acuity is 20/200 or \n    less in that eye and that your visual acuity loss satisfies the criterion in 102.02A or 102.02B4 , as appropriate, when these test results are consistent with the other evidence in your case record. \n    If you have a positive response to VER testing in an eye, we will not use that result to determine your best-corrected central visual acuity in that eye. Back to Top 6. How do we measure visual fields? a. General. We generally need visual field testing when you have a visual disorder that could result in visual field loss, \n    such as glaucoma, retinitis pigmentosa, or optic neuropathy, or when you  display behaviors that suggest a visual field loss. \n    When we need to measure the extent of your visual field loss, we use visual field testing (also referred to as perimetry) \n    carried out using automated static threshold perimetry performed on an acceptable perimeter. \n    (For perimeter requirements, see 102.00A9 .) b. Automated static threshold perimetry requirements. (i) The test must use a white size III Goldmann stimulus and a 31.5 apostilb (asb) white background (or a 10 candela per square meter (cd/m 2 ) white background). The stimuli  test locations must be no more than 6 degrees apart horizontally or vertically.  Measurements must be reported on standard charts and include a description of  the size and intensity of the test stimulus. (ii) We measure the extent of your visual field loss by determining the portion of the visual field  in which you can see a white III4e stimulus. The \"III\" refers to the  standard Goldmann test stimulus size III (4 mm 2 ), and the  \"4e\" refers to the standard Goldmann intensity filter (0 decibel (dB)  attenuation, which allows presentation of the maximum luminance) used to  determine the intensity of the stimulus. (iii) In automated static threshold perimetry, the intensity of the stimulus varies. The intensity of the  stimulus is expressed in decibels (dB). A perimeter's maximum stimulus  luminance is usually assigned the value 0 dB. We need to determine the dB level  that corresponds to a 4e intensity for the particular perimeter being used. We  will then use the dB printout to determine which points you see at a 4e  intensity level (a \"seeing point\"). For example: A. When the maximum stimulus luminance (0 dB stimulus) on an acceptable perimeter is 10,000  asb, a 10 dB stimulus is equivalent to a 4e stimulus. Any point you see at 10  dB or greater is a seeing point. B. When the maximum stimulus luminance (0 dB stimulus) on an acceptable perimeter is 4,000  asb, a 6 dB stimulus is equivalent to a 4e stimulus. Any point you see at 6 dB  or greater is a seeing point. C. When the maximum stimulus luminance (0 dB stimulus) on an acceptable perimeter is 1,000  asb, a 0 dB stimulus is equivalent to a 4e stimulus. Any point you see at 0 dB  or greater is a seeing point. c. Evaluation under 102.03A . To determine statutory blindness based on  visual field loss in your better eye ( 102.03A ),\n    we need the results of a visual  field test that measures the central 24 to 30 degrees of your visual field;\n    that is, the area measuring 24 to 30 degrees from the point of fixation.\n    Acceptable tests include the Humphrey Field Analyzer (HFA) 30–2, HFA 24–2, and  Octopus 32. d. Evaluation under 102.03B . To determine whether your visual field loss meets listing 102.03B , \n    we use the mean deviation or defect (MD) from  acceptable automated static threshold perimetry that measures the central 30  degrees of the visual field. \n    MD is the average sensitivity deviation from  normal values for all measured visual field locations. When using results from  HFA tests, \n    which report the MD as a negative number, we use the absolute value  of the MD to determine whether your visual field loss meets listing 102.03B .\n    We cannot use tests that do not measure the central 30 degrees of the visual  field, such as the HFA 24–2,\n    to determine if your impairment meets or medically equals 102.03B . e. Other types of perimetry. If your case record contains visual field  measurements obtained using manual or automated kinetic perimetry, \n    such as Goldmann perimetry or the HFA \"SSA Test Kinetic,\" we can generally use these results if the kinetic test was performed using a white III4e stimulus projected on a white 31.5 asb \n    (10 cd/m 2 ) background.  Automated kinetic perimetry, such as the HFA \"SSA Test Kinetic,\" does not detect limitations in the central visual field because testing along a \n    meridian stops when you see the stimulus. If your visual disorder has progressed to the point at which it is likely to result in a significant limitation in the central visual field, \n    such as a scotoma (see 102.00A6h ), we will not use automated kinetic perimetry to determine the extent of your visual field loss.\n    Instead, we will determine the extent of your visual field loss using automated static threshold  perimetry or manual kinetic perimetry. f. Screening tests. We will not use the results of visual field screening tests, such as confrontation tests, tangent screen tests, \n    or automated static screening tests, to determine that your  impairment meets or medically equals a listing, or functionally equals the listings. \n    We can consider normal results from visual field screening tests to  determine whether your visual disorder is severe when these test results are consistent with the other evidence in your case record. \n    (See §416.924(c) of  this chapter.)\n    We will not consider normal test results to be consistent with the other evidence if the clinical findings indicate that your visual disorder has progressed\n    to the point that it is likely to cause visual field loss, or you have a history of an operative procedure for retinal detachment. g. Use of corrective lenses . You must not wear eyeglasses during visual field testing because they limit your field of vision.  You may wear contact lenses to correct your visual acuity during the visual  field test to obtain the most accurate visual field measurements. For this  single purpose, you do not need to demonstrate that you have the ability to use  the contact lenses on a sustained basis. h. Scotoma. A scotoma is a field defect or non-seeing area (also  referred to as a “blind spot”) in the visual field surrounded by a normal field  or seeing area. When we measure your visual field, we subtract the length of  any scotoma, other than the normal blind spot, from the overall length of any  diameter on which it falls. Back to Top 7. How do we determine your visual acuity efficiency, visual field efficiency, and visual efficiency? a. General. Visual efficiency ,  a calculated value of your remaining visual function, is the combination of  your visual acuity efficiency and  your visual field efficiency expressed as a percentage. b. Visual acuity  efficiency. Visual acuity  efficiency is a percentage that corresponds to the best-corrected central  visual acuity for distance in your better eye. See Table 1. Table 1 - Visual Acuity  Efficiency Snellen best-corrected central visual acuity for    distance Visual acuity efficiency (%) (102.04A) English Metric 20/16 6/5 100 20/20 6/6 100 20/25 6/7.5 95 20/30 6/9 90 20/40 6/12 85 20/50 6/15 75 20/60 6/18 70 20/70 6/21 65 20/80 6/24 60 20/100 6/30 50 c. Visual field  efficiency. Visual field  efficiency is a percentage that corresponds to the visual field in your better  eye. Under 102.03C, we require kinetic perimetry to determine your visual field  efficiency percentage. We calculate the visual field efficiency  percentage by adding the number of degrees you see along the eight principal  meridians found on a visual field chart (0, 45, 90, 135, 180, 225, 270, and  315) in your better eye and dividing by 5. For example, in Figure 1: A. The diagram  of the left eye illustrates a visual field, as measured with a III4e stimulus,  contracted to 30 degrees in two meridians (180 and 225) and to 20 degrees in  the remaining six meridians. The visual efficiency percentage of this field is:  (( 2 x 30) + (6 x 20)) / 5 = 36 percent. B. The diagram  of the right eye illustrates the extent of a normal visual field as measured  with a III4e stimulus. The sum of the eight principal meridians of this field  is 500 degrees. The visual efficiency percentage of this field is 500 / 5 =  100 percent. Figure 1: d. Visual efficiency. Under 102.04A , we calculate the  visual efficiency percentage by multiplying your visual acuity efficiency percentage\n    (see 102.00A7b ) by your visual field efficiency percentage (see 102.00A7c ) and dividing by 100.\n    For example, if your visual acuity efficiency percentage is 75 and your visual field efficiency percentage is 36,\n    your visual efficiency percentage is: (75 x 36) / 100 = 27 percent. 8. How do we determine your visual acuity impairment value, visual field impairment value, and visual impairment value? a. General. Visual impairment value , a calculated value of your loss of visual function, is the combination of your visual acuity impairment value and your visual  field impairment value . b. Visual acuity  impairment value. Your visual acuity impairment value corresponds to the  best-corrected central visual acuity for distance in your better eye. See Table  2. Back to Top Table 2 - Visual Acuity  Impairment Value Snellen best-corrected central visual acuity for    distance Visual acuity impairment value (102.04B) English Metric 20/16 6/5 0.00 20/20 6/6 0.00 20/25 6/7.5 0.10 20/30 6/9 0.18 20/40 6/12 0.30 20/50 6/15 0.40 20/60 6/18 0.48 20/70 6/21 0.54 20/80 6/24 0.60 20/100 6/30 0.70 c. Visual field  impairment value. Your visual  field impairment value corresponds to the visual field in your better eye. Using  the MD from acceptable automated static threshold perimetry, we calculate the  visual field impairment value by dividing the absolute value of the MD by 22.  For example, if your MD on an HFA 30-2 is -16, your visual field impairment  value is: |-16| / 22 = 0.73. d. Visual impairment value. Under 102.04B , we calculate the visual impairment value by adding your visual acuity impairment value\n    (see 102.00A8b ) and your visual field  impairment value (see 102.00A8c ).\n    For example, if your visual acuity impairment value is 0.48 and your visual field impairment value is 0.73,\n    your visual impairment value is: 0.48 + 0.73 = 1.21. 9. What  are our requirements for an acceptable perimeter? We will use results from automated static threshold perimetry performed on a perimeter that: a.  Uses optical projection to generate the test stimuli. b.  Has an internal normative database for  automatically comparing your performance with that of the general population. c.  Has a statistical analysis package that is able to calculate visual field indices, particularly mean deviation or mean defect. d.  Demonstrates the ability to correctly detect visual field loss and correctly identify normal visual fields. e.  Demonstrates good test-retest reliability. f.  Has undergone clinical validation studies by three  or more independent laboratories with results published in peer-reviewed  ophthalmic journals. Back to Top B. How do we evaluate hearing loss? 1. What evidence do we need? a. We need evidence showing that you have a medically determinable impairment that causes your hearing loss and audiometric measurements of the severity of your hearing loss. We generally require  both an otologic examination and audiometric testing to establish that you have  a medically determinable impairment that causes your hearing loss. You should  have this audiometric testing within 2 months of the otologic examination. Once  we have evidence that you have a medically determinable impairment, we can use  the results of later audiometric testing to assess the severity of your hearing  loss without another otologic examination. We will consider your test scores together with any other relevant information we have about your hearing, including information from outside of the test setting. b. The otologic  examination must be performed by a licensed physician (medical or osteopathic  doctor) or audiologist. It must include your medical history, your description  of how your hearing loss affects you, and the physician’s or audiologist’s  description of the appearance of the external ears (pinnae and external ear  canals), evaluation of the tympanic membranes, and assessment of any middle ear  abnormalities. c. Audiometric testing  must be performed by, or under the direct supervision of, a licensed  audiologist or an otolaryngologist. Back to Top 2. What audiometric testing do we need when you do not have a cochlear implant? a. General. We need either physiologic or behavioral testing (other than screening testing, see 102.00B2g ) that is appropriate for your age at the time of testing.\n    See 102.00B2c - 102.00B2f .\n    We will make every reasonable effort to obtain the results of physiologic testing that has been done; however, we will not purchase such testing. b. Testing requirements. The testing must be conducted in accordance with the most recently published standards of the American National Standards Institute (ANSI). \n    You must not wear hearing aids during the testing. \n    Additionally, a person described in 102.00B1c must perform an otoscopic examination immediately before the audiometric testing.\n    (An otoscopic examination provides a description of the appearance of your external ear canals and an evaluation of the tympanic membranes.\n    In these rules, we use the term to include otoscopic examinations performed by physicians and otoscopic inspections performed by audiologists and others.)\n    The otoscopic examination must show that there are no conditions that would prevent valid audiometric testing, such as fluid in the ear, ear infection, or obstruction in an ear canal.\n    The person performing the test should also report on any other factors, such as your ability to maintain attention, that can affect the interpretation of the test results. c. Children from birth to the attainment of age 6 months. (i) We need physiologic testing, such as auditory brainstem response (ABR) testing. (ii) To determine whether your hearing loss meets 102.10A , \n    we will average your hearing thresholds at 500, 1000, 2000, and 4000 Hertz (Hz). \n    If you do not have a response at a particular frequency, \n    we will use a threshold of 5 decibels (dB) over the limit of the audiometer. d. Children from age 6 months to the attainment of age 2. (i) We need air conduction thresholds determined by a behavioral assessment, usually visual reinforcement audiometry (VRA). We can use ABR testing if the behavioral assessment cannot be completed or if the results are inconclusive or unreliable. (ii) To determine whether your hearing loss meets 102.10A , \n    we will average your hearing thresholds at 500, 1000, 2000, and 4000 Hz. \n    If you do not have a response at a particular frequency, we will use a threshold of 5 dB over the limit of the audiometer. (iii) For this age group, behavioral assessments are often performed in a sound field, and each ear is not tested separately. \n    If each ear is not tested separately, we will consider the test results to represent the hearing in the better ear. e. Children from age 2 to the attainment of age 5. Back to Top (i) We need air conduction thresholds determined by a behavioral assessment, such as conditioned play audiometry (CPA), tangible or visually reinforced operant conditioning audiometry (TROCA, VROCA), or VRA. If you have had ABR testing, we can use the results of that testing if the behavioral assessment cannot be completed or the results are inconclusive or unreliable. (ii) To determine whether your hearing loss meets 102.10A , \n    we will average your hearing thresholds at 500, 1000, 2000, and 4000 Hz. \n    If you do not have a response at a particular frequency, we will use a threshold of 5 dB over the limit of the audiometer. (iii) For this age group, behavioral assessments are often performed in a sound field and each ear is not tested separately. If each ear is not tested separately, we will consider the test results to represent the hearing in the better ear. f. Children from age 5 to the attainment of age 18. (i) We generally need pure tone air conduction and bone conduction testing, speech reception threshold (SRT) testing (also referred to as \"spondee threshold'' or \"ST'' testing), and word recognition testing (also referred to as \"word discrimination'' or \"speech discrimination'' testing). This testing must be conducted in a sound-treated booth or room and must be in accordance with the most recently published ANSI standards. Each ear must be tested separately. (ii) To determine whether your hearing loss meets the air and bone \n    conduction criterion in 102.10B1 or 102.10B3 ,\n    we will average your hearing thresholds at 500, 1000, 2000, and 4000 Hz.\n    If you do not have a response at a particular frequency, we will use a threshold of 5 dB over the limit of the audiometer. (iii) The SRT is the minimum dB level required for you to recognize 50 percent of the words on a standard list of spondee words. (Spondee words are two-syllable words that have equal stress on each syllable.) The SRT is usually within 10 dB of the average pure tone air conduction hearing thresholds at 500, 1000, and 2000 Hz. If the SRT is not within 10 dB of the average pure tone air conduction threshold, the reason for the discrepancy must be documented. If we cannot determine that there is a medical basis for the discrepancy, we will not use the results of the testing to determine whether your hearing loss meets a listing. (iv) Word recognition testing determines your ability to recognize an age-appropriate, standardized list of phonetically balanced monosyllabic words in the absence of any visual cues. This testing must be performed in quiet. The list may be recorded or presented live, but in either case, the words should be presented at a level of amplification that will measure your maximum ability to discriminate words, usually 35 to 40 dB above your SRT. However, the amplification level used in the testing must be medically appropriate, and you must be able to tolerate it. If you cannot be tested at 35 to 40 dB above your SRT, the person who performs the test should report your word recognition testing score at your highest comfortable level of amplification. >g. Screening testing. Physiologic testing, such as ABR and otoacoustic emissions (OAE), \n    and pure tone testing can be used as hearing screening tests. \n    We will not use these tests to determine that your hearing loss meets or medically equals a listing, or to assess functional limitations due to your hearing loss, when they are used only as screening tests. \n    We can consider normal results from hearing screening tests to determine that your hearing loss is not \"severe'' when these test results are consistent with the other evidence in your case record. \n    See Sec. 416.924(c) . 3. What audiometric testing do we need when you have a cochlear implant? a. If you have a cochlear implant, we will consider you to be disabled until age 5, or for 1 year after initial implantation, whichever is later. b. After that period, we need word recognition testing performed with any age-appropriate version of the Hearing in Noise Test \n    (HINT) or the Hearing in Noise Test for Children (HINT-C) to determine whether your impairment meets 102.11B .\n    This testing must be conducted in quiet in a sound field. Your implant must be functioning properly and adjusted to your normal settings. The sentences should be presented at 60 dB HL (Hearing Level) and without any visual cues. 4. How do we evaluate your word recognition ability if you are not fluent in English? If you are not fluent in English, you should have word recognition testing using an appropriate word list for the language in which you are most fluent. \n    The person conducting the test should be fluent in the language used for the test. If there is no appropriate word list or no person who is fluent in the language and qualified to perform the test, \n    it may not be possible to measure your word recognition ability. If your word recognition ability cannot be measured, \n    your hearing loss cannot meet 102.10B2 or 102.11B .\n    Instead, we will consider the facts of your case to determine whether you have difficulty understanding words in the language in which you are most fluent,\n    and if so, whether that degree of difficulty medically equals 102.10B2 or 102.11B .\n    For example, we will consider how you interact with family members, interpreters,\n    and other persons who speak the language in which you are most fluent. 5. What do we mean by a marked limitation in speech or language as used in 102.10B3 ? a. We will consider you to have a marked limitation in speech if: (i) Entire phrases or sentences in your conversation are intelligible to unfamiliar listeners at least 50 percent (half) of the time but no more than 67 percent (two-thirds) of the time on your first attempt; and (ii) Your sound production or phonological patterns (the ways in which you combine speech sounds) are atypical for your age. b. We will consider you to have a marked limitation in language when your current and valid test score on an appropriate comprehensive, \n    standardized test of overall language functioning is at least two standard deviations below the mean. \n    In addition, the evidence of your daily communication functioning must be consistent with your test score. If you are not fluent in English, it may not be possible to test your language performance. \n    If we cannot test your language performance, your hearing loss cannot meet 102.10B3 .\n    Instead, we will consider the facts of your case to determine whether your hearing loss medically equals 102.10B3 . 102.01 Category of Impairments, Special Senses and Speech 102.02 Loss of central visual acuity. A. Remaining vision in the better eye after best correction is 20/200 or less. OR B. An inability to participate in visual acuity  testing using Snellen methodology or other comparable testing, clinical findings that fixation and visual-following behavior are absent in the better  eye, and one of the following: 1. Abnormal anatomical findings indicating a visual acuity of 20/200 or less in the better eye (such as the presence of Stage III or worse retinopathy of prematurity despite  surgery, hypoplasia of the optic nerve, albinism with macular aplasia, or  bilateral optic atrophy); or 2. Abnormal neuroimaging documenting damage to the cerebral cortex which would be expected to prevent the development of a visual acuity better than 20/200 in the better eye (such  as neuroimaging showing bilateral encephalomyelitis or bilateral  encephalomalacia); or 3. Abnormal electroretinogram documenting the presence of Leber’s congenital amaurosis or achromatopsia in the better eye; or 4. An absent response to VER testing in the better eye. 102.03 Contraction of the visual field in the better eye, with: A. The widest diameter subtending an angle around the point of fixation no greater than 20 degrees. OR B. An MD of 22 decibels or greater, determined by automated static threshold perimetry that measures the central 30 degrees of the visual field \n            (see 102.00A6d ). OR C. A visual field efficiency of 20 percent or less,  determined by kinetic perimetry \n    (see 102.00A7c ). 102.04 Loss ofvisual efficiency, or visual impairment, in the better eye : A. A visual efficiency percentage of 20 or less after best correction (see 102.00A7d ). OR B. A visual impairment value of 1.00 or greater after best correction (see 102.00A8d ). 102.10 Hearing loss not treated with cochlear implantation. A. For children from birth to the attainment of age 5, \n    an average air conduction hearing threshold of 50 decibels or greater in the better ear (see 102.00B2 ). OR B . For children from age 5 to the attainment of age 18: 1. An average air conduction hearing threshold of 70 decibels or greater in the better ear and an average bone conduction hearing threshold of \n    40 decibels or greater in the better ear (see 102.00B2f ); or 2. A word recognition score of 40 percent or less in the better ear determined using a standardized list of phonetically balanced monosyllabic words \n    (see 102.00B2f ); or 3. An average air conduction hearing threshold of 50 decibels or greater in the better ear and a marked limitation in speech or language \n    (see 102.00B2f and 102.00B5 ). 102.11 Hearing loss treated with cochlear implantation. A. Consider under a disability until the attainment of age 5 or for 1 year after initial implantation, whichever is later. OR B. Upon the attainment of age 5 or 1 year after initial implantation, whichever is later, \n    a word recognition score of 60 percent or less determined using the HINT or the HINT-C (see 102.00B3b ). Back to Top",
    "headings": [
      {
        "level": 2,
        "text": "Medical/Professional Relations"
      },
      {
        "level": 2,
        "text": "Disability Evaluation Under Social Security102.00 Special Senses and Speech - Childhood"
      }
    ],
    "tables": [
      [
        [
          "Snellen best-corrected central visual acuity for    distance",
          "Visual acuity efficiency (%)(102.04A)"
        ],
        [
          "English",
          "Metric"
        ],
        [
          "20/16",
          "6/5",
          "100"
        ],
        [
          "20/20",
          "6/6",
          "100"
        ],
        [
          "20/25",
          "6/7.5",
          "95"
        ],
        [
          "20/30",
          "6/9",
          "90"
        ],
        [
          "20/40",
          "6/12",
          "85"
        ],
        [
          "20/50",
          "6/15",
          "75"
        ],
        [
          "20/60",
          "6/18",
          "70"
        ],
        [
          "20/70",
          "6/21",
          "65"
        ],
        [
          "20/80",
          "6/24",
          "60"
        ],
        [
          "20/100",
          "6/30",
          "50"
        ]
      ],
      [
        [
          "Snellen best-corrected central visual acuity for    distance",
          "Visual acuity impairment value(102.04B)"
        ],
        [
          "English",
          "Metric"
        ],
        [
          "20/16",
          "6/5",
          "0.00"
        ],
        [
          "20/20",
          "6/6",
          "0.00"
        ],
        [
          "20/25",
          "6/7.5",
          "0.10"
        ],
        [
          "20/30",
          "6/9",
          "0.18"
        ],
        [
          "20/40",
          "6/12",
          "0.30"
        ],
        [
          "20/50",
          "6/15",
          "0.40"
        ],
        [
          "20/60",
          "6/18",
          "0.48"
        ],
        [
          "20/70",
          "6/21",
          "0.54"
        ],
        [
          "20/80",
          "6/24",
          "0.60"
        ],
        [
          "20/100",
          "6/30",
          "0.70"
        ]
      ]
    ],
    "links": [
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#content",
      "https://www.ssa.gov/myaccount/",
      "https://www.ssa.gov/manage-benefits/get-benefit-letter",
      "https://www.ssa.gov",
      "https://www.ssa.gov/disability",
      "https://www.ssa.gov/disability/professionals/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/index.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/AdultListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/ChildhoodListings.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/general-info.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/evidentiary.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/listing-impairments.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/revisions-rules.html",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_01",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_02",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_03",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_04",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_10",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_10",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_11",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00A5",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00A6",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_02A",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_02B",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_03A",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_02A",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_02B",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_03A",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_03B",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_03C",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_04A",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_04B",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00A2",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0981.htm",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0983.htm",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00A5",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00A6",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_02",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_03",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_04",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_02A",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_02B4",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00A9",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_03A",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_03A",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_03B",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_03B",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_03B",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_03B",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00A6h",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0924.htm#c",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_04A",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00A7b",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00A7c",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_04B",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00A8b",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00A8c",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00B2g",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00B2c",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00B2f",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00B1c",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_10A",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_10A",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_10A",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_10B1",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_10B3",
      "https://www.ssa.gov/OP_Home/cfr20/416/416-0924.htm#c",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_11B",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_10B2",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_11B",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_10B2",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_11B",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_10B3",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_10B3",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_10B3",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00A6d",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00A7c",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00A7d",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00A8d",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00B2",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00B2f",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00B2f",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00B2f",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00B5",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#102_00B3b",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm#Top",
      "https://www.ssa.gov/disability/professionals/bluebook/102.00-SpecialSensesandSpeech-Childhood.htm"
    ],
    "html_file": "ssa_bluebook_data/html/0161bda829b11dcfc951980e6b3c2768.html",
    "fetched_at": 1762482962.8399155
  }
]